CZ2003154A3 - Antigeny streptokoka - Google Patents
Antigeny streptokoka Download PDFInfo
- Publication number
- CZ2003154A3 CZ2003154A3 CZ2003154A CZ2003154A CZ2003154A3 CZ 2003154 A3 CZ2003154 A3 CZ 2003154A3 CZ 2003154 A CZ2003154 A CZ 2003154A CZ 2003154 A CZ2003154 A CZ 2003154A CZ 2003154 A3 CZ2003154 A3 CZ 2003154A3
- Authority
- CZ
- Czechia
- Prior art keywords
- polypeptide
- bvh
- polynucleotide
- sequence
- new
- Prior art date
Links
- 108091007433 antigens Proteins 0.000 title abstract description 21
- 102000036639 antigens Human genes 0.000 title abstract description 21
- 241000194017 Streptococcus Species 0.000 title abstract description 12
- 239000000427 antigen Substances 0.000 title description 19
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 254
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 246
- 229920001184 polypeptide Polymers 0.000 claims abstract description 244
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 89
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 89
- 239000002157 polynucleotide Substances 0.000 claims abstract description 89
- 229960005486 vaccine Drugs 0.000 claims abstract description 20
- 241001465754 Metazoa Species 0.000 claims abstract description 13
- 238000011321 prophylaxis Methods 0.000 claims abstract description 8
- 208000035143 Bacterial infection Diseases 0.000 claims abstract 4
- 208000022362 bacterial infectious disease Diseases 0.000 claims abstract 4
- 239000012634 fragment Substances 0.000 claims description 77
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 37
- 239000013598 vector Substances 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 19
- 206010061372 Streptococcal infection Diseases 0.000 claims description 18
- 230000014509 gene expression Effects 0.000 claims description 16
- 230000027455 binding Effects 0.000 claims description 14
- 230000000295 complement effect Effects 0.000 claims description 10
- 239000002671 adjuvant Substances 0.000 claims description 9
- 238000011282 treatment Methods 0.000 claims description 9
- 230000003248 secreting effect Effects 0.000 claims description 8
- 206010035664 Pneumonia Diseases 0.000 claims description 7
- 241000282414 Homo sapiens Species 0.000 claims description 6
- 208000031729 Bacteremia Diseases 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 4
- 201000009906 Meningitis Diseases 0.000 claims description 3
- 206010033078 Otitis media Diseases 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 241000187654 Nocardia Species 0.000 claims description 2
- 241000191967 Staphylococcus aureus Species 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims 6
- 230000000069 prophylactic effect Effects 0.000 claims 4
- 241000193996 Streptococcus pyogenes Species 0.000 claims 1
- 229940076156 streptococcus pyogenes Drugs 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 abstract description 23
- 238000003556 assay Methods 0.000 abstract description 3
- 238000010188 recombinant method Methods 0.000 abstract description 2
- 238000002560 therapeutic procedure Methods 0.000 abstract description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 236
- 108020004414 DNA Proteins 0.000 description 182
- 108090000623 proteins and genes Proteins 0.000 description 144
- 108010038633 aspartylglutamate Proteins 0.000 description 81
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 71
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 71
- 108010049041 glutamylalanine Proteins 0.000 description 67
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 54
- 238000002649 immunization Methods 0.000 description 50
- 230000003053 immunization Effects 0.000 description 50
- LKDIBBOKUAASNP-FXQIFTODSA-N Glu-Ala-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LKDIBBOKUAASNP-FXQIFTODSA-N 0.000 description 48
- 239000000047 product Substances 0.000 description 48
- WUXCHQZLUHBSDJ-LKXGYXEUSA-N Ser-Thr-Asp Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(O)=O)C(O)=O WUXCHQZLUHBSDJ-LKXGYXEUSA-N 0.000 description 46
- 150000001413 amino acids Chemical class 0.000 description 44
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 43
- 102000004169 proteins and genes Human genes 0.000 description 41
- 108010050848 glycylleucine Proteins 0.000 description 39
- BCYGDJXHAGZNPQ-DCAQKATOSA-N Glu-Lys-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O BCYGDJXHAGZNPQ-DCAQKATOSA-N 0.000 description 34
- PGUYEUCYVNZGGV-QWRGUYRKSA-N Asp-Gly-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PGUYEUCYVNZGGV-QWRGUYRKSA-N 0.000 description 32
- 241000699670 Mus sp. Species 0.000 description 32
- 239000013615 primer Substances 0.000 description 32
- 108010063431 methionyl-aspartyl-glycine Proteins 0.000 description 31
- DWBZEJHQQIURML-IMJSIDKUSA-N Asp-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O DWBZEJHQQIURML-IMJSIDKUSA-N 0.000 description 30
- FPQMQEOVSKMVMA-ACRUOGEOSA-N Lys-Tyr-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)NC(=O)[C@H](CCCCN)N)O FPQMQEOVSKMVMA-ACRUOGEOSA-N 0.000 description 30
- 108010092854 aspartyllysine Proteins 0.000 description 30
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 30
- 108010034529 leucyl-lysine Proteins 0.000 description 30
- 108010051110 tyrosyl-lysine Proteins 0.000 description 30
- UHVIQGKBMXEVGN-WDSKDSINSA-N Glu-Gly-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O UHVIQGKBMXEVGN-WDSKDSINSA-N 0.000 description 29
- OLIFSFOFKGKIRH-WUJLRWPWSA-N Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CN OLIFSFOFKGKIRH-WUJLRWPWSA-N 0.000 description 29
- GVNNAHIRSDRIII-AJNGGQMLSA-N Ile-Lys-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N GVNNAHIRSDRIII-AJNGGQMLSA-N 0.000 description 29
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 29
- 108010089804 glycyl-threonine Proteins 0.000 description 29
- 108010064235 lysylglycine Proteins 0.000 description 29
- BBBXWRGITSUJPB-YUMQZZPRSA-N Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O BBBXWRGITSUJPB-YUMQZZPRSA-N 0.000 description 28
- NNKLKUUGESXCBS-KBPBESRZSA-N Lys-Gly-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NNKLKUUGESXCBS-KBPBESRZSA-N 0.000 description 28
- ALGGDNMLQNFVIZ-SRVKXCTJSA-N Lys-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N ALGGDNMLQNFVIZ-SRVKXCTJSA-N 0.000 description 28
- MIJWOJAXARLEHA-WDSKDSINSA-N Ser-Gly-Glu Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O MIJWOJAXARLEHA-WDSKDSINSA-N 0.000 description 28
- YUJLIIRMIAGMCQ-CIUDSAMLSA-N Ser-Leu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YUJLIIRMIAGMCQ-CIUDSAMLSA-N 0.000 description 28
- 108010005233 alanylglutamic acid Proteins 0.000 description 28
- VNXQRBXEQXLERQ-CIUDSAMLSA-N Asp-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N VNXQRBXEQXLERQ-CIUDSAMLSA-N 0.000 description 27
- 108010050475 glycyl-leucyl-tyrosine Proteins 0.000 description 27
- TUTIHHSZKFBMHM-WHFBIAKZSA-N Glu-Asn Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O TUTIHHSZKFBMHM-WHFBIAKZSA-N 0.000 description 26
- 108010047495 alanylglycine Proteins 0.000 description 26
- UJGRZQYSNYTCAX-SRVKXCTJSA-N Asp-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UJGRZQYSNYTCAX-SRVKXCTJSA-N 0.000 description 25
- QSFHZPQUAAQHAQ-CIUDSAMLSA-N Asp-Ser-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O QSFHZPQUAAQHAQ-CIUDSAMLSA-N 0.000 description 25
- YKNBJXOJTURHCU-DCAQKATOSA-N Leu-Asp-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YKNBJXOJTURHCU-DCAQKATOSA-N 0.000 description 25
- HQVDJTYKCMIWJP-YUMQZZPRSA-N Lys-Asn-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O HQVDJTYKCMIWJP-YUMQZZPRSA-N 0.000 description 25
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 25
- YIUWWXVTYLANCJ-NAKRPEOUSA-N Ser-Ile-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O YIUWWXVTYLANCJ-NAKRPEOUSA-N 0.000 description 25
- UDQBCBUXAQIZAK-GLLZPBPUSA-N Thr-Glu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UDQBCBUXAQIZAK-GLLZPBPUSA-N 0.000 description 25
- AYHSJESDFKREAR-KKUMJFAQSA-N Tyr-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AYHSJESDFKREAR-KKUMJFAQSA-N 0.000 description 25
- 239000013612 plasmid Substances 0.000 description 25
- 108010048818 seryl-histidine Proteins 0.000 description 25
- RDDSZZJOKDVPAE-ACZMJKKPSA-N Glu-Asn-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RDDSZZJOKDVPAE-ACZMJKKPSA-N 0.000 description 24
- KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 24
- MRWYPDWDZSLWJM-ACZMJKKPSA-N Glu-Ser-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O MRWYPDWDZSLWJM-ACZMJKKPSA-N 0.000 description 24
- MFVQGXGQRIXBPK-WDSKDSINSA-N Gly-Ala-Glu Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFVQGXGQRIXBPK-WDSKDSINSA-N 0.000 description 24
- IIWQTXMUALXGOV-PCBIJLKTSA-N Ile-Phe-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)O)C(=O)O)N IIWQTXMUALXGOV-PCBIJLKTSA-N 0.000 description 24
- LXKNSJLSGPNHSK-KKUMJFAQSA-N Leu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N LXKNSJLSGPNHSK-KKUMJFAQSA-N 0.000 description 24
- HEUVHBXOVZONPU-BJDJZHNGSA-N Ser-Leu-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HEUVHBXOVZONPU-BJDJZHNGSA-N 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 24
- SSZGOKWBHLOCHK-DCAQKATOSA-N Arg-Lys-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N SSZGOKWBHLOCHK-DCAQKATOSA-N 0.000 description 23
- JJKKWYQVHRUSDG-GUBZILKMSA-N Glu-Ala-Lys Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O JJKKWYQVHRUSDG-GUBZILKMSA-N 0.000 description 23
- FMNHBTKMRFVGRO-FOHZUACHSA-N Gly-Asn-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CN FMNHBTKMRFVGRO-FOHZUACHSA-N 0.000 description 23
- CVFOYJJOZYYEPE-KBPBESRZSA-N Gly-Lys-Tyr Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CVFOYJJOZYYEPE-KBPBESRZSA-N 0.000 description 23
- DGTOKVBDZXJHNZ-WZLNRYEVSA-N Ile-Thr-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N DGTOKVBDZXJHNZ-WZLNRYEVSA-N 0.000 description 23
- LAFKUZYWNCHOHT-WHFBIAKZSA-N Ser-Glu Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O LAFKUZYWNCHOHT-WHFBIAKZSA-N 0.000 description 23
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 23
- QQACQIHVWCVBBR-GVARAGBVSA-N Ala-Ile-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O QQACQIHVWCVBBR-GVARAGBVSA-N 0.000 description 22
- MFMDKJIPHSWSBM-GUBZILKMSA-N Ala-Lys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFMDKJIPHSWSBM-GUBZILKMSA-N 0.000 description 22
- PMQXMXAASGFUDX-SRVKXCTJSA-N Ala-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCCN PMQXMXAASGFUDX-SRVKXCTJSA-N 0.000 description 22
- VCSABYLVNWQYQE-SRVKXCTJSA-N Ala-Lys-Lys Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O VCSABYLVNWQYQE-SRVKXCTJSA-N 0.000 description 22
- VFUXXFVCYZPOQG-WDSKDSINSA-N Asp-Glu-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O VFUXXFVCYZPOQG-WDSKDSINSA-N 0.000 description 22
- HQUXQAMSWFIRET-AVGNSLFASA-N Leu-Glu-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN HQUXQAMSWFIRET-AVGNSLFASA-N 0.000 description 22
- GQFDWEDHOQRNLC-QWRGUYRKSA-N Lys-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN GQFDWEDHOQRNLC-QWRGUYRKSA-N 0.000 description 22
- RMOKGALPSPOYKE-KATARQTJSA-N Lys-Thr-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O RMOKGALPSPOYKE-KATARQTJSA-N 0.000 description 22
- FJVJLMZUIGMFFU-BQBZGAKWSA-N Met-Asp-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O FJVJLMZUIGMFFU-BQBZGAKWSA-N 0.000 description 22
- LVVBAKCGXXUHFO-ZLUOBGJFSA-N Ser-Ala-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O LVVBAKCGXXUHFO-ZLUOBGJFSA-N 0.000 description 22
- ZIFYDQAFEMIZII-GUBZILKMSA-N Ser-Leu-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZIFYDQAFEMIZII-GUBZILKMSA-N 0.000 description 22
- GQPQJNMVELPZNQ-GBALPHGKSA-N Thr-Ser-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N)O GQPQJNMVELPZNQ-GBALPHGKSA-N 0.000 description 22
- VBMOVTMNHWPZJR-SUSMZKCASA-N Thr-Thr-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VBMOVTMNHWPZJR-SUSMZKCASA-N 0.000 description 22
- 239000002773 nucleotide Substances 0.000 description 22
- 125000003729 nucleotide group Chemical group 0.000 description 22
- DCGLNNVKIZXQOJ-FXQIFTODSA-N Arg-Asn-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N DCGLNNVKIZXQOJ-FXQIFTODSA-N 0.000 description 21
- ORXCYAFUCSTQGY-FXQIFTODSA-N Asn-Ala-Met Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)N)N ORXCYAFUCSTQGY-FXQIFTODSA-N 0.000 description 21
- VJGQRELPQWNURN-JYJNAYRXSA-N Leu-Tyr-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O VJGQRELPQWNURN-JYJNAYRXSA-N 0.000 description 21
- NPBGTPKLVJEOBE-IUCAKERBSA-N Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N NPBGTPKLVJEOBE-IUCAKERBSA-N 0.000 description 21
- YOSLMIPKOUAHKI-OLHMAJIHSA-N Thr-Asp-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O YOSLMIPKOUAHKI-OLHMAJIHSA-N 0.000 description 21
- WXVIGTAUZBUDPZ-DTLFHODZSA-N Thr-His Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 WXVIGTAUZBUDPZ-DTLFHODZSA-N 0.000 description 21
- YRJOLUDFVAUXLI-GSSVUCPTSA-N Thr-Thr-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O YRJOLUDFVAUXLI-GSSVUCPTSA-N 0.000 description 21
- 108010047857 aspartylglycine Proteins 0.000 description 21
- 108010056582 methionylglutamic acid Proteins 0.000 description 21
- 230000001681 protective effect Effects 0.000 description 21
- XAJRHVUUVUPFQL-ACZMJKKPSA-N Asp-Glu-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O XAJRHVUUVUPFQL-ACZMJKKPSA-N 0.000 description 20
- KPJJOZUXFOLGMQ-CIUDSAMLSA-N Lys-Asp-Asn Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N KPJJOZUXFOLGMQ-CIUDSAMLSA-N 0.000 description 20
- SFZKGGOGCNQPJY-CIUDSAMLSA-N Ser-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N SFZKGGOGCNQPJY-CIUDSAMLSA-N 0.000 description 20
- GSCVDSBEYVGMJQ-SRVKXCTJSA-N Ser-Tyr-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CO)N)O GSCVDSBEYVGMJQ-SRVKXCTJSA-N 0.000 description 20
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 20
- HNXWVVHIGTZTBO-LKXGYXEUSA-N Asn-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O HNXWVVHIGTZTBO-LKXGYXEUSA-N 0.000 description 19
- YQAQQKPWFOBSMU-WDCWCFNPSA-N Glu-Thr-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O YQAQQKPWFOBSMU-WDCWCFNPSA-N 0.000 description 19
- JLCYOCDGIUZMKQ-JBACZVJFSA-N Glu-Trp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CCC(=O)O)N JLCYOCDGIUZMKQ-JBACZVJFSA-N 0.000 description 19
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 19
- MPGHETGWWWUHPY-CIUDSAMLSA-N Lys-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN MPGHETGWWWUHPY-CIUDSAMLSA-N 0.000 description 19
- DDYIRGBOZVKRFR-AVGNSLFASA-N Phe-Asp-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N DDYIRGBOZVKRFR-AVGNSLFASA-N 0.000 description 19
- 101100460200 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) NEW1 gene Proteins 0.000 description 19
- 101100273916 Schizosaccharomyces pombe (strain 972 / ATCC 24843) wip1 gene Proteins 0.000 description 19
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 19
- KXEVYGKATAMXJJ-ACZMJKKPSA-N Ala-Glu-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O KXEVYGKATAMXJJ-ACZMJKKPSA-N 0.000 description 18
- TZFQICWZWFNIKU-KKUMJFAQSA-N Asn-Leu-Tyr Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 TZFQICWZWFNIKU-KKUMJFAQSA-N 0.000 description 18
- PZXPWHFYZXTFBI-YUMQZZPRSA-N Asp-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O PZXPWHFYZXTFBI-YUMQZZPRSA-N 0.000 description 18
- BUZMZDDKFCSKOT-CIUDSAMLSA-N Glu-Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O BUZMZDDKFCSKOT-CIUDSAMLSA-N 0.000 description 18
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 18
- 108091028043 Nucleic acid sequence Proteins 0.000 description 18
- QQWNRERCGGZOKG-WEDXCCLWSA-N Thr-Gly-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O QQWNRERCGGZOKG-WEDXCCLWSA-N 0.000 description 18
- 108010081551 glycylphenylalanine Proteins 0.000 description 18
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 18
- 108010048397 seryl-lysyl-leucine Proteins 0.000 description 18
- 108010061238 threonyl-glycine Proteins 0.000 description 18
- FJVAQLJNTSUQPY-CIUDSAMLSA-N Ala-Ala-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN FJVAQLJNTSUQPY-CIUDSAMLSA-N 0.000 description 17
- NALWOULWGHTVDA-UWVGGRQHSA-N Asp-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NALWOULWGHTVDA-UWVGGRQHSA-N 0.000 description 17
- XBBKIIGCUMBKCO-JXUBOQSCSA-N Leu-Ala-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XBBKIIGCUMBKCO-JXUBOQSCSA-N 0.000 description 17
- NSTPXGARCQOSAU-VIFPVBQESA-N N-formyl-L-phenylalanine Chemical compound O=CN[C@H](C(=O)O)CC1=CC=CC=C1 NSTPXGARCQOSAU-VIFPVBQESA-N 0.000 description 17
- 108010041407 alanylaspartic acid Proteins 0.000 description 17
- 108010068265 aspartyltyrosine Proteins 0.000 description 17
- 102000037865 fusion proteins Human genes 0.000 description 17
- 108020001507 fusion proteins Proteins 0.000 description 17
- 108010009298 lysylglutamic acid Proteins 0.000 description 17
- CCDFBRZVTDDJNM-GUBZILKMSA-N Ala-Leu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CCDFBRZVTDDJNM-GUBZILKMSA-N 0.000 description 16
- JZDHUJAFXGNDSB-WHFBIAKZSA-N Glu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O JZDHUJAFXGNDSB-WHFBIAKZSA-N 0.000 description 16
- IDAHFEPYTJJZFD-PEFMBERDSA-N Ile-Asp-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N IDAHFEPYTJJZFD-PEFMBERDSA-N 0.000 description 16
- HUORUFRRJHELPD-MNXVOIDGSA-N Ile-Leu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N HUORUFRRJHELPD-MNXVOIDGSA-N 0.000 description 16
- HYMLKESRWLZDBR-WEDXCCLWSA-N Leu-Gly-Thr Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O HYMLKESRWLZDBR-WEDXCCLWSA-N 0.000 description 16
- BIZNDKMFQHDOIE-KKUMJFAQSA-N Leu-Phe-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(O)=O)CC1=CC=CC=C1 BIZNDKMFQHDOIE-KKUMJFAQSA-N 0.000 description 16
- SQBLRDDJTUJDMV-ACZMJKKPSA-N Ser-Glu-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O SQBLRDDJTUJDMV-ACZMJKKPSA-N 0.000 description 16
- CQNFRKAKGDSJFR-NUMRIWBASA-N Thr-Glu-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O CQNFRKAKGDSJFR-NUMRIWBASA-N 0.000 description 16
- 108010015792 glycyllysine Proteins 0.000 description 16
- BUDNAJYVCUHLSV-ZLUOBGJFSA-N Ala-Asp-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O BUDNAJYVCUHLSV-ZLUOBGJFSA-N 0.000 description 15
- FBODFHMLALOPHP-GUBZILKMSA-N Asn-Lys-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O FBODFHMLALOPHP-GUBZILKMSA-N 0.000 description 15
- QDXQWFBLUVTOFL-FXQIFTODSA-N Asn-Met-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)N)N QDXQWFBLUVTOFL-FXQIFTODSA-N 0.000 description 15
- ILWHFUZZCFYSKT-AVGNSLFASA-N Glu-Lys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ILWHFUZZCFYSKT-AVGNSLFASA-N 0.000 description 15
- BGVYNAQWHSTTSP-BYULHYEWSA-N Gly-Asn-Ile Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BGVYNAQWHSTTSP-BYULHYEWSA-N 0.000 description 15
- IDMNOFVUXYYZPF-DKIMLUQUSA-N Ile-Lys-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N IDMNOFVUXYYZPF-DKIMLUQUSA-N 0.000 description 15
- PVMPDMIKUVNOBD-CIUDSAMLSA-N Leu-Asp-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O PVMPDMIKUVNOBD-CIUDSAMLSA-N 0.000 description 15
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 15
- NFDYGNFETJVMSE-BQBZGAKWSA-N Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CO NFDYGNFETJVMSE-BQBZGAKWSA-N 0.000 description 15
- XTCNBOBTROGWMW-RWRJDSDZSA-N Thr-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N XTCNBOBTROGWMW-RWRJDSDZSA-N 0.000 description 15
- AHERARIZBPOMNU-KATARQTJSA-N Thr-Ser-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O AHERARIZBPOMNU-KATARQTJSA-N 0.000 description 15
- HPYDSVWYXXKHRD-VIFPVBQESA-N Tyr-Gly Chemical compound [O-]C(=O)CNC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 HPYDSVWYXXKHRD-VIFPVBQESA-N 0.000 description 15
- 108010028188 glycyl-histidyl-serine Proteins 0.000 description 15
- 108010092114 histidylphenylalanine Proteins 0.000 description 15
- 108091008146 restriction endonucleases Proteins 0.000 description 15
- 108010069117 seryl-lysyl-aspartic acid Proteins 0.000 description 15
- PBVLJOIPOGUQQP-CIUDSAMLSA-N Asp-Ala-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O PBVLJOIPOGUQQP-CIUDSAMLSA-N 0.000 description 14
- SJPMNHCEWPTRBR-BQBZGAKWSA-N Glu-Glu-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O SJPMNHCEWPTRBR-BQBZGAKWSA-N 0.000 description 14
- GPSHCSTUYOQPAI-JHEQGTHGSA-N Glu-Thr-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O GPSHCSTUYOQPAI-JHEQGTHGSA-N 0.000 description 14
- STVHDEHTKFXBJQ-LAEOZQHASA-N Gly-Glu-Ile Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O STVHDEHTKFXBJQ-LAEOZQHASA-N 0.000 description 14
- TVTZEOHWHUVYCG-KYNKHSRBSA-N Gly-Thr-Thr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O TVTZEOHWHUVYCG-KYNKHSRBSA-N 0.000 description 14
- CANPXOLVTMKURR-WEDXCCLWSA-N Lys-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN CANPXOLVTMKURR-WEDXCCLWSA-N 0.000 description 14
- WVJNGSFKBKOKRV-AJNGGQMLSA-N Lys-Leu-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WVJNGSFKBKOKRV-AJNGGQMLSA-N 0.000 description 14
- WRODMZBHNNPRLN-SRVKXCTJSA-N Lys-Leu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O WRODMZBHNNPRLN-SRVKXCTJSA-N 0.000 description 14
- UROWNMBTQGGTHB-DCAQKATOSA-N Met-Leu-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O UROWNMBTQGGTHB-DCAQKATOSA-N 0.000 description 14
- 241000283973 Oryctolagus cuniculus Species 0.000 description 14
- WSTIOCFMWXNOCX-YUMQZZPRSA-N Ser-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CO)N WSTIOCFMWXNOCX-YUMQZZPRSA-N 0.000 description 14
- UYTYTDMCDBPDSC-URLPEUOOSA-N Thr-Ile-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N UYTYTDMCDBPDSC-URLPEUOOSA-N 0.000 description 14
- VGYVVSQFSSKZRJ-OEAJRASXSA-N Thr-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@H](O)C)CC1=CC=CC=C1 VGYVVSQFSSKZRJ-OEAJRASXSA-N 0.000 description 14
- 108010008685 alanyl-glutamyl-aspartic acid Proteins 0.000 description 14
- 238000010367 cloning Methods 0.000 description 14
- 108010054155 lysyllysine Proteins 0.000 description 14
- XAXMJQUMRJAFCH-CQDKDKBSSA-N Ala-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=C(O)C=C1 XAXMJQUMRJAFCH-CQDKDKBSSA-N 0.000 description 13
- ASQKVGRCKOFKIU-KZVJFYERSA-N Arg-Thr-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O ASQKVGRCKOFKIU-KZVJFYERSA-N 0.000 description 13
- KXFCBAHYSLJCCY-ZLUOBGJFSA-N Asn-Asn-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O KXFCBAHYSLJCCY-ZLUOBGJFSA-N 0.000 description 13
- USNJAPJZSGTTPX-XVSYOHENSA-N Asp-Phe-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O USNJAPJZSGTTPX-XVSYOHENSA-N 0.000 description 13
- MFNUFCFRAZPJFW-JYJNAYRXSA-N Glu-Lys-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MFNUFCFRAZPJFW-JYJNAYRXSA-N 0.000 description 13
- LLXVQPKEQQCISF-YUMQZZPRSA-N Gly-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN LLXVQPKEQQCISF-YUMQZZPRSA-N 0.000 description 13
- FFALDIDGPLUDKV-ZDLURKLDSA-N Gly-Thr-Ser Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O FFALDIDGPLUDKV-ZDLURKLDSA-N 0.000 description 13
- NOQPTNXSGNPJNS-YUMQZZPRSA-N His-Asn-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O NOQPTNXSGNPJNS-YUMQZZPRSA-N 0.000 description 13
- UCGDDTHMMVWVMV-FSPLSTOPSA-N Ile-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(O)=O UCGDDTHMMVWVMV-FSPLSTOPSA-N 0.000 description 13
- KBAPKNDWAGVGTH-IGISWZIWSA-N Ile-Ile-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KBAPKNDWAGVGTH-IGISWZIWSA-N 0.000 description 13
- UIEZQYNXCYHMQS-BJDJZHNGSA-N Ile-Lys-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)N UIEZQYNXCYHMQS-BJDJZHNGSA-N 0.000 description 13
- OTSVBELRDMSPKY-PCBIJLKTSA-N Ile-Phe-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N OTSVBELRDMSPKY-PCBIJLKTSA-N 0.000 description 13
- IWWMPCPLFXFBAF-SRVKXCTJSA-N Lys-Asp-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O IWWMPCPLFXFBAF-SRVKXCTJSA-N 0.000 description 13
- KZOHPCYVORJBLG-AVGNSLFASA-N Lys-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)N KZOHPCYVORJBLG-AVGNSLFASA-N 0.000 description 13
- ZLGQEBCCANLYRA-RYUDHWBXSA-N Phe-Gly-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O ZLGQEBCCANLYRA-RYUDHWBXSA-N 0.000 description 13
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 13
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 13
- BQBCIBCLXBKYHW-CSMHCCOUSA-N Thr-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@@H]([NH3+])[C@@H](C)O BQBCIBCLXBKYHW-CSMHCCOUSA-N 0.000 description 13
- 108010003700 lysyl aspartic acid Proteins 0.000 description 13
- 108010038320 lysylphenylalanine Proteins 0.000 description 13
- BLTRAARCJYVJKV-QEJZJMRPSA-N Ala-Lys-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(O)=O BLTRAARCJYVJKV-QEJZJMRPSA-N 0.000 description 12
- OLGCWMNDJTWQAG-GUBZILKMSA-N Asn-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(N)=O OLGCWMNDJTWQAG-GUBZILKMSA-N 0.000 description 12
- CKAJHWFHHFSCDT-WHFBIAKZSA-N Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O CKAJHWFHHFSCDT-WHFBIAKZSA-N 0.000 description 12
- MUSGDMDGNGXULI-DCAQKATOSA-N Glu-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O MUSGDMDGNGXULI-DCAQKATOSA-N 0.000 description 12
- GGEJHJIXRBTJPD-BYPYZUCNSA-N Gly-Asn-Gly Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GGEJHJIXRBTJPD-BYPYZUCNSA-N 0.000 description 12
- OCDLPQDYTJPWNG-YUMQZZPRSA-N Gly-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)CN OCDLPQDYTJPWNG-YUMQZZPRSA-N 0.000 description 12
- MOJKRXIRAZPZLW-WDSKDSINSA-N Gly-Glu-Ala Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MOJKRXIRAZPZLW-WDSKDSINSA-N 0.000 description 12
- HMHRTKOWRUPPNU-RCOVLWMOSA-N Gly-Ile-Gly Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O HMHRTKOWRUPPNU-RCOVLWMOSA-N 0.000 description 12
- HZYHBDVRCBDJJV-HAFWLYHUSA-N Ile-Asn Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O HZYHBDVRCBDJJV-HAFWLYHUSA-N 0.000 description 12
- WIDZHJTYKYBLSR-DCAQKATOSA-N Leu-Glu-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WIDZHJTYKYBLSR-DCAQKATOSA-N 0.000 description 12
- DGAAQRAUOFHBFJ-CIUDSAMLSA-N Lys-Asn-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O DGAAQRAUOFHBFJ-CIUDSAMLSA-N 0.000 description 12
- DMEYUTSDVRCWRS-ULQDDVLXSA-N Phe-Lys-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 DMEYUTSDVRCWRS-ULQDDVLXSA-N 0.000 description 12
- RIAKPZVSNBBNRE-BJDJZHNGSA-N Ser-Ile-Leu Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O RIAKPZVSNBBNRE-BJDJZHNGSA-N 0.000 description 12
- PURRNJBBXDDWLX-ZDLURKLDSA-N Ser-Thr-Gly Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CO)N)O PURRNJBBXDDWLX-ZDLURKLDSA-N 0.000 description 12
- FHXGMDRKJHKLKW-QWRGUYRKSA-N Ser-Tyr-Gly Chemical compound OC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 FHXGMDRKJHKLKW-QWRGUYRKSA-N 0.000 description 12
- 230000034994 death Effects 0.000 description 12
- 231100000517 death Toxicity 0.000 description 12
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 12
- 108010019832 glycyl-asparaginyl-glycine Proteins 0.000 description 12
- 108010012581 phenylalanylglutamate Proteins 0.000 description 12
- 239000002953 phosphate buffered saline Substances 0.000 description 12
- 230000009257 reactivity Effects 0.000 description 12
- 210000002966 serum Anatomy 0.000 description 12
- YAXNATKKPOWVCP-ZLUOBGJFSA-N Ala-Asn-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O YAXNATKKPOWVCP-ZLUOBGJFSA-N 0.000 description 11
- SHYYAQLDNVHPFT-DLOVCJGASA-N Ala-Asn-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SHYYAQLDNVHPFT-DLOVCJGASA-N 0.000 description 11
- PUBLUECXJRHTBK-ACZMJKKPSA-N Ala-Glu-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O PUBLUECXJRHTBK-ACZMJKKPSA-N 0.000 description 11
- PCIFXPRIFWKWLK-YUMQZZPRSA-N Ala-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N PCIFXPRIFWKWLK-YUMQZZPRSA-N 0.000 description 11
- MMLHRUJLOUSRJX-CIUDSAMLSA-N Ala-Ser-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN MMLHRUJLOUSRJX-CIUDSAMLSA-N 0.000 description 11
- AKEBUSZTMQLNIX-UWJYBYFXSA-N Asn-Ala-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N AKEBUSZTMQLNIX-UWJYBYFXSA-N 0.000 description 11
- ACKNRKFVYUVWAC-ZPFDUUQYSA-N Asn-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N ACKNRKFVYUVWAC-ZPFDUUQYSA-N 0.000 description 11
- GLWFAWNYGWBMOC-SRVKXCTJSA-N Asn-Leu-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O GLWFAWNYGWBMOC-SRVKXCTJSA-N 0.000 description 11
- RCFGLXMZDYNRSC-CIUDSAMLSA-N Asn-Lys-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O RCFGLXMZDYNRSC-CIUDSAMLSA-N 0.000 description 11
- JDDYEZGPYBBPBN-JRQIVUDYSA-N Asp-Thr-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JDDYEZGPYBBPBN-JRQIVUDYSA-N 0.000 description 11
- 238000002965 ELISA Methods 0.000 description 11
- PHONAZGUEGIOEM-GLLZPBPUSA-N Glu-Glu-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PHONAZGUEGIOEM-GLLZPBPUSA-N 0.000 description 11
- PJBVXVBTTFZPHJ-GUBZILKMSA-N Glu-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N PJBVXVBTTFZPHJ-GUBZILKMSA-N 0.000 description 11
- IUZGUFAJDBHQQV-YUMQZZPRSA-N Gly-Leu-Asn Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IUZGUFAJDBHQQV-YUMQZZPRSA-N 0.000 description 11
- DCRODRAURLJOFY-XPUUQOCRSA-N His-Ala-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)NCC(O)=O DCRODRAURLJOFY-XPUUQOCRSA-N 0.000 description 11
- LPXHYGGZJOCAFR-MNXVOIDGSA-N Ile-Glu-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N LPXHYGGZJOCAFR-MNXVOIDGSA-N 0.000 description 11
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 11
- BRTVHXHCUSXYRI-CIUDSAMLSA-N Leu-Ser-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O BRTVHXHCUSXYRI-CIUDSAMLSA-N 0.000 description 11
- ZXEUFAVXODIPHC-GUBZILKMSA-N Lys-Glu-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ZXEUFAVXODIPHC-GUBZILKMSA-N 0.000 description 11
- OWRUUFUVXFREBD-KKUMJFAQSA-N Lys-His-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O OWRUUFUVXFREBD-KKUMJFAQSA-N 0.000 description 11
- ZKOKTQPHFMRSJP-YJRXYDGGSA-N Ser-Thr-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZKOKTQPHFMRSJP-YJRXYDGGSA-N 0.000 description 11
- GNHRVXYZKWSJTF-HJGDQZAQSA-N Thr-Asp-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O GNHRVXYZKWSJTF-HJGDQZAQSA-N 0.000 description 11
- BDYBHQWMHYDRKJ-UNQGMJICSA-N Thr-Phe-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(=O)O)N)O BDYBHQWMHYDRKJ-UNQGMJICSA-N 0.000 description 11
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 11
- 108010087823 glycyltyrosine Proteins 0.000 description 11
- 230000002163 immunogen Effects 0.000 description 11
- RAKKBBHMTJSXOY-XVYDVKMFSA-N Asn-His-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(O)=O RAKKBBHMTJSXOY-XVYDVKMFSA-N 0.000 description 10
- DJIMLSXHXKWADV-CIUDSAMLSA-N Asn-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O DJIMLSXHXKWADV-CIUDSAMLSA-N 0.000 description 10
- BKFXFUPYETWGGA-XVSYOHENSA-N Asn-Phe-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BKFXFUPYETWGGA-XVSYOHENSA-N 0.000 description 10
- KHBLRHKVXICFMY-GUBZILKMSA-N Asp-Glu-Lys Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O KHBLRHKVXICFMY-GUBZILKMSA-N 0.000 description 10
- RJONUNZIMUXUOI-GUBZILKMSA-N Glu-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N RJONUNZIMUXUOI-GUBZILKMSA-N 0.000 description 10
- IRXNJYPKBVERCW-DCAQKATOSA-N Glu-Leu-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IRXNJYPKBVERCW-DCAQKATOSA-N 0.000 description 10
- UXJHNZODTMHWRD-WHFBIAKZSA-N Gly-Asn-Ala Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O UXJHNZODTMHWRD-WHFBIAKZSA-N 0.000 description 10
- DGKBSGNCMCLDSL-BYULHYEWSA-N Gly-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN DGKBSGNCMCLDSL-BYULHYEWSA-N 0.000 description 10
- OHUKZZYSJBKFRR-WHFBIAKZSA-N Gly-Ser-Asp Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O OHUKZZYSJBKFRR-WHFBIAKZSA-N 0.000 description 10
- LLWQVJNHMYBLLK-CDMKHQONSA-N Gly-Thr-Phe Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LLWQVJNHMYBLLK-CDMKHQONSA-N 0.000 description 10
- JCOSMKPAOYDKRO-AVGNSLFASA-N His-Glu-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N JCOSMKPAOYDKRO-AVGNSLFASA-N 0.000 description 10
- DGWXCIORNLWGGG-CIUDSAMLSA-N Lys-Asn-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O DGWXCIORNLWGGG-CIUDSAMLSA-N 0.000 description 10
- VQXAVLQBQJMENB-SRVKXCTJSA-N Lys-Glu-Met Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O VQXAVLQBQJMENB-SRVKXCTJSA-N 0.000 description 10
- ATIPDCIQTUXABX-UWVGGRQHSA-N Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN ATIPDCIQTUXABX-UWVGGRQHSA-N 0.000 description 10
- MUXNCRWTWBMNHX-SRVKXCTJSA-N Lys-Leu-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O MUXNCRWTWBMNHX-SRVKXCTJSA-N 0.000 description 10
- SFKOEHXABNPLRT-KBPBESRZSA-N Phe-His-Gly Chemical compound N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NCC(O)=O SFKOEHXABNPLRT-KBPBESRZSA-N 0.000 description 10
- SRTCFKGBYBZRHA-ACZMJKKPSA-N Ser-Ala-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SRTCFKGBYBZRHA-ACZMJKKPSA-N 0.000 description 10
- RDFQNDHEHVSONI-ZLUOBGJFSA-N Ser-Asn-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RDFQNDHEHVSONI-ZLUOBGJFSA-N 0.000 description 10
- PPQRSMGDOHLTBE-UWVGGRQHSA-N Ser-Phe Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PPQRSMGDOHLTBE-UWVGGRQHSA-N 0.000 description 10
- MQUZANJDFOQOBX-SRVKXCTJSA-N Ser-Phe-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O MQUZANJDFOQOBX-SRVKXCTJSA-N 0.000 description 10
- YIKDYZDNRCNFQB-KKUMJFAQSA-N Tyr-His-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O YIKDYZDNRCNFQB-KKUMJFAQSA-N 0.000 description 10
- ZZDYJFVIKVSUFA-WLTAIBSBSA-N Tyr-Thr-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O ZZDYJFVIKVSUFA-WLTAIBSBSA-N 0.000 description 10
- NZBSVMQZQMEUHI-WZLNRYEVSA-N Tyr-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N NZBSVMQZQMEUHI-WZLNRYEVSA-N 0.000 description 10
- 239000012472 biological sample Substances 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 10
- MEFGKQUUYZOLHM-GMOBBJLQSA-N Asn-Arg-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MEFGKQUUYZOLHM-GMOBBJLQSA-N 0.000 description 9
- HCZQKHSRYHCPSD-IUKAMOBKSA-N Asn-Thr-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HCZQKHSRYHCPSD-IUKAMOBKSA-N 0.000 description 9
- PCJOFZYFFMBZKC-PCBIJLKTSA-N Asp-Phe-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O PCJOFZYFFMBZKC-PCBIJLKTSA-N 0.000 description 9
- 241000588724 Escherichia coli Species 0.000 description 9
- YKZAMJXNJUWFIK-JBDRJPRFSA-N Ile-Ser-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)N YKZAMJXNJUWFIK-JBDRJPRFSA-N 0.000 description 9
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 9
- JGAMUXDWYSXYLM-SRVKXCTJSA-N Lys-Arg-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O JGAMUXDWYSXYLM-SRVKXCTJSA-N 0.000 description 9
- NJNRBRKHOWSGMN-SRVKXCTJSA-N Lys-Leu-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O NJNRBRKHOWSGMN-SRVKXCTJSA-N 0.000 description 9
- 108091034117 Oligonucleotide Proteins 0.000 description 9
- LDSOBEJVGGVWGD-DLOVCJGASA-N Phe-Asp-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 LDSOBEJVGGVWGD-DLOVCJGASA-N 0.000 description 9
- ICHZYBVODUVUKN-SRVKXCTJSA-N Ser-Asn-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ICHZYBVODUVUKN-SRVKXCTJSA-N 0.000 description 9
- MFEBUIFJVPNZLO-OLHMAJIHSA-N Thr-Asp-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O MFEBUIFJVPNZLO-OLHMAJIHSA-N 0.000 description 9
- ZSPQUTWLWGWTPS-HJGDQZAQSA-N Thr-Lys-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O ZSPQUTWLWGWTPS-HJGDQZAQSA-N 0.000 description 9
- KCPFDGNYAMKZQP-KBPBESRZSA-N Tyr-Gly-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O KCPFDGNYAMKZQP-KBPBESRZSA-N 0.000 description 9
- MFEVVAXTBZELLL-GGVZMXCHSA-N Tyr-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MFEVVAXTBZELLL-GGVZMXCHSA-N 0.000 description 9
- 108010070783 alanyltyrosine Proteins 0.000 description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
- 230000028993 immune response Effects 0.000 description 9
- 108010016686 methionyl-alanyl-serine Proteins 0.000 description 9
- RVLOMLVNNBWRSR-KNIFDHDWSA-N (2s)-2-aminopropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O RVLOMLVNNBWRSR-KNIFDHDWSA-N 0.000 description 8
- ZJLORAAXDAJLDC-CQDKDKBSSA-N Ala-Tyr-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O ZJLORAAXDAJLDC-CQDKDKBSSA-N 0.000 description 8
- IIFDPDVJAHQFSR-WHFBIAKZSA-N Asn-Glu Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O IIFDPDVJAHQFSR-WHFBIAKZSA-N 0.000 description 8
- SVABRQFIHCSNCI-FOHZUACHSA-N Asp-Gly-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O SVABRQFIHCSNCI-FOHZUACHSA-N 0.000 description 8
- RFTVTKBHDXCEEX-WDSKDSINSA-N Glu-Ser-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RFTVTKBHDXCEEX-WDSKDSINSA-N 0.000 description 8
- ZOTGXWMKUFSKEU-QXEWZRGKSA-N Gly-Ile-Met Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(O)=O ZOTGXWMKUFSKEU-QXEWZRGKSA-N 0.000 description 8
- YTSVAIMKVLZUDU-YUMQZZPRSA-N Gly-Leu-Asp Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O YTSVAIMKVLZUDU-YUMQZZPRSA-N 0.000 description 8
- LPBWRHRHEIYAIP-KKUMJFAQSA-N His-Tyr-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O LPBWRHRHEIYAIP-KKUMJFAQSA-N 0.000 description 8
- JRHFQUPIZOYKQP-KBIXCLLPSA-N Ile-Ala-Glu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O JRHFQUPIZOYKQP-KBIXCLLPSA-N 0.000 description 8
- CZCSUZMIRKFFFA-CIUDSAMLSA-N Leu-Ala-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O CZCSUZMIRKFFFA-CIUDSAMLSA-N 0.000 description 8
- ZURHXHNAEJJRNU-CIUDSAMLSA-N Leu-Asp-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ZURHXHNAEJJRNU-CIUDSAMLSA-N 0.000 description 8
- YVKSMSDXKMSIRX-GUBZILKMSA-N Leu-Glu-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O YVKSMSDXKMSIRX-GUBZILKMSA-N 0.000 description 8
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 8
- SLQJJFAVWSZLBL-BJDJZHNGSA-N Lys-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCCCN SLQJJFAVWSZLBL-BJDJZHNGSA-N 0.000 description 8
- HVAUKHLDSDDROB-KKUMJFAQSA-N Lys-Lys-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O HVAUKHLDSDDROB-KKUMJFAQSA-N 0.000 description 8
- HSJIGJRZYUADSS-IHRRRGAJSA-N Met-Lys-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O HSJIGJRZYUADSS-IHRRRGAJSA-N 0.000 description 8
- DWYAUVCQDTZIJI-VZFHVOOUSA-N Thr-Ala-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O DWYAUVCQDTZIJI-VZFHVOOUSA-N 0.000 description 8
- BCYUHPXBHCUYBA-CUJWVEQBSA-N Thr-Ser-His Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O BCYUHPXBHCUYBA-CUJWVEQBSA-N 0.000 description 8
- 230000000890 antigenic effect Effects 0.000 description 8
- 238000000684 flow cytometry Methods 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- 108010028295 histidylhistidine Proteins 0.000 description 8
- 238000002703 mutagenesis Methods 0.000 description 8
- 231100000350 mutagenesis Toxicity 0.000 description 8
- 108010003137 tyrosyltyrosine Proteins 0.000 description 8
- GJLXVWOMRRWCIB-MERZOTPQSA-N (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanamide Chemical compound C([C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)C1=CC=C(O)C=C1 GJLXVWOMRRWCIB-MERZOTPQSA-N 0.000 description 7
- LMFXXZPPZDCPTA-ZKWXMUAHSA-N Ala-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N LMFXXZPPZDCPTA-ZKWXMUAHSA-N 0.000 description 7
- 206010003445 Ascites Diseases 0.000 description 7
- HXWUJJADFMXNKA-BQBZGAKWSA-N Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(N)=O HXWUJJADFMXNKA-BQBZGAKWSA-N 0.000 description 7
- PAYPSKIBMDHZPI-CIUDSAMLSA-N Asp-Leu-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O PAYPSKIBMDHZPI-CIUDSAMLSA-N 0.000 description 7
- DSPQRJXOIXHOHK-WDSKDSINSA-N Glu-Asp-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O DSPQRJXOIXHOHK-WDSKDSINSA-N 0.000 description 7
- NKLRYVLERDYDBI-FXQIFTODSA-N Glu-Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NKLRYVLERDYDBI-FXQIFTODSA-N 0.000 description 7
- UQHGAYSULGRWRG-WHFBIAKZSA-N Glu-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CO)C(O)=O UQHGAYSULGRWRG-WHFBIAKZSA-N 0.000 description 7
- YHYDTTUSJXGTQK-UWVGGRQHSA-N Gly-Met-Leu Chemical compound CSCC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(O)=O YHYDTTUSJXGTQK-UWVGGRQHSA-N 0.000 description 7
- XBGGUPMXALFZOT-VIFPVBQESA-N Gly-Tyr Chemical compound NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-VIFPVBQESA-N 0.000 description 7
- HQSKKSLNLSTONK-JTQLQIEISA-N Gly-Tyr-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 HQSKKSLNLSTONK-JTQLQIEISA-N 0.000 description 7
- DGLAHESNTJWGDO-SRVKXCTJSA-N His-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N DGLAHESNTJWGDO-SRVKXCTJSA-N 0.000 description 7
- PHIXPNQDGGILMP-YVNDNENWSA-N Ile-Glu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N PHIXPNQDGGILMP-YVNDNENWSA-N 0.000 description 7
- WMDZARSFSMZOQO-DRZSPHRISA-N Ile-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WMDZARSFSMZOQO-DRZSPHRISA-N 0.000 description 7
- HYIFFZAQXPUEAU-QWRGUYRKSA-N Leu-Gly-Leu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C HYIFFZAQXPUEAU-QWRGUYRKSA-N 0.000 description 7
- PJWOOBTYQNNRBF-BZSNNMDCSA-N Leu-Phe-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)O)N PJWOOBTYQNNRBF-BZSNNMDCSA-N 0.000 description 7
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 7
- QZPXMHVKPHJNTR-DCAQKATOSA-N Met-Leu-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O QZPXMHVKPHJNTR-DCAQKATOSA-N 0.000 description 7
- 101100460204 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new4 gene Proteins 0.000 description 7
- FQPDRTDDEZXCEC-SVSWQMSJSA-N Thr-Ile-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O FQPDRTDDEZXCEC-SVSWQMSJSA-N 0.000 description 7
- VTVVYQOXJCZVEB-WDCWCFNPSA-N Thr-Leu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O VTVVYQOXJCZVEB-WDCWCFNPSA-N 0.000 description 7
- OLWFDNLLBWQWCP-STQMWFEESA-N Tyr-Gly-Met Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O OLWFDNLLBWQWCP-STQMWFEESA-N 0.000 description 7
- OSXNCKRGMSHWSQ-ACRUOGEOSA-N Tyr-His-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OSXNCKRGMSHWSQ-ACRUOGEOSA-N 0.000 description 7
- UZQJVUCHXGYFLQ-AYDHOLPZSA-N [(2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-4-[(2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hy Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@@]1(C=O)C)C)(C)CC(O)[C@]1(CCC(CC14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZQJVUCHXGYFLQ-AYDHOLPZSA-N 0.000 description 7
- 210000004408 hybridoma Anatomy 0.000 description 7
- 239000013600 plasmid vector Substances 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- SLKLLQWZQHXYSV-CIUDSAMLSA-N Asn-Ala-Lys Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O SLKLLQWZQHXYSV-CIUDSAMLSA-N 0.000 description 6
- MDDXKBHIMYYJLW-FXQIFTODSA-N Asn-Met-Asp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N MDDXKBHIMYYJLW-FXQIFTODSA-N 0.000 description 6
- OMSMPWHEGLNQOD-UWVGGRQHSA-N Asn-Phe Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OMSMPWHEGLNQOD-UWVGGRQHSA-N 0.000 description 6
- QNNBHTFDFFFHGC-KKUMJFAQSA-N Asn-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QNNBHTFDFFFHGC-KKUMJFAQSA-N 0.000 description 6
- GWTLRDMPMJCNMH-WHFBIAKZSA-N Asp-Asn-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GWTLRDMPMJCNMH-WHFBIAKZSA-N 0.000 description 6
- NVFSJIXJZCDICF-SRVKXCTJSA-N Asp-Lys-Lys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N NVFSJIXJZCDICF-SRVKXCTJSA-N 0.000 description 6
- 101100150905 Caenorhabditis elegans ham-3 gene Proteins 0.000 description 6
- GLWXKFRTOHKGIT-ACZMJKKPSA-N Glu-Asn-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O GLWXKFRTOHKGIT-ACZMJKKPSA-N 0.000 description 6
- LGYZYFFDELZWRS-DCAQKATOSA-N Glu-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O LGYZYFFDELZWRS-DCAQKATOSA-N 0.000 description 6
- HKTRDWYCAUTRRL-YUMQZZPRSA-N Glu-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 HKTRDWYCAUTRRL-YUMQZZPRSA-N 0.000 description 6
- VSRCAOIHMGCIJK-SRVKXCTJSA-N Glu-Leu-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O VSRCAOIHMGCIJK-SRVKXCTJSA-N 0.000 description 6
- WNRZUESNGGDCJX-JYJNAYRXSA-N Glu-Leu-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WNRZUESNGGDCJX-JYJNAYRXSA-N 0.000 description 6
- SYAYROHMAIHWFB-KBIXCLLPSA-N Glu-Ser-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SYAYROHMAIHWFB-KBIXCLLPSA-N 0.000 description 6
- FUESBOMYALLFNI-VKHMYHEASA-N Gly-Asn Chemical compound NCC(=O)N[C@H](C(O)=O)CC(N)=O FUESBOMYALLFNI-VKHMYHEASA-N 0.000 description 6
- BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 6
- HUFUVTYGPOUCBN-MBLNEYKQSA-N Gly-Thr-Ile Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HUFUVTYGPOUCBN-MBLNEYKQSA-N 0.000 description 6
- OEROYDLRVAYIMQ-YUMQZZPRSA-N His-Gly-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O OEROYDLRVAYIMQ-YUMQZZPRSA-N 0.000 description 6
- FFAUOCITXBMRBT-YTFOTSKYSA-N Ile-Lys-Ile Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FFAUOCITXBMRBT-YTFOTSKYSA-N 0.000 description 6
- IRMLZWSRWSGTOP-CIUDSAMLSA-N Leu-Ser-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O IRMLZWSRWSGTOP-CIUDSAMLSA-N 0.000 description 6
- JGKHAFUAPZCCDU-BZSNNMDCSA-N Leu-Tyr-Leu Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)CC1=CC=C(O)C=C1 JGKHAFUAPZCCDU-BZSNNMDCSA-N 0.000 description 6
- FZIJIFCXUCZHOL-CIUDSAMLSA-N Lys-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN FZIJIFCXUCZHOL-CIUDSAMLSA-N 0.000 description 6
- VMTYLUGCXIEDMV-QWRGUYRKSA-N Lys-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN VMTYLUGCXIEDMV-QWRGUYRKSA-N 0.000 description 6
- GAHJXEMYXKLZRQ-AJNGGQMLSA-N Lys-Lys-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O GAHJXEMYXKLZRQ-AJNGGQMLSA-N 0.000 description 6
- WXHHTBVYQOSYSL-FXQIFTODSA-N Met-Ala-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O WXHHTBVYQOSYSL-FXQIFTODSA-N 0.000 description 6
- SOAYQFDWEIWPPR-IHRRRGAJSA-N Met-Ser-Tyr Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O SOAYQFDWEIWPPR-IHRRRGAJSA-N 0.000 description 6
- ZZVUXQCQPXSUFH-JBACZVJFSA-N Phe-Glu-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=CC=C1 ZZVUXQCQPXSUFH-JBACZVJFSA-N 0.000 description 6
- RBRNEFJTEHPDSL-ACRUOGEOSA-N Phe-Phe-Lys Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 RBRNEFJTEHPDSL-ACRUOGEOSA-N 0.000 description 6
- WOUIMBGNEUWXQG-VKHMYHEASA-N Ser-Gly Chemical compound OC[C@H](N)C(=O)NCC(O)=O WOUIMBGNEUWXQG-VKHMYHEASA-N 0.000 description 6
- PPNPDKGQRFSCAC-CIUDSAMLSA-N Ser-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPNPDKGQRFSCAC-CIUDSAMLSA-N 0.000 description 6
- NADLKBTYNKUJEP-KATARQTJSA-N Ser-Thr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NADLKBTYNKUJEP-KATARQTJSA-N 0.000 description 6
- IOWJRKAVLALBQB-IWGUZYHVSA-N Thr-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O IOWJRKAVLALBQB-IWGUZYHVSA-N 0.000 description 6
- KZURUCDWKDEAFZ-XVSYOHENSA-N Thr-Phe-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O KZURUCDWKDEAFZ-XVSYOHENSA-N 0.000 description 6
- STUAPCLEDMKXKL-LKXGYXEUSA-N Thr-Ser-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O STUAPCLEDMKXKL-LKXGYXEUSA-N 0.000 description 6
- BSCBBPKDVOZICB-KKUMJFAQSA-N Tyr-Leu-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O BSCBBPKDVOZICB-KKUMJFAQSA-N 0.000 description 6
- SOAUMCDLIUGXJJ-SRVKXCTJSA-N Tyr-Ser-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O SOAUMCDLIUGXJJ-SRVKXCTJSA-N 0.000 description 6
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
- 108010070944 alanylhistidine Proteins 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 108010012058 leucyltyrosine Proteins 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- RJUHZPRQRQLCFL-IMJSIDKUSA-N Asn-Asn Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O RJUHZPRQRQLCFL-IMJSIDKUSA-N 0.000 description 5
- ZUFPUBYQYWCMDB-NUMRIWBASA-N Asn-Thr-Glu Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZUFPUBYQYWCMDB-NUMRIWBASA-N 0.000 description 5
- FYRVDDJMNISIKJ-UWVGGRQHSA-N Asn-Tyr Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FYRVDDJMNISIKJ-UWVGGRQHSA-N 0.000 description 5
- KRXIWXCXOARFNT-ZLUOBGJFSA-N Asp-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O KRXIWXCXOARFNT-ZLUOBGJFSA-N 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- 239000003155 DNA primer Substances 0.000 description 5
- 239000003298 DNA probe Substances 0.000 description 5
- JVSBYEDSSRZQGV-GUBZILKMSA-N Glu-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCC(O)=O JVSBYEDSSRZQGV-GUBZILKMSA-N 0.000 description 5
- SOEPMWQCTJITPZ-SRVKXCTJSA-N Glu-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N SOEPMWQCTJITPZ-SRVKXCTJSA-N 0.000 description 5
- AFWYPMDMDYCKMD-KBPBESRZSA-N Gly-Leu-Tyr Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 AFWYPMDMDYCKMD-KBPBESRZSA-N 0.000 description 5
- VBOFRJNDIOPNDO-YUMQZZPRSA-N His-Gly-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N VBOFRJNDIOPNDO-YUMQZZPRSA-N 0.000 description 5
- IPYVXYDYLHVWHU-GMOBBJLQSA-N Ile-Asn-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCSC)C(=O)O)N IPYVXYDYLHVWHU-GMOBBJLQSA-N 0.000 description 5
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 5
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 5
- QOOWRKBDDXQRHC-BQBZGAKWSA-N L-lysyl-L-alanine Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN QOOWRKBDDXQRHC-BQBZGAKWSA-N 0.000 description 5
- WXUOJXIGOPMDJM-SRVKXCTJSA-N Leu-Lys-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O WXUOJXIGOPMDJM-SRVKXCTJSA-N 0.000 description 5
- RZXLZBIUTDQHJQ-SRVKXCTJSA-N Leu-Lys-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O RZXLZBIUTDQHJQ-SRVKXCTJSA-N 0.000 description 5
- HVHRPWQEQHIQJF-AVGNSLFASA-N Leu-Lys-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O HVHRPWQEQHIQJF-AVGNSLFASA-N 0.000 description 5
- IMAKMJCBYCSMHM-AVGNSLFASA-N Lys-Glu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN IMAKMJCBYCSMHM-AVGNSLFASA-N 0.000 description 5
- FMIIKPHLJKUXGE-GUBZILKMSA-N Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN FMIIKPHLJKUXGE-GUBZILKMSA-N 0.000 description 5
- RIJCHEVHFWMDKD-SRVKXCTJSA-N Lys-Lys-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O RIJCHEVHFWMDKD-SRVKXCTJSA-N 0.000 description 5
- ZOKVLMBYDSIDKG-CSMHCCOUSA-N Lys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN ZOKVLMBYDSIDKG-CSMHCCOUSA-N 0.000 description 5
- 101100390985 Schizosaccharomyces pombe (strain 972 / ATCC 24843) fmc1 gene Proteins 0.000 description 5
- 101100460203 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new2 gene Proteins 0.000 description 5
- CAOYHZOWXFFAIR-CIUDSAMLSA-N Ser-His-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O CAOYHZOWXFFAIR-CIUDSAMLSA-N 0.000 description 5
- XUDRHBPSPAPDJP-SRVKXCTJSA-N Ser-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO XUDRHBPSPAPDJP-SRVKXCTJSA-N 0.000 description 5
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 5
- 241000193998 Streptococcus pneumoniae Species 0.000 description 5
- XOWKUMFHEZLKLT-CIQUZCHMSA-N Thr-Ile-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O XOWKUMFHEZLKLT-CIQUZCHMSA-N 0.000 description 5
- RPECVQBNONKZAT-WZLNRYEVSA-N Thr-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H]([C@@H](C)O)N RPECVQBNONKZAT-WZLNRYEVSA-N 0.000 description 5
- PRONOHBTMLNXCZ-BZSNNMDCSA-N Tyr-Leu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PRONOHBTMLNXCZ-BZSNNMDCSA-N 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 5
- 108010018006 histidylserine Proteins 0.000 description 5
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 5
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- ALBODLTZUXKBGZ-JUUVMNCLSA-N (2s)-2-amino-3-phenylpropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1 ALBODLTZUXKBGZ-JUUVMNCLSA-N 0.000 description 4
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 4
- FUSPCLTUKXQREV-ACZMJKKPSA-N Ala-Glu-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O FUSPCLTUKXQREV-ACZMJKKPSA-N 0.000 description 4
- CXISPYVYMQWFLE-VKHMYHEASA-N Ala-Gly Chemical compound C[C@H]([NH3+])C(=O)NCC([O-])=O CXISPYVYMQWFLE-VKHMYHEASA-N 0.000 description 4
- CFPQUJZTLUQUTJ-HTFCKZLJSA-N Ala-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](C)N CFPQUJZTLUQUTJ-HTFCKZLJSA-N 0.000 description 4
- SUHLZMHFRALVSY-YUMQZZPRSA-N Ala-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O SUHLZMHFRALVSY-YUMQZZPRSA-N 0.000 description 4
- DDBMKOCQWNFDBH-RHYQMDGZSA-N Arg-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O DDBMKOCQWNFDBH-RHYQMDGZSA-N 0.000 description 4
- SJUXYGVRSGTPMC-IMJSIDKUSA-N Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O SJUXYGVRSGTPMC-IMJSIDKUSA-N 0.000 description 4
- VKCOHFFSTKCXEQ-OLHMAJIHSA-N Asn-Asn-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VKCOHFFSTKCXEQ-OLHMAJIHSA-N 0.000 description 4
- FHETWELNCBMRMG-HJGDQZAQSA-N Asn-Leu-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FHETWELNCBMRMG-HJGDQZAQSA-N 0.000 description 4
- NSTBNYOKCZKOMI-AVGNSLFASA-N Asn-Tyr-Glu Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O NSTBNYOKCZKOMI-AVGNSLFASA-N 0.000 description 4
- WCFCYFDBMNFSPA-ACZMJKKPSA-N Asp-Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(O)=O WCFCYFDBMNFSPA-ACZMJKKPSA-N 0.000 description 4
- VAWNQIGQPUOPQW-ACZMJKKPSA-N Asp-Glu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O VAWNQIGQPUOPQW-ACZMJKKPSA-N 0.000 description 4
- DGKCOYGQLNWNCJ-ACZMJKKPSA-N Asp-Glu-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O DGKCOYGQLNWNCJ-ACZMJKKPSA-N 0.000 description 4
- ORRJQLIATJDMQM-HJGDQZAQSA-N Asp-Leu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O ORRJQLIATJDMQM-HJGDQZAQSA-N 0.000 description 4
- KGHLGJAXYSVNJP-WHFBIAKZSA-N Asp-Ser-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O KGHLGJAXYSVNJP-WHFBIAKZSA-N 0.000 description 4
- HJIFPJUEOGZWRI-GUBZILKMSA-N Glu-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N HJIFPJUEOGZWRI-GUBZILKMSA-N 0.000 description 4
- YKBUCXNNBYZYAY-MNXVOIDGSA-N Glu-Lys-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YKBUCXNNBYZYAY-MNXVOIDGSA-N 0.000 description 4
- XUORRGAFUQIMLC-STQMWFEESA-N Gly-Arg-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CN)O XUORRGAFUQIMLC-STQMWFEESA-N 0.000 description 4
- SOEATRRYCIPEHA-BQBZGAKWSA-N Gly-Glu-Glu Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SOEATRRYCIPEHA-BQBZGAKWSA-N 0.000 description 4
- LLZXNUUIBOALNY-QWRGUYRKSA-N Gly-Leu-Lys Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN LLZXNUUIBOALNY-QWRGUYRKSA-N 0.000 description 4
- LHYJCVCQPWRMKZ-WEDXCCLWSA-N Gly-Leu-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LHYJCVCQPWRMKZ-WEDXCCLWSA-N 0.000 description 4
- TXLQHACKRLWYCM-DCAQKATOSA-N His-Glu-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O TXLQHACKRLWYCM-DCAQKATOSA-N 0.000 description 4
- KWBISLAEQZUYIC-UWJYBYFXSA-N His-His-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CN=CN2)N KWBISLAEQZUYIC-UWJYBYFXSA-N 0.000 description 4
- CWSZWFILCNSNEX-CIUDSAMLSA-N His-Ser-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)O)N CWSZWFILCNSNEX-CIUDSAMLSA-N 0.000 description 4
- QTMKFZAYZKBFRC-BZSNNMDCSA-N His-Tyr-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CC3=CN=CN3)N)O QTMKFZAYZKBFRC-BZSNNMDCSA-N 0.000 description 4
- KIAOPHMUNPPGEN-PEXQALLHSA-N Ile-Gly-His Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N KIAOPHMUNPPGEN-PEXQALLHSA-N 0.000 description 4
- UWBDLNOCIDGPQE-GUBZILKMSA-N Ile-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN UWBDLNOCIDGPQE-GUBZILKMSA-N 0.000 description 4
- WCNWGAUZWWSYDG-SVSWQMSJSA-N Ile-Thr-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)O)N WCNWGAUZWWSYDG-SVSWQMSJSA-N 0.000 description 4
- IZPVWNSAVUQBGP-CIUDSAMLSA-N Leu-Ser-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IZPVWNSAVUQBGP-CIUDSAMLSA-N 0.000 description 4
- ISHNZELVUVPCHY-ZETCQYMHSA-N Lys-Gly-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O ISHNZELVUVPCHY-ZETCQYMHSA-N 0.000 description 4
- QBEPTBMRQALPEV-MNXVOIDGSA-N Lys-Ile-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCCCN QBEPTBMRQALPEV-MNXVOIDGSA-N 0.000 description 4
- LMKSBGIUPVRHEH-FXQIFTODSA-N Met-Ala-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(N)=O LMKSBGIUPVRHEH-FXQIFTODSA-N 0.000 description 4
- YYEIFXZOBZVDPH-DCAQKATOSA-N Met-Lys-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O YYEIFXZOBZVDPH-DCAQKATOSA-N 0.000 description 4
- LHXFNWBNRBWMNV-DCAQKATOSA-N Met-Ser-His Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N LHXFNWBNRBWMNV-DCAQKATOSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- AUEJLPRZGVVDNU-UHFFFAOYSA-N N-L-tyrosyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-UHFFFAOYSA-N 0.000 description 4
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 4
- 241001644525 Nastus productus Species 0.000 description 4
- 101100342977 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) leu-1 gene Proteins 0.000 description 4
- MIDZLCFIAINOQN-WPRPVWTQSA-N Phe-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 MIDZLCFIAINOQN-WPRPVWTQSA-N 0.000 description 4
- CYZBFPYMSJGBRL-DRZSPHRISA-N Phe-Ala-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CYZBFPYMSJGBRL-DRZSPHRISA-N 0.000 description 4
- VZFPYFRVHMSSNA-JURCDPSOSA-N Phe-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=CC=C1 VZFPYFRVHMSSNA-JURCDPSOSA-N 0.000 description 4
- PEFJUUYFEGBXFA-BZSNNMDCSA-N Phe-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 PEFJUUYFEGBXFA-BZSNNMDCSA-N 0.000 description 4
- 208000035109 Pneumococcal Infections Diseases 0.000 description 4
- 101100172625 Schizosaccharomyces pombe (strain 972 / ATCC 24843) erh1 gene Proteins 0.000 description 4
- 238000012300 Sequence Analysis Methods 0.000 description 4
- LTFSLKWFMWZEBD-IMJSIDKUSA-N Ser-Asn Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O LTFSLKWFMWZEBD-IMJSIDKUSA-N 0.000 description 4
- VBKBDLMWICBSCY-IMJSIDKUSA-N Ser-Asp Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O VBKBDLMWICBSCY-IMJSIDKUSA-N 0.000 description 4
- HMRAQFJFTOLDKW-GUBZILKMSA-N Ser-His-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O HMRAQFJFTOLDKW-GUBZILKMSA-N 0.000 description 4
- PPCZVWHJWJFTFN-ZLUOBGJFSA-N Ser-Ser-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPCZVWHJWJFTFN-ZLUOBGJFSA-N 0.000 description 4
- LDEBVRIURYMKQS-WISUUJSJSA-N Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CO LDEBVRIURYMKQS-WISUUJSJSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 241000680505 Streptococcus pneumoniae WU2 Species 0.000 description 4
- XDARBNMYXKUFOJ-GSSVUCPTSA-N Thr-Asp-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XDARBNMYXKUFOJ-GSSVUCPTSA-N 0.000 description 4
- BVOVIGCHYNFJBZ-JXUBOQSCSA-N Thr-Leu-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O BVOVIGCHYNFJBZ-JXUBOQSCSA-N 0.000 description 4
- VRUFCJZQDACGLH-UVOCVTCTSA-N Thr-Leu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VRUFCJZQDACGLH-UVOCVTCTSA-N 0.000 description 4
- IQHUITKNHOKGFC-MIMYLULJSA-N Thr-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IQHUITKNHOKGFC-MIMYLULJSA-N 0.000 description 4
- MXNAOGFNFNKUPD-JHYOHUSXSA-N Thr-Phe-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MXNAOGFNFNKUPD-JHYOHUSXSA-N 0.000 description 4
- XHWCDRUPDNSDAZ-XKBZYTNZSA-N Thr-Ser-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N)O XHWCDRUPDNSDAZ-XKBZYTNZSA-N 0.000 description 4
- JWHOIHCOHMZSAR-QWRGUYRKSA-N Tyr-Asp-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JWHOIHCOHMZSAR-QWRGUYRKSA-N 0.000 description 4
- NQJDICVXXIMMMB-XDTLVQLUSA-N Tyr-Glu-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O NQJDICVXXIMMMB-XDTLVQLUSA-N 0.000 description 4
- AZZLDIDWPZLCCW-ZEWNOJEFSA-N Tyr-Ile-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O AZZLDIDWPZLCCW-ZEWNOJEFSA-N 0.000 description 4
- AOLHUMAVONBBEZ-STQMWFEESA-N Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AOLHUMAVONBBEZ-STQMWFEESA-N 0.000 description 4
- KLQPIEVIKOQRAW-IZPVPAKOSA-N Tyr-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O KLQPIEVIKOQRAW-IZPVPAKOSA-N 0.000 description 4
- RUCNAYOMFXRIKJ-DCAQKATOSA-N Val-Ala-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN RUCNAYOMFXRIKJ-DCAQKATOSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 108010013835 arginine glutamate Proteins 0.000 description 4
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 4
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 238000010369 molecular cloning Methods 0.000 description 4
- 108010024607 phenylalanylalanine Proteins 0.000 description 4
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 4
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- TTXMOJWKNRJWQJ-FXQIFTODSA-N Ala-Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N TTXMOJWKNRJWQJ-FXQIFTODSA-N 0.000 description 3
- XEXJJJRVTFGWIC-FXQIFTODSA-N Ala-Asn-Arg Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N XEXJJJRVTFGWIC-FXQIFTODSA-N 0.000 description 3
- GSCLWXDNIMNIJE-ZLUOBGJFSA-N Ala-Asp-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O GSCLWXDNIMNIJE-ZLUOBGJFSA-N 0.000 description 3
- GWFSQQNGMPGBEF-GHCJXIJMSA-N Ala-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N GWFSQQNGMPGBEF-GHCJXIJMSA-N 0.000 description 3
- BLIMFWGRQKRCGT-YUMQZZPRSA-N Ala-Gly-Lys Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN BLIMFWGRQKRCGT-YUMQZZPRSA-N 0.000 description 3
- DWYROCSXOOMOEU-CIUDSAMLSA-N Ala-Met-Glu Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N DWYROCSXOOMOEU-CIUDSAMLSA-N 0.000 description 3
- IPWKGIFRRBGCJO-IMJSIDKUSA-N Ala-Ser Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](CO)C([O-])=O IPWKGIFRRBGCJO-IMJSIDKUSA-N 0.000 description 3
- RMAWDDRDTRSZIR-ZLUOBGJFSA-N Ala-Ser-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RMAWDDRDTRSZIR-ZLUOBGJFSA-N 0.000 description 3
- AENHOIXXHKNIQL-AUTRQRHGSA-N Ala-Tyr-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]([NH3+])C)CC1=CC=C(O)C=C1 AENHOIXXHKNIQL-AUTRQRHGSA-N 0.000 description 3
- JQFZHHSQMKZLRU-IUCAKERBSA-N Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N JQFZHHSQMKZLRU-IUCAKERBSA-N 0.000 description 3
- BVLIJXXSXBUGEC-SRVKXCTJSA-N Asn-Asn-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BVLIJXXSXBUGEC-SRVKXCTJSA-N 0.000 description 3
- PPMTUXJSQDNUDE-CIUDSAMLSA-N Asn-Glu-Arg Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PPMTUXJSQDNUDE-CIUDSAMLSA-N 0.000 description 3
- OLVIPTLKNSAYRJ-YUMQZZPRSA-N Asn-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N OLVIPTLKNSAYRJ-YUMQZZPRSA-N 0.000 description 3
- UQBGYPFHWFZMCD-ZLUOBGJFSA-N Asp-Asn-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O UQBGYPFHWFZMCD-ZLUOBGJFSA-N 0.000 description 3
- VILLWIDTHYPSLC-PEFMBERDSA-N Asp-Glu-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VILLWIDTHYPSLC-PEFMBERDSA-N 0.000 description 3
- 241000672609 Escherichia coli BL21 Species 0.000 description 3
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- SBCYJMOOHUDWDA-NUMRIWBASA-N Glu-Asp-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SBCYJMOOHUDWDA-NUMRIWBASA-N 0.000 description 3
- AUTNXSQEVVHSJK-YVNDNENWSA-N Glu-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O AUTNXSQEVVHSJK-YVNDNENWSA-N 0.000 description 3
- LRPXYSGPOBVBEH-IUCAKERBSA-N Glu-Gly-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O LRPXYSGPOBVBEH-IUCAKERBSA-N 0.000 description 3
- YGLCLCMAYUYZSG-AVGNSLFASA-N Glu-Lys-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 YGLCLCMAYUYZSG-AVGNSLFASA-N 0.000 description 3
- HDNXXTBKOJKWNN-WDSKDSINSA-N Gly-Glu-Asn Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O HDNXXTBKOJKWNN-WDSKDSINSA-N 0.000 description 3
- KGVHCTWYMPWEGN-FSPLSTOPSA-N Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CN KGVHCTWYMPWEGN-FSPLSTOPSA-N 0.000 description 3
- IKAIKUBBJHFNBZ-LURJTMIESA-N Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CN IKAIKUBBJHFNBZ-LURJTMIESA-N 0.000 description 3
- KZTLOHBDLMIFSH-XVYDVKMFSA-N His-Ala-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O KZTLOHBDLMIFSH-XVYDVKMFSA-N 0.000 description 3
- STOOMQFEJUVAKR-KKUMJFAQSA-N His-His-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)C1=CNC=N1 STOOMQFEJUVAKR-KKUMJFAQSA-N 0.000 description 3
- CZVQSYNVUHAILZ-UWVGGRQHSA-N His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 CZVQSYNVUHAILZ-UWVGGRQHSA-N 0.000 description 3
- QADCTXFNLZBZAB-GHCJXIJMSA-N Ile-Asn-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)O)N QADCTXFNLZBZAB-GHCJXIJMSA-N 0.000 description 3
- WKXVAXOSIPTXEC-HAFWLYHUSA-N Ile-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O WKXVAXOSIPTXEC-HAFWLYHUSA-N 0.000 description 3
- WIZPFZKOFZXDQG-HTFCKZLJSA-N Ile-Ile-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O WIZPFZKOFZXDQG-HTFCKZLJSA-N 0.000 description 3
- ZUPJCJINYQISSN-XUXIUFHCSA-N Ile-Met-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)N ZUPJCJINYQISSN-XUXIUFHCSA-N 0.000 description 3
- FXJLRZFMKGHYJP-CFMVVWHZSA-N Ile-Tyr-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N FXJLRZFMKGHYJP-CFMVVWHZSA-N 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- KWTVLKBOQATPHJ-SRVKXCTJSA-N Leu-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)N KWTVLKBOQATPHJ-SRVKXCTJSA-N 0.000 description 3
- MLTRLIITQPXHBJ-BQBZGAKWSA-N Leu-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O MLTRLIITQPXHBJ-BQBZGAKWSA-N 0.000 description 3
- MYGQXVYRZMKRDB-SRVKXCTJSA-N Leu-Asp-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN MYGQXVYRZMKRDB-SRVKXCTJSA-N 0.000 description 3
- VCHVSKNMTXWIIP-SRVKXCTJSA-N Leu-Lys-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O VCHVSKNMTXWIIP-SRVKXCTJSA-N 0.000 description 3
- IBSGMIPRBMPMHE-IHRRRGAJSA-N Leu-Met-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(O)=O IBSGMIPRBMPMHE-IHRRRGAJSA-N 0.000 description 3
- AEDWWMMHUGYIFD-HJGDQZAQSA-N Leu-Thr-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O AEDWWMMHUGYIFD-HJGDQZAQSA-N 0.000 description 3
- VDIARPPNADFEAV-WEDXCCLWSA-N Leu-Thr-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O VDIARPPNADFEAV-WEDXCCLWSA-N 0.000 description 3
- FACUGMGEFUEBTI-SRVKXCTJSA-N Lys-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCCN FACUGMGEFUEBTI-SRVKXCTJSA-N 0.000 description 3
- GCMWRRQAKQXDED-IUCAKERBSA-N Lys-Glu-Gly Chemical compound [NH3+]CCCC[C@H]([NH3+])C(=O)N[C@@H](CCC([O-])=O)C(=O)NCC([O-])=O GCMWRRQAKQXDED-IUCAKERBSA-N 0.000 description 3
- LNIIRLODKOWQIY-IHRRRGAJSA-N Phe-Asn-Met Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O LNIIRLODKOWQIY-IHRRRGAJSA-N 0.000 description 3
- HWMGTNOVUDIKRE-UWVGGRQHSA-N Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 HWMGTNOVUDIKRE-UWVGGRQHSA-N 0.000 description 3
- GMWNQSGWWGKTSF-LFSVMHDDSA-N Phe-Thr-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O GMWNQSGWWGKTSF-LFSVMHDDSA-N 0.000 description 3
- 101100460202 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new25 gene Proteins 0.000 description 3
- SSJMZMUVNKEENT-IMJSIDKUSA-N Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CO SSJMZMUVNKEENT-IMJSIDKUSA-N 0.000 description 3
- OLIJLNWFEQEFDM-SRVKXCTJSA-N Ser-Asp-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OLIJLNWFEQEFDM-SRVKXCTJSA-N 0.000 description 3
- UOLGINIHBRIECN-FXQIFTODSA-N Ser-Glu-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UOLGINIHBRIECN-FXQIFTODSA-N 0.000 description 3
- LALNXSXEYFUUDD-GUBZILKMSA-N Ser-Glu-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LALNXSXEYFUUDD-GUBZILKMSA-N 0.000 description 3
- QKQDTEYDEIJPNK-GUBZILKMSA-N Ser-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CO QKQDTEYDEIJPNK-GUBZILKMSA-N 0.000 description 3
- DYEGLQRVMBWQLD-IXOXFDKPSA-N Ser-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CO)N)O DYEGLQRVMBWQLD-IXOXFDKPSA-N 0.000 description 3
- SNXUIBACCONSOH-BWBBJGPYSA-N Ser-Thr-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CO)C(O)=O SNXUIBACCONSOH-BWBBJGPYSA-N 0.000 description 3
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 3
- AQAMPXBRJJWPNI-JHEQGTHGSA-N Thr-Gly-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AQAMPXBRJJWPNI-JHEQGTHGSA-N 0.000 description 3
- JAWUQFCGNVEDRN-MEYUZBJRSA-N Thr-Tyr-Leu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N)O JAWUQFCGNVEDRN-MEYUZBJRSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- GFHYISDTIWZUSU-QWRGUYRKSA-N Tyr-Asn-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GFHYISDTIWZUSU-QWRGUYRKSA-N 0.000 description 3
- GAYLGYUVTDMLKC-UWJYBYFXSA-N Tyr-Asp-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 GAYLGYUVTDMLKC-UWJYBYFXSA-N 0.000 description 3
- 108010045350 alanyl-tyrosyl-alanine Proteins 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 230000005875 antibody response Effects 0.000 description 3
- 108010062796 arginyllysine Proteins 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 3
- 108010077435 glycyl-phenylalanyl-glycine Proteins 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000005847 immunogenicity Effects 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000037432 silent mutation Effects 0.000 description 3
- 238000002741 site-directed mutagenesis Methods 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 108010078580 tyrosylleucine Proteins 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- GGNHBHYDMUDXQB-KBIXCLLPSA-N Ala-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)N GGNHBHYDMUDXQB-KBIXCLLPSA-N 0.000 description 2
- NHLAEBFGWPXFGI-WHFBIAKZSA-N Ala-Gly-Asn Chemical compound C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N NHLAEBFGWPXFGI-WHFBIAKZSA-N 0.000 description 2
- XHNLCGXYBXNRIS-BJDJZHNGSA-N Ala-Lys-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XHNLCGXYBXNRIS-BJDJZHNGSA-N 0.000 description 2
- ZBLQIYPCUWZSRZ-QEJZJMRPSA-N Ala-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 ZBLQIYPCUWZSRZ-QEJZJMRPSA-N 0.000 description 2
- BUQICHWNXBIBOG-LMVFSUKVSA-N Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)N BUQICHWNXBIBOG-LMVFSUKVSA-N 0.000 description 2
- GCTANJIJJROSLH-GVARAGBVSA-N Ala-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C)N GCTANJIJJROSLH-GVARAGBVSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- MAISCYVJLBBRNU-DCAQKATOSA-N Arg-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N MAISCYVJLBBRNU-DCAQKATOSA-N 0.000 description 2
- UFBURHXMKFQVLM-CIUDSAMLSA-N Arg-Glu-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O UFBURHXMKFQVLM-CIUDSAMLSA-N 0.000 description 2
- MSILNNHVVMMTHZ-UWVGGRQHSA-N Arg-His-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CN=CN1 MSILNNHVVMMTHZ-UWVGGRQHSA-N 0.000 description 2
- FFEUXEAKYRCACT-PEDHHIEDSA-N Arg-Ile-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)C(O)=O FFEUXEAKYRCACT-PEDHHIEDSA-N 0.000 description 2
- NMRHDSAOIURTNT-RWMBFGLXSA-N Arg-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N NMRHDSAOIURTNT-RWMBFGLXSA-N 0.000 description 2
- QMQZYILAWUOLPV-JYJNAYRXSA-N Arg-Tyr-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)CC1=CC=C(O)C=C1 QMQZYILAWUOLPV-JYJNAYRXSA-N 0.000 description 2
- XWGJDUSDTRPQRK-ZLUOBGJFSA-N Asn-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O XWGJDUSDTRPQRK-ZLUOBGJFSA-N 0.000 description 2
- HAJWYALLJIATCX-FXQIFTODSA-N Asn-Asn-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N HAJWYALLJIATCX-FXQIFTODSA-N 0.000 description 2
- DAPLJWATMAXPPZ-CIUDSAMLSA-N Asn-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(N)=O DAPLJWATMAXPPZ-CIUDSAMLSA-N 0.000 description 2
- MSBDSTRUMZFSEU-PEFMBERDSA-N Asn-Glu-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MSBDSTRUMZFSEU-PEFMBERDSA-N 0.000 description 2
- KLKHFFMNGWULBN-VKHMYHEASA-N Asn-Gly Chemical compound NC(=O)C[C@H](N)C(=O)NCC(O)=O KLKHFFMNGWULBN-VKHMYHEASA-N 0.000 description 2
- HYQYLOSCICEYTR-YUMQZZPRSA-N Asn-Gly-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O HYQYLOSCICEYTR-YUMQZZPRSA-N 0.000 description 2
- OWUCNXMFJRFOFI-BQBZGAKWSA-N Asn-Gly-Met Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O OWUCNXMFJRFOFI-BQBZGAKWSA-N 0.000 description 2
- WQLJRNRLHWJIRW-KKUMJFAQSA-N Asn-His-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)N)N)O WQLJRNRLHWJIRW-KKUMJFAQSA-N 0.000 description 2
- QJMCHPGWFZZRID-BQBZGAKWSA-N Asn-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(N)=O QJMCHPGWFZZRID-BQBZGAKWSA-N 0.000 description 2
- ZYPWIUFLYMQZBS-SRVKXCTJSA-N Asn-Lys-Lys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N ZYPWIUFLYMQZBS-SRVKXCTJSA-N 0.000 description 2
- RAUPFUCUDBQYHE-AVGNSLFASA-N Asn-Phe-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O RAUPFUCUDBQYHE-AVGNSLFASA-N 0.000 description 2
- REQUGIWGOGSOEZ-ZLUOBGJFSA-N Asn-Ser-Asn Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)C(=O)N REQUGIWGOGSOEZ-ZLUOBGJFSA-N 0.000 description 2
- QYRMBFWDSFGSFC-OLHMAJIHSA-N Asn-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QYRMBFWDSFGSFC-OLHMAJIHSA-N 0.000 description 2
- BLQBMRNMBAYREH-UWJYBYFXSA-N Asp-Ala-Tyr Chemical compound N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O BLQBMRNMBAYREH-UWJYBYFXSA-N 0.000 description 2
- CNKAZIGBGQIHLL-GUBZILKMSA-N Asp-Arg-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N CNKAZIGBGQIHLL-GUBZILKMSA-N 0.000 description 2
- VGRHZPNRCLAHQA-IMJSIDKUSA-N Asp-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O VGRHZPNRCLAHQA-IMJSIDKUSA-N 0.000 description 2
- JHFNSBBHKSZXKB-VKHMYHEASA-N Asp-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(O)=O JHFNSBBHKSZXKB-VKHMYHEASA-N 0.000 description 2
- SNDBKTFJWVEVPO-WHFBIAKZSA-N Asp-Gly-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SNDBKTFJWVEVPO-WHFBIAKZSA-N 0.000 description 2
- RWHHSFSWKFBTCF-KKUMJFAQSA-N Asp-His-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)O)N RWHHSFSWKFBTCF-KKUMJFAQSA-N 0.000 description 2
- SWTQDYFZVOJVLL-KKUMJFAQSA-N Asp-His-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)O)N)O SWTQDYFZVOJVLL-KKUMJFAQSA-N 0.000 description 2
- GWIJZUVQVDJHDI-AVGNSLFASA-N Asp-Phe-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O GWIJZUVQVDJHDI-AVGNSLFASA-N 0.000 description 2
- ZBYLEBZCVKLPCY-FXQIFTODSA-N Asp-Ser-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ZBYLEBZCVKLPCY-FXQIFTODSA-N 0.000 description 2
- XXAMCEGRCZQGEM-ZLUOBGJFSA-N Asp-Ser-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O XXAMCEGRCZQGEM-ZLUOBGJFSA-N 0.000 description 2
- JJQGZGOEDSSHTE-FOHZUACHSA-N Asp-Thr-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O JJQGZGOEDSSHTE-FOHZUACHSA-N 0.000 description 2
- GCACQYDBDHRVGE-LKXGYXEUSA-N Asp-Thr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC(O)=O GCACQYDBDHRVGE-LKXGYXEUSA-N 0.000 description 2
- RSMZEHCMIOKNMW-GSSVUCPTSA-N Asp-Thr-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RSMZEHCMIOKNMW-GSSVUCPTSA-N 0.000 description 2
- UTKUTMJSWKKHEM-WDSKDSINSA-N Glu-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O UTKUTMJSWKKHEM-WDSKDSINSA-N 0.000 description 2
- KKCUFHUTMKQQCF-SRVKXCTJSA-N Glu-Arg-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O KKCUFHUTMKQQCF-SRVKXCTJSA-N 0.000 description 2
- CKRUHITYRFNUKW-WDSKDSINSA-N Glu-Asn-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O CKRUHITYRFNUKW-WDSKDSINSA-N 0.000 description 2
- SVZIKUHLRKVZIF-GUBZILKMSA-N Glu-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N SVZIKUHLRKVZIF-GUBZILKMSA-N 0.000 description 2
- ZOXBSICWUDAOHX-GUBZILKMSA-N Glu-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O ZOXBSICWUDAOHX-GUBZILKMSA-N 0.000 description 2
- FYYSIASRLDJUNP-WHFBIAKZSA-N Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FYYSIASRLDJUNP-WHFBIAKZSA-N 0.000 description 2
- ZJFNRQHUIHKZJF-GUBZILKMSA-N Glu-His-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(O)=O ZJFNRQHUIHKZJF-GUBZILKMSA-N 0.000 description 2
- QLPYYTDOUQNJGQ-AVGNSLFASA-N Glu-His-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N QLPYYTDOUQNJGQ-AVGNSLFASA-N 0.000 description 2
- ATVYZJGOZLVXDK-IUCAKERBSA-N Glu-Leu-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O ATVYZJGOZLVXDK-IUCAKERBSA-N 0.000 description 2
- MWMJCGBSIORNCD-AVGNSLFASA-N Glu-Leu-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O MWMJCGBSIORNCD-AVGNSLFASA-N 0.000 description 2
- NJCALAAIGREHDR-WDCWCFNPSA-N Glu-Leu-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NJCALAAIGREHDR-WDCWCFNPSA-N 0.000 description 2
- IDEODOAVGCMUQV-GUBZILKMSA-N Glu-Ser-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O IDEODOAVGCMUQV-GUBZILKMSA-N 0.000 description 2
- WXONSNSSBYQGNN-AVGNSLFASA-N Glu-Ser-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O WXONSNSSBYQGNN-AVGNSLFASA-N 0.000 description 2
- PMNHJLASAAWELO-FOHZUACHSA-N Gly-Asp-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PMNHJLASAAWELO-FOHZUACHSA-N 0.000 description 2
- IEFJWDNGDZAYNZ-BYPYZUCNSA-N Gly-Glu Chemical compound NCC(=O)N[C@H](C(O)=O)CCC(O)=O IEFJWDNGDZAYNZ-BYPYZUCNSA-N 0.000 description 2
- DKEXFJVMVGETOO-LURJTMIESA-N Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CN DKEXFJVMVGETOO-LURJTMIESA-N 0.000 description 2
- LRQXRHGQEVWGPV-NHCYSSNCSA-N Gly-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN LRQXRHGQEVWGPV-NHCYSSNCSA-N 0.000 description 2
- ZWRDOVYMQAAISL-UWVGGRQHSA-N Gly-Met-Lys Chemical compound CSCC[C@H](NC(=O)CN)C(=O)N[C@H](C(O)=O)CCCCN ZWRDOVYMQAAISL-UWVGGRQHSA-N 0.000 description 2
- GAFKBWKVXNERFA-QWRGUYRKSA-N Gly-Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 GAFKBWKVXNERFA-QWRGUYRKSA-N 0.000 description 2
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 2
- DBUNZBWUWCIELX-JHEQGTHGSA-N Gly-Thr-Glu Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O DBUNZBWUWCIELX-JHEQGTHGSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- VPZXBVLAVMBEQI-VKHMYHEASA-N Glycyl-alanine Chemical compound OC(=O)[C@H](C)NC(=O)CN VPZXBVLAVMBEQI-VKHMYHEASA-N 0.000 description 2
- UWNUQPZUSRFIIN-JUKXBJQTSA-N His-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CN=CN2)N UWNUQPZUSRFIIN-JUKXBJQTSA-N 0.000 description 2
- MRVZCDSYLJXKKX-ACRUOGEOSA-N His-Tyr-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CN=CN3)N MRVZCDSYLJXKKX-ACRUOGEOSA-N 0.000 description 2
- AQCUAZTZSPQJFF-ZKWXMUAHSA-N Ile-Ala-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O AQCUAZTZSPQJFF-ZKWXMUAHSA-N 0.000 description 2
- HYXQKVOADYPQEA-CIUDSAMLSA-N Ile-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HYXQKVOADYPQEA-CIUDSAMLSA-N 0.000 description 2
- LVQDUPQUJZWKSU-PYJNHQTQSA-N Ile-Arg-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N LVQDUPQUJZWKSU-PYJNHQTQSA-N 0.000 description 2
- BCVIOZZGJNOEQS-XKNYDFJKSA-N Ile-Ile Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)[C@@H](C)CC BCVIOZZGJNOEQS-XKNYDFJKSA-N 0.000 description 2
- SJLVSMMIFYTSGY-GRLWGSQLSA-N Ile-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SJLVSMMIFYTSGY-GRLWGSQLSA-N 0.000 description 2
- ZLFNNVATRMCAKN-ZKWXMUAHSA-N Ile-Ser-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N ZLFNNVATRMCAKN-ZKWXMUAHSA-N 0.000 description 2
- NURNJECQNNCRBK-FLBSBUHZSA-N Ile-Thr-Thr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NURNJECQNNCRBK-FLBSBUHZSA-N 0.000 description 2
- 206010061598 Immunodeficiency Diseases 0.000 description 2
- 108010065920 Insulin Lispro Proteins 0.000 description 2
- WNGVUZWBXZKQES-YUMQZZPRSA-N Leu-Ala-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O WNGVUZWBXZKQES-YUMQZZPRSA-N 0.000 description 2
- LIINDKYIGYTDLG-PPCPHDFISA-N Leu-Ile-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LIINDKYIGYTDLG-PPCPHDFISA-N 0.000 description 2
- PTRKPHUGYULXPU-KKUMJFAQSA-N Leu-Phe-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O PTRKPHUGYULXPU-KKUMJFAQSA-N 0.000 description 2
- XGDCYUQSFDQISZ-BQBZGAKWSA-N Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O XGDCYUQSFDQISZ-BQBZGAKWSA-N 0.000 description 2
- JIHDFWWRYHSAQB-GUBZILKMSA-N Leu-Ser-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O JIHDFWWRYHSAQB-GUBZILKMSA-N 0.000 description 2
- LFSQWRSVPNKJGP-WDCWCFNPSA-N Leu-Thr-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(O)=O LFSQWRSVPNKJGP-WDCWCFNPSA-N 0.000 description 2
- BTEMNFBEAAOGBR-BZSNNMDCSA-N Leu-Tyr-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCCN)C(=O)O)N BTEMNFBEAAOGBR-BZSNNMDCSA-N 0.000 description 2
- ALSRJRIWBNENFY-DCAQKATOSA-N Lys-Arg-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O ALSRJRIWBNENFY-DCAQKATOSA-N 0.000 description 2
- JPNRPAJITHRXRH-BQBZGAKWSA-N Lys-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O JPNRPAJITHRXRH-BQBZGAKWSA-N 0.000 description 2
- QYOXSYXPHUHOJR-GUBZILKMSA-N Lys-Asn-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QYOXSYXPHUHOJR-GUBZILKMSA-N 0.000 description 2
- UGTZHPSKYRIGRJ-YUMQZZPRSA-N Lys-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O UGTZHPSKYRIGRJ-YUMQZZPRSA-N 0.000 description 2
- GJJQCBVRWDGLMQ-GUBZILKMSA-N Lys-Glu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O GJJQCBVRWDGLMQ-GUBZILKMSA-N 0.000 description 2
- NVGBPTNZLWRQSY-UWVGGRQHSA-N Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN NVGBPTNZLWRQSY-UWVGGRQHSA-N 0.000 description 2
- UQRZFMQQXXJTTF-AVGNSLFASA-N Lys-Lys-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O UQRZFMQQXXJTTF-AVGNSLFASA-N 0.000 description 2
- GHKXHCMRAUYLBS-CIUDSAMLSA-N Lys-Ser-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O GHKXHCMRAUYLBS-CIUDSAMLSA-N 0.000 description 2
- MGKFCQFVPKOWOL-CIUDSAMLSA-N Lys-Ser-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)N MGKFCQFVPKOWOL-CIUDSAMLSA-N 0.000 description 2
- JMNRXRPBHFGXQX-GUBZILKMSA-N Lys-Ser-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O JMNRXRPBHFGXQX-GUBZILKMSA-N 0.000 description 2
- DIBZLYZXTSVGLN-CIUDSAMLSA-N Lys-Ser-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O DIBZLYZXTSVGLN-CIUDSAMLSA-N 0.000 description 2
- GIKFNMZSGYAPEJ-HJGDQZAQSA-N Lys-Thr-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O GIKFNMZSGYAPEJ-HJGDQZAQSA-N 0.000 description 2
- PPNCMJARTHYNEC-MEYUZBJRSA-N Lys-Tyr-Thr Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@H](O)C)C(O)=O)CC1=CC=C(O)C=C1 PPNCMJARTHYNEC-MEYUZBJRSA-N 0.000 description 2
- OSOLWRWQADPDIQ-DCAQKATOSA-N Met-Asp-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O OSOLWRWQADPDIQ-DCAQKATOSA-N 0.000 description 2
- HOZNVKDCKZPRER-XUXIUFHCSA-N Met-Lys-Ile Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HOZNVKDCKZPRER-XUXIUFHCSA-N 0.000 description 2
- RMLLCGYYVZKKRT-CIUDSAMLSA-N Met-Ser-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O RMLLCGYYVZKKRT-CIUDSAMLSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- BXNGIHFNNNSEOS-UWVGGRQHSA-N Phe-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 BXNGIHFNNNSEOS-UWVGGRQHSA-N 0.000 description 2
- HTTYNOXBBOWZTB-SRVKXCTJSA-N Phe-Asn-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N HTTYNOXBBOWZTB-SRVKXCTJSA-N 0.000 description 2
- KLYYKKGCPOGDPE-OEAJRASXSA-N Phe-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O KLYYKKGCPOGDPE-OEAJRASXSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 description 2
- 238000012181 QIAquick gel extraction kit Methods 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 101100167780 Schizosaccharomyces pombe (strain 972 / ATCC 24843) coa2 gene Proteins 0.000 description 2
- WXUBSIDKNMFAGS-IHRRRGAJSA-N Ser-Arg-Tyr Chemical compound NC(N)=NCCC[C@H](NC(=O)[C@H](CO)N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WXUBSIDKNMFAGS-IHRRRGAJSA-N 0.000 description 2
- WXWDPFVKQRVJBJ-CIUDSAMLSA-N Ser-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N WXWDPFVKQRVJBJ-CIUDSAMLSA-N 0.000 description 2
- GZBKRJVCRMZAST-XKBZYTNZSA-N Ser-Glu-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GZBKRJVCRMZAST-XKBZYTNZSA-N 0.000 description 2
- JFWDJFULOLKQFY-QWRGUYRKSA-N Ser-Gly-Phe Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JFWDJFULOLKQFY-QWRGUYRKSA-N 0.000 description 2
- RJHJPZQOMKCSTP-CIUDSAMLSA-N Ser-His-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O RJHJPZQOMKCSTP-CIUDSAMLSA-N 0.000 description 2
- QGAHMVHBORDHDC-YUMQZZPRSA-N Ser-His-Gly Chemical compound OC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CN=CN1 QGAHMVHBORDHDC-YUMQZZPRSA-N 0.000 description 2
- NBUKGEFVZJMSIS-XIRDDKMYSA-N Ser-His-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CO)N NBUKGEFVZJMSIS-XIRDDKMYSA-N 0.000 description 2
- BXLYSRPHVMCOPS-ACZMJKKPSA-N Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CO BXLYSRPHVMCOPS-ACZMJKKPSA-N 0.000 description 2
- NNFMANHDYSVNIO-DCAQKATOSA-N Ser-Lys-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NNFMANHDYSVNIO-DCAQKATOSA-N 0.000 description 2
- XZKQVQKUZMAADP-IMJSIDKUSA-N Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(O)=O XZKQVQKUZMAADP-IMJSIDKUSA-N 0.000 description 2
- UBTNVMGPMYDYIU-HJPIBITLSA-N Ser-Tyr-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UBTNVMGPMYDYIU-HJPIBITLSA-N 0.000 description 2
- ZVBCMFDJIMUELU-BZSNNMDCSA-N Ser-Tyr-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)N ZVBCMFDJIMUELU-BZSNNMDCSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- WFUAUEQXPVNAEF-ZJDVBMNYSA-N Thr-Arg-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CCCN=C(N)N WFUAUEQXPVNAEF-ZJDVBMNYSA-N 0.000 description 2
- UQTNIFUCMBFWEJ-IWGUZYHVSA-N Thr-Asn Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O UQTNIFUCMBFWEJ-IWGUZYHVSA-N 0.000 description 2
- NOWXWJLVGTVJKM-PBCZWWQYSA-N Thr-Asp-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O NOWXWJLVGTVJKM-PBCZWWQYSA-N 0.000 description 2
- XFTYVCHLARBHBQ-FOHZUACHSA-N Thr-Gly-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O XFTYVCHLARBHBQ-FOHZUACHSA-N 0.000 description 2
- GXDLGHLJTHMDII-WISUUJSJSA-N Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(O)=O GXDLGHLJTHMDII-WISUUJSJSA-N 0.000 description 2
- AAZOYLQUEQRUMZ-GSSVUCPTSA-N Thr-Thr-Asn Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(N)=O AAZOYLQUEQRUMZ-GSSVUCPTSA-N 0.000 description 2
- GQEXFCQNAJHJTI-IHPCNDPISA-N Trp-Phe-Asp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N GQEXFCQNAJHJTI-IHPCNDPISA-N 0.000 description 2
- PDSLRCZINIDLMU-QWRGUYRKSA-N Tyr-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PDSLRCZINIDLMU-QWRGUYRKSA-N 0.000 description 2
- NZFCWALTLNFHHC-JYJNAYRXSA-N Tyr-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NZFCWALTLNFHHC-JYJNAYRXSA-N 0.000 description 2
- HHFMNAVFGBYSAT-IGISWZIWSA-N Tyr-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N HHFMNAVFGBYSAT-IGISWZIWSA-N 0.000 description 2
- GULIUBBXCYPDJU-CQDKDKBSSA-N Tyr-Leu-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 GULIUBBXCYPDJU-CQDKDKBSSA-N 0.000 description 2
- KSCVLGXNQXKUAR-JYJNAYRXSA-N Tyr-Leu-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O KSCVLGXNQXKUAR-JYJNAYRXSA-N 0.000 description 2
- GZOCMHSZGGJBCX-ULQDDVLXSA-N Tyr-Lys-Met Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(O)=O GZOCMHSZGGJBCX-ULQDDVLXSA-N 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 229920001429 chelating resin Polymers 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000007330 chocolate agar Substances 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 239000013599 cloning vector Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 108010040030 histidinoalanine Proteins 0.000 description 2
- -1 i.e. Polymers 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- DVCSNHXRZUVYAM-BQBZGAKWSA-N leu-asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O DVCSNHXRZUVYAM-BQBZGAKWSA-N 0.000 description 2
- 108010076756 leucyl-alanyl-phenylalanine Proteins 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000001823 molecular biology technique Methods 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 229940124733 pneumococcal vaccine Drugs 0.000 description 2
- 229960001973 pneumococcal vaccines Drugs 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N serine Chemical compound OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- 108010031491 threonyl-lysyl-glutamic acid Proteins 0.000 description 2
- 108010072986 threonyl-seryl-lysine Proteins 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 108010035534 tyrosyl-leucyl-alanine Proteins 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 101150033839 4 gene Proteins 0.000 description 1
- 108010036211 5-HT-moduline Proteins 0.000 description 1
- HHGYNJRJIINWAK-FXQIFTODSA-N Ala-Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HHGYNJRJIINWAK-FXQIFTODSA-N 0.000 description 1
- YLTKNGYYPIWKHZ-ACZMJKKPSA-N Ala-Ala-Glu Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O YLTKNGYYPIWKHZ-ACZMJKKPSA-N 0.000 description 1
- JBGSZRYCXBPWGX-BQBZGAKWSA-N Ala-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N JBGSZRYCXBPWGX-BQBZGAKWSA-N 0.000 description 1
- SKHCUBQVZJHOFM-NAKRPEOUSA-N Ala-Arg-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SKHCUBQVZJHOFM-NAKRPEOUSA-N 0.000 description 1
- CVGNCMIULZNYES-WHFBIAKZSA-N Ala-Asn-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O CVGNCMIULZNYES-WHFBIAKZSA-N 0.000 description 1
- XQGIRPGAVLFKBJ-CIUDSAMLSA-N Ala-Asn-Lys Chemical compound N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O XQGIRPGAVLFKBJ-CIUDSAMLSA-N 0.000 description 1
- XAEWTDMGFGHWFK-IMJSIDKUSA-N Ala-Asp Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O XAEWTDMGFGHWFK-IMJSIDKUSA-N 0.000 description 1
- NHCPCLJZRSIDHS-ZLUOBGJFSA-N Ala-Asp-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O NHCPCLJZRSIDHS-ZLUOBGJFSA-N 0.000 description 1
- BTYTYHBSJKQBQA-GCJQMDKQSA-N Ala-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N)O BTYTYHBSJKQBQA-GCJQMDKQSA-N 0.000 description 1
- MPLOSMWGDNJSEV-WHFBIAKZSA-N Ala-Gly-Asp Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MPLOSMWGDNJSEV-WHFBIAKZSA-N 0.000 description 1
- BEMGNWZECGIJOI-WDSKDSINSA-N Ala-Gly-Glu Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O BEMGNWZECGIJOI-WDSKDSINSA-N 0.000 description 1
- NBTGEURICRTMGL-WHFBIAKZSA-N Ala-Gly-Ser Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O NBTGEURICRTMGL-WHFBIAKZSA-N 0.000 description 1
- ZSOICJZJSRWNHX-ACZMJKKPSA-N Ala-Ile Chemical compound CC[C@H](C)[C@@H](C([O-])=O)NC(=O)[C@H](C)[NH3+] ZSOICJZJSRWNHX-ACZMJKKPSA-N 0.000 description 1
- NMXKFWOEASXOGB-QSFUFRPTSA-N Ala-Ile-His Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 NMXKFWOEASXOGB-QSFUFRPTSA-N 0.000 description 1
- QUIGLPSHIFPEOV-CIUDSAMLSA-N Ala-Lys-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O QUIGLPSHIFPEOV-CIUDSAMLSA-N 0.000 description 1
- AJBVYEYZVYPFCF-CIUDSAMLSA-N Ala-Lys-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O AJBVYEYZVYPFCF-CIUDSAMLSA-N 0.000 description 1
- SDZRIBWEVVRDQI-CIUDSAMLSA-N Ala-Lys-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O SDZRIBWEVVRDQI-CIUDSAMLSA-N 0.000 description 1
- OINVDEKBKBCPLX-JXUBOQSCSA-N Ala-Lys-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OINVDEKBKBCPLX-JXUBOQSCSA-N 0.000 description 1
- FSHURBQASBLAPO-WDSKDSINSA-N Ala-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](C)N FSHURBQASBLAPO-WDSKDSINSA-N 0.000 description 1
- OMDNCNKNEGFOMM-BQBZGAKWSA-N Ala-Met-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)NCC(O)=O OMDNCNKNEGFOMM-BQBZGAKWSA-N 0.000 description 1
- SYIFFFHSXBNPMC-UWJYBYFXSA-N Ala-Ser-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N SYIFFFHSXBNPMC-UWJYBYFXSA-N 0.000 description 1
- KTXKIYXZQFWJKB-VZFHVOOUSA-N Ala-Thr-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O KTXKIYXZQFWJKB-VZFHVOOUSA-N 0.000 description 1
- IETUUAHKCHOQHP-KZVJFYERSA-N Ala-Thr-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)C(O)=O IETUUAHKCHOQHP-KZVJFYERSA-N 0.000 description 1
- LYILPUNCKACNGF-NAKRPEOUSA-N Ala-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)N LYILPUNCKACNGF-NAKRPEOUSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- JSLGXODUIAFWCF-WDSKDSINSA-N Arg-Asn Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O JSLGXODUIAFWCF-WDSKDSINSA-N 0.000 description 1
- JSHVMZANPXCDTL-GMOBBJLQSA-N Arg-Asp-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JSHVMZANPXCDTL-GMOBBJLQSA-N 0.000 description 1
- PNQWAUXQDBIJDY-GUBZILKMSA-N Arg-Glu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNQWAUXQDBIJDY-GUBZILKMSA-N 0.000 description 1
- SKTGPBFTMNLIHQ-KKUMJFAQSA-N Arg-Glu-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SKTGPBFTMNLIHQ-KKUMJFAQSA-N 0.000 description 1
- BNODVYXZAAXSHW-IUCAKERBSA-N Arg-His Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 BNODVYXZAAXSHW-IUCAKERBSA-N 0.000 description 1
- UBCPNBUIQNMDNH-NAKRPEOUSA-N Arg-Ile-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O UBCPNBUIQNMDNH-NAKRPEOUSA-N 0.000 description 1
- FLYANDHDFRGGTM-PYJNHQTQSA-N Arg-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N FLYANDHDFRGGTM-PYJNHQTQSA-N 0.000 description 1
- UZGFHWIJWPUPOH-IHRRRGAJSA-N Arg-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UZGFHWIJWPUPOH-IHRRRGAJSA-N 0.000 description 1
- COXMUHNBYCVVRG-DCAQKATOSA-N Arg-Leu-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O COXMUHNBYCVVRG-DCAQKATOSA-N 0.000 description 1
- XNSKSTRGQIPTSE-ACZMJKKPSA-N Arg-Thr Chemical compound C[C@@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O XNSKSTRGQIPTSE-ACZMJKKPSA-N 0.000 description 1
- QHUOOCKNNURZSL-IHRRRGAJSA-N Arg-Tyr-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O QHUOOCKNNURZSL-IHRRRGAJSA-N 0.000 description 1
- CMLGVVWQQHUXOZ-GHCJXIJMSA-N Asn-Ala-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O CMLGVVWQQHUXOZ-GHCJXIJMSA-N 0.000 description 1
- NPDLYUOYAGBHFB-WDSKDSINSA-N Asn-Arg Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NPDLYUOYAGBHFB-WDSKDSINSA-N 0.000 description 1
- KXEGPPNPXOKKHK-ZLUOBGJFSA-N Asn-Asp-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O KXEGPPNPXOKKHK-ZLUOBGJFSA-N 0.000 description 1
- XSGBIBGAMKTHMY-WHFBIAKZSA-N Asn-Asp-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O XSGBIBGAMKTHMY-WHFBIAKZSA-N 0.000 description 1
- OPEPUCYIGFEGSW-WDSKDSINSA-N Asn-Gly-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O OPEPUCYIGFEGSW-WDSKDSINSA-N 0.000 description 1
- JQSWHKKUZMTOIH-QWRGUYRKSA-N Asn-Gly-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N JQSWHKKUZMTOIH-QWRGUYRKSA-N 0.000 description 1
- FTCGGKNCJZOPNB-WHFBIAKZSA-N Asn-Gly-Ser Chemical compound NC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FTCGGKNCJZOPNB-WHFBIAKZSA-N 0.000 description 1
- MQLZLIYPFDIDMZ-HAFWLYHUSA-N Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(N)=O MQLZLIYPFDIDMZ-HAFWLYHUSA-N 0.000 description 1
- NYGILGUOUOXGMJ-YUMQZZPRSA-N Asn-Lys-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O NYGILGUOUOXGMJ-YUMQZZPRSA-N 0.000 description 1
- JWKDQOORUCYUIW-ZPFDUUQYSA-N Asn-Lys-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JWKDQOORUCYUIW-ZPFDUUQYSA-N 0.000 description 1
- MYVBTYXSWILFCG-BQBZGAKWSA-N Asn-Met-Gly Chemical compound CSCC[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC(=O)N)N MYVBTYXSWILFCG-BQBZGAKWSA-N 0.000 description 1
- AEZCCDMZZJOGII-DCAQKATOSA-N Asn-Met-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O AEZCCDMZZJOGII-DCAQKATOSA-N 0.000 description 1
- GMUOCGCDOYYWPD-FXQIFTODSA-N Asn-Pro-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O GMUOCGCDOYYWPD-FXQIFTODSA-N 0.000 description 1
- SONUFGRSSMFHFN-IMJSIDKUSA-N Asn-Ser Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O SONUFGRSSMFHFN-IMJSIDKUSA-N 0.000 description 1
- VWADICJNCPFKJS-ZLUOBGJFSA-N Asn-Ser-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O VWADICJNCPFKJS-ZLUOBGJFSA-N 0.000 description 1
- MKJBPDLENBUHQU-CIUDSAMLSA-N Asn-Ser-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O MKJBPDLENBUHQU-CIUDSAMLSA-N 0.000 description 1
- YSYTWUMRHSFODC-QWRGUYRKSA-N Asn-Tyr-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O YSYTWUMRHSFODC-QWRGUYRKSA-N 0.000 description 1
- KDFQZBWWPYQBEN-ZLUOBGJFSA-N Asp-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N KDFQZBWWPYQBEN-ZLUOBGJFSA-N 0.000 description 1
- XEDQMTWEYFBOIK-ACZMJKKPSA-N Asp-Ala-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O XEDQMTWEYFBOIK-ACZMJKKPSA-N 0.000 description 1
- XBQSLMACWDXWLJ-GHCJXIJMSA-N Asp-Ala-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XBQSLMACWDXWLJ-GHCJXIJMSA-N 0.000 description 1
- YNQIDCRRTWGHJD-ZLUOBGJFSA-N Asp-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(O)=O YNQIDCRRTWGHJD-ZLUOBGJFSA-N 0.000 description 1
- BUVNWKQBMZLCDW-UGYAYLCHSA-N Asp-Asn-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BUVNWKQBMZLCDW-UGYAYLCHSA-N 0.000 description 1
- UGKZHCBLMLSANF-CIUDSAMLSA-N Asp-Asn-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O UGKZHCBLMLSANF-CIUDSAMLSA-N 0.000 description 1
- TVVYVAUGRHNTGT-UGYAYLCHSA-N Asp-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O TVVYVAUGRHNTGT-UGYAYLCHSA-N 0.000 description 1
- GHODABZPVZMWCE-FXQIFTODSA-N Asp-Glu-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O GHODABZPVZMWCE-FXQIFTODSA-N 0.000 description 1
- WBDWQKRLTVCDSY-WHFBIAKZSA-N Asp-Gly-Asp Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O WBDWQKRLTVCDSY-WHFBIAKZSA-N 0.000 description 1
- HSPSXROIMXIJQW-BQBZGAKWSA-N Asp-His Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 HSPSXROIMXIJQW-BQBZGAKWSA-N 0.000 description 1
- ILQCHXURSRRIRY-YUMQZZPRSA-N Asp-His-Gly Chemical compound C1=C(NC=N1)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC(=O)O)N ILQCHXURSRRIRY-YUMQZZPRSA-N 0.000 description 1
- WSXDIZFNQYTUJB-SRVKXCTJSA-N Asp-His-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O WSXDIZFNQYTUJB-SRVKXCTJSA-N 0.000 description 1
- BSWHERGFUNMWGS-UHFFFAOYSA-N Asp-Ile Chemical compound CCC(C)C(C(O)=O)NC(=O)C(N)CC(O)=O BSWHERGFUNMWGS-UHFFFAOYSA-N 0.000 description 1
- NHSDEZURHWEZPN-SXTJYALSSA-N Asp-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CC(=O)O)N NHSDEZURHWEZPN-SXTJYALSSA-N 0.000 description 1
- HOBNTSHITVVNBN-ZPFDUUQYSA-N Asp-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N HOBNTSHITVVNBN-ZPFDUUQYSA-N 0.000 description 1
- DWOGMPWRQQWPPF-GUBZILKMSA-N Asp-Leu-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O DWOGMPWRQQWPPF-GUBZILKMSA-N 0.000 description 1
- OAMLVOVXNKILLQ-BQBZGAKWSA-N Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O OAMLVOVXNKILLQ-BQBZGAKWSA-N 0.000 description 1
- VSMYBNPOHYAXSD-GUBZILKMSA-N Asp-Lys-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O VSMYBNPOHYAXSD-GUBZILKMSA-N 0.000 description 1
- DINOVZWPTMGSRF-QXEWZRGKSA-N Asp-Pro-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O DINOVZWPTMGSRF-QXEWZRGKSA-N 0.000 description 1
- WMLFFCRUSPNENW-ZLUOBGJFSA-N Asp-Ser-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O WMLFFCRUSPNENW-ZLUOBGJFSA-N 0.000 description 1
- JSHWXQIZOCVWIA-ZKWXMUAHSA-N Asp-Ser-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O JSHWXQIZOCVWIA-ZKWXMUAHSA-N 0.000 description 1
- GXHDGYOXPNQCKM-XVSYOHENSA-N Asp-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O GXHDGYOXPNQCKM-XVSYOHENSA-N 0.000 description 1
- BJDHEININLSZOT-KKUMJFAQSA-N Asp-Tyr-Lys Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(O)=O BJDHEININLSZOT-KKUMJFAQSA-N 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 238000000035 BCA protein assay Methods 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 102100021277 Beta-secretase 2 Human genes 0.000 description 1
- 101710150190 Beta-secretase 2 Proteins 0.000 description 1
- 101100380241 Caenorhabditis elegans arx-2 gene Proteins 0.000 description 1
- 101100512078 Caenorhabditis elegans lys-1 gene Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108010060123 Conjugate Vaccines Proteins 0.000 description 1
- KKZHXOOZHFABQQ-UWJYBYFXSA-N Cys-Ala-Tyr Chemical compound SC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KKZHXOOZHFABQQ-UWJYBYFXSA-N 0.000 description 1
- IXPSSIBVVKSOIE-SRVKXCTJSA-N Cys-Ser-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)N)O IXPSSIBVVKSOIE-SRVKXCTJSA-N 0.000 description 1
- 102100035861 Cytosolic 5'-nucleotidase 1A Human genes 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 238000000729 Fisher's exact test Methods 0.000 description 1
- RLZBLVSJDFHDBL-KBIXCLLPSA-N Glu-Ala-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RLZBLVSJDFHDBL-KBIXCLLPSA-N 0.000 description 1
- ITYRYNUZHPNCIK-GUBZILKMSA-N Glu-Ala-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O ITYRYNUZHPNCIK-GUBZILKMSA-N 0.000 description 1
- IRDASPPCLZIERZ-XHNCKOQMSA-N Glu-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N IRDASPPCLZIERZ-XHNCKOQMSA-N 0.000 description 1
- KBKGRMNVKPSQIF-XDTLVQLUSA-N Glu-Ala-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KBKGRMNVKPSQIF-XDTLVQLUSA-N 0.000 description 1
- XXCDTYBVGMPIOA-FXQIFTODSA-N Glu-Asp-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XXCDTYBVGMPIOA-FXQIFTODSA-N 0.000 description 1
- CGOHAEBMDSEKFB-FXQIFTODSA-N Glu-Glu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O CGOHAEBMDSEKFB-FXQIFTODSA-N 0.000 description 1
- IQACOVZVOMVILH-FXQIFTODSA-N Glu-Glu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O IQACOVZVOMVILH-FXQIFTODSA-N 0.000 description 1
- LSPKYLAFTPBWIL-BYPYZUCNSA-N Glu-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(O)=O LSPKYLAFTPBWIL-BYPYZUCNSA-N 0.000 description 1
- MTAOBYXRYJZRGQ-WDSKDSINSA-N Glu-Gly-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MTAOBYXRYJZRGQ-WDSKDSINSA-N 0.000 description 1
- CUXJIASLBRJOFV-LAEOZQHASA-N Glu-Gly-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O CUXJIASLBRJOFV-LAEOZQHASA-N 0.000 description 1
- WVTIBGWZUMJBFY-GUBZILKMSA-N Glu-His-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O WVTIBGWZUMJBFY-GUBZILKMSA-N 0.000 description 1
- SNFUTDLOCQQRQD-ZKWXMUAHSA-N Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O SNFUTDLOCQQRQD-ZKWXMUAHSA-N 0.000 description 1
- CXRWMMRLEMVSEH-PEFMBERDSA-N Glu-Ile-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O CXRWMMRLEMVSEH-PEFMBERDSA-N 0.000 description 1
- XTZDZAXYPDISRR-MNXVOIDGSA-N Glu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N XTZDZAXYPDISRR-MNXVOIDGSA-N 0.000 description 1
- YBAFDPFAUTYYRW-YUMQZZPRSA-N Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O YBAFDPFAUTYYRW-YUMQZZPRSA-N 0.000 description 1
- FBEJIDRSQCGFJI-GUBZILKMSA-N Glu-Leu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FBEJIDRSQCGFJI-GUBZILKMSA-N 0.000 description 1
- IOUQWHIEQYQVFD-JYJNAYRXSA-N Glu-Leu-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O IOUQWHIEQYQVFD-JYJNAYRXSA-N 0.000 description 1
- SWRVAQHFBRZVNX-GUBZILKMSA-N Glu-Lys-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O SWRVAQHFBRZVNX-GUBZILKMSA-N 0.000 description 1
- OCJRHJZKGGSPRW-IUCAKERBSA-N Glu-Lys-Gly Chemical compound NCCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O OCJRHJZKGGSPRW-IUCAKERBSA-N 0.000 description 1
- SUIAHERNFYRBDZ-GVXVVHGQSA-N Glu-Lys-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O SUIAHERNFYRBDZ-GVXVVHGQSA-N 0.000 description 1
- QOXDAWODGSIDDI-GUBZILKMSA-N Glu-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N QOXDAWODGSIDDI-GUBZILKMSA-N 0.000 description 1
- JSIQVRIXMINMTA-ZDLURKLDSA-N Glu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O JSIQVRIXMINMTA-ZDLURKLDSA-N 0.000 description 1
- HZISRJBYZAODRV-XQXXSGGOSA-N Glu-Thr-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O HZISRJBYZAODRV-XQXXSGGOSA-N 0.000 description 1
- QCMVGXDELYMZET-GLLZPBPUSA-N Glu-Thr-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QCMVGXDELYMZET-GLLZPBPUSA-N 0.000 description 1
- CAQXJMUDOLSBPF-SUSMZKCASA-N Glu-Thr-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAQXJMUDOLSBPF-SUSMZKCASA-N 0.000 description 1
- DXMOIVCNJIJQSC-QEJZJMRPSA-N Glu-Trp-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N DXMOIVCNJIJQSC-QEJZJMRPSA-N 0.000 description 1
- RMWAOBGCZZSJHE-UMNHJUIQSA-N Glu-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N RMWAOBGCZZSJHE-UMNHJUIQSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- JBRBACJPBZNFMF-YUMQZZPRSA-N Gly-Ala-Lys Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN JBRBACJPBZNFMF-YUMQZZPRSA-N 0.000 description 1
- XCLCVBYNGXEVDU-WHFBIAKZSA-N Gly-Asn-Ser Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O XCLCVBYNGXEVDU-WHFBIAKZSA-N 0.000 description 1
- SCCPDJAQCXWPTF-VKHMYHEASA-N Gly-Asp Chemical compound NCC(=O)N[C@H](C(O)=O)CC(O)=O SCCPDJAQCXWPTF-VKHMYHEASA-N 0.000 description 1
- KQDMENMTYNBWMR-WHFBIAKZSA-N Gly-Asp-Ala Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O KQDMENMTYNBWMR-WHFBIAKZSA-N 0.000 description 1
- MHHUEAIBJZWDBH-YUMQZZPRSA-N Gly-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN MHHUEAIBJZWDBH-YUMQZZPRSA-N 0.000 description 1
- LCNXZQROPKFGQK-WHFBIAKZSA-N Gly-Asp-Ser Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O LCNXZQROPKFGQK-WHFBIAKZSA-N 0.000 description 1
- JSNNHGHYGYMVCK-XVKPBYJWSA-N Gly-Glu-Val Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O JSNNHGHYGYMVCK-XVKPBYJWSA-N 0.000 description 1
- UQJNXZSSGQIPIQ-FBCQKBJTSA-N Gly-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)CN UQJNXZSSGQIPIQ-FBCQKBJTSA-N 0.000 description 1
- INLIXXRWNUKVCF-JTQLQIEISA-N Gly-Gly-Tyr Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 INLIXXRWNUKVCF-JTQLQIEISA-N 0.000 description 1
- LPCKHUXOGVNZRS-YUMQZZPRSA-N Gly-His-Ser Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O LPCKHUXOGVNZRS-YUMQZZPRSA-N 0.000 description 1
- CCBIBMKQNXHNIN-ZETCQYMHSA-N Gly-Leu-Gly Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CCBIBMKQNXHNIN-ZETCQYMHSA-N 0.000 description 1
- NNCSJUBVFBDDLC-YUMQZZPRSA-N Gly-Leu-Ser Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O NNCSJUBVFBDDLC-YUMQZZPRSA-N 0.000 description 1
- BXICSAQLIHFDDL-YUMQZZPRSA-N Gly-Lys-Asn Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BXICSAQLIHFDDL-YUMQZZPRSA-N 0.000 description 1
- PTIIBFKSLCYQBO-NHCYSSNCSA-N Gly-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CN PTIIBFKSLCYQBO-NHCYSSNCSA-N 0.000 description 1
- IGOYNRWLWHWAQO-JTQLQIEISA-N Gly-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 IGOYNRWLWHWAQO-JTQLQIEISA-N 0.000 description 1
- IRJWAYCXIYUHQE-WHFBIAKZSA-N Gly-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CN IRJWAYCXIYUHQE-WHFBIAKZSA-N 0.000 description 1
- JQFILXICXLDTRR-FBCQKBJTSA-N Gly-Thr-Gly Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)NCC(O)=O JQFILXICXLDTRR-FBCQKBJTSA-N 0.000 description 1
- XHVONGZZVUUORG-WEDXCCLWSA-N Gly-Thr-Lys Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN XHVONGZZVUUORG-WEDXCCLWSA-N 0.000 description 1
- DNAZKGFYFRGZIH-QWRGUYRKSA-N Gly-Tyr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 DNAZKGFYFRGZIH-QWRGUYRKSA-N 0.000 description 1
- MJNWEIMBXKKCSF-XVYDVKMFSA-N His-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N MJNWEIMBXKKCSF-XVYDVKMFSA-N 0.000 description 1
- YPLYIXGKCRQZGW-SRVKXCTJSA-N His-Arg-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O YPLYIXGKCRQZGW-SRVKXCTJSA-N 0.000 description 1
- ZPVJJPAIUZLSNE-DCAQKATOSA-N His-Arg-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O ZPVJJPAIUZLSNE-DCAQKATOSA-N 0.000 description 1
- JWTKVPMQCCRPQY-SRVKXCTJSA-N His-Asn-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JWTKVPMQCCRPQY-SRVKXCTJSA-N 0.000 description 1
- HRGGKHFHRSFSDE-CIUDSAMLSA-N His-Asn-Ser Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N HRGGKHFHRSFSDE-CIUDSAMLSA-N 0.000 description 1
- RXVOMIADLXPJGW-GUBZILKMSA-N His-Asp-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O RXVOMIADLXPJGW-GUBZILKMSA-N 0.000 description 1
- BDHUXUFYNUOUIT-SRVKXCTJSA-N His-Asp-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N BDHUXUFYNUOUIT-SRVKXCTJSA-N 0.000 description 1
- LYCVKHSJGDMDLM-LURJTMIESA-N His-Gly Chemical compound OC(=O)CNC(=O)[C@@H](N)CC1=CN=CN1 LYCVKHSJGDMDLM-LURJTMIESA-N 0.000 description 1
- FDQYIRHBVVUTJF-ZETCQYMHSA-N His-Gly-Gly Chemical compound [O-]C(=O)CNC(=O)CNC(=O)[C@@H]([NH3+])CC1=CN=CN1 FDQYIRHBVVUTJF-ZETCQYMHSA-N 0.000 description 1
- FSOXZQBMPBQKGJ-QSFUFRPTSA-N His-Ile-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]([NH3+])CC1=CN=CN1 FSOXZQBMPBQKGJ-QSFUFRPTSA-N 0.000 description 1
- VYUXYMRNGALHEA-DLOVCJGASA-N His-Leu-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O VYUXYMRNGALHEA-DLOVCJGASA-N 0.000 description 1
- OQDLKDUVMTUPPG-AVGNSLFASA-N His-Leu-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O OQDLKDUVMTUPPG-AVGNSLFASA-N 0.000 description 1
- YAALVYQFVJNXIV-KKUMJFAQSA-N His-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CN=CN1 YAALVYQFVJNXIV-KKUMJFAQSA-N 0.000 description 1
- QEYUCKCWTMIERU-SRVKXCTJSA-N His-Lys-Asp Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N QEYUCKCWTMIERU-SRVKXCTJSA-N 0.000 description 1
- UXSATKFPUVZVDK-KKUMJFAQSA-N His-Lys-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC1=CN=CN1)N UXSATKFPUVZVDK-KKUMJFAQSA-N 0.000 description 1
- WSEITRHJRVDTRX-QTKMDUPCSA-N His-Met-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC1=CN=CN1)N)O WSEITRHJRVDTRX-QTKMDUPCSA-N 0.000 description 1
- KRBMQYPTDYSENE-BQBZGAKWSA-N His-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CNC=N1 KRBMQYPTDYSENE-BQBZGAKWSA-N 0.000 description 1
- STGQSBKUYSPPIG-CIUDSAMLSA-N His-Ser-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 STGQSBKUYSPPIG-CIUDSAMLSA-N 0.000 description 1
- HIJIJPFILYPTFR-ACRUOGEOSA-N His-Tyr-Tyr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O HIJIJPFILYPTFR-ACRUOGEOSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000802744 Homo sapiens Cytosolic 5'-nucleotidase 1A Proteins 0.000 description 1
- 101000804764 Homo sapiens Lymphotactin Proteins 0.000 description 1
- 101000581940 Homo sapiens Napsin-A Proteins 0.000 description 1
- 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
- 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 1
- KTGFOCFYOZQVRJ-ZKWXMUAHSA-N Ile-Glu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O KTGFOCFYOZQVRJ-ZKWXMUAHSA-N 0.000 description 1
- KIMHKBDJQQYLHU-PEFMBERDSA-N Ile-Glu-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N KIMHKBDJQQYLHU-PEFMBERDSA-N 0.000 description 1
- KFVUBLZRFSVDGO-BYULHYEWSA-N Ile-Gly-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O KFVUBLZRFSVDGO-BYULHYEWSA-N 0.000 description 1
- PDTMWFVVNZYWTR-NHCYSSNCSA-N Ile-Gly-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](CCCCN)C(O)=O PDTMWFVVNZYWTR-NHCYSSNCSA-N 0.000 description 1
- CSQNHSGHAPRGPQ-YTFOTSKYSA-N Ile-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O)N CSQNHSGHAPRGPQ-YTFOTSKYSA-N 0.000 description 1
- PKGGWLOLRLOPGK-XUXIUFHCSA-N Ile-Leu-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PKGGWLOLRLOPGK-XUXIUFHCSA-N 0.000 description 1
- PMMMQRVUMVURGJ-XUXIUFHCSA-N Ile-Leu-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O PMMMQRVUMVURGJ-XUXIUFHCSA-N 0.000 description 1
- YSGBJIQXTIVBHZ-AJNGGQMLSA-N Ile-Lys-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O YSGBJIQXTIVBHZ-AJNGGQMLSA-N 0.000 description 1
- ZNOBVZFCHNHKHA-KBIXCLLPSA-N Ile-Ser-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZNOBVZFCHNHKHA-KBIXCLLPSA-N 0.000 description 1
- PXKACEXYLPBMAD-JBDRJPRFSA-N Ile-Ser-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PXKACEXYLPBMAD-JBDRJPRFSA-N 0.000 description 1
- DRCKHKZYDLJYFQ-YWIQKCBGSA-N Ile-Thr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DRCKHKZYDLJYFQ-YWIQKCBGSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- LJHGALIOHLRRQN-DCAQKATOSA-N Leu-Ala-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N LJHGALIOHLRRQN-DCAQKATOSA-N 0.000 description 1
- XIRYQRLFHWWWTC-QEJZJMRPSA-N Leu-Ala-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XIRYQRLFHWWWTC-QEJZJMRPSA-N 0.000 description 1
- HASRFYOMVPJRPU-SRVKXCTJSA-N Leu-Arg-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O HASRFYOMVPJRPU-SRVKXCTJSA-N 0.000 description 1
- STAVRDQLZOTNKJ-RHYQMDGZSA-N Leu-Arg-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O STAVRDQLZOTNKJ-RHYQMDGZSA-N 0.000 description 1
- WUFYAPWIHCUMLL-CIUDSAMLSA-N Leu-Asn-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O WUFYAPWIHCUMLL-CIUDSAMLSA-N 0.000 description 1
- DBVWMYGBVFCRBE-CIUDSAMLSA-N Leu-Asn-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O DBVWMYGBVFCRBE-CIUDSAMLSA-N 0.000 description 1
- FIJMQLGQLBLBOL-HJGDQZAQSA-N Leu-Asn-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FIJMQLGQLBLBOL-HJGDQZAQSA-N 0.000 description 1
- IIKJNQWOQIWWMR-CIUDSAMLSA-N Leu-Cys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)N IIKJNQWOQIWWMR-CIUDSAMLSA-N 0.000 description 1
- RVVBWTWPNFDYBE-SRVKXCTJSA-N Leu-Glu-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RVVBWTWPNFDYBE-SRVKXCTJSA-N 0.000 description 1
- HFBCHNRFRYLZNV-GUBZILKMSA-N Leu-Glu-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HFBCHNRFRYLZNV-GUBZILKMSA-N 0.000 description 1
- LESXFEZIFXFIQR-LURJTMIESA-N Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(O)=O LESXFEZIFXFIQR-LURJTMIESA-N 0.000 description 1
- CCQLQKZTXZBXTN-NHCYSSNCSA-N Leu-Gly-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O CCQLQKZTXZBXTN-NHCYSSNCSA-N 0.000 description 1
- APFJUBGRZGMQFF-QWRGUYRKSA-N Leu-Gly-Lys Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN APFJUBGRZGMQFF-QWRGUYRKSA-N 0.000 description 1
- SEMUSFOBZGKBGW-YTFOTSKYSA-N Leu-Ile-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SEMUSFOBZGKBGW-YTFOTSKYSA-N 0.000 description 1
- DSFYPIUSAMSERP-IHRRRGAJSA-N Leu-Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DSFYPIUSAMSERP-IHRRRGAJSA-N 0.000 description 1
- OTXBNHIUIHNGAO-UWVGGRQHSA-N Leu-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN OTXBNHIUIHNGAO-UWVGGRQHSA-N 0.000 description 1
- SQUFDMCWMFOEBA-KKUMJFAQSA-N Leu-Ser-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 SQUFDMCWMFOEBA-KKUMJFAQSA-N 0.000 description 1
- SVBJIZVVYJYGLA-DCAQKATOSA-N Leu-Ser-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O SVBJIZVVYJYGLA-DCAQKATOSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- 102100035304 Lymphotactin Human genes 0.000 description 1
- PNPYKQFJGRFYJE-GUBZILKMSA-N Lys-Ala-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNPYKQFJGRFYJE-GUBZILKMSA-N 0.000 description 1
- VHXMZJGOKIMETG-CQDKDKBSSA-N Lys-Ala-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CCCCN)N VHXMZJGOKIMETG-CQDKDKBSSA-N 0.000 description 1
- VHNOAIFVYUQOOY-XUXIUFHCSA-N Lys-Arg-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VHNOAIFVYUQOOY-XUXIUFHCSA-N 0.000 description 1
- ZQCVMVCVPFYXHZ-SRVKXCTJSA-N Lys-Asn-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCCN ZQCVMVCVPFYXHZ-SRVKXCTJSA-N 0.000 description 1
- HGZHSNBZDOLMLH-DCAQKATOSA-N Lys-Asn-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)N HGZHSNBZDOLMLH-DCAQKATOSA-N 0.000 description 1
- CIOWSLJGLSUOME-BQBZGAKWSA-N Lys-Asp Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O CIOWSLJGLSUOME-BQBZGAKWSA-N 0.000 description 1
- HKCCVDWHHTVVPN-CIUDSAMLSA-N Lys-Asp-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O HKCCVDWHHTVVPN-CIUDSAMLSA-N 0.000 description 1
- WGCKDDHUFPQSMZ-ZPFDUUQYSA-N Lys-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCCCN WGCKDDHUFPQSMZ-ZPFDUUQYSA-N 0.000 description 1
- NRQRKMYZONPCTM-CIUDSAMLSA-N Lys-Asp-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O NRQRKMYZONPCTM-CIUDSAMLSA-N 0.000 description 1
- DCRWPTBMWMGADO-AVGNSLFASA-N Lys-Glu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DCRWPTBMWMGADO-AVGNSLFASA-N 0.000 description 1
- HGNRJCINZYHNOU-LURJTMIESA-N Lys-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(O)=O HGNRJCINZYHNOU-LURJTMIESA-N 0.000 description 1
- DAOSYIZXRCOKII-SRVKXCTJSA-N Lys-His-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(O)=O DAOSYIZXRCOKII-SRVKXCTJSA-N 0.000 description 1
- MYZMQWHPDAYKIE-SRVKXCTJSA-N Lys-Leu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O MYZMQWHPDAYKIE-SRVKXCTJSA-N 0.000 description 1
- URGPVYGVWLIRGT-DCAQKATOSA-N Lys-Met-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O URGPVYGVWLIRGT-DCAQKATOSA-N 0.000 description 1
- ALEVUGKHINJNIF-QEJZJMRPSA-N Lys-Phe-Ala Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 ALEVUGKHINJNIF-QEJZJMRPSA-N 0.000 description 1
- ZJSZPXISKMDJKQ-JYJNAYRXSA-N Lys-Phe-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(O)=O)CC1=CC=CC=C1 ZJSZPXISKMDJKQ-JYJNAYRXSA-N 0.000 description 1
- UDXSLGLHFUBRRM-OEAJRASXSA-N Lys-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N)O UDXSLGLHFUBRRM-OEAJRASXSA-N 0.000 description 1
- AIXUQKMMBQJZCU-IUCAKERBSA-N Lys-Pro Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O AIXUQKMMBQJZCU-IUCAKERBSA-N 0.000 description 1
- CNGOEHJCLVCJHN-SRVKXCTJSA-N Lys-Pro-Glu Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O CNGOEHJCLVCJHN-SRVKXCTJSA-N 0.000 description 1
- YTJFXEDRUOQGSP-DCAQKATOSA-N Lys-Pro-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O YTJFXEDRUOQGSP-DCAQKATOSA-N 0.000 description 1
- YSPZCHGIWAQVKQ-AVGNSLFASA-N Lys-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN YSPZCHGIWAQVKQ-AVGNSLFASA-N 0.000 description 1
- RQILLQOQXLZTCK-KBPBESRZSA-N Lys-Tyr-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O RQILLQOQXLZTCK-KBPBESRZSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- JPCHYAUKOUGOIB-HJGDQZAQSA-N Met-Glu-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JPCHYAUKOUGOIB-HJGDQZAQSA-N 0.000 description 1
- ZRACLHJYVRBJFC-ULQDDVLXSA-N Met-Lys-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ZRACLHJYVRBJFC-ULQDDVLXSA-N 0.000 description 1
- WEDDFMCSUNNZJR-WDSKDSINSA-N Met-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(O)=O WEDDFMCSUNNZJR-WDSKDSINSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 102100027343 Napsin-A Human genes 0.000 description 1
- 241000588650 Neisseria meningitidis Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- HHOOEUSPFGPZFP-QWRGUYRKSA-N Phe-Asn-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O HHOOEUSPFGPZFP-QWRGUYRKSA-N 0.000 description 1
- JXWLMUIXUXLIJR-QWRGUYRKSA-N Phe-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 JXWLMUIXUXLIJR-QWRGUYRKSA-N 0.000 description 1
- FMMIYCMOVGXZIP-AVGNSLFASA-N Phe-Glu-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O FMMIYCMOVGXZIP-AVGNSLFASA-N 0.000 description 1
- KYYMILWEGJYPQZ-IHRRRGAJSA-N Phe-Glu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 KYYMILWEGJYPQZ-IHRRRGAJSA-N 0.000 description 1
- KJJROSNFBRWPHS-JYJNAYRXSA-N Phe-Glu-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O KJJROSNFBRWPHS-JYJNAYRXSA-N 0.000 description 1
- GLUBLISJVJFHQS-VIFPVBQESA-N Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 GLUBLISJVJFHQS-VIFPVBQESA-N 0.000 description 1
- WPTYDQPGBMDUBI-QWRGUYRKSA-N Phe-Gly-Asn Chemical compound N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O WPTYDQPGBMDUBI-QWRGUYRKSA-N 0.000 description 1
- QPVFUAUFEBPIPT-CDMKHQONSA-N Phe-Gly-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O QPVFUAUFEBPIPT-CDMKHQONSA-N 0.000 description 1
- JWBLQDDHSDGEGR-DRZSPHRISA-N Phe-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 JWBLQDDHSDGEGR-DRZSPHRISA-N 0.000 description 1
- BSHMIVKDJQGLNT-ACRUOGEOSA-N Phe-Lys-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 BSHMIVKDJQGLNT-ACRUOGEOSA-N 0.000 description 1
- SZYBZVANEAOIPE-UBHSHLNASA-N Phe-Met-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O SZYBZVANEAOIPE-UBHSHLNASA-N 0.000 description 1
- GKZIWHRNKRBEOH-HOTGVXAUSA-N Phe-Phe Chemical compound C([C@H]([NH3+])C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)C1=CC=CC=C1 GKZIWHRNKRBEOH-HOTGVXAUSA-N 0.000 description 1
- BONHGTUEEPIMPM-AVGNSLFASA-N Phe-Ser-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O BONHGTUEEPIMPM-AVGNSLFASA-N 0.000 description 1
- GLJZDMZJHFXJQG-BZSNNMDCSA-N Phe-Ser-Phe Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O GLJZDMZJHFXJQG-BZSNNMDCSA-N 0.000 description 1
- BSKMOCNNLNDIMU-CDMKHQONSA-N Phe-Thr-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O BSKMOCNNLNDIMU-CDMKHQONSA-N 0.000 description 1
- FSXRLASFHBWESK-HOTGVXAUSA-N Phe-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 FSXRLASFHBWESK-HOTGVXAUSA-N 0.000 description 1
- GTMSCDVFQLNEOY-BZSNNMDCSA-N Phe-Tyr-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N GTMSCDVFQLNEOY-BZSNNMDCSA-N 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- CGBYDGAJHSOGFQ-LPEHRKFASA-N Pro-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 CGBYDGAJHSOGFQ-LPEHRKFASA-N 0.000 description 1
- SSSFPISOZOLQNP-GUBZILKMSA-N Pro-Arg-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O SSSFPISOZOLQNP-GUBZILKMSA-N 0.000 description 1
- VJLJGKQAOQJXJG-CIUDSAMLSA-N Pro-Asp-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VJLJGKQAOQJXJG-CIUDSAMLSA-N 0.000 description 1
- YHUBAXGAAYULJY-ULQDDVLXSA-N Pro-Tyr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O YHUBAXGAAYULJY-ULQDDVLXSA-N 0.000 description 1
- 101100029566 Rattus norvegicus Rabggta gene Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 101100329108 Schizosaccharomyces pombe (strain 972 / ATCC 24843) cmc2 gene Proteins 0.000 description 1
- 101100288066 Schizosaccharomyces pombe (strain 972 / ATCC 24843) ksh1 gene Proteins 0.000 description 1
- 101100460197 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new13 gene Proteins 0.000 description 1
- 101100460198 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new14 gene Proteins 0.000 description 1
- 101100459356 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new18 gene Proteins 0.000 description 1
- 101100460201 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new22 gene Proteins 0.000 description 1
- 101100322386 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new8 gene Proteins 0.000 description 1
- 101100460205 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new9 gene Proteins 0.000 description 1
- 101100255212 Schizosaccharomyces pombe (strain 972 / ATCC 24843) rsa3 gene Proteins 0.000 description 1
- 101100203685 Schizosaccharomyces pombe (strain 972 / ATCC 24843) spc1 gene Proteins 0.000 description 1
- 101100210181 Schizosaccharomyces pombe (strain 972 / ATCC 24843) vts1 gene Proteins 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- WTUJZHKANPDPIN-CIUDSAMLSA-N Ser-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N WTUJZHKANPDPIN-CIUDSAMLSA-N 0.000 description 1
- YQHZVYJAGWMHES-ZLUOBGJFSA-N Ser-Ala-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YQHZVYJAGWMHES-ZLUOBGJFSA-N 0.000 description 1
- XVAUJOAYHWWNQF-ZLUOBGJFSA-N Ser-Asn-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O XVAUJOAYHWWNQF-ZLUOBGJFSA-N 0.000 description 1
- OBXVZEAMXFSGPU-FXQIFTODSA-N Ser-Asn-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N)CN=C(N)N OBXVZEAMXFSGPU-FXQIFTODSA-N 0.000 description 1
- UBRXAVQWXOWRSJ-ZLUOBGJFSA-N Ser-Asn-Asp Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CO)N)C(=O)N UBRXAVQWXOWRSJ-ZLUOBGJFSA-N 0.000 description 1
- YMEXHZTVKDAKIY-GHCJXIJMSA-N Ser-Asn-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(O)=O YMEXHZTVKDAKIY-GHCJXIJMSA-N 0.000 description 1
- FTVRVZNYIYWJGB-ACZMJKKPSA-N Ser-Asp-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O FTVRVZNYIYWJGB-ACZMJKKPSA-N 0.000 description 1
- QPFJSHSJFIYDJZ-GHCJXIJMSA-N Ser-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CO QPFJSHSJFIYDJZ-GHCJXIJMSA-N 0.000 description 1
- SMIDBHKWSYUBRZ-ACZMJKKPSA-N Ser-Glu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O SMIDBHKWSYUBRZ-ACZMJKKPSA-N 0.000 description 1
- UICKAKRRRBTILH-GUBZILKMSA-N Ser-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N UICKAKRRRBTILH-GUBZILKMSA-N 0.000 description 1
- AEGUWTFAQQWVLC-BQBZGAKWSA-N Ser-Gly-Arg Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O AEGUWTFAQQWVLC-BQBZGAKWSA-N 0.000 description 1
- MUARUIBTKQJKFY-WHFBIAKZSA-N Ser-Gly-Asp Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MUARUIBTKQJKFY-WHFBIAKZSA-N 0.000 description 1
- CLKKNZQUQMZDGD-SRVKXCTJSA-N Ser-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC1=CN=CN1 CLKKNZQUQMZDGD-SRVKXCTJSA-N 0.000 description 1
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 1
- SBMNPABNWKXNBJ-BQBZGAKWSA-N Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CO SBMNPABNWKXNBJ-BQBZGAKWSA-N 0.000 description 1
- GVMUJUPXFQFBBZ-GUBZILKMSA-N Ser-Lys-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GVMUJUPXFQFBBZ-GUBZILKMSA-N 0.000 description 1
- CRJZZXMAADSBBQ-SRVKXCTJSA-N Ser-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO CRJZZXMAADSBBQ-SRVKXCTJSA-N 0.000 description 1
- WGDYNRCOQRERLZ-KKUMJFAQSA-N Ser-Lys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)N WGDYNRCOQRERLZ-KKUMJFAQSA-N 0.000 description 1
- NVNPWELENFJOHH-CIUDSAMLSA-N Ser-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)N NVNPWELENFJOHH-CIUDSAMLSA-N 0.000 description 1
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 1
- PYTKULIABVRXSC-BWBBJGPYSA-N Ser-Ser-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PYTKULIABVRXSC-BWBBJGPYSA-N 0.000 description 1
- SQHKXWODKJDZRC-LKXGYXEUSA-N Ser-Thr-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O SQHKXWODKJDZRC-LKXGYXEUSA-N 0.000 description 1
- HAYADTTXNZFUDM-IHRRRGAJSA-N Ser-Tyr-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O HAYADTTXNZFUDM-IHRRRGAJSA-N 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 241001505901 Streptococcus sp. 'group A' Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- IGROJMCBGRFRGI-YTLHQDLWSA-N Thr-Ala-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O IGROJMCBGRFRGI-YTLHQDLWSA-N 0.000 description 1
- TYVAWPFQYFPSBR-BFHQHQDPSA-N Thr-Ala-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(O)=O TYVAWPFQYFPSBR-BFHQHQDPSA-N 0.000 description 1
- DGDCHPCRMWEOJR-FQPOAREZSA-N Thr-Ala-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 DGDCHPCRMWEOJR-FQPOAREZSA-N 0.000 description 1
- HYLXOQURIOCKIH-VQVTYTSYSA-N Thr-Arg Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N HYLXOQURIOCKIH-VQVTYTSYSA-N 0.000 description 1
- VIBXMCZWVUOZLA-OLHMAJIHSA-N Thr-Asn-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O VIBXMCZWVUOZLA-OLHMAJIHSA-N 0.000 description 1
- LMMDEZPNUTZJAY-GCJQMDKQSA-N Thr-Asp-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O LMMDEZPNUTZJAY-GCJQMDKQSA-N 0.000 description 1
- YBXMGKCLOPDEKA-NUMRIWBASA-N Thr-Asp-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YBXMGKCLOPDEKA-NUMRIWBASA-N 0.000 description 1
- OHAJHDJOCKKJLV-LKXGYXEUSA-N Thr-Asp-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O OHAJHDJOCKKJLV-LKXGYXEUSA-N 0.000 description 1
- LGNBRHZANHMZHK-NUMRIWBASA-N Thr-Glu-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O LGNBRHZANHMZHK-NUMRIWBASA-N 0.000 description 1
- LHEZGZQRLDBSRR-WDCWCFNPSA-N Thr-Glu-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LHEZGZQRLDBSRR-WDCWCFNPSA-N 0.000 description 1
- HJOSVGCWOTYJFG-WDCWCFNPSA-N Thr-Glu-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O HJOSVGCWOTYJFG-WDCWCFNPSA-N 0.000 description 1
- DJDSEDOKJTZBAR-ZDLURKLDSA-N Thr-Gly-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O DJDSEDOKJTZBAR-ZDLURKLDSA-N 0.000 description 1
- KBBRNEDOYWMIJP-KYNKHSRBSA-N Thr-Gly-Thr Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O KBBRNEDOYWMIJP-KYNKHSRBSA-N 0.000 description 1
- LUMXICQAOKVQOB-YWIQKCBGSA-N Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)[C@@H](C)O LUMXICQAOKVQOB-YWIQKCBGSA-N 0.000 description 1
- LCCSEJSPBWKBNT-OSUNSFLBSA-N Thr-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N LCCSEJSPBWKBNT-OSUNSFLBSA-N 0.000 description 1
- KZSYAEWQMJEGRZ-RHYQMDGZSA-N Thr-Leu-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O KZSYAEWQMJEGRZ-RHYQMDGZSA-N 0.000 description 1
- MGJLBZFUXUGMML-VOAKCMCISA-N Thr-Lys-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N)O MGJLBZFUXUGMML-VOAKCMCISA-N 0.000 description 1
- KERCOYANYUPLHJ-XGEHTFHBSA-N Thr-Pro-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O KERCOYANYUPLHJ-XGEHTFHBSA-N 0.000 description 1
- IVDFVBVIVLJJHR-LKXGYXEUSA-N Thr-Ser-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IVDFVBVIVLJJHR-LKXGYXEUSA-N 0.000 description 1
- WPSKTVVMQCXPRO-BWBBJGPYSA-N Thr-Ser-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WPSKTVVMQCXPRO-BWBBJGPYSA-N 0.000 description 1
- ZMYCLHFLHRVOEA-HEIBUPTGSA-N Thr-Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ZMYCLHFLHRVOEA-HEIBUPTGSA-N 0.000 description 1
- COYHRQWNJDJCNA-NUJDXYNKSA-N Thr-Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O COYHRQWNJDJCNA-NUJDXYNKSA-N 0.000 description 1
- WCRFXRIWBFRZBR-GGVZMXCHSA-N Thr-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WCRFXRIWBFRZBR-GGVZMXCHSA-N 0.000 description 1
- ABCLYRRGTZNIFU-BWAGICSOSA-N Thr-Tyr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N)O ABCLYRRGTZNIFU-BWAGICSOSA-N 0.000 description 1
- LVRFMARKDGGZMX-IZPVPAKOSA-N Thr-Tyr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=C(O)C=C1 LVRFMARKDGGZMX-IZPVPAKOSA-N 0.000 description 1
- FYBFTPLPAXZBOY-KKHAAJSZSA-N Thr-Val-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O FYBFTPLPAXZBOY-KKHAAJSZSA-N 0.000 description 1
- PWONLXBUSVIZPH-RHYQMDGZSA-N Thr-Val-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N)O PWONLXBUSVIZPH-RHYQMDGZSA-N 0.000 description 1
- MHNHRNHJMXAVHZ-AAEUAGOBSA-N Trp-Asn-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)O)N MHNHRNHJMXAVHZ-AAEUAGOBSA-N 0.000 description 1
- YYXIWHBHTARPOG-HJXMPXNTSA-N Trp-Ile-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N YYXIWHBHTARPOG-HJXMPXNTSA-N 0.000 description 1
- WTXQBCCKXIKKHB-JYJNAYRXSA-N Tyr-Arg-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WTXQBCCKXIKKHB-JYJNAYRXSA-N 0.000 description 1
- JBBYKPZAPOLCPK-JYJNAYRXSA-N Tyr-Arg-Met Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(O)=O JBBYKPZAPOLCPK-JYJNAYRXSA-N 0.000 description 1
- ONWMQORSVZYVNH-UWVGGRQHSA-N Tyr-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 ONWMQORSVZYVNH-UWVGGRQHSA-N 0.000 description 1
- DKKHULUSOSWGHS-UWJYBYFXSA-N Tyr-Asn-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N DKKHULUSOSWGHS-UWJYBYFXSA-N 0.000 description 1
- CKKFTIQYURNSEI-IHRRRGAJSA-N Tyr-Asn-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CKKFTIQYURNSEI-IHRRRGAJSA-N 0.000 description 1
- QZOSVNLXLSNHQK-UWVGGRQHSA-N Tyr-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 QZOSVNLXLSNHQK-UWVGGRQHSA-N 0.000 description 1
- RCLOWEZASFJFEX-KKUMJFAQSA-N Tyr-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 RCLOWEZASFJFEX-KKUMJFAQSA-N 0.000 description 1
- VFJIWSJKZJTQII-SRVKXCTJSA-N Tyr-Asp-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O VFJIWSJKZJTQII-SRVKXCTJSA-N 0.000 description 1
- WVRUKYLYMFGKAN-IHRRRGAJSA-N Tyr-Glu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 WVRUKYLYMFGKAN-IHRRRGAJSA-N 0.000 description 1
- NOOMDULIORCDNF-IRXDYDNUSA-N Tyr-Gly-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O NOOMDULIORCDNF-IRXDYDNUSA-N 0.000 description 1
- ZQOOYCZQENFIMC-STQMWFEESA-N Tyr-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)C1=CC=C(O)C=C1 ZQOOYCZQENFIMC-STQMWFEESA-N 0.000 description 1
- ARSHSYUZHSIYKR-ACRUOGEOSA-N Tyr-His-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ARSHSYUZHSIYKR-ACRUOGEOSA-N 0.000 description 1
- USYGMBIIUDLYHJ-GVARAGBVSA-N Tyr-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 USYGMBIIUDLYHJ-GVARAGBVSA-N 0.000 description 1
- QSFJHIRIHOJRKS-ULQDDVLXSA-N Tyr-Leu-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QSFJHIRIHOJRKS-ULQDDVLXSA-N 0.000 description 1
- ARJASMXQBRNAGI-YESZJQIVSA-N Tyr-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N ARJASMXQBRNAGI-YESZJQIVSA-N 0.000 description 1
- JLKVWTICWVWGSK-JYJNAYRXSA-N Tyr-Lys-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JLKVWTICWVWGSK-JYJNAYRXSA-N 0.000 description 1
- JXGUUJMPCRXMSO-HJOGWXRNSA-N Tyr-Phe-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 JXGUUJMPCRXMSO-HJOGWXRNSA-N 0.000 description 1
- NHOVZGFNTGMYMI-KKUMJFAQSA-N Tyr-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NHOVZGFNTGMYMI-KKUMJFAQSA-N 0.000 description 1
- UMSZZGTXGKHTFJ-SRVKXCTJSA-N Tyr-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 UMSZZGTXGKHTFJ-SRVKXCTJSA-N 0.000 description 1
- MDXLPNRXCFOBTL-BZSNNMDCSA-N Tyr-Ser-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MDXLPNRXCFOBTL-BZSNNMDCSA-N 0.000 description 1
- BIVIUZRBCAUNPW-JRQIVUDYSA-N Tyr-Thr-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O BIVIUZRBCAUNPW-JRQIVUDYSA-N 0.000 description 1
- UUBKSZNKJUJQEJ-JRQIVUDYSA-N Tyr-Thr-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O UUBKSZNKJUJQEJ-JRQIVUDYSA-N 0.000 description 1
- GZWPQZDVTBZVEP-BZSNNMDCSA-N Tyr-Tyr-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O GZWPQZDVTBZVEP-BZSNNMDCSA-N 0.000 description 1
- UUJHRSTVQCFDPA-UFYCRDLUSA-N Tyr-Tyr-Val Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 UUJHRSTVQCFDPA-UFYCRDLUSA-N 0.000 description 1
- WDIGUPHXPBMODF-UMNHJUIQSA-N Val-Glu-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N WDIGUPHXPBMODF-UMNHJUIQSA-N 0.000 description 1
- SDUBQHUJJWQTEU-XUXIUFHCSA-N Val-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](C(C)C)N SDUBQHUJJWQTEU-XUXIUFHCSA-N 0.000 description 1
- CKTMJBPRVQWPHU-JSGCOSHPSA-N Val-Phe-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O)N CKTMJBPRVQWPHU-JSGCOSHPSA-N 0.000 description 1
- UJMCYJKPDFQLHX-XGEHTFHBSA-N Val-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N)O UJMCYJKPDFQLHX-XGEHTFHBSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 101150092805 actc1 gene Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000007818 agglutination assay Methods 0.000 description 1
- 108010028939 alanyl-alanyl-lysyl-alanine Proteins 0.000 description 1
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 1
- 108010050025 alpha-glutamyltryptophan Proteins 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 238000011091 antibody purification Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009640 blood culture Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 238000005277 cation exchange chromatography Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 229940031670 conjugate vaccine Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 101150047356 dec-1 gene Proteins 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 102000054767 gene variant Human genes 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 108010010096 glycyl-glycyl-tyrosine Proteins 0.000 description 1
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 1
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 1
- 108010020688 glycylhistidine Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 108700039582 histidine triad Proteins 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 108010036413 histidylglycine Proteins 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
- 238000012872 hydroxylapatite chromatography Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 108010078274 isoleucylvaline Proteins 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 101150093139 ompT gene Proteins 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229940080469 phosphocellulose Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108010004914 prolylarginine Proteins 0.000 description 1
- 108010015796 prolylisoleucine Proteins 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- ZZIZZTHXZRDOFM-XFULWGLBSA-N tamsulosin hydrochloride Chemical compound [H+].[Cl-].CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1 ZZIZZTHXZRDOFM-XFULWGLBSA-N 0.000 description 1
- 229960000814 tetanus toxoid Drugs 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 125000004149 thio group Chemical group *S* 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
Předkládaný vynález se týká antigenů, epitopů a protilátek směrovaných na tyto epitopy, konkrétněji polypeptidových antigenů patogenu streptococcus pneumoniae, které jsou použitelné pro profylaxi, diagnostiku nebo léčení streptokokové infekce.
Dosavadní stav techniky
S. pneumoniae je důležitý činitel nemocnosti u lidí, zejména u dětí, starších osob a imunokompromitovaných osob. Jedná se o baktérii často izolovanou z pacientů s invazivními nemocemi, jako je bakteriemie/septikemie, pneumonie, meningitida s vysokou nemocností a úmrtností po celém světě. Dokonce i v případě vhodné léčby antibiotiky vedou pnemokokové infekce k mnoha úmrtím. Ačkoliv objev antimikrobiálních léků snížil celkovou úmrtnost způsobenou pneumokokovými nemocemi, existence odolných pneumokokových organismů se stala hlavním problémem dnešního světa. Účinné vakcíny proti pneumokokům by měly velký vliv na nemocnost a úmrtnost související s nemocemi způsobenými S. pneumoniae. Takové vakcíny by také byly případně použitelné pro prevenci zánětu středního ucha u kojenců a mladších dětí.
Pokusy o vyvinutí pneumokokové vakcíny byly obecně zaměřeny na vyvolání imunitních reakcí na pneumokokový kapsulární polysacharid. Na základě antigenních rozdílů bylo identifikováno více než 80 pneumokokových kapsulárních serotypů. V současnosti dostupné pneumokokové vakcíny 23 kapsulárních polysacharidů, které nej častěji nemoc, mají podstatný nedostatek týkající se slabé imunogenicity některých kapsulárních obsahuj ící způsobuj í primárně • · · · • ·
polysacharidů, rozdílnosti serotypů a rozdílů v istribuci serotypů v čase, geografických oblastech a věkových skupinách. Konkrétně v současnosti existující vakcíny a kapsulární konjugátové vakcíny selhávající v rozvoji ochrany mladých dětí proti všem serotypům vedou k hodnocení i dalších složek S. pneumoniae. Ačkoliv lze imunogenicitu kapsulárních polysacharidů zlepšit, serotypová specifita bude vždy představovat hlavní omezení vakcín na bázi polysacharidů. Použití antigenicky konzervativního imunogenního pneumokokového proteinového antigenu, buď samostatně nebo v kombinaci s dalšími složkami, nabízí možnost vytvoření pneumokokové vakcíny na bázi proteinu.
PCT WO 98/18930 vydaný 7. května 1998 s titulem „Střeptococcus Pneumoniae antigens and vaccines popisuje určité polypeptidy, které jsou patentově nárokovány jako antigenní. Nicméně nebyla uvedena žádná biologická aktivita těchto polypeptidů. Podobně nebylo uvedeno žádná konzervativnost sekvence, což je nezbytné pro obecně účinnou vakcínu.
PCT WO 00/39299 popisuje polypeptidy a polynukleotidy kódující tyto polypeptidy. PCT WO 00/39299 prokazuje, že polypeptidy označené jako BVH-3 a BVH-11 poskytují ochranu proti smrtelné infekci pneumokokem.
Proto existuje nenaplněná potřeba antigenů streptokoku, které lze použít jako složky pro profylaxi, diagnostiku a/nebo terapii infekce streptokokem.
Podstata vynálezu
Shrnutí vynálezu
Izolovaný polynukleotid obsahující polynukleotid vybraný z (a) polynukleotidu kódujícího polypeptid, který je alespoň ze 70 % identický s druhým polypeptidem vybraným z tabulky A, B, D, E nebo H;
(b) polynukleotidu kódujícího polypeptid, který je alespoň z 95 % identický s druhým polypeptidem vybraným z tabulky A, B, D, E nebo H;
(c) polynukleotidu kódujícího polypeptid, který má aminokyselinovou sekvenci vybranou z tabulky A, B, D, E nebo H; nebo jeho fragmentů, analog nebo derivátů;
(d) polynukleotidu kódujícího polypeptid vybraný z tabulky A, B, D, E nebo H;
(e) polynukleotidu kódujícího polypeptid schopný vytvořit protilátky mající vazebnou specifitu k polypeptidu, který má sekvenci vybranou z tabulky A, B, D, E nebo H;
(f) polynukleotidu kódujícího epitop nesoucí část polypeptidu vybraného z tabulky A, B, D, E nebo H; a (g) polynukleotidu komplementárního s polynukleotidem z (a) , (b) , (c) , (d) , (e) nebo (f) .
V dalších aspektech jsou poskytnuty nové polypeptidy kódované polynukleotidy podle předkládaného vynálezu, léky nebo vakcínové prostředky, vektory obsahující polynukleotidy podle předkládaného vynálezu funkčně spojené s kontrolní oblastí exprese, stejně jako hostitelské buňky transfekované těmito vektory a způsoby výroby polypeptidů zahrnující kultivaci hostitelských buněk za podmínek vhodných pro expresi.
Stručný | popis | obrázků | |||
Obrázek | 1 je | DNA sekvence | genu SP64 | BVH-3; sekvence | id. |
Obrázek | 2 je | DNA sekvence | obsahuj ící | kompletní gen | SP64 |
BVH-3 mezi nukleotidy 1777 až 4896; sekvence id. č. 2.
Obrázek 3 je DNA sekvence genu SP64 BVH-11; sekvence id.
č. 3.
Obrázek 4 je DNA sekvence obsahující kompletní gen SP64 BVH-11 mezi nukleotidy 45 až 2567; sekvence id. č. 4.
9
Obrázek 5 je DNA sekvence obsahující kompletní gen SP64 BVH-11-2 mezi nukleotidy 114 až 2630; sekvence id. č. 5.
Obrázek 6 je aminokyselinová sekvence polypeptidů SP64 BVH-3; sekvence id. č. 6.
Obrázek 7 je aminokyselinová sekvence polypeptidů SP64 BVH-11; sekvence id. č. 7.
Obrázek 8 je aminokyselinová sekvence polypeptidů SP64 BVH-11-2; sekvence id. č. 8.
Obrázek 9 je DNA sekvence genu SP64 BVH-3; sekvence id.
č. 9.
Obrázek 10 je aminokyselinová sekvence polypeptidů SP63
BVH-3; sekvence | id. je | č. 10. | ||||
Obrázek | 11 | ami nokys e1inová | sekvence | polypeptidů | 4D4.9; | |
sekvence id. | č. | 11. | ||||
Obrázek | 12 | je | aminokyselinová | sekvence polypeptidů | 7G11.7; | |
sekvence id. | č. | 12. | ||||
Obrázek | 13 | je | aminokyselinová | sekvence | polypeptidů | 7G11.9; |
sekvence id. | č. | 13. | ||||
Obrázek | 14 | je | aminokyselinová | sekvence | polypeptidů | 4D3.4; |
sekvence id. | č. | 14. | ||||
Obrázek | 15 | je | ami noky s e 1 i nová | sekvence | polypeptidů | 8E3.1; |
sekvence id. | č. | 15. | ||||
Obrázek | 16 | je | ami nokys e1inová | sekvence | polypeptidů | 1G2.2; |
sekvence id. | č. | 16. |
Obrázek 17 je aminokyselinová sekvence polypeptidů 10C12.7; sekvence id. č. 17.
Obrázek 18 je aminokyselinová sekvence polypeptidů 14F6.3; sekvence id. č. 18.
Obrázek 19 je aminokyselinová sekvence polypeptidů B12D8.2; sekvence id. č. 19.
Obrázek | 20 | je | ami nokys e1inová | sekvence | polypeptidů 7F4.1; |
sekvence id. | č. | 20. | |||
Obrázek | 21 | je | aminokyselinová | sekvence | polypeptidů 10D7.5; |
sekvence id. | č. | 21. |
• · · · • · · · • · · · • · · * · · • ••••5 ·· ·· ” * *
Obrázek 22 je aminokyselinová sekvence polypeptidu 10G9.3, polypeptidu 10A2.2 a polypeptidu B11B8.1; sekvence id. č. 22.
Obrázek 23 je aminokyselinová sekvence polypeptidu 11B8.4; sekvence id. č. 23.
Obrázek 24 je aminokyselinová sekvence cílového epitopu Mab H11B-11B8; sekvence id. č. 163.
Obrázek 25 je schématická reprezentace genu BVH-3 stejně jako umístění sekvencí genu kódujících polypeptidy plné délky a zkrácené polypeptidy. Vztahy mezi fragmenty DNA jsou uvedeny s ohledem na každý další.
Obrázek 26 je schématická reprezentace genu BVH-11 stejně jako umístění sekvencí genu kódujících polypeptidy plné délky a zkrácené polypeptidy. Vztahy mezi fragmenty DNA jsou uvedeny s ohledem na každý další.
Obrázek 27 je schématická reprezentace genu BVH-11-2 stejně jako umístění sekvencí genu kódujících polypeptidy plné délky a zkrácené polypeptidy. Vztahy mezi fragmenty DNA jsou uvedeny s ohledem na každý další.
Obrázek 28 je schématická reprezentace proteinu BVH-3 a umístění vnitřních a povrchových epitopů rozpoznávaných některými monoklonálními protilátkami.
Obrázek 29 je schématická reprezentace proteinu BVH-11-2 a umístění vnitřních a povrchových epitopů rozpoznávaných některými monoklonálními protilátkami.
Obrázek 30 je mapa plasmidu pURV22.HIS. KanR, vůči kanamycinu odolný kódující oblast; cI857, bakteriofág λ cI857 teplotně citlivý represorový gen; lambda pL, bakteriofág λ promotér transkripce; His-tag, 6-histidin kódující oblast; terminátor, Tl transkripční terminátor; ori, colEl počátek erplikace.
Obrázek 31 zobrazuje porovnání aminokyselinových sekvencí proteinů BVH-3M (sp64) a BVH-3 (Sp63) pomocí programu Clustal W od MacVector sekvenčního analytického software • ·
• · · · • · • · · · · (verze 6.5.3). Pod porovnáním je řádek shody, kde znaky * a . ukazují stejné a podobné aminokyseliny.
Obrázek 32 zobrazuje porovnání aminokyselinových sekvencí proteinů BVH-3, BVH-1 a BVH-11-2 pomocí programu Clustal W od MacVector sekvenčního analytického software (verze 6.5.3). Pod porovnáním je řádek shody, kde znaky * a . ukazují stejné a podobné aminokyseliny.
Obrázek 33 je DNA sekvence genu NEW43 (sekvence id. č. 257).
Obrázek 34 je odvozená aminokyselinová sekvence polypeptidu NEW34 (sekvence id. č. 258).
Podrobný popis vynálezu
Bylo zjištěno, že části polypeptidů BVH-3 a BVH-11 byly interní. Další části nebyly přítomny v důležitých kmenech jako je zapouzdřený s. pneumonia způsobující onemocnění. Bylo by výhodné mít polypeptid, který obsahuje část, která není interní. Když jsou velké části polypeptidu interní, tyto části nejsou na baktérii odkryty. Nicméně tyto části jsou v rekombinantním polypeptidu velmi imunogenní a nebudou přispívat k ochraně proti infekcím. Také by bylo výhodné mít polypeptid, který obsahuje část, která je přítomna ve většině kmenů.
Předkládaný vynález se zabývá polypeptidy, ve kterých byly nežádoucí části odstraněny a/nebo upraveny tak, aby se získala specifická imunitní reakce.
Podle předkládaného vynálezu jsou také poskytovány polypeptidy nebo polynukleotidy kódující takové polypeptidy obsahující ochranné domény.
Překvapivě si polypeptidy udržely požadované biologické vlastnosti i potom, co byla nežádoucí část polypeptidů odstraněna nebo upravena. To je překvapivé z hlediska skutečnosti, že některé z těchto částí byly popsány jako epitop nesoucí části v patentové přihlášce PCT WO 98/18930.
V dalších publikacích, jako je PCT WO 00/37105, byly části identifikované jako histidinová triádová oblast a oblast svinuté šroubovice označeny jako důležité oblasti. Autoři předkládaného vynálezu zjistili, že varianty polypeptidu BVH-3 a BVH-11, ve kterých byly odstraněny a/nebo upraveny určité části a chiméry těchto polypeptidu mají biologické vlastnosti a vyvolávají specifickou imunitní reakci.
Podle jednoho aspektu poskytuje předkládaný vynález izolovaný polynukleotid kódující polypeptid, který je alespoň ze 70 % identický s druhým polypeptidem obsahujícím sekvenci, která je popsána v předkládané přihlášce, tabulkách a obrázcích.
Podle jednoho aspektu předkládaného vynálezu je poskytován izolovaný polynukleotid obsahující polynukleotid vybraný z (a) polynukleotidu kódujícího polypeptid, který je alespoň ze 70 % identický s druhým polypeptidem vybraným z tabulky B, E nebo H;
(b) polynukleotidu kódujícího polypeptid, který je alespoň z 95 % identický s druhým polypeptidem vybraným z tabulky B, E nebo H;
(c) polynukleotidu kódujícího polypeptid, který má aminokyselinovou sekvenci vybranou z tabulky B, E nebo H; nebo jeho fragmentů, analog nebo derivátů;
(d) polynukleotidu kódujícího polypeptid vybraný z tabulky B, E nebo H;
(e) polynukleotidu kódujícího polypeptid schopný vytvořit protilátky mající vazebnou specifitu k polypeptidu, který má sekvenci vybranou z tabulky B, E nebo H;
(f) polynukleotidu kódujícího epitop nesoucí část polypeptidu vybraného z tabulky B, E nebo H; a (g) polynukleotidu komplementárního s polynukleotidem z (a) , (b) , (c) , (d) , (e) nebo (f) .
Podle jednoho aspektu poskytuje předkládaný vynález izolovaný polynukleotid kódující polypeptid, který je alespoň • · · ·
ze 70 % identický s druhým polypeptidem obsahujícím sekvenci vybranou z tabulky A, B, D, E, G nebo H nebo jeho fragmenty, analogy nebo deriváty.
Podle jednoho aspektu poskytuje předkládaný vynález izolovaný polynukleotid kódující polypeptid, který je alespoň z 95 % identický s druhým polypeptidem obsahujícím sekvenci vybranou z tabulky A, B, D, E, G nebo H nebo jeho fragmenty, analogy nebo deriváty.
Podle jednoho aspektu se předkládaný vynález týká polypeptidů vyznačujících se aminokyselinovou sekvencí vybranou z tabulky A, B, D, E, G nebo H nebo jejími fragmenty, analogy nebo deriváty.
Podle jednoho aspektu poskytuje předkládaný vynález izolovaný polynukleotid kódující polypeptid, který je alespoň ze 70 % identický s druhým polypeptidem obsahujícím sekvenci vybranou z tabulky A, B, D, E, G nebo H.
Podle jednoho aspektu poskytuje předkládaný vynález izolovaný polynukleotid kódující polypeptid, který je alespoň z 95 % identický s druhým polypeptidem obsahujícím sekvenci vybranou z tabulky A, B, D, E, G nebo H.
Podle jednoho aspektu se předkládaný vynález týká polypeptidů vyznačujících se aminokyselinovou sekvencí vybranou z tabulky A, B, D, E, G nebo H.
Podle jednoho aspektu poskytuje předkládaný vynález izolovaný polynukleotid kódující polypeptid, který je alespoň ze 70 % identický s druhým polypeptidem obsahujícím sekvenci vybranou z tabulky B, E nebo H nebo jeho fragmenty, analogy nebo deriváty.
Podle jednoho aspektu poskytuje předkládaný vynález izolovaný polynukleotid kódující polypeptid, který je alespoň z 95 % identický s druhým polypeptidem obsahujícím sekvenci vybranou z tabulky B, E nebo H nebo jeho fragmenty, analogy nebo deriváty.
• · · · • · · ·
Podle jednoho aspektu se předkládaný vynález týká polypeptidů vyznačujících se aminokyselinovou sekvencí vybranou z tabulky B, E nebo H nebo jejími fragmenty, analogy nebo deriváty.
Podle jednoho aspektu poskytuje předkládaný vynález izolovaný polynukleotid kódující polypeptid, který je alespoň ze 70 % identický s druhým polypeptidem obsahujícím sekvenci vybranou z tabulky B, E nebo H.
Podle jednoho aspektu poskytuje předkládaný vynález izolovaný polynukleotid kódující polypeptid, který je alespoň z 95 % identický s druhým polypeptidem obsahujícím sekvenci vybranou z tabulky B, E nebo H.
Podle jednoho aspektu se předkládaný vynález týká polypeptidů vyznačujících se aminokyselinovou sekvencí vybranou z tabulky B, E nebo H.
Podle předkládaného vynálezu všechny nukleotidy kódující polypeptidy a chimérní polypeptidy spadají do rámce předkládaného vynálezu.
V dalším provedení jsou polypeptidy nebo chimérní polypeptidy podle předkládaného vynálezu antigenní.
V dalším provedení jsou polypeptidy nebo chimérní polypeptidy podle předkládaného vynálezu imunogenní.
V dalším provedení dokáží polypeptidy nebo chimérní polypeptidy podle předkládaného vynálezu vyvolat imunitní reakci u daného jedince.
V dalším provedení se předkládaný vynález také týká polypeptidů, které jsou schopné vyvolat vznik protilátek, které mají vazebnou specifitu k polypeptidům nebo chimérním polypeptidům podle předkládaného vynálezu, které již byly definovány výše.
V jednom provedení polypeptidy z tabulky A (BVH-3) nebo tabulky D (BVH-11) obsahují alespoň jednu epitop nesoucí část.
V dalším provedení budou fragmenty polypeptidů podle předkládaného vynálezu obsahovat jednu nebo více epitop • · · · • · · · · • ·· 10 nesoucích částí identifikovaných v tabulce C a F. Fragment bude obsahovat alespoň 15 po sobě jdoucích aminokyselin z polypeptidu z tabulky C a F. Fragment bude obsahovat alespoň 20 po sobě jdoucích aminokyselin z polypeptidu z tabulky C a F.
V dalším provedení epitop nesoucí část polypeptidu z tabulky A (BVH-3) obsahuje alespoň jeden polypeptid vypsaný v tabulce C.
V dalším provedení epitop nesoucí část polypeptidu z tabulky B (BVH-11) obsahuje alespoň jeden polypeptid vypsaný v tabulce F.
Protilátka, která „má vazebnou specifitu, je protilátka, která rozpoznává a váže vybraný polypeptid, ale která v podstatě nerozpoznává a neváže ostatní molekuly ve vzorku jako je biologický vzorek. Specifickou vazbu lze měřit za použití ELISA testu, ve kterém se vybraný polypeptid používá jako antigen.
Pokud není definováno jinak, všechny technické a vědecké termíny použité v předkládaném vynálezu mají stejný význam jaký se běžně rozumí odborníkem v dané problematice, kterému je předkládaný vynález určen. Všechny publikace, patentové přihlášky, patenty a další odkazy uvedené v předkládaném vynálezu jsou zde uvedeny v celku jako reference. V případě rozporu bude předkládaná přihláška, včetně definicí, použita jako reference. Navíc materiály, způsoby a příklady jsou pouze ilustrativní a nelze je pokládat za nějaké omezení.
Podle předkládaného vynálezu je „ochrana v biologických studiích definována podstatným zvýšením křivky přežití, úrovně nebo doby. Statistická analýza za použití logaritmického testu pořadí při porovnání křivek přežití a Fisherův přesný test pro porovnání úrovní přežití a počtů dnů do úmrtí lze použít pro výpočet P hodnot a stanovit, zda je rozdíl mezi dvěma skupinami statisticky významný. P hodnoty 0,05 jsou pokládány za nevýznamné.
• · • · · · • · • · · ·
Tak jak se používá v předkládaném vynálezu, „fragmenty, „deriváty nebo „analogy polypeptidu podle předkládaného vynálezu zahrnují ty polypeptidy, ve kterých jedna nebo více aminokyselin je nahrazeno konzervativní nebo nekonzervativní aminokyselinou (s výhodou konzervativní), která je přirozená nebo nepřirozená. V jednom provedení budou deriváty a analogy polypeptidu podle předkládaného vynálezu mít 70 % shody se sekvencemi ilustrovanými v obrázcích nebo jeho fragmentech. To znamená, že 70 % zbytků je stejných. V dalším provedení budou mít polypeptidy z více než 75 % homologické. V dalším provedení budou polypeptidy z více než 80 % homologické. V dalším provedení budou polypeptidy z více než 85 % homologické. V dalším provedení budou polypeptidy z více než 90 % homologické. V dalším provedení budou polypeptidy z více než 95 % homologické. V dalším provedení budou polypeptidy z více než 99 % homologické. V dalším provedení budou deriváty a analogy polypeptidů podle předkládaného vynálezu mít nahrazeno, upraveno nebo vynecháno méně než 20 aminokyselin a výhodněji méně než 10. Preferované náhrady jsou takové, které jsou v dané problematice známé jako konzervativní, tj . nahrazované aminokyseliny mají stejné fyzikální nebo chemické vlastnosti, jako je hydrofobicita, velikost, náboj nebo funkční skupiny.
Odborník ocení, že analogy nebo deriváty proteinů nebo polypeptidů podle předkládaného vynálezu budou také použitelné v kontextu předkládaného vynálezu, tj. jako antigenní / imunogenní materiál. Proto do předkládaného vynálezu spadají například proteiny nebo polypeptidy, které obsahují jedno nebo více doplnění, vynechání, náhrad a podobně. Navíc je možno nahradit jednu aminokyselinu jinou podobného „typu. Například nahrazení jedné hydrofobní aminokyseliny jinou hydrofobní aminokyselinou.
Pro porovnání aminokyselinových sekvencí lze použít program j ako j e
CLUSTAL.
Tento program porovnává • · · ·
12·’ aminokyselinové sekvence a hledá optimální srovnání vložením míst do jakékoliv sekvence podle potřeby. Je možné vypočítat aminokyselinovou identitu nebo podobnost (identita plus aminokyseliny konzervativního typu) pro optimální srovnání. Program jako BLASTx bude porovnávat nejdelší dosah podobných sekvencí a stanoví odpovídající hodnotu. Tak je možné získat porovnání v případě, že existuje několik oblastí podobnosti tím, že každá má jiné hodnocení. Oba typy analýzy identity spadají do předkládaného vynálezu.
V alternativním přístupu jsou analogy nebo deriváty případně fúzní proteiny obsahující skupiny, které vedou k tomu, že čištění je snazší, například účinným značením požadovaného proteinu nebo polypeptidu. Někdy je potřeba odstranit „značku nebo se případně jedná o případ, kdy samotný fúzní protein má dostatečnou antigenicitu tak, aby byl použitelný.
V dalším aspektu předkládaného vynálezu jsou poskytovány antigenní / imunogenní fragmenty proteinů nebo polypeptidů podle předkládaného vynálezu nebo jejich analogů nebo derivátů.
Fragmenty podle předkládaného vynálezu by měly zahrnovat jeden nebo více takových epitopových oblastí nebo by měly být takovým oblastem dostatečně podobné tak, aby si udržely jejich antigenní / imunogenní vlastnosti. Proto je pro fragmenty podle předkládaného vynálezu stupeň irelevantní, protože jsou případně ze s konkrétní částí proteinu nebo polypeptidu, analogu nebo derivátu, které jsou popsány v předkládaném vynálezu. Klíčový bod je, aby si fragment udržel antigenní / imunogenní vlastnosti.
Pro analogy, deriváty a fragmenty je tak důležité, že mají alespoň takový stupeň antigenicity / imunogenicity jako měl protein nebo polypeptid, od kterého jsou odvozeny.
identity možná 100 % identické • * · ·
V předkládaném vynálezu polypeptidy podle předkládaného vynálezu zahrnují polypeptidy i chimérní polypeptidy.
Také sem spadají polypeptidy, které jsou navíc připojeny k dalším sloučeninám, které změní biologické nebo farmakologické vlastnosti polypeptidů, tj. polyethylenglykol (PEG) pro zvýšení životnosti; vedoucí nebo sekreční aminokyselinové sekvence pro usnadnění čištění; prepro- a prosekvence; a (póly)sacharidy.
Navíc v těchto situacích, kde bylo zjištěno, že aminokyselinové oblasti jsou polymorfní, je případně žádoucí změnit jednu nebo více konkrétních aminokyselin tak, aby se účinněji napodobily různé epitopy z různých kmenů streptokoku.
Navíc lze polypeptidy podle předkládaného vynálezu upravit acylací koncové -NH2 (např. acetylací nebo amidací thioglykolovou kyselinou, koncovou karboxyamidací, např. amoniakem nebo methylaminem) , čímž se zvýší stabilita, zvýší se hydrofobicita pro připojení nebo vazbu k nosiči nebo k jiné molekule.
Do předkládaného vynálezu také spadají hetero a homo polypeptidové multimery z polypeptidových fragmentů, analogů a derivátů. Tyto polymerní formy zahrnují například jeden nebo více polypeptidů, které byly zesíťovány zešíťovacími činidly jako je avidin/biotin, gluteraldehyd nebo dimethylsuperimidát. Takové polymerní formy také zahrnují polypeptidy obsahující dva nebo více tandemových nebo obrácených na sebe navazujících sekvencí vzniklých z multicistronových mRNA vzniklých technologií rekombinantní DNA.
S výhodou fragment, analog nebo derivát polypeptidu podle předkládaného vynálezu bude obsahovat alespoň jednu antigenní oblast tj. alespoň jeden epitop.
Aby se dosáhlo vzniku antigenních polymerů (tj . syntetických multimerů), lze použít polypeptidy nesoucí bishaloacetylové skupiny, nitroarylhalogenidy a podobně, kde jsou činidla specifická na thioskupiny. Proto spojky mezi »» ·· • · » » « · • 9 · » · •«14
Podle prostředky polypeptidů dvěma thiolovými skupinami různých peptidů jsou jednoduché vazby nebo jsou složeny ze spojujících skupin sestávajících alespoň ze dvou, typicky alespoň čtyř, a ne více než 16, ale obvykle ne více než 14 atomů uhlíku.
V konkrétním provedení polypeptidové fragmenty, analogy a deriváty podle předkládaného vynálezu neobsahují methioninový (Met) počáteční zbytek. S výhodou polypeptidy neobsahují vedoucí nebo sekreční sekvenci (signální sekvence). Signálovou část polypeptidu podle předkládaného vynálezu lze stanovit pomocí známých technik molekulární biologie. Obecně lze polypeptidy, které nás zajímají, izolovat ze streptokokové kultury a následně sekvenovat tak, aby se stanovil počáteční zbytek maturovaného proteinu a tím i sekvence maturovaného polypeptidu.
dalšího aspektu jsou poskytována vakcínové obsahující jeden nebo podle předkládaného s farmaceuticky přijatelným nosičem, ředidlem nebo adjuvans. Vhodná adjuvans zahrnují oleje, tj. Freundův kompletní nebo nekompletní adjuvant; soli, tj . AlK(SO4)2, AlNa(SO4)2, A1NH4(SO4)2, oxid křemičitý, kaolin, uhlíkaté polynukleotidy, tj . póly IC a polyAU. Preferovaná adjuvans zahrnují QuilA a Alhydrogel. Vakcíny podle předkládaného vynálezu lze podávat parenterálně injekcí, rychlou infuzí, absorpcí nosohltanem, absorpcí pokožkou nebo bukálně nebo orálně. Farmaceuticky přijatelné nosiče zahrnují také toxoid tetanu.
Pojem vakcína také zahrnuje protilátky. V souladu s předkládaným vynálezem je také poskytováno použití jedné nebo více protilátek, které se specificky váží k polypeptidům podle předkládaného vynálezu, za účelem léčení nebo profylaxe streptokokové infekce a/nebo nemocí vyvolaných streptokokovou infekcí.
více streptokokových vynálezu ve směsi
Vakcínové prostředky podle předkládaného vynálezu se používají pro léčení nebo profylaxi streptokokové infekce
4« | 44 | ·<··· | 4 · | 4 444 | ||
• » | • | 4 | • 4 | 4 | ||
4 | ||||||
4 4 4 4 | 4 | • | 4 4 | 4 4 | • | |
4 | 4 | « | 4 4 | 4 4 | 4 4 | |
4 4 | ς | 44 | • * | » 4 | 4 4 |
a/nebo nemocí a příznaků vyvolaných streptokokovou infekcí,
E. J. Baron, Manual of
D. C. , šesté jak je popsáno v knize P. R. Murray (editor),
M. A. Pfaller, F. C. Tenover a R. H. Yolken,
Clinical Microbilogy, AMS Press, Washington, vydání, 1995, str. 1482, která je zde uvedena jako reference. V jednom provedení se vakcínové prostředky podle předkládaného vynálezu používají pro léčení nebo profylaxi meningitidy, zánětu středního ucha, bakteriemie nebo pneumonie. V jednom provedení se vakcínové prostředky podle předkládaného vynálezu používají pro léčení nebo profylaxi streptokokové infekce a/nebo nemocí a příznaků vyvolaných streptokokovou infekcí, zejména S. pneumoniae, skupina A streptococcus (pyogenes), skupina B streptococcus (GBS nebo agalactiae) , dysgalactiae, uberis, nocardia stejně jako Staphylococcus aureus. V dalším provedení je streptokoková infekce S. pneumoniae.
V konkrétním provedení se vakcíny podávají jedincům, u kterých existuje riziko streptokokové infekce, jako jsou děti, starší osoby a imunokompromitovaní jedinci.
Tak jak se používá v předkládaném vynálezu, pojem „jedinci zahrnuje savce. V dalším provedení je savec člověk.
Vakcínové prostředky jsou s výhodou v jednotkové dávkovači formě 0,001 až 100 pg/kg (protilátky na tělesnou hmotnost) a výhodněji 0,01 až 100 pg/kg a nejvýhodněji 0,1 až 1 pg/kg jednou až třikrát v intervalu jeden až šest týdnů mezi imunizacemi.
Vakcínové prostředky jsou s výhodou v jednotkové dávkovači formě 0,1 pg až 10 mg a výhodněji 0,1 pg až 1 mg a nejvýhodněji 10 až 100 pg jednou až třikrát v intervalu jeden až šest týdnů mezi imunizacemi.
Podle dalšího aspektu jsou poskytovány polynukleotidy kódující polypeptidy vyznačující se aminokyselinovou sekvencí vybranou za tabulky A, B, D, E, G nebo H nebo jejich fragmenty, analogy nebo deriváty.
• · · ·
Ϊ6
Podle dalšího aspektu jsou poskytovány polynukleotidy kódující polypeptidy vyznačující se aminokyselinovou sekvencí vybranou za tabulky B, E nebo H nebo jejich fragmenty, analogy nebo deriváty.
V jednom provedení jsou polynukleotidy ty, které jsou ilustrovány v tabulce A, B, D, E, G nebo H, které kódují polypeptidy podle předkládaného vynálezu.
V jednom provedení jsou polynukleotidy ty, které jsou ilustrovány v tabulce B, E nebo H, které kódují polypeptidy podle předkládaného vynálezu.
Je cenné, že polynukleotidové sekvence ilustrované na obrázcích lze změnit pomocí degenerativních kodonů, které také kódují polypeptidy podle předkládaného vynálezu. Proto tedy předkládaný vynález dále poskytuje polynukleotidy, které hybridizují s dalšími polynukleotidovými sekvencemi, které již
byly v předkládaném | vynálezu | popsány | (nebo s ; | j ej ich | |||
komplementárními sekvencemi), které mají | 50' | ‘s identitu | mezi | ||||
sekvencemi. | V | j ednom | provedení | alespoň | 70% | identitu | mezi |
sekvencemi. | V | j ednom | provedení | alespoň | 75% | identitu | mezi |
sekvencemi. | V | j ednom | provedení | alespoň | 80% | identitu | mezi |
sekvencemi. | V | j ednom | provedení | alespoň | 85% | identitu | mezi |
sekvencemi. | V | j ednom | provedení | alespoň | 90% | identitu | mezi |
sekvencemi. | V dalším provedení jsou | polynukleotidy |
hybridizovatelné za přesně řízených podmínek, tj . mají alespoň 95% identitu. V dalším provedení více než 97% identitu.
Vhodné přesné podmínky pro hybridizaci odborník v dané problematice snadno stanoví (viz například Sambrook a kol., (1989) Molecular cloning: A Laboratory Manual, 2. vydání, Cold Spring Harbor, N.Y.; Current Protocols in Molecular Biology, (1999) editor F.M. Ausubel a kol., John Wiley & Sons, lne. , N.Y.).
V dalším provedení poskytuje předkládaný vynález polynukleotidy, které hybridizují za přesných podmínek na (a) DNA sekvenci kódující polypeptid nebo • · • · · · (b) komplement DNA sekvence kódující polypeptid;
kde tento polypeptid obsahuje sekvenci vybranou z tabulky
A, B, D, E, G nebo H nebo jeho fragmentů nebo analogů.
V dalším provedení poskytuje předkládaný vynález polynukleotidy, které hybridizují za přesných podmínek na (c) DNA sekvenci kódující polypeptid nebo (d) komplement DNA sekvence kódující polypeptid;
kde tento polypeptid obsahuje sekvenci vybranou z tabulky
B, E nebo H nebo jeho fragmentů nebo analogů.
V dalším provedení poskytuje předkládaný vynález polynukleotidy, které hybridizují za přesných podmínek na (a) DNA sekvenci kódující polypeptid nebo (b) komplement DNA sekvence kódující polypeptid;
kde tento polypeptid obsahuje alespoň 10 po sobě jdoucích aminokyselin z polypeptid obsahující sekvence vybrané z tabulky A, B, D, E, G nebo H nebo jejich fragmentů nebo analogů.
V dalším provedení poskytuje předkládaný vynález polynukleotidy, které hybridizují za přesných podmínek na (a) DNA sekvenci kódující polypeptid nebo (b) komplement DNA sekvence kódující polypeptid;
kde tento polypeptid obsahuje alespoň 10 po sobě jdoucích aminokyselin z polypeptid obsahující sekvence vybrané z tabulky B, E nebo H nebo jejich fragmentů nebo analogů.
V dalším provedení jsou polynukleotidy ty, které kódují polypeptidy podle předkládaného vynálezu ilustrované v tabulce A, B, D, E, G nebo H.
Jak si odborník v dané problematice snadno všimne, polynukleotidy zahrnují DNA i RNA.
Předkládaný vynález také zahrnuje polynukleotidy komplementární k polynukleotidům popsaným v předkládané přihlášce.
V dalším aspektu lze polynukleotidy kódující polypeptidy podle předkládaného vynálezu nebo jejich fragmenty, analogy • · · ·
nebo deriváty použít ve způsobu DNA imunizace. To znamená, že je lze zabudovat do vektoru, který je po injikování replikovatelný a exprimovatelný a tím produkuje antigenní polypeptid in vivo. Například polynukleotidy lze zabudovat do plasmidového vektoru kontrolovaného CMV promotérem, který je funkční v euraryotických buňkách. S výhodou je vektor injikován intramuskulárně.
V dalším aspektu je poskytován způsob produkce polypeptidů podle předkládaného vynálezu rekombinantními technikami exprimováním polynukleotidu kódujícího takový polypeptid v hostitelské buňce a odebráním exprimovaného polypeptidového produktu. Alternativně lze polypeptidy produkovat známými syntetickými chemickými technikami, tj. syntézou oligopeptidů, které jsou pak spojeny tak, aby vytvořily celý polypeptid (blokové spojování), prováděnou v roztoku nebo na pevné fázi.
Obecné způsoby získání a zhodnocení polynukleotidů a polypeptidů jsou popsány v následujících odkazech: Sambrook a kol., Molecular Cloning: A Laboratory Manual, 2. vydání, Cold Spring Harbor, N.Y., 1989; Current Protocols in Molecular Biology, editor F.M. Ausubel a kol, John Wiley and Sons, lne. New York; PCR Cloning Protocols, from Molecular Cloning to Genetic Engineering, editor B.A. White, Human Press, Totowa, New Jersey, 1997, 490 stran; Protein Purification, Principles and Practices, R.K. Scopes, Springer-Verlag, New York, 3. vydání, 1993, 380 stran; Current Protocols in Immunology, editor J.E. Coligan a kol., John Wiley & Sons lne. , New York, které jsou zde uvedeny jako reference.
Pro rekombinantní produkci se hostitelské buňky transfekují vektory, které kódují polypeptid, a pak kultivují v živném médiu upraveném podle potřeb pro aktivaci promotérů a následně se vyberou transformanty nebo se zesilují geny. Vhodné vektory jsou takové, které jsou životaschopné a replikovatelné ve vybraném hostiteli a zahrnují chromosomové, nechromosomové a syntetické DNA sekvence např. bakteriálních • ·
plasmidů, fágové DNA, bacilovirů, kvasinkových plasmidů, vektorů odvozených z kombinace plasmidů a fágové DNA. Polypeptidovou sekvenci lze ve vhodném místě vložit do vektoru za použití restrikčních enzymů tak, že je funkčně spojen s kontrolní oblastí exprese zahrnující promotér, vazebné místo pro ribosom (konvenční oblast nebo sekvence Shine-Dalgarno) a případně operátor (kontrolní prvek). Odborník v dané problematice dokáže zvolit jednotlivé složky kontrolní oblasti exprese, které jsou vhodné pro daného hostitele a vektor, na základě známých principů molekulární biologie (Sambrook a kol., Molecular Cloning: A Laboratory Manual, 2. vydání, Cold Spring Harbor, N.Y., 1989; Current Protocols in Molecular Biology, editor F.M. Ausubel a kol., John Wiley & Sons, lne. New York, které jsou zde uvedeny jako reference). Vhodné promotéry zahrnují, ale nejsou tímto výčtem nijako omezeny, promotér LTR nebo SV40, promotéry E. coli lac, tac nebo trp a promotér fágu lambda PL. Vektory budou s výhodou obsahovat počátek replikace stejně jako výběrové značky, tj. gen odolnosti proti ampicilinu. Vhodné bakteriální vektory zahrnují pET, pQE70, pQE60, pQE-9, pbs, pDlO fágový skript, psiX174, pblue skript SK, pbsks, pNH8A, pNH16a, pNH18A, pNH46A, ptcr99a, pKK223-3, pKK233-3, pDR540, pRIT5 a eukaryotické vektory pBlueBacIII, pWLNEO, pSV2CAT, pOG44, pXTl, pSG, pSVK3, pBPV, pMSG a pSVL. Hostitelské buňky jsou bakteriální tj. E. coli, Bacillus subtilis, Streptomyces; plísňové, tj . Aspergillus niger, Aspergillus nidulins; kvasinkové, tj. Saccharomyces nebo eukaryotické, tj. CHO, COS.
Po expresi polypeptidu v kultuře se buňky typicky oddělují odstředěním, pak se fyzikálními nebo chemickými prostředky rozruší (pokud se exprimovaný polypeptid nevylučuje do média) a výsledný surový extrakt se použije pro izolaci polypeptidu, který nás zajímá. Čištění polypeptidu z kultivačního média nebo lyzátu lze provést známými technikami v závislosti na vlastnostech polypeptidu, tj . použitím srážení pomocí síranu • · :···.
• 20 detekování kdy lze amonného nebo pomocí ethanolu, kyselé extrakce, aniontově nebo kationtově výměnné chromatografie, fosfocelulosové chromatografie, hydrofobní interakční chromatografie, hydroxylapatitové chromatografie a lektinové chromatografie. Konečné čištění se provádí pomocí HPLC.
Polypeptid lze exprimovat s nebo bez vedoucí nebo sekreční sekvence. V prvním případě lze vedoucí sekvenci odstranit použitím post-translačního zpracování (viz US 4 431 739; US 4 425 437 a US 4 338 397, které jsou zde uvedeny jako reference) nebo ji lze chemicky odstranit po čištění exprimovaného polypeptidu.
V dalším aspektu lze streptokokové polypeptidy podle předkládaného vynálezu použít na diagnostický test infekce streptokokem, zejména infekce S. pneumoniae. Možné je použiti několika diagnostických způsobů, například streptokokového organismu v biologickém vzorku, postupovat podle následujícího postupu:
a) získání biologického vzorku od pacienta;
b) inkubace protilátky nebo jejího fragmentu reagujícího se streptokokovým polypeptidem podle předkládaného vynálezu s biologickým vzorkem tak, aby vznikla směs; a
c) detekce specificky vázané protilátky nebo vázaného fragmentu ve směsi, což ukazuje na přítomnost streptokoka.
Alternativně lze postup detekce protilátky specifické na streptokokový antigen v biologickém vzorku obsahujícím nebo podezřelým, že obsahuje takovou protilátku, provést následujícím způsobem:
a) získání biologického vzorku od pacienta;
b) inkubace jednoho nebo více streptokokových polypeptidů podle předkládaného vynálezu nebo jejich fragmentů s biologickým vzorkem tak, aby vznikla směs; a
c) detekce specificky vázaného antigenu nebo vázaného fragmentu ve směsi, což ukazuje na přítomnost protilátky specifické na streptokoka.
Odborníkovi v dané problematice je zřejmé, že tento diagnostický test lze provést různými způsoby, včetně imunologického testu jako je imunosorbční test spojený s enzymem (ELISA), radioimunotest nebo latexový aglutinační test, které umožní stanovení toho, zda jsou v organismu přítomny protilátky specifické na polypeptid.
DNA sekvence kódující polypeptidy podle předkládaného vynálezu lze také použít pro návrh DNA sond pro použití při detekci přítomnosti streptokoka v biologickém vzorku, u kterého se předpokládá, že takové bakterie obsahuje. Způsob detekce podle předkládaného vynálezu zahrnuje:
a) získání biologického vzorku od pacienta;
b) inkubace jedné nebo více DNA sond, které mají DNA sekvenci kódující polypeptid podle předkládaného vynálezu nebo jeho fragmenty s biologickým vzorkem tak, aby vznikla směs; a
c) detekce specificky vázané DNA sondy ve směsi, což ukazuje na přítomnost streptokokové baktérie.
DNA sondy podle předkládaného vynálezu lze také použít pro detekci streptokoka v oběhu, tj. nukleových kyselin S. pneumoniae ve vzorku, například s použitím polymerasové řetězové reakce, jako způsobu diagnózy streptokokových infekcí. Sondu lze syntetizovat za použití běžných technik a lze ji imobilizovat na pevné fázi nebo ji lze označit detekovatelnou značkou. Preferovaná DNA sonda pro takové použití je oligomer mající sekvenci komplementární s alespoň šesti po sobě jdoucími oligonukleotidy polypeptidů streptococcus pneumoniae podle předkládaného vynálezu.
Další diagnostický způsob detekce streptokoka u pacienta zahrnuj e:
a) označení protilátky reaktivní s polypeptidem podle předkládaného vynálezu nebo jeho fragmentem pomocí detekovatelné značky;
b) podání značené protilátky nebo pacientovi; a značeného fragmentu • · · · ·
c) detekce specificky vázané protilátky nebo značeného fragmentu v pacientovi, což ukazuje na přítomnost streptokoka.
Dalším aspektem předkládaného vynálezu je použití streptokokových polypeptidů podle předkládaného vynálezu jako imunogenů pro produkci specifických protilátek pro diagnózu a zejména léčení streptokokové infekce. Vhodné protilátky lze určit za použití vhodných třídících způsobů, například měřením schopnosti konkrétní protilátky pasivně chránit proti streptokokové infekci u testovaného modelu. Jeden příklad zvířecího modelu je myší model popsaný v příkladech provedení vynálezu. Protilátka je celá protilátka nebo její antigen vázající fragment a případně patří do jakékoliv skupiny imunoglobulinů. Protilátka nebo fragment je případně zvířecího původu, zejména savčího původu a konkrétněji myšího, krysího nebo lidského původu. Jedná se o přirozenou protilátku nebo její fragment, nebo, pokud je to žádoucí, rekombinantní protilátku nebo fragment protilátky. Pojem rekombinantní protilátka nebo fragment protilátky označuje protilátku nebo fragmenty protilátky, které jsou případně polyklonální nebo s výhodou monoklonální. Případně jsou specifické na několik epitopů spojených s polypeptidy streptococcus pneumoniae, ale s výhodou jsou specifické pouze na jeden.
Dalším aspektem předkládaného vynálezu je použití protilátek směrovaných na streptokokové polypeptidy podle předkládaného vynálezu za účelem pasivní imunizace. Pro tuto imunizaci lze použít protilátky popsané v předkládaném vynálezu. Vhodné protilátky lze zjistit pomocí vhodných postupů třídění, například měřením schopnosti konkrétní protilátky pasivně ochraňovat proti infekci streptokokem u testovaného modelu. Jedním příkladem zvířecího modelu je myší model popsaný v příkladech provedení vynálezu. Protilátka je buď celá protilátka nebo její antigen vážící fragment a případně patří do jakékoliv skupiny imunoglobulinů. Protilátka nebo fragment je případně zvířecího původu, zejména savčího • » '25* původu a konkrétněji myšího, krysího nebo lidského původu. Jedná se o přirozenou protilátku nebo její fragment, nebo, pokud je to žádoucí, rekombinantní protilátku nebo fragment Pojem rekombinantní protilátka nebo fragment protilátky protilátky nebo fragmenty protilátky, označuje protilátku které jsou případně polyklonální nebo s výhodou monoklonální. Případně jsou specifické na několik epitopů spojených s polypeptidy streptococcus pneumoniae, ale s výhodou jsou specifické pouze na jeden.
Tabulka A, B a C variantů a epitopů BVH-3
Tabulka A
Skupina | Polypeptid sekvence id. č. |
BVH-3 | |
New 21 | aa 396 až 1039 ze sekvence id. č. 6 |
New 2 5 | aa 233 až 1039 ze sekvence id. č. 6 |
New 40 | aa 408 až 1039 ze sekvence id. č. 6 |
Tabulka B
Skupina | Polypeptid sekvence id. č. |
BVH-3 | |
NEWl-mutl** | 235 |
NEW35A | 236 |
NEW42 | 237 |
NEW49 | 238 |
NEW50 | 239 |
NEW51 | 240 |
NEW52 | 241 |
NEW53 | 242 |
♦ · · · •24’
NEW54 | 243 |
NEW55 | 244 |
NEW 5 6 | 245 |
NEW56-mut2** | 245 |
NEW56-mut3** | 245 |
NEW57 | 246 |
NEW63 | 247 |
NEW64 | 248 |
NEW65 | 249 |
NEW66 | 250 |
NEW76 | 251 |
NEW105 | 252 |
NEW106 | 253 |
NEW107 | 254 |
** tichá mutace, tj . polypeptid je stejný jako Newl nebo New 56
Tabulka C Epitopy BVH-3
7G11.7 | 12 |
7G11.9 | 13 |
B12D8.2 | 19 |
7F4.1 | 20 |
14F6.3 | 18 |
4D3.4 | 14 |
10C12.7 | 17 |
8E3.1 | 15 |
1G2.2 | 16 |
··. ···: . · • · i . . . · .: .: · : · : :. :
·· ··
Tabulka D, E a F
Tabulka D
Skupina | Polypeptid sekvence id. č. |
BVH-11 | |
Newl9 | aa 497 až 838 ze sekvence id. č. 8 |
New24 | aa 227 až 838 ze sekvence id. č. 8 |
Tabulka E
Skupina | Polypeptid sekvence id. č. |
BVH-11 | |
New 4 3 | 258 |
NEW60 | 293 |
NEW61 | 294 |
NEW62 | 295 |
NEW80 | 296 |
NEW81 | 297 |
NEW82 | 298 |
NEW83 | 299 |
NEW84 | 300 |
NEW85 | 301 |
NEW88D1 | 302 |
NEW88D2 | 303 |
NEW88 | 304 |
Tabulka F Epitopy BVH-11
10D7.5 | 21 |
10G9.3 | 22 |
B11B8.1 | 22 |
10A2.2 | 22 |
llb8.4 | 23 |
3A4.1 | 24 |
Tabulka G a Η Chiméry
Tabulka G
Skupina | Polypeptid sekvence id. č. |
Chiméry s BVH-11 a BVH3 | |
Newl7 | M*-NEW5-G*P*-NEW1 |
New20 | M*-NEW1-G*P*-NEW5 |
New26 | M*-NEW10-G*P*-NEW25 |
New27 | M*-NEW19-G*P*-NEW25 |
New28 | M*-NEW10-G*P*-NEW1 |
New2 9 | M*-NEW5 - G* P*-NEW2 5 |
New3 0 | M*-NEW4-G*P*-NEW25 |
New31 | M*-NEW4-G*P*-NEW1 |
New32 | M*-NE19-G*P*-NEW1 |
* Volitelná aminokyselina
Tabulka H
Skupina | Polypeptid sekvence id. č. |
Chiméry s BVH-11 a BVH-3 | |
VP 89 | 305 |
VP 90 | 306 |
VP 91 | 307 |
VP 92 | 308 |
VP 93 | 309 |
VP 94 | 310 |
VP 108 | 311 |
VP109 | 312 |
VP 110 | 313 |
• • | - · · · · · · : . .•'•z : : ·’ : '··· · : :. : ’ · *· · : • ·· ·· ••27* |
VP 111 | 314 |
VP112 | 315 |
VP113 | 316 |
VP114 | 317 |
VP115 | 318 |
VP116 | 319 |
VP117 | 320 |
VP119 | 321 |
VP12 0 | 322 |
VP121 | 323 |
VP122 | 324 |
VP123 | 325 |
VP124 | 326 |
Příklady provedení vynálezu
Příklad 1
Tento příklad popisuje bakteriální kmeny, plasmidy, PCR primery, rekombinantní proteiny a hybridomové protilátky použité v předkládaném vynálezu.
S. pneumoniae SP64 (seroskupina 6) a SP63 (seroskupina 9) klinické izoláty poskytla Laboratoire de la Santé Publique du Québec, Sinte-Anně-de-Bellevue; Rxl kmen, nezapouzdřený derivát typu 2 kmenu D3 9 a typu 3 kmenu WU2 poskytl David E. Briles z University of Alabama, Birmingham a typ 3 klinického izolátu P4241 poskytlo Centre de Recherche en Infectiologie du Centre Hospitalier de 1'Universitě Laval, Sainte-Foy. V této studii byly použity E. coli kmeny DH5a (Gibco BRL, Gaithesburg, MD) ; AD494 (ÁDE3) (Novagen, Madison, WI) a BL21 (ÁDE3) (Novagen) stejně jako plasmidový spojovací pSL301 vektor (Invitrogen, San Diego, CA); pCMV-GH vektor (dar od Dr. Stephena A. Johnstona, Department for Biochemistry, University of Texas, Dallas, Texas); pET32 a pET21 (Novagen) a pURV22.HIS • · • · · · expresní vektory (obrázek 30). pURV22.HIS vektor obsahující kazetu bakteriofágového λ cI857 teplotně citlivého represorového genu, ze kterého byl odstraněn funkční PR promotér. Deaktivace cI857 represoru zvýšením teploty z rozsahu 30 až 37 °C na 37 až 42 °C vedlo k indukci genu pod kontrolou promotéru ÁPL. PCR primery použité pro vytvoření rekombinantních plasmidů měly restrikční endonukleasové centrum na 5' konci, čímž umožňují směrové klonování zesílených produktů do naštěpeného plasmidového vektoru. Použité PCR oligonukleotidové primery jsou vypsány v následující tabulce 1. Umístění genových sekvencí kódujících BVH-3, BVH-11 a BVH-11-2 genové produkty je shrnuto na obrázku 25, obrázku 26 a obrázku 27.
Tabulka 1
Seznam PCR oligonukleotidových primerů
Primer | Sek- vence id. č. | Sekvence 5' - 3' | Pozice nukleotidu | Restrikční centra |
OCRR 479 | 25 | cagtagatctgtgcctatgcact aaac | sekvence id. č. 1: 61-78 sekvence id. č. 9: 1-18 | BglII |
OCRR 480 | 26 | gatctctagactactgctattcc ttacgctatg | sekvence id. č. 2: 4909-4887 sekvence id. č. 9: 2528-2519 | Xbal |
OCRR 497 | 27 | atcactcgagcattacctggata atcctgt | sekvence id. č. 1: 1525-1506 | Xhol |
*29
Primer | Sek- vence id. č. | Sekvence 5' - 3' | Pozice nukleotidu | Restrikční centra |
OCRR 498 | 28 | ctgctaagcttatgaaagattta gat | sekvence id. č. 1: 1534-1548 | HindlII |
OCRR 499 | 29 | gatactcgagctgctattcctta c | sekvence id. č. 2: 4906-4893 | Xhol |
HAMJ 172 | 30 | gaatctcgagttaagctgctgct aattc | sekvence id. č. 1: 675-661 | Xhol |
HAMJ 247 | 31 | gacgctcgagcgctatgaaatca gataaattc | sekvence id. č. 1: 3117-3096 | Xhol |
HAMJ 248 | 32 | gacgctcgagggcattacctgga taatcctgttcatg | sekvence id. č. 1: 1527-1501 | Xhol |
HAMJ 249 | 33 | cagtagatctcttcatcatttat tgaaaagagg | sekvence id. č. 2: 1749-1771 | BglII |
HAMJ 278 | 34 | ttatttcttccatatggacttga cagaagagcaaattaag | sekvence id. č. 1: 1414-1437 | Ndel |
HAMJ 279 | 35 | cgccaagcttcgctatgaaatca gataaattc | sekvence id. č. 1: 3117-3096 | HindlII |
HAMJ 280 | 36 | cgccaagcttttccacaatataa gtcgattgatt | sekvence id. č. 1: 2400-2377 | HindlII |
HAMJ 281 | 37 | ttatttcttccatatggaagtac ctatcttggaaaaagaa | sekvence id. č. 1: 2398-2421 | Ndel |
HAMJ | 38 | ttatttcttccatatggtgccta | sekvence | Ndel |
•3V
Primer | Sek- vence id. č. | Sekvence 5' - 3' | Pozice nukleotidu | Restrikční centra |
300 | tgcactaaaccagc | id. č. 1: 62-82 | ||
HAMJ 313 | 39 | ataagaatgcggccgcttccaca atataagtcgattgatt | sekvence id. č. 1: 2400-2377 | Notl |
OCRR 487 | 40 | cagtagatctgtgcttatgaact aggtttgc | sekvence id. č. 3: 58-79 | BglII |
OCRR 488 | 41 | gatcaagcttgctgctaccttta cttactctc | sekvence id. č. 4: 2577-2556 | HindlII |
HAMJ 171 | 42 | ctgagatatccgttatcgttcaa acc | sekvence id. č. 3: 1060-1075 | EcoRV |
HAMJ 251 | 43 | ctgcaagcttttaaaggggaata atacg | sekvence id. č. 3: 1059-1045 | HindlII |
HAMJ 264 | 44 | cagtagatctgcagaagccttcc tatctg | sekvence id. č. 3: 682-700 | BglII |
HAMJ 282 | 45 | tcgccaagcttcgttatcgttca aaccattggg | sekvence id. č. 3: 1060-1081 | HindlII |
HAMJ 283 | 46 | ataagaatgcggccgccttactc tcctttaataaagccaatagtt | sekvence id. č. 3: 2520-2492 | Notl |
HAMJ 284 | 47 | catgccatggacattgatagtct cttgaaacagc | sekvence id. č. 3: 856-880 | Ncol |
HAMJ 285 | 48 | cgccaagcttcttactctccttt aataaagccaatag | sekvence id. č. 3: | HindlII |
Primer | Sek- vence id. č. | Sekvence 5' - 3' | Pozice nukleotidu | Restrikční centra |
2520-2494 | ||||
HAMJ 286 | 49 | cgacaagcttaacatggtcgcta gcgttacc | sekvence id. č. 3: 2139-2119 sekvence id. č. 5: 2210-2190 | HindiII |
HAMJ 287 | 50 | cataccatgggcctttatgaggc acctaag | sekvence id. č. 3: 2014-2034 | Ncol |
HAMJ 288 | 51 | cgacaagcttaagtaaatcttca gcctctctcag | sekvence id. č. 3: 2376-2353 | HindiII |
HAMJ 289 | 52 | gataccatggctagcgaccatgt tcaaagaa | sekvence id. č. 3: 2125-2146 | Ncol |
HAMJ 290 | 53 | cgccaagcttatcatccactaac ttgactttatcac | sekvence id. č. 3: 1533-1508 | HindiII |
HAMJ 291 | 54 | cataccatggatattcttgcctt cttagctccg | sekvence id. č. 3: 1531-1554 | Ncol |
HAMJ 301 | 55 | catgccatggtgcttatgaacta ggtttgc | sekvence id. č. 3: 59-79 | Ncol |
HAMJ 302 | 56 | cgccaagctttagcgttaccaaa accattatc | sekvence id. č. 3: 2128-2107 | HindiII |
HAMJ 160 | 57 | gtattagatctgttcctatgaac ttggtcgtcacca | sekvence id. č. 5: 172-196 | BglII |
····
32** ·· ··
Primer | Sek- vence id. č. | Sekvence 5' - 3' | Pozice nukleotidu | Restrikční centra |
HAMJ 186 | 58 | cgcctctagactactgtatagga gccgg | sekvence id. č. 5: 2613-2630 | Xbal |
HAMJ 292 | 59 | catgccatggaaaacatttcaag ccttttacgtg | sekvence id. č. 5: 925-948 | Ncol |
HAMJ 293 | 60 | cgacaagcttctgtataggagcc ggttgactttc | sekvence id. č. 5: 2627-2604 | HindiII |
HAMJ 294 | 61 | catgccatggttcgtaaaaataa ggcagaccaag | sekvence id. č. 5: 2209-2232 | Ncol |
HAMJ 297 | 62 | catgccatggaagcctattggaa tgggaag | sekvence id. č. 5: 793-812 | Ncol |
HAMJ 352 | 63 | catgccatggaagcctattggaa tgggaagc | sekvence id. č. 5: 793-813 | Ncol |
HAMJ 353 | 64 | cgccaagcttgtaggtaatttgc gcatttgg | sekvence id. č. 5: 1673-1653 | HindiII |
HAMJ 354 | 65 | cgccaagcttctgtataggagcc ggttgac | sekvence id. č. 5: 2627-2608 | HindlII |
HAMJ 355 | 66 | catgccatggatattcttgcctt cttagctcc | sekvence id. č. 5: 1603-1624 | Ncol |
HAMJ 404 | 67 | ttatttcttccatatgcatggtg atcatttccattaca | sekvence id. č. 1: 1186-1207 | Ndel |
HAMJ | 68 | gatgcatatgaatatgcaaccga | sekvence | Ndel |
« * « · 9 · | 1 · ·
• · ’ • · · *
Primer | Sek- vence id. č. | Sekvence 5' - 3' | Pozice nukleotidu | Restrikční centra |
464 | gtcagttaagc | id. č. 1: 697-720 | ||
HAMJ 465 | 69 | gatgctcgagagcatcaaatccg tatccatc | sekvence id. č. 1: 1338-1318 | Xhol |
HAMJ 466 | 70 | gatgcatatggatcatttccatt acattcca | sekvence id. č. 1: 1192-1212 | Ndel |
HAMJ 467 | 71 | gacaagcttggcattacctggat aatcctg | sekvence id. č. 1: 1527-1507 | HindiII |
HAMJ 352 | 72 | catgccatggaagcctattggaa tgggaagc | sekvence id. č. 5: 793-813 | Ncol |
HAMJ 470 | 73 | ataagaatgcggccgccgctatg aaatcagataaattc | sekvence id. č. 1: 3096-3117 | Notl |
HAMJ 471 | 168 | atatgggcccctgtataggagcc ggttgactttc | sekvence id. č. 5: 2626-2604 | Apa I |
HAMJ 472 | 169 | atatgggcccaatatgcaaccga gtcagttaagc | sekvence id. č. 1: 720-697 | Apa I |
HAMJ 350 | 170 | atatgggcccaacatggtcgcta gcgttacc | sekvence id. č. 3: 2139-2119 | Apa I |
HAMJ 351 | 171 | tcccgggcccgacttgacagaag agcaaattaag | sekvence id. č. 1: 1414-1437 | Apa I |
HAMJ 358 | 172 | catgccatgggacttgacagaag agcaaattaag | sekvence id. č. 1: | Ncol |
···· • ·> ·
3^·’
Primer | Sek- vence id. č. | Sekvence 5' - 3' | Pozice nukleotidu | Restrikční centra |
1415-1437 | ||||
HAMJ 359 | 173 | tcccgggccccgctatgaaatca gataaattc | sekvence id. č. 1: 3116-3096 | Apa I |
HAMJ 403 | 174 | atatgggcccgacattgatagtc tcttgaaacagc | sekvence id. č. 3: 856-880 | Apa I |
HAMJ 361 | 175 | cgccaagcttaacatggtcgcta cgcttacc | sekvence id. č. 3: 2139-2119 | Hind III |
HAMJ 483 | 176 | atatgggccccttactctccttt aataaagccaatag | sekvence id. č. 3: 2520-2494 | Apa I |
Techniky molekulární biologie byly provedeny standardními postupy. Viz například J. Sambrook, E.F. Fritsch, T. Maniatis, „Molecular cloning. A laboratory manual svazky 1, 2 a 3 (druhé vydání) Cold Spring Harbour Laboratory Press, 1989, New York, který je zde uveden jako reference. Produkty zesílené PCR byly naštěpeny restrikčními endonukleasami a ligovány buď do linearizovaného plasmidového pSL301, pCMV-GH, pET nebo pURV22.HIS expresního vektoru naštěpeného podobně nebo naštěpeného enzymy, které produkují kompatibilní kohezní konce. Rekombinantní palsmid pSL301 a rekombinantní plasmid pCMV-GH byly naštěpeny restrikčními enzymy pro klonování v pET expresním vektoru uvnitř rámce. Když byly použity pET vektory, byly klony nejprve stabilizovány v E. coli DH5ot a pak vloženy do E. coli BL21 (ÁDE3) nebo AD494 (ADE3) , aby exprimovaly molekuly BVH-3, BVH-11 nebo BVH-11-2 plné délky nebo zkrácené délky. Každý z výsledných plasmidových konstruktů byl ověřen nukleotidovou sekvenční analýzou. Rekombinantní proteiny byly ·· ···· ·* ···* ► · · « *4 < * exprimovány tak, že na N-konci byly připojeny k His-tag (pET21 expresní systém); nebo byly na N-konci připojeny k His-tag (pURV22.HIS expresní systém). Exprimované rekombinantní proteiny byly vyčištěny od podílů roztoku zbylého na usazeninou po odstředění sonikované IPIG (pET systémy) nebo teplem (pURV22.HIS) vyvolané E. coli za použití His-Bind kov chelatující pryskyřice (QIAgen, Chatswort, CA). Genové pneumoniae SP64 jsou vypsány Genový fragment kódující protein
BVH-3-Sp63 (aminokyselinové zbytky 21 až 840 sekvence id. č. 10) byl získán z S. pneumoniae SP63 za použití sady PCR primerů OCRR479-OCRR480 a klonování vektoru pSL301.
Rekombinantní pSL301-BVH-3Sp63 byl naštěpen pro klonování v rámci pET32 vektoru, aby došlo k expresi molekuly
BVH-3-Sp63.
produkty získané z S. v následující tabulce 2.
Tabulka 2
Seznamy zkrácených BVH-3, BVH-11, BVH-11-2 a chimerových genových produktů získaných z S. pneumoniae SP64
Sada PCR primerů | Označení proteinu | Identifikace | Kódované aminoky- seliny (sekvence id. č. 6) | Klonuj ící vektor |
OCRR479-OCRR480 | BVH-3M | BVH-3 w/o ss | 21-1039 | pSL301 |
OCRR479-OCRR497 | BVH-3AD | BVH-3 Ν' konec w/o ss | 21-509 | pSL301 |
HAMJ248-HAMJ249 | L-BVH-3AD | BVH-3 Ν' konec | 1-509 | pET-21(+) |
OCRR498-OCRR499 | BVH-3B | BVH-3 C' konec | 512-1039 | pSL301 |
OCRR479-HAMJ172 | BVH-3C | BVH-3 Ν' konec w/o ss | 21-225 | pET-32 C ( + ) |
• · · ·
OCRR487-OCRR488 | BVH-11M | BVH-llw/o ss | 20-840 | pCMV-GH |
HAMJ251-OCRR487 | BVH-1ΙΑ | BVH-11 Ν' konec w/o ss | 20-353 | pET-32 C ( + ) |
HAMJ171-OCRR488 | BVH | BVH-11 C' konec | 354-840 | pET-32 a(+) |
HAMJ264-OCRR488 | BVH | BVH-11 C' konec | 228-840 | pET-32 a(+) |
HAMJ278-HAMJ279 | NEW1 | BVH-3 C' konec | 472-1039 | pET-21 b( + ) |
HAMJ278-HAMJ280 | NEW2 | BVH-3 C' konec | 472-800 | pET-21 b(+) |
HAMJ281-HAMJ279 | NEW3 | BVH-3 C' konec | 800-1039 | pET-21 b(+) |
HAMJ284-HAMJ285 | NEW4 | BVH-11 C' konec | 286-840 | pET-21 d(+) |
HAMJ284-HAMJ286 | NEW5 | BVH-11 | 286-713 | pET-21 d(+) |
HAMJ287-HAMJ288 | NEW6 | BVH-11 | 672-792 | pET-21 d(+) |
HAMJ285-HAMJ289 | NEW7 | BVH-3 C' konec | 709-840 | pET-21 d(+) |
HAMJ284-HAMJ290 | NEW8 | BVH-11 | 286-511 | pET-21 d(+) |
HAMJ286-HAMJ291 | NEW9 | BVH-11 | 511-713 | pET-21 d( + ) |
HAMJ160-HAMJ186 | BVH | BVH-11-2 w/o | 20-838 | pSL301 |
HAMJ292-HAMJ293 | NEW10 | BVH-11-2 | 271-838 | pET-21 d(+) |
HAMJ293-HAMJ294 | NEW11 | BVH-11-2 | 699-838 | pET-21 d(+) |
HAMJ282-HAMJ283 | NEW13 | BVH-11 C' konec | 354-840 | pET-21 b( + ) |
HAMJ286-HAMJ297 | NEW14 | BVH-11-2 | 227-699 | pET-21 d(+) |
HAMJ300-HAMJ313 | NEW 15 | BVH-3 Ν' konec | 21-800 | pET-21 b( + ) |
HAMJ301-HAMJ302 | NEW 16 | BVH-11 Ν' konec w/o ss | 20-709 | pET-21 d( + ) |
HAMJ352-HAMJ353 | NEW18 | BVH-11-2 vnitřní | 227-520 | pET-21 d( + ) |
.1 .··.
• ·
3*?’
HAMJ354-HAMJ355 | NEW 19 | BVH-11-2 C4 konec | 497-838 | pET-21 d(+) |
HAMJ404-HAMJ279 | NEW21 | BVH-3 C' konec | 396-1039 | pET-21 b( + ) |
HAMJ464-HAMJ465 | NEW22 | BVH-3 vnitřní | 233-446 | pET-21 a(+) |
HAMJ466-HAMJ467 | NEW23 | BVH-3 vnitřní | 398-509 | pET-21 b(+) |
HAMJ352-HAMJ292 | NEW24 | BVH-11-2 C' konec | 227-838 | pET-21 d(+) |
HAMJ464-HAMJ470 | NEW25 | BVH-3 C' konec | 233-1039 | pET-21 b( + ) |
HAMJ278-HAMJ279 (NEW 1) HAMJ282-HAMJ283 (NEW 13) | NEW1 2 | Chiméra* | M-NEW 1 -KL- NEW 13 | pET 21 b( + ) |
HAMJ284-HAMJ350 (NEW 5) HAMJ351-HAMJ279 (NEW 1) | NEW1 7 | Chiméra* | M- NEW 5 -GP- NEW 1 | pET 21 d(+) |
HAMJ358-HAMJ359 (NEW 1) HAMJ403-HAMJ361 (NEW 5) | NEW2 0 | Chiméra* | M- NEW 1 -GP- NEW 5 | pET 21 d( + ) |
HAMJ292-HAMJ471 (NEW 10) HAMJ472-HAMJ470 (NEW 25) | NEW26 | Chiméra* | M- NEW 10 -GP- NEW 25 | pET 21 d( + ) |
HAMJ355-HAMJ471 (NEW 19) HAMJ472-HAMJ470 (NEW 25) | NEW27 | Chiméra* | M- NEW 19 -GP- NEW 25 | pET 21 d(+) |
HAMJ292-HAMJ471 (NEW 10) | NEW28 | Chiméra* | M- NEW 10 -GP- | pET 21 d{+) |
• · · ·
38· • * • · · · • ·
HAMJ351-HAMJ279 (NEW 1) | NEW 1 | |||
HAMJ284-HAMJ350 (NEW 5) HAMJ472-HAMJ470 (NEW 25) | NEW2 9 | Chiméra* | M- NEW 5 -GP- NEW 2 5 | pET 21 d( + ) |
HAMJ284-HAMJ483 (NEW 4) HAMJ472-HAMJ470 (NEW 25) | NEW3 0 | Chiméra* | M- NEW 4 -GP- NEW 25 | pET 21 d(+) |
HAMJ284-HAMJ483 (NEW 4) HAMJ351-HAMJ279 (NEW 1) | NEW31 | Chiméra* | M- NEW 4 -GP- NEW 1 | pET 21 d(+) |
HAMJ355-HAMJ471 (NEW 19) HAMJ351-HAMJ279 (NEW 1) | NEW32 | Chiméra* | M- NEW 19 -GP- NEW 1 | pET 21 d(+) |
w/o ss: bez signálové sekvence. Analýza BVH-3, BVH-11 a BVH-11-2 proteinových sekvencí ukázala přítomnost putativních hydrofobních vedoucích sekvencí.
* kódované aminokyseliny pro chiméry jsou exprimovány jako genový produkt, přidány byly další neesenciální aminokyseliny, M je methionin, K je lysin, L je leucin, G je glycin a P je prolin.
Hybridomy vylučující monoklonální protilátku (Mab) byly získány spojením buněk sleziny z imunizovaných myší a nevylučujících buněk HGPRT deficientního myšího myelomu SP2/0 postupem podle Fazekas De St-Groth a Scheidegger (J. Immunol. Methods 35: 1-21, 1980) s úpravami podle J. Hammel a kol., J. Med. Microbiol. 23: 163-170, 1987). Samice BALB/c myší (Charles River, St-Constant, Quebec, Canada) byly imunizovány BVH-3M (systém thioredoxin-His«Tag-BVH-3M fúzní protein / • · · · • · · · * · • fc · · pET32), BVH-11M (systém thioredoxin-His»Tag-BVH-11M fúzní protein / pET32), BVH-11B (systém thioredoxin-His«Tag-BVH-11B fúzní protein / pET32), BVH-3M (systém His»Tag-BVH-3 fúzní protein / pURV22.HIS) nebo NEW1 (systém NEWl-His«Tag fúzní protein / pET21) genovými produkty z kmenu S. pneumoniae SP64, aby vznikly série Mab H3-, H11-, H12-, H11B-, H3V- a HN1-.
Roztoky z kultivace hybridomů byly nejprve tříděny pomocí imunosorbčního testu spojeného s enzymem (ELISA) postupem podle Hamel a kol. (viz výše) za použití desek pokrytých přípravkem z rekombinantních proteinů BVH-3, BVH-11 a/nebo BVH-11-2 nebo suspenzí teplem zabitých buněk S. pneumoniae. Mab vylučující hybridomy vybrané pro další charakterizaci jsou vypsány v tabulce 3 a tabulce 4 v následujícím příkladu 2. Skupina a podskupina Mab imunoglobulinů byly stanoveny pomocí ELISA za použití komerčně dostupných činidel (Southern Biotechnology Associates, Birmingham, Al).
Navíc je popsáno klonování a exprese chimerních genů kódujících chimerní polypeptidy a ochrana vyvolaná po vakcinaci těmito chimerními polypeptidy.
Genové fragmenty BVH-3 a BVH11 odpovídající 3' konci genů byly zesíleny pomocí PCR za použití párů oligonukleotidů upravených tak, aby zesílily genové fragmenty, které by měly být zahrnuty v chimerních genech. Použité primery měly restrikční endonukleasové centrum na 5' konci, čímž umožňuje v rámci přímé klonování zesíleného produktu do naštěpených plasmidových vektorů (tabulka 1 a tabulka 2). PCR zesílené produkty byly naštěpeny restrikčními endonukleasami a linearizovaných plasmidových pET21 nebo Výsledné plasmidové konstrukty byly ověřeny nukleotidovou sekvenční analýzou. Rekombinantní pET21 plasmidy obsahující PCR produkt byly linearizovány štěpením restrikčními enzymy pro klonování druhého DNA fragmentu v rámci a vytvoření chimerního genu kódujícího chimerní pneumokokovou proteinovou molekulu. Rekombinantní pSL301 spoj ovány do pSL301 vektorů • · · · • · • · « · « ·
plasmidy obsahující PCR produkt byly štěpeny restrikčními enzymy, čímž se získaly DNA inserty. Výsledné fragmenty DNA insertu byly čištěny a inserty odpovídající danému chimernímu genu byly spojeny do pET21 vektoru, čímž vznikl chimerní gen. Rekombinantní chimerní polypeptidy vypsané v tabulce 2 byly na C konci spojeny s His-značkou. Exprimované rekombinantní proteiny byly čištěny z tekutiny nad usazeninou získanou z centrifugace sonikovaných IPTG vyvolaných kultur E. coli za použití His-Bind kov chelatující pryskyřice (QIAgen, Chatsworth, CA).
Skupiny osmi samic BALB/c myší (Charles River) byly imunizovány subkutánně dvakrát ve třítýdenních intervalech 25 pg jakéhokoliv afinitně čištěného His*Tag fúzního proteinu identifikovaného v přítomnosti 15 až 20 pg QuilA adjuvans. Deset až 14 dnů po poslední imunizaci bylo myším intravenózně podáno 10E5-10E6 CFU S. pneumoniae typu 3 kmenu WU2. Polypeptidy a fragmenty jsou schopné vyvolat ochrannou imunitní reakci.
Tabulka 2A
Experiment | Imunogen | Živé : mrtvé | Dny do smrti po infekci |
1 | žádný | 0 : 8 | 1, 1, 1, 1, 1, 1, 1, 1 |
NEW 1 | 2 : 6 | 1, 2, 2, 2, 2, 2, >14, >14 | |
NEW 13 | 1 : 7 | 1, 1, 3, 3, 4, 5, 5, >14 | |
NEW 12 | 6 : 2 | 3, 11, 6 x >14 | |
BVH-3M | 1 : 7 | 3, 3, 3, 3, 3, 3, 3, >14 | |
! r ’· <· a i* * . s* f* *>·>. 4L -· · | ** ÍAřV’ *iSi * · o žádný | 0 : 8 | p |
2 | 1, 1, 1, 1, 1, 1, 1, 1 | ||
NEW 17 | 7 : 1 | 4, 7 x >14 | |
NEW 12 | 3 : 5 | 3, 3, 3, 4, 5, >14, >14, >14 | |
3 | žádný | 0 : 8 | 2, 2, 2, 2, 2, 2, 2, 2 |
NEW 18 | 1 : 7 | 2, 2, 2, 2, 3, 3, 3, 3 |
• · · : .· · ·· · : ··: * :
41·......
NEW 19 | 8 : 0 | 8 x >14 | |
NEW 10 | 8 : 0 | 8 x >14 | |
BVH-11-2 | 8 : 0 | 8 x >14 |
Příklad 2
Tento příklad popisuje identifikaci peptidových domén nesoucích cílové epitopy za použití Mab a rekombinantních zkrácených proteinů popsaných v příkladu 1.
Hybridomy byly testovány pomocí ELISA proti zkráceným BVH-3, BVH-11 nebo BVH-11-2 genovým produktům, aby se zjistily epitopy rozeznávané Mab. Zkrácené genové produkty byly získány z kmenu S. pneumoniae SP64 s výjimkou BVH-3-Sp63, který byl získán z kmenu S. pneumoniae SP63. Jako pozitivní kontrola byla reaktivita každé protilátky testována rekombinantními proteiny BVH-3, BVH-11 nebo BVH-11-2 plné délky. V některých případech byla reaktivita Mab vyhodnocena Western imunoblotací po oddělení genového produktu pomocí SDS-PAGE a přesunu na nitrocelulosový papír. Tyto pozorované reaktivity jsou uvedeny v následující tabulce 3 a 4.
• · · · íti
ELISA reaktivita BVH-3 reaktivních Mab se skupinou jedenácti BVH-3 genových produktů molekulou BVH-11M
Testované genové produkty | BVH- 11M L. . .. | + | + | + | 1 | 1 | + | + | + | 1 | 1 | 1 | |
BVH-3 Sp63 i | + | + | + | 1 | + | + | + | + | + | + | + | + | |
NEW 23 | 1 | 1 | 1 | 1 | + | 1 | S | £ | a | 1 | 1 | 1 | |
NEW 22 | t | l | + | 1 | 1 | NT | NT | NT | 1 | 1 | 1 | ||
NEW 21 | 1 | 1 | 1 | 1 | + | + | £ | NT | NT | + | + | + | |
NEW 3 | 1 | 1 | 1 | 1 | + | 1 | 1 | í | 1 | 1 | 1 | ||
NEW 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | + | 1 | + | + | ||
NEW 1 | 1 | 1 | 1 | 1 | 1 | + | 1 | 1 | + | + | + | + | |
BVH-3C | + | + | + | 1 | 1 | 1 | + | + | + | 1 | 1 | 1 | |
BVH-3B | 1 | 1 | 1 | 1 | 1 | + | 1 | + | + | + | + | ||
BVH- 3AD | + | + | + | + | + | 1 | + | + | + | 1 | 1 | ||
BVH-3M | + | + | + | + | + | + | + | + | + | + | + | + | |
Mab (IgG isotyp) | H3-4F9 (1) | H3-4D4 (1) | H3-9H12 (1) | H3-7G2 (1) | H3-10A1 (1) | H3-4D3 (1) | H11-6E7 (1) | H11-10H10 (2a) | H11-7G11 (2b) | H3V-4F3 (1) | H3V-2F2 (1) | H3V-7F4 (1) |
ΓΩ
Testované genové produkty | BVH- 11M | 1 | 1 | + /- | 1 | 1 | 1 + | 1 | 1 | 1 | 1 | 1 |
BVH-3 Sp63 | + | + | l + | I | 1 | + | NT | + | + | + | + | |
NEW 2 3 | 1 | I | l | 1 | + | + | 1 | 1 | 1 | 1 | ||
NEW 22 | 1 | 1 | + | + | 1 | + | + | 1 | 1 | 1 | 1 | |
NEW 21 | 4- | + | 1 | 1 | + | + | + | + | + | + | + | |
NEW 3 | + | + | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
NEW 2 | 1 | 1 | 1 | 1 | 1 | + | + | 1 | 1 | 1 | + | |
NEW 1 | + | + | 1 | 1 | + | + | + | + | + | + | ||
BVH-3C | 1 | 1 | 1 + | 1 | 1 | 1 + | Η a | NT | NT | NT | NT | |
m ΓΩ 1 | + | + | 1 | I | 1 | + | NT 1 | + | + | + | + | |
£ § ffl | 1 | + | + | + | + | + | 1 | 1 | 1 | 1 | ||
BVH-3M , i | + | + | + | + | + | + | + | + | + | + | + | |
o JJ 03 <Ú -J s H | H3V-7H3 (1)1 | H3V-13B8 (1) | H3V-9C2 (1) | H3V-9C6 (1) | H3V-16A7 (1) | H3V-15A10 (1) | H3V-6B3 (1/2) | HN1-5H3 (2b) | HN1-8E3 (2a) | HN1-14F6 (2a) | HN1-2G2 (1) |
=T
Ί1 a a a
Λ S τ—1 m | 1 | 1 | 1 | 1 | 1 |
7 ” Λ νη ξ a m ω | + | + | + | + | + |
NEW 23 | 1 | 1 | 1 | 1 | + |
NEW 22 | 1 | 1 | 1 | 1 | 1 |
NEW 21 | + | + | + | + | + |
NEW 3 | 1 | 1 | + | + | 1 |
NEW 2 | + | + | 1 | 1 | + |
NEW 1 | + | + | + | + | + |
BVH-3C | NT | NT | NT | NT | 1 |
BVH-3B | + | + | + | + | 1 |
BVH- 3AD | 1 | 1 | 1 | 1 | + |
2 n m | + | + | + | + | + |
o _ ÍU >1 4-> η θ Φ 2 2 | HN1-12D8 (2a) | HN1-14B2 (2a) | HN1-1G2 (2a) | HN1-10C12 (1) | HN1-3E5 (1) |
Λ
Φ
S (Ο
Ρ
Ν tú >
'Φ υ
•Η
4-1
-Η υ
φ ϋ
ω
Φ 'Φ £
>Ν
Ο e
Ή
τ)
Φ
Ν ο
&
>Ν
Φ £
Ή >ω >ω £
φ ι—I Φ
Φ
4->
-Η >
•Η
4->
Φ
Φ
Μ 'Φ \φ Ή > tí Ο
4-> -Η ω £ Φ ι—1 -U φ ·· ι
Η \ S + • · • ·· ·
Lf) ρ
i—I
Ρ
Η
ΓΊ i
m re!
I ac >
0Ί •rl
-P o
'íO β
P
-P >u o
c
Ή a
Pí
CO <1) m
b rej
S p
o
Ή β
>
•H
-P
Pí (0
Φ
P cg i
m o
Λ
Φ β
(Ώ
-Ρ
-ιΗ >
-Η
4->
Ρ <υ
Ρ ω
Μ
Ρ ω
s η
I π
>
(Ώ
Ο ι—I 3 Ρί (D Η Ο e
°3
Ρ
Ρ
Ό
Ο
Ρ a
ρ υ
'>ι >
Ο β
ω a
Ρ
Ρ
Ο
Ρ a
'© >
ο η
φ tn '© β
π) >
Ο μ
m
Φ
Η
BVH- 3Μ | + | + | + | + | + | + | 1 | 1 | 1 | 1 | 1 | 1 |
BVH- 11- 2-Μ | + | + | + | + | + | + | + | + | + | + | + | + |
NEW 19 | 1 | 1 | 1 | 1 | 1 | 1 | I | 1 | 1 | 1 | 1 | |
NEW 18 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | + | + | + | + | |
NEW 14 | 1 | 1 | 1 | 1 | 1 | I | + | + | + | + | ||
NEW 11 | 1 | 1 | 1 | 1 | 1 | t | • | 1 | 1 | 1 | 1 | 1 |
NEW 10 | 1 | 1 | 1 | 1 | 1 | + | + | + | + | |||
NEW 9 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
NEW 8 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | * I | * 1 | * 1 | + |
NEW 7 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
NEW 6 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
NEW 5 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | I | + | + | + | + |
BVH- 11C | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | + | + | + | S |
BVH- 11B | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | + | + | + | + |
BVH- 11A | + | + | + | + | + | + | + | + | 1 | 1 | 1 | 1 |
BVH- 11M | + | + | + | + | + | + | + | + | + | + | + | + |
Mab (IgG isotyp) | H3-4F9 (1) | H3-4D4 (1) | H3-9H12 (1) | H11-6E7 (1) | H11-10H10 (2a) | H11-7G11 (2b) | H11-1B12 (1) | H11-7B9 (2a) | H11-3H5 (1) | H11-10B8 (1) | H11-1A2 (1) | H112-3A1 (1) |
• 9 · · • 9 « «
Testované genové produkty | 1 £ > CQ PQ | 1 | 1 | I | 1 | 1 | 1 | 1 | 1 | l |
BVH- 11- 2-M | + | + | + | + | + | + | + | + | + | |
« 2 | 1 | ( | + | + | + | 1 | 1 | 1 | ||
NEW 18 | + | + | + | 1 | 1 | 1 | l | 1 | l | |
NEW 14 | + | + | + | + | + | + | + | t | 1 | |
NEW 11 | 1 | 1 | I | 1 | 1 | 1 | 1 | 1 | 1 | |
NEW 10 | + | + | + | + | + | + | + | 1 | 1 | |
NEW 9 | 1 | 1 | 1 | + | + | 1 | 1 | 1 | ||
NEW 8 | + | + | + | t | 1 + | 1 + | 1 | 1 | 1 | |
NEW 7 | l | 1 | 1 | 1 | í | i | 1 | 1 | ||
NEW 6 | » | 1 | 1 | 1 | 1 | 1 | I | í | 1 | |
NEW 5 | + | + | + | + | + | + | + | 1 | 1 | |
BVH- 11C | NT | NT | NT | NT | NT | NT | NT | NT | NT | |
BVH- 11B | + | 1 | + | + | + | + | 1 | |||
BVH- 11A | +/- | + | + | 1 | 1 | 1 | 1 | + | + | |
BVH- 11M | + | + | + | + | + | + | + | + | + | |
O _ -U n o s H | H112-13C11 (!) | H112-10H10 (1) | H112-1D8 (2a) | H112-10G9 (2b) | H112-10A2 (1) | H112-3E8 (2a) | H112-10D7 (2a) | H112-2H7 (2a) | H112-6H7 (1) |
• · • · • · · u * ·
Testované genové produkty | BVH- 3M | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
BVH- 11- 2-M | + | + | + | + | + | + | + | + | + | + | |
NEW 19 | + | + | + | l | 1 | 1 | 1 | 1 | 1 | + | |
NEW 18 | 1 | t | f | + | + | 1 + | 1 | + | + | l | |
NEW 14 | 1 | 1 | 1 | + | + | 1 | 1 | + | + | + | |
NEW 11 | + | + | + | 1 | - | 1 | 1 | 1 | i | ||
NEW 10 | + | + | + | + | 1 | 1 + | + | + | + | ||
!δ ω cn 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | + | |
NEW 8 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | + | + | 1 | |
NEW 7 | 1 | i | 1 | 1 | í | l | t | í | |||
NEW 6 | 1 | 1 | 1 | í | 1 | 1 | 1 | 1 | 1 | ||
NEW 5 | 1 | 1 | 1 | 1 | 1 | + | + | + | |||
BVH- 11C | NT | NT | NT | NT | NT | NT | NT | + | + | + | |
BVH- 11B | 1 | 1 | 1 | 1 | 1 | 1 | + | + | + | ||
i << PQ '“t | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
BVH- 11M | 1 | 1 | 1 | l | 1 | 1 + | 1 + | + | + | + | |
Mab (IgG isotyp) | H112-3A4 (2a) | H112-10C5 (1) | H112-14H6 (1) | H112-7G2 (1) | H112-13H10 (2a) | H112-7E8 (2b) | H112-7H6 (1) | H11B-5F10 (1) | H11B-15G2 (1) | H11B-13D5 |
Λ · · » · • · « ·
BVH- | 3M | 1 | 1 | I | I | 1 | ||||
BVH- | 11- | 2-M | + | + | + | 1 | 1 | |||
NEW | 19 | + | 1 | 1 | 1 | 1 | ||||
NEW | 18 | 1 | 1 | 1 | 1 | 1 | ||||
NEW | 14 1 | + | + | + | 1 | 1 | ||||
>, | NEW | 11 | 1 | t | 1 | 1 | 1 | |||
4J λ: Ό 0 | NEW | 10 | + | + | + | 1 | 1 | |||
Μ Ρ. 'Φ S | NEW | σ> | + | 1 | 1 | 1 | 1 | |||
0 β φ tn | NEW | 00 | 1 | 1 | 1 | 1 | 1 | |||
'Φ β Φ > 0 | NEW | 1 | 1 | t | + | + | ||||
Test | NEW | vo | 1 | 1 | 1 | 1 | 1 | |||
NEW | tn | + | + | + | 1 | • | ||||
BVH- | 11C | + | + | + | + | + | ||||
BVH- | 11B | + | + | + | + | + | ||||
BVH- | r-Í r~4 | 1 | 1 | 1 | 1 | 1 | ||||
BVH- | 11M | + | + | + | + | + | ||||
C5 tn H Λ fd 2 | isotyp) | CN | H11B-11B8 (1) | H11B-7E11 | rH | H11B-1C9 (1) | H11B-5E3 (2) | H11B-6E8 (1) |
Λ <d £ | ||
(d Λ N (d > \(d o •H | <—1 | |
Φ4 | 'fd | |
-H | β | |
O | tn | |
<u | Η | |
ω | ||
ra Φ | ||
β | β | |
'ftí | 1—I -Η | |
β | W | |
>N 0 | β | |
g | >Φ | |
4-> >ω | ||
•Η | ||
n | ΓΊ | |
fd | Ν | |
N 0 | Γ-1 | |
a | ||
>N Φ | Λ Ή | |
β | β | |
Ή | '<d ί> | |
>CQ | ο | |
>ω | 4-> | |
£ φ r-d | ο κ Ό β | |
id | ρ | |
φ 4-> | ||
(d | m | |
4J | ω | |
•H | & | |
> H | Ή | |
4J | ο | |
Λί | ο | |
(d | g | |
Φ | ο | |
M | α | |
'(d | \Η | |
O | X | β |
β | N | 'td |
'fd | Ή | > |
ř> | β | Ο |
0 | 4-> | |
4-) | •rl | ω |
ra | g | φ |
0) | i—1 | 4-> |
4J | φ | |
Φ | t> | •γΗ |
β | >0 | |
I | 04 | |
1 | • . | |
£ | + | * |
Odvozená umístění epitopů jsou shrnuta na obrázku 28 a na obrázku 29. Jak lze vidět z údajů v tabulce 3, BVH-3 reaktivní Mab lze rozdělit do dvou skupin: BVH-3A a BVH-3B reaktivní Mab s výjimkou Mab H11-7G11 a H3V-15A10, které reagují s oběma molekulami BVH-3A a BVH-3B. BVH-3A reaktivní Mab lze rozdělit do dvou podskupin protilátek v závislosti na jejich reaktivitě nebo nereaktivitě v BVH-3C rekombinantním proteinem. Mab reaktivní s BVH-3C proteinem rozpoznává epitopy sdílené oběma proteiny BVH-3 a BVH-11. Jak lze vidět z tabulky 4, tyto BVH-3 a BVH-11 zkříženě reaktivní Mab byly také reaktivní s BVH-11A a BVH-11-2M rekombinantními proteiny. BVH-3B reaktivní Mab lze rozdělit do třech podskupin na základě jejich reaktivity s NEW1, NEW2 a NEW3 rekombinantními proteiny. Některé Mab jsou reaktivní pouze s NEW1 proteinem, zatímco jiné Mab byly reaktivní s NEW1 a NEW2 nebo NEW1 a NEW3 rekombinantními proteiny.
Mab H11-7G11 a H3V-15A10 reagují s epitopy na více než jedné pozici BVH-3. Reaktivita H11-7G11 s molekulami BVH-3AD, BVH-3B, BVH-3C, BVH-11A a BVH-11-2M vede k názoru, že H11-7G11 epitop případně obsahuje sekvenci HXXHXH. Tato sekvence se opakuje šestkrát a pětkrát v BVH-3 a BVH-ll/BVH-11-2 proteinových sekvencích. Nereaktivita Mab H11-7G11 s molekulou NEW 10 vede k názoru, že epitop obsahuje sekvenci HGDHXH. Reaktivita Mab se dvěma BVH-3 fragmenty, které se nepřekrývají, vede k názoru, že existuje vícenásobná pozice mapování epitopu H3V-15A10 na BVH-3.
Zajímavé je, že Mab H3-7G2 a H3V-16A7 nebyly reaktivní s BVH-3 Sp63, což umožňuje umístění jejich odpovídajících epitopů na 177 aminokyselinový fragment obsažený mezi aminokyselinami 244 a 420 na molekule BVH-3 S. pneumoniea SP64 (obrázek 31).
Jak lze vidět z údajů v tabulce 4, Mab, které jsou reaktivní a BVH-11 a/nebo BVH-11-2 a nerozpoznávají molekuly BVH-3 lze rozdělit do třech podskupin na základě jejich • · : ·.·: · 1 ; : :. *:
• · ·· ··
5V.....
reaktivit s BVH-11A a NEW10 rekombinantnimi proteiny. Některé Mab reagují výlučně s BVH-11A nebo NEW10 proteinem, zatímco jiné Mab reagují s oběma BVH-11A a NEW10 rekombinantnimi proteiny.
Příklad 3
Tento příklad popisuje konstrukci BVH-3 a BVH-11-2 genové knihovny pro mapování epitopů.
BVH-3 a BVH-ll-2 genové knihovny byly konstruovány za použití rekombinantní pCMV-GH a PSL301 plasmidové DNA obsahující BVH-3 genovou sekvenci mezi nukleotidy 1837 až 4909 (sekvence id. č. 2) nebo BVH-11-2 genovou sekvenci mezi nukleotidy 172 až 2630 (sekvence id. č. 5) a Novatope® systém pro konstrukci knihovny a třídění (Novagen). Rekombinantní plasmidy obsahující BVH-3 nebo BVH-11-2 genový fragment byly čištěny za použití sady QIAgen (Chatsworth, CA) a štěpeny pomocí restrikčních enzymů BglII a Xbal. Výsledné DNA fragmenty BglII-Xbal byly čištěny za použití gelové extrakční sady QIAquick od QIAgen a štěpeny Dnasou I, aby se získala náhodně štěpená DNA. Fragmenty DNA o velikosti 50 až 200 párů bází byly čištěny, upraveny T4 DNA polymerasou, aby se zarovnaly konce cílové DNA a přidal jeden zbytek 3' dA a pak se provedlo spojení na pSCREEN-T-Vector (Novagen) postupem podle návodu výrobce (Novatope® Systém, Novagen). Genové knihovny klonů E. coli, z nichž každý exprimoval malý peptid odvozený od BVH-3 nebo BVH-11-2 standardními postupy posunu kolonií imunosond. Třídění kolonií nebylo úspěšné při použití Mab produkujících velmi vysoké pozadí při posunu kolonií. Navíc v některých případech Mab selhaly při detekci kolonií exprimujících epitop. Nedostatečnou reaktivita lze malým množstvím produkovaných nebo rozpoznáváním konformačně genu, byly tříděny za použití Mab jako pravděpodobně rekombinantních vysvětlit proteinů závislých epitopů sestávajících z různých proteinových domén.
51*
Sekvenováním DNA insertů z pozitivních klonů se stanovilo umístění segmentu, který kóduje cílový epitop. Údaje jsou uvedeny v tabulce 5. Peptidy kódované DNA inserty do rekombinantniho pSCREEN-T vektoru lze čistit a použít jako imunogeny, které jsou popsány dále v příkladu 6.
Peptidové sekvence získané tříděním BVH-3 a BVH-11-2 genových knihoven pomocí Mab jsou v souladu s Mab ELISA reaktivitami proti zkráceným genovým produktům. Podle očekávání aminokyselinové sekvence získané z H11-7G11 obsahují sekvenci HGDHXH. Tato zjištění poskytují přídavný důkaz pro umístění epitopů rozpoznaných Mab. Je zajímavé, že ačkoliv Mab H112-10G9, H112-10A2 a H11B-11B8 byly reaktivní vůči stejné peptidové sekvenci (aminokyselinové zbytky 594 až 679 na proteinové sekvenci BVH-11-2), klony odpovídající sekvenci mezi aminokyselinami 658 a 698 byly vybrány pouze Mab H11B-11B8, čímž se ukázalo umístění H11B-11B8 epitopu mezi aminokyselinami 658 a 679 (sekvence id. č. 163) . Mab H112-10G9, H112-10A2 a H11B-11B8 byly směřovány na peptidovou sekvenci odpovídající aminokyselinám 594 až 679 (sekvence id. č. 22) .
• · · · • ·
CM
LP
Λ ra
U
0) í>
o
XI •rd β
Ai xi u
£ o
x
a) tj)
CO
I rd rH
I fa >
ffl
Φ co m
Ή x
><D
Ό
Ή >X
4->
N 'Φ c
<e cg
Ή
N
Φ
O β
Φ >
X
Φ to fa 'Φ >
Φ O 42 Ό i—I Ή
-U Λ CM (ΰ ai X Ρ-ι
Φ | |
0 | • |
β | >0 |
Φ | |
> | • |
A2 | τ) |
Φ | rl |
CO |
(1) o
a <u >
A!
Φ
IQ '«J
O β
•rl i-1
Φ ra >1 a;
o β
X vrl β
>Φ
-P n
Ή s
Ή β
$ w
Ή g
rl β
ID >0 β
N
O s
co n
r4
O* fa a
•r| ι—I a>
ca fa
A!
O a
rl
Ό rl
4J
O
CD rX
A!
β a
o iX
A2 a
rl
CD
4-1
O
M ft
XI w
w ω
fa
X a
>4
CM
Š
O a
>4 >4 fa >4 fa
Q
O fa
CO
X >
>4
O a
Q
X
1-4
1-4 >
1-4 cx w
c*
H
CM
XI co
CM co
CM
X á
co
a | a a | o | X |
04 | fa | ||
Ό | 40 | Ό | O |
•rd | C—1 | Ή | r-1 |
Φ | k€> | Φ | 'TT |
CJ | CJ | 40 | |
X | X | ||
Φ | •. | Φ | • . |
> | kO | > | 40 |
42 | 42 | ||
Φ | Φ | ||
co | >CJ | CO | >o |
Φ
CJ
X
Φ í>
a;
φ cg
Q v
v
Q šf
I co fa >o
O fa
CO
CO
Φ
CJ
X
Φ í>
a:
Φ
CG rd o
i>
r4 fa >CJ
T3
-X
4D r4
CO
I
CO
CM
X
X
CM
O
O
1-4
O fa co a
CM
1-4 >4 fa fa w
o o
fa fa >
H %
<<
X fa
O >
CM
X
CM >
fa fa
X
X co a
co
X fa
1-4 >
CO a
x o
X o
>4
0)
O
X
a) >
x;
Φ co
I o
co >0 co co
Φ o
X
Φ >
Φ m
i fa) fa) >0
O
Ό
X
Φ
CJ
X
Φ >
Φ
CO
1—t o >U
CO
O rX
Ό
X
Φ
U
X
Φ >
Φ m
Φ
CJ
X
Φ &
Φ
CG >CJ •X t—l rd O
CO co r4
I
Φ
CJ
X
Φ í>
a;
φ
CG co
Q o1 i
co fa >CJ •X o
>
CO
I fa fa
CO
Φ
CJ
X
Φ >
Φ
CG >CJ
Ό
-x o
co
I—I co
I sr o
o co
Φ
CJ
X
Φ >
Φ • ·· ·
C0
ΟΛ η
if)
Φ
Ο β
Φ >
Λί
Φ
Μ >ϋ
Ό •Η
Γ1—I
Ο
CN rd
CN
(Z | Ω | > | > | ||||||||
Ω | 3 | 0 | w | H | |||||||
W | W | 3 | > | > | |||||||
Hd | O | Ω | 0 | H | Ω | ||||||
Η | > | >-) | 3 | w | >-i | Ω | |||||
0 | Ω | Hd | 0 | w | CX | Ω | |||||
Ω | Ω | Hd | W | Ω | Ω | W | |||||
2 | > | 3 | W | 3 | Ω | ||||||
φ | 3 | H | X | tu | >-i | CO | |||||
ϋ | tu | Ω | 2 | Ω | Ω | i* | |||||
β | Hd | > | M | > | W | S | 0 | ||||
φ | > | W | 2 | 0 | >-1 | Ω | 3 | ||||
> | co | H | W | Ω | Ω | Ω | |||||
Μ | Ω | Ω | H | co | 0 | Ω | c | ||||
φ | Ω | H | > | Ω | E | W | Ω | ω | |||
ω | 0 | co | Hd | 3 | co | Ω | tx | ||||
Ω | 3 | co | (u | ffi | CO | 2 | Ω | ||||
ιφ | 0 | co | w | Ω | 0 | H | 3 | 0 | |||
ř> | i* | H | (V | ω | l-l | 1-1 | gi | W | |||
0 | CO | co | 2 | >-< | 0 | Ω | 2 | Ω | |||
β | 3 | > | 3 | > | Ω | 2 | tu | ||||
rd | H | 0 | 0 | co | Ω | Ω | > | 3 | |||
rd | tu | H | 3 | w | Ω | 3 | ω | ||||
φ | 3 | W | CX | co | K | tu | 3 | fa | |||
CQ | W | co | 3 | 3 | ω | hd | ÍH | 3 | |||
Η | Ω | Ω | s | 0 | Ω | >1 | Hd | Hd | |||
Λί | 3 | Η | 3 | H | 1-1 | 1-1 | 0 | 3 | |||
0 | H | tu | W | 0 | 0 | Ω | Ω | ω | 3 | ||
β | σ | Ω | > | A | M | C | >1 | ||||
-rd | > | co | w | H | Ω | E-i | 0 | 3 | |||
6 | Ω | Ω | L> | 3 | 3 | 2 | H | 3 | Ω | ||
říj | Ω | J2 | ω | tu | ω | >· | i* | ||||
> | S | ω | ω | W | w | 0 | W | 3 | |||
& | C0 | Hd | Ω | Ω | H | 0 | H | Ω | |||
Ω | )—I | £H | 3 | hd | 0 | 3 | Hd | ||||
> | 3 | 3 | Ω | > | Ω | 0 | Hd | ||||
ω | W | Ω | Ω | A | Ω | X | Ω | co | Ω | ||
ω | 0 | ω | Ω | 2 | í* | 3 | ril | Ω | CO | ||
Ω | CO | ω | Θ | w | hd | 0 | > | σ | 0 | ||
Ω | í> | 2 | 3 | Hd | cx | 3 | |||||
Ω | Ω | & | 2 | K | < | 3 | Hd | Ω | bž |
Ή β
>Φ
-μ
W 'Η
I β
•Η rd
Φ ω
ί· ο
β “Η ι
Lf) Ο Ο ι—I ιο >υ σ\ γω ο
ι—1
Ό
-Η φ
ο β
0) >
λ:
φ ω
I
ΓΩ
C0 (Τι
LD >υ σ>
ΓΩ ο
i—I
Ό •Η
Ο) ο
β φ
>
Λί
Φ ω
I η
γω co <0 >υ (Μ
Γοο •Η
Φ υ
β
Φ >
λ:
φ ω
I (Μ γΗ m
ιο σ
οο ιη >υ
Ό •Η
Φ υ
β
Φ >
λ:
φ ω
ι
Lf) lf)
Lf) σ
Lf) >υ
Ti •rd φ
υ β
φ >
λ;
φ ω
Lf) (Μ
Lf)
CO γω ιη ω
>υ
Φ
U β
Φ >
η φ
ω ^τ σ
lf) οο >υ
Ή β
>Φ
Ρ
W •rl g
-Ϊ3
-rl
JJ
O
Φ r—i
Λ4 β
β >υ
Ό
-rd ο (Μ 1“1 ΓΩ I
Γι—I σ
ΓΩ φ
υ β
φ š
φ ω
>υ τ5
Η
Ο η
ι—Ι
ΓΩ
I
ΓΩ σ
Γ] φ
ο β
φ
Š φ
ω >Φ
Ό
Η οο τ—) Ό CN I
I—I ο
lf)
Ο) φ
υ β
φ £
φ ω
>υ
Ό •Η
ΓΙΟ
Γ1—1
I
ΓΩ
ΓΩ
V ι—Ι
Φ υ
β φ
£ φ
ω >ϋ
Ό
Η lf) co Γ~ 1—I I
ΓΩ ΓΩ ΙΟ I—I φ
υ β
φ
Š φ
ω
Lf) >υ
Ό •rd lf) ιο
C—
I—)
I
Lf) οο
Ό
Φ ϋ
β
Φ £
Φ
W
Lf) >υ
Ό
-rd rl β
φ >0
π) β
Ν
Ο % ο ι—ι Λ!
β β
•Η
Φ
Ρ ο
Μ
Ω
Γη rd υ
ο ι—)
ΓΩ
Ό
Γυ η
οο α
η ι—) (Ώ
Ό
Ρυ
ΓΩ ο
rd !
CX1 • · φ
ιη
Φ ϋ
β
Φ >
Φ w
>0
Ό
Η
CN <Ν (Ν
CM ω
ΓΊ
Φ
OJ
> | > | > | > | X | Ω | ||||||
ω | Ω | ω | Ω | Ω | Ω | ||||||
> | > | 0 | 0 | ||||||||
Ω | Ω | Ω | Ω | 0 | |||||||
Ω | Ω | Ω | Ω | a | X | ||||||
α | Ω | Ο | Ω | 0 | Ω | ||||||
Ω | Η | Ω | W | 0 | |||||||
a | Ω | S | Ω | 0 | Ω | ||||||
φ | Ω | ω | Ω | X | a | Ω | |||||
ϋ | Oj | Ω | Ο | Ω | Ω | Ω | |||||
β | 2 | U | 2 | 0 | 0 | ω | |||||
φ | X | X | X | X | X | ||||||
> | α | Ο | Ω | Ο | Ο | ||||||
44 | ω | Ω | X | a | Μ | ||||||
Φ | Οι | ω | Ο | ω | Μ | ο | ο | ||||
η | !> | Ω | Ω | a | X | ||||||
2 | Ω | 2 | Ω | ο | Η | ο | |||||
'Φ | X | 0 | X | 0 | X | 0 | ο | ||||
> | <* | ω | ω | W | ο | 0 | |||||
0 | 2 | Ω | 2 | Ω | > | Ω | Η | ||||
β | 2 | 2 | X | >Η | Ω | X | |||||
•Η | > | a | > | a | Ω | > | Ω | ||||
γΗ | ο | ω | X | ω | X | X | Ω | ||||
φ | a | ο | a | > | ω | ||||||
η | Ω | X | ω | X | Ω | Ω | Ω | ||||
Ω | Μ | H | Η | Η1 | C | Ω | Ω | ||||
44 | 2 | a | Ω | 0 | |||||||
0 | ω | X | ω | X | Ω | ω | 0 | ||||
β | Ω | Ω | Ω | £> | |||||||
Ή | ο | X | 0 | X | Η | X | |||||
ε | χ | Ω | X | Ω | Ω | § | < | ||||
Ω | Ω | 0 | Μ | 0 | |||||||
Η | X | Μ | X | Ω | X | H | |||||
Η | Ο | Η | Ο | 0 | Ω | ||||||
a | Η | a | Μ | X | a | ||||||
ο | Μ | 0 | Η | Ο | Η | 2 | |||||
σι | Ω | 0 | Ω | > | Ω | ||||||
> | Ω | ω | > | Ω | 0 | > | ω | 0 | X | ||
Ω | Ο | 0 | Ω | Ο | 0 | Ω | Ω | a | Ω | ||
Ω | X | Ω | X | Ω | Ω | ω | 0 | ||||
X | Ω | £ | X | Ω | X | X | 0 | > | Ω | ||
β | φ | , | φ | ||||||||
•Η | Τ5 | Ό ι | Ό | 1 | |||||||
Ή | γΗ | -Η | -Η | •Η CO | Ή | σι | |||||
β | φ | ΟΛ | σ> | ΙΌ | νο |
U0 [— >Φ μ
η »rl §
η >1
Λ!
β
-Η
Φ
U β
Φ >
Φ co
LO σι ι>
VD >υ
Φ υ
β φ
>
Φ
OT
LO >Ο
ΟΊ
ΓΙΟ
Φ
Ο β
φ >
Φ
C0 >Φ σι ό
Ή β
>Φ +>
Ή
I β Ό Η 4J Ο Φ i—I λ:
β β
Φ
U β
Φ ί>
Φ m
ΙΓ) >υ
Ό
-Η ο ΙΌ 1—I Ο] I η
σι co
Η
Φ
U β
Φ >
Φ
CQ
ΙΌ >Φ
Ό •Η
Ο ΙΌ ι—I ΓΜ I η
σι co
Ο
Φ υ
β φ
>
Φ m
ΙΌ >υ
Ό
-Η
CN
CN
I
ΙΌ
Ο
CN
Φ | 00 |
> | |
44 | • |
Φ | >υ |
ω | |
Φ ϋ | LO |
>υ [>
m οο β
φ ί>
Φ ω
Ό
-Η <Ν νο
CN
I
I—I CN φ Ό1
Η
C
Φ >0
Φ β
Ν
Ο β
β
-Η
Φ
4J
Ο
Μ
Οι
CN ο
m γΗ ι—I I χ
rd ν*Η χ
οο X γΗ γ-i I
X r-1 rH
X • · • · · ·
. · • · · • · ·· · 5 fc· ·· | • · · • ♦ · • · · • · · · • · ·· | • · • · · • · · · • · · · • · · · | ||
Příklad 4 | ||||
Tento příklad | popisuj e | imunizaci | zvířat | rekombinantními |
proteiny tak, aby | došlo | k produkci | protilátky reaktivní |
s BVH-3, BVH-11 a/nebo BVH-11-2.
Králíci NZW (Charles Ríver Laboratories, St-Constant,
Québec, Kanada) byli imunizovány subkutánně na více místech 50 pg nebo 100 pg čištěného BVH-3M, L-BVH-3AD, NEW1, NEW13 nebo L-BVH-11 rekombinantního proteinu v přítomnosti 80 pg adjuvans QuilA (Cedarlane Laboratories Ltd, Hornby, Kanada). Králíkům byla dvakrát ve třítýdenních intervalech podána podporovací dávka stejného antigenu a vzorky krve byly odebrány před každou imunizací a 6 až 28 dnů po poslední imunizaci. Vzorky séra byly označeny jako „před imunizací, „po první imunizaci, „po druhé imunizaci nebo „po třetí imunizaci. Imunitní reakce králíků na imunizaci byla vyhodnocena pomoci ELISA s použitím rekombinantních BVH-3M (systém BVH-3M-His*Tag fúzní protein / pET21) nebo BVH-11M (systém BVH-llM-His»Tag fúzní protein / pET21) proteinů nebo suspenzí teplem zabitých buněk S. pneumoniae Rx-1 jako nanesených antigenů. ELISA titr byl definován jako převrácená hodnota nejvyššího zředění séra, při kterém hodnota A4i0 byla o 0,1 nad hodnotou pozadí. Protilátky reaktivní s BVH-3 a/nebo BVH-11 epitopy byly zjištěny po imunizaci ve všech zvířatech, jak je uvedeno v následující tabulce 6. Protilátka reaktivní s rekombinantními nebo pneumokokovými antigeny nebyla přítomna v séru před imunizací. Imunitní reakce na imunizaci byla detekovatelná v séru každého králíka po jediné injekci rekombinantního antigenu. Protilátková reakce po druhé injekci v případě kteréhokoliv testovaného antigenu se vyznačovala silným zvýšením titru protilátky. Zajímavé je, že byly získány dobré titry protilátky reaktivní s buňkami S. pneumoniae s průměrným titrem 52 000 po třetí imunizaci, což vede k názoru, že přirozené pneumokokové epitopy jsou exprimovány na rekombinantních genových produktech E. coli. Tyto údaje • · · · v ·
• · podporují potenciální použití BVH-3, BVH-11 a/nebo BVH-11-2 genových produktů a protilátky proti BVH-3, BVH-11 a/nebo BVH-11-2 genovým produktům jako vakcíny pro prevenci a léčení pneumokokových nemocí.
Tabulka 6
Protilátková reakce králíků na imunizaci genovými produkty BVH-3 a BVH-11
ELISA titr s naneseným antigenem | |||||
Králík | Imunogen | Vzorek séra | BVH-3M | BVH-11M | S. pneumoniae |
č. 15 | BVH-3M (50 pg) | Před imunizací | NT | NT | 200 |
Po první imunizaci | NT | NT | 1600 | ||
Po druhé imunizaci | NT | NT | 20 000 | ||
Po třetí imunizaci | 512 000 | NT | 40 000 | ||
č. 16 | BVH-3M (100 pg) | Před imunizací | NT | NT | 200 |
Po první imunizaci | NT | NT | 1600 | ||
Po druhé imunizaci | NT | NT | 40 000 | ||
Po třetí imunizaci | 106 | NT | 80 000 | ||
č. 112 | L-BVH-3AD (50 pg) | Před imunizací | <100 | NT | NT |
Po první imunizaci | 16 000 | NT | NT | ||
Po druhé imunizaci | 512 000 | NT | NT |
• · * · • ·
• · · · ·« ··
Po třetí imunizaci | 2 x 106 | NT | 32 000 | |||
č. | 113 | New 1 | Před imunizací | <100 | NT | NT |
(50 pg) | Po první imunizaci | 16 000 | NT | NT | ||
Po druhé imunizaci | 512 000 | NT | NT | |||
Po třetí imunizaci | 106 | NT | 64 000 | |||
č. | 114 | New 13 | Před imunizací | NT | <100 | NT |
(50 pg) | Po první imunizaci | NT | 16 000 | NT | ||
Po druhé imunizaci | NT | 64 000 | NT | |||
Po třetí imunizaci | NT | 256 000 | 32 000 | |||
č. | 116 | L-BVH-11 | Před imunizací | NT | <100 | NT |
(50 pg) | Po první imunizaci | NT | 64 000 | NT | ||
Po druhé imunizaci | NT | 106 | NT | |||
Po třetí imunizaci | NT | 2 x 106 | 64 000 |
NT: netestováno
Příklad 5
Tento příklad popisuje ochranu zvířat proti fatální experimentální pneumokokové infekci podáváním protilátky proti BVH-3, BVH-11 nebo BVH-11-2 genovým produktů.
v « ·· · ·
Vysoký titr Mab přípravků byl získán z tekutiny z ascites myši naočkovaných intraperitoneálně
Mab vylučuj íčími hybridomovými buňkami postupem podle Brodeur a kol. (J.
Vzorky sera
Immunol. Methods, 71: 265-272, 1984).
odebrány z králíků imunizovaných BVH-3M postupem popsaným v příkladu 4. Králičí sérum odebrané po třetí imunizaci a tekutina z ascites byly použity pro čištění protilátek srážením za použití 45% až 50% nasyceného roztoku síranu amonného, vyjádřeno v procentech hmotnostních. Protilátkové přípravky byly rozpuštěny a dialyzovány proti fyziologickému roztoku pufrovanému fosfátem (PBS).
Myším CBA/N (xid) (National Cancer Institute, Frederick, MA) bylo injikováno 0,1 ml čištěných králičích protilátek nebo 0,2 ml tekutiny z ascites před intravenózním podáním 200 CFU typu 3 S. pneumoniae kmen WU2 . Kontrolní myši obdržely sterilní PBS nebo protilátky čištěné ze séra odebraného králíkům před imunizací nebo séra z králíků imunizovaných nepříbuzným N. meningitidis rekombinantním proteinovým antigenem. Jedné skupině myší byl podán S. pneumoniae před podáním anti-BVH-3 protilátky. Vzorky podávaného S. pneumoniae inokula byly umístěny na čokoládové agarové desky, aby se stanovil počet CFU a ověřila podávaná dávka. CBA/N myši byly vybrány, protože mají vysokou susceptibilitu na infekci S. pneumoniae. Bylo stanoveno, že LD50 WU2 injikovaného intravenózně CBA/N myším je < 10 CFU. Úmrtí byla zaznamenávána ve 24 h intervalech po dobu alespoň sedmi dnů.
Údaje o ochraně získané z injikováno králičí protilátky anti-BVH-3 myším jsou uvedeny v následující tabulce 7. Devět z deseti myší, které obdržely anti-BVH-3 protilátku, přežilo expozici na rozdíl od žádné z deseti myší injikovaných kontrolní protilátkou nebo PBS pufrem. Pozorování, že protilátka vytvořená proti molekule BVH-3-M pasivně chrání dokonce i při podání po expozici prokázalo schopnost byly <a« * · • · · -·· «
5-9 protilátky anti-BVH-3 bránit úmrtí dokonce i při již rozvinuté infekci.
Tabulka 7
Ochranný efekt králičí protilátky na genu BVH-3-M u CBA/N myší, kterým byl intravenózně podán pneumokok WU2.
Přípravek protilátky | Cas podání protilátky | Živé | : mrtvé | Dny do smrti po infekci |
Anti-BVH3M | 1 h před infekcí | 5 | : 0 | >14, >14, >14, >14, >14 |
Anti-N. meningitidis | 1 h před infekcí | 0 | : 5 | 2, 2, 2, 2, 2 |
Anti-BVH-3M | 0,5 h po infekci | 4 | : 1 | 2, >14, >14, >14, >14, |
Žádný (PBS) | 1 h před infekcí | 0 | : 5 | 1, 2, 2, 2, 2 |
CBA/N myši byly infikovány 1000 CFU WU2 S. pneumoniae před nebo po intraperitoneálním podání 0,1 ml králičí protilátky.
V dalším experimentu bylo 0,1 ml králičí protilátky připravené ze séra odebraného před imunizací a séra odebraného po imunizaci podáno intraperitoneálně CBA/N myším čtyři hodiny před intranasálním podání 280 CFU kmenu S. pneumoniae P4241 typ 3. Jak je vidět v následující tabulce 8, všechny imunizované myši přežily expozici, zatímco žádná z devíti myší, které obdržely protilátku ze séra odebraného před imunizací nebo samotný pufr, nebyla šestý den po infekci živá. S. pneumoniae hemokultury byly u všech přeživších myší 11. den po expozici negativní. Navíc byla pozorována 100% ochrana u myší, které obdržely monoklonální protilátky H112-10G9 nebo směs H112-10G9 a H11B-7E11, které jsou směřovány proti BVH-ll/BVH-11-2.
·· ····
Tabulka 8
Ochranný efekt pasivního přenosu králičí protilátky na BVH-3-M genový produkt nebo anti-BVH-ll/BVH-11-2 specifické Mab u CBA/N myší, kterým byl intravenózně podán pneumokok P4241.
Přípravek protilátky | Živé : mrtvé | Dny do smrti po infekci | |||
Anti-BVH-3M | 5 | : 0 | >11, >11, | >11, >11, | >11, |
Protilátka ze séra před imunizací | 0 | : 5 | 3, 3, | 3, 6, 6 | |
H112-10G9 | 4 | : 0 | >11, | >11, >11, | >11, |
H112-10G9+H11B-7E11 | 5 | : 0 | >11, >11, | >11, >11, | >11, |
Žádný (PBS) | 0 | : 4 | 3, 3, | 3, 3 |
infekce.
H112-10D7
Výsledky z tabulky 7 a z tabulky 8 dohromady jasně ukazují, že imunizace zvířat BVH-3 genovým produktem jako jsou BVH-3M vyvolané ochranné protilátky dokáže zabránit experimentální bakterémii a pneumónii.
Údaje o ochraně získaná pro myši injikované tekutinou z ascites jsou uvedena v následující tabulce 9. Podávání objemu 0,2 ml tekutiny z ascites z 0,2 ml některých sad tekutiny z ascites bránilo úmrtí v důsledku experimentální Například H112-3A4 + H112-10G9 a H112-10G2 + sady dvou Mab vedly k úplné ochraně před experimentální infekcí. Tyto údaje ukazují, že protilátka cílená na epitopy BVH-11 a/nebo BVH-11-2 poskytuje účinnou ochranu. Mab H112-3A4, H112-10G9, H112-10D7, H112-10A2,
H112-3E8, H112-10C5, H11B-11B8, H11B-15G2, H11B-1C9,
H11B-7E11, H11B-13D5 a H11-10B8 byly přítomny alespoň v jednom ochranném páru Mab a byly určeny jako ochranné a reaktivní proti ochranným epitopům. Umístění epitopů poskytujících ochranu na molekulách BVH-11-2 jsou shrnuta v tabulce 10 a
• ·· ·· · < • « · • ··· | ·· ··»· ·· » · · 1 i • · · · * • * * · · ; ! • * · · »· ·· ·· | i··· ·» • • • · « · | ||
obrázku | 29. Ochranné | Mab H112-3A4, | H112-10G9, | H112-10D7, |
H112-10A2 | , H112-3E8, | H112-10C5, | H11B-11B8, | H11B-15G2, |
H11B-1C9, | H11B-7E11, | H11B-13D5 a | H11-10B8 byly všechny | |
reaktivní | s proteinem | New 10 odpovídajícím aminokyselinovým |
zbytkům 271 až 838 na molekule BVH-11-2. Šest z těchto dvanácti Mab bylo směrováno proti epitopům přítomným v proteinu NEW 19 a tři ochranné Mab rozpoznávaly NEW 14. Zajímavé je, že Mab H112-3A4 a H112-10C5 reagovaly s odlišnými epitopy kromě BVH-11-2 umístěného na karboxylovém konci obsaženém mezi aminokyselinami 769 a 837. Také Mab H11-7G11, H11-6E7 a H3-4F9 reaktivní s epitopy sdílejícími pneumokokové molekuly BVH-3, BVH-11 a BVH-11-2 nedokázaly poskytnout ochranu dokonce i při podání kombinace ochranných Mab H112-10G9 nebo H112-11B8. Tyto Mab rozpoznávají epitopy umístěné na aminokyselinovém konci molekul BVH-3, BV-11 a BVH-11-2 obsahujících prvních 225, 228 a 26 aminokyselin. Porovnání proteinových sekvencí BVH-3, BVH-11 a BVH-11-2 ukázalo, že velké množství aminokyselin na aminové koncové části těchto 225 až 228 aminokyselin bylo konzervativních s celkovou identitou 72,8 % (obrázek 32).
Údaje uvedené v tabulce 9 a tabulce 10 dohromady ukazují, že ochrana proti epitopům BVH-11 a BVH-11-2 zahrnuje na karboxylovém konci produkt obsahující aminokyseliny 229 až 840 a 227 až 838 v proteinech BVH-11 a BVH-11-2.
Tabulka 9
Pasivní imunizace pomocí BVH-11 a/nebo BVH-11-2 specifických Mab dokáže ochránit myši před letální pneumokokovou experimentální infekcí.
Experiment | Mab | Živé : mrtvé | Dny do smrti po infekci | |
1 | H112 3A4 + H112-10G9 | 6 | 0 | 6 x >10 |
H112-3A4 + H112-10D7 | 5 | 1 | 4, 5 x >10 | |
Žádná | 0 | 6 | 2, 2, 2, 2, 2, 6 |
• ·
62.
2 | H112-10A2 + H112-10D7 | 5 | : 1 | 3, 5 X >10 |
H112-3E8 + H112-10G9 | 6 | : 0 | 6 x >10 | |
Žádná | 0 | : 6 | 2, 2, 2, 2, 2, 2 | |
3 | H112-10D7 + H11B-11B8 | 6 | : 0 | 6 x >10 |
H112-10G9 + H11B-15G2 | 3 | : 3 | 2, 6, 6, 3 x >10 | |
Žádná | 0 | : 6 | 2, 2, 2, 2, 2, 2 | |
4 | H112-10D7 + H11B-11B8 | 5 | : 0 | 5 x >11 |
Žádná | 0 | : 5 | 2, 2, 2 , 2, 2 | |
5 | H112-10G9 + H11-10B8 | 4 | : 1 | 8, 4 X >14 |
H112-10G9 + H11B-7E11 | 5 | : 0 | 5 x >14 | |
Žádná | 0 | : 3 | 1, 2, 2 | |
6 | H112-10G9 + H11B-1C9 | 4 | : 1 | 4, 4 x >14 |
Žádná | 0 | : 3 | 2, 2, 2 | |
7 | H112-10C5 + H11B-13D5 | 5 | : 0 | 5 x >14 |
Žádná | 3 | : 3 | 2, 2, 2 |
CBA/N myším bylo injikováno intraperitoneálně celkem 0,2 ml tekutiny z ascites 4 hodiny před intravenózním podáním S. pneumoniae WU2.
Tabulka 10
Odvozená umístění epitopů poskytujících ochranu na molekulách BVH-11-2
Mab | Ochrana | Genové produkty nesoucí Mab-epitop |
H112-3A4 | + | NEW 19 a NEW 11 |
H112-10G9 | + | NEW 19 |
H112-10D7 | + | NEW 14 a NEW 10 |
H112-10A2 | + | NEW 19 |
H112-3E8 | + | NEW 19 |
H11B-11B8 | + | NEW 19 |
H11B-15G2 | + | NEW 18 |
H11B-7E11 | + | NEW 14 a NEW 10 |
• ·
H11-10B8 | + | NEW 18 |
H11B-1C9 | + | NEW 14 a NEW 10 |
H112-3A1 | - | NEW 18 a NEW 8 |
H112-10H10 | - | NEW 18 a NEW 8 |
H112-2H7 | - | BVH-11-2M |
H112-6H7 | - | BVH-11-2M |
H11-7G11 | - | BVH-11A a BVH-3C |
H11-6E7 | - | BVH-11A a BVH-3C |
H112-10C5 | + | NEW 19, NEW 11 a 3A4.1 |
H11B-13D5 | + | NEW 19 |
H112-7G2 | - | NEW 18 |
H112-7E8 | - | BVH-11-2M |
H3-4F9 | - | BVH-11A a BVH-3C |
Dohromady údaje uvedené v tomto příkladu opodstatňují potenciální použití protilátek proti molekulám BVH_3, BVH-11 nebo BVH-11-2 jako terapeutických prostředků pro prevenci, diagnózu nebo léčení onemocnění způsobených S. pneumoniae.
Příklad 6
Tento příklad popisuje lokalizaci povrchové peptidové domény za použití Mab popsaných v příkladu 1
S. pneumoniae typ 3 kmen WU2 byl kultivován v bujónu Todd Hewitt (TH) (Difco Laboratories, Detroit MI) obohaceném o 0,5% extrakt z kvasnic (Difco Laboratories) při teplotě 37 °C v atmosféře 8 % objemových CO2, čímž bylo dosaženo OD600 0,260 (108 CFU na ml) . Bakteriální suspenze pak byla rozdělena na vzorky o objemu 1 ml a buňky S. pneumoniae byly stlačeny odstředěním a resuspendovány v kultivačním roztoku hybridomů. Bakteriální suspenze pak byly kultivovány po dobu 2 h při teplotě 4 °C. Vzorky byly dvakrát promyty v blokovacím pufru (PBS obsahující 2% serumalbumin (BSA)) a pak byl přidán 1 ml kozího s fluoresceinem (FITC) spojeného anti myšího IgG + IgM zředěného v blokovacím pufru. Po dalších 60 minutách za » · • · · 6*4* laboratorní teploty byly vzorky dvakrát promyty blokovacím pufrem a fixovány 0,25 % formaldehydu v PBS pufru po dobu 18 až 24 h při teplotě 4 °C. Buňky byly jednou promyty PBS pufrem
a resuspendovány v | 500 μΐ | PBS | pufru. | Buňky | byly | ponechány |
v temnu při teplotě | 4 °C až | do | analýzy | průtokovou | cytometrií | |
(Epics° XL; Beckman | Coulter, | lne. | .). Deset | tisíc | (10 | 000) buněk |
bylo analyzováno v | jednom vzorku a výsledky | byly | vyj ádřeny |
j ako fluorescence a hodnoty indexu fluorescence (FI) .
fluorescence je počet pneumoniae dělené 100 fluoresceinem značených buněk S. a hodnota FI je průměr hodnoty fluorescence pneumokoka upraveného tekutinou z Mab dělené hodnotou fluorescence pneumokoka upraveného samotným konjugátem nebo kontrolní nepříbuznou Mab. Hodnota FI 1 ukazuje, že Mab nebyla zjištěna na povrchu baktérie, zatímco hodnota FI vyšší než 2 byla pokládána za pozitivní pokud alespoň 10 % buněk pneumokoka bylo označeno a tím bylo zjištěno, že Mab reagovala s epitopy na buněčném povrchu. Následující tabulka 11 shrnuje údaje získané s Mab testovanými průtokovou cytometrií.
Analýza průtokovou cytometrií ukázala, že se Mab reaktivní s molekulami BVH-3C a/nebo BVH-11A neváží k buněčnému povrchu. Naopak s výjimkou Mab H3V-9C6 a H3V-16A7 byly Mab reaktivní s NEW 1, NEW 2, NEW 3, NEW 22 nebo NEW 23 BVH-3 genovými produkty detekovány na povrchu pneumokoka. Tyto údaje ukazují, že prvních 256 aminokyselinových zbytků umístěných na aminovém konci BVH-3 je interních. To, že se Mab H3V-9C6 a H3V-16A7 neváží, ukazuje, že některé části sekvence odpovídající 177 aminokyselinám chybějícím z molekuly BVH-3 S. pneumoniae SP63 nejsou pro protilátky přístupné.
Výsledky z BVH-11 a/nebo BV-11-2 reaktivních Mab ukázaly, že existuje dobrá korelace mezi ochranou a umístěním na povrchu. Všechny Mab reaktivní s interními epitopy, jak bylo stanoveno průtokovou cytometrií, nebyly ochranné, zatímco všechny ochranné Mab popsané v příkladu 5 poskytly pozitivní
I · signál v průtokové cytometrii. Ačkoliv s Mab H11-7G11 byla získána hodnota FI 9,0 a % fluorescence 81,2, ukázalo se, že tato Mab neposkytuje žádnou ochranu. Pro další zhodnocení toho, zda se tato Mab a její odpovídající epitop účastní v antiinfekční imunitě, lze provést další testy.
Tabulka 11
Výsledky vazby Mab na povrchu S. pneumoniae pomocí průtokové cytometrie
Mab | % fluorescence | FI | Vazba | Genové produkty nesoucí Mab-epitop |
H3-4F9 | 3,4 | 1,2 | - | BVH-3C a BVH-11A |
H3-4D4 | 3,4 | 1,2 | - | BVH-3C a BVH-11A |
H3-9H12 | 2,5 | 1,1 | - | BVH-3C a BVH-11A |
H3-7G2 | 66,2 | 6,3 | + | NEW 22 |
H3-10A1 | 58,8 | 5,6 | + | NEW 23 |
H3-4D3 | 33,2 | 3,5 | + | NEW 3 |
H3V-4F3 | 24,4 | 2,9 | + | NEW 1 |
H3V-2F2 | 15,6 | 2,4 | + | NEW 2 |
H3V-7F4 | 58,7 | 5,6 | + | NEW 2 |
H3V-7H3 | 68,8 | 6,9 | + | NEW 3 |
H3V-13B8 | 75,0 | 7,7 | + | NEW 3 |
H3V-9C2 | 66,4 | 6,2 | + | NEW 22 |
H3V-9C6 | 2,9 | 1,0 | - | NEW 22 |
H3V-16A7 | 6,6 | 1,7 | - | NEW 2 3 |
H3V-15A10 | 58,7 | 5,7 | + | NEW 22 a NEW 23 |
HN1-5H3 | 43,4 | 5,3 | + | NEW 1 |
HN1-8E3 | 57,4 | 6,6 | + | NEW 1 |
HN1-14F6 | 57,8 | 6,7 | + | NEW 1 |
HN1-2G2 | 54,8 | 6,3 | + | NEW 2 |
HN1-12D8 | 14,3 | 3,0 | + | NEW 2 |
HN1-14B2 | 11,5 | 2,7 | + | NEW 2 |
HN1-1G2 | 59,9 | 7,0 | + | NEW 3 |
• · · ·
··· 6β
Mab | % fluorescence | FI | Vazba | Genové produkty nesoucí Mab-epitop |
HN1-10C12 | 13,6 | 2,8 | + | NEW 3 |
Η11-6Ε7 | 4,9 | 1,2 | - | BVH-3C a BVH-11A |
Η11-10Η10 | 6,5 | 1,6 | - | BVH-3C a BVH-11A |
H11-7G11 | 81,2 | 9,0 | + | BVH-3C a NEW 2 |
H11-1B12 | 3,1 | 1,2 | - | BVH-11A |
H11-7B9 | 2,4 | 1,1 | - | BVH-11A |
H11-10B8 | 81,1 | 9,1 | + | NEW 18 a NEW 8 |
H11-1A2 | 84,4 | 10 | + | NEW 18 a NEW 8 |
H11-3H5 | 84,0 | 9,8 | + | NEW 18 a NEW 8 |
H112-13C11 | 49,3 | 5,9 | + | NEW 18 a NEW 8 |
H112-10H10 | 0,4 | 1,0 | - | BVH-11A a NEW 18 |
H112-1D8 | 0,4 | 1,0 | - | BVH-11A a NEW 18 |
H112-10G9 | 78,9 | 10,4 | + | NEW 19 |
H112-10A2 | 75,5 | 9,6 | + | NEW 19 |
H112-3E8 | 62,5 | 7,5 | + | NEW 19 |
H112-10D7 | 64,5 | 7,7 | + | NEW 14 |
H112-2H7 | 0,7 | 1,1 | - | BVH-11A |
H112-6H7 | 0,3 | 1,0 | - | BVH-11A |
H112-3A4 | 70,1 | 8,9 | + | NEW 11 |
H112-10C5 | 86,3 | 9,2 | + | NEW 11 a 3A4.1 |
H112-14H6 | 89,6 | 11 | + | NEW 11 |
H112-14H6 | 0,8 | 1,4 | - | NEW 11 |
H112-7G2 | 4,7 | 2,0 | - | NEW 18 |
H112-13H10 | 0,5 | 1,0 | - | NEW 18 |
H112-7E8 | 0,4 | 1,0 | - | BVH-11-2M |
H112-7H6 | 0,2 | 1,0 | - | BVH-11-2M |
H11B-5F10 | 3,1 | 1,1 | - | NEW 18 |
H11B-15G2 | 60,2 | 5,7 | + | NEW 18 a NEW 8 |
H11B-13D5 | 75,7 | 8,3 | + | NEW 19 |
H11B-11B8 | 78,4 | 8,3 | + | NEW 19 |
H11B-7E11 | 32,3 | 3,5 | + | NEW 14 |
Mab | % fluorescence | FI | Vazba | Genové produkty nesoucí Mab-epitop |
H11B-1C9 | 57,3 | 5,5 | + | NEW 14 |
H11B-5E3 | 1,8 | 1,0 | - | NEW 7 |
H11B-6E8 | 2,4 | 1,0 | - | NEW 7 |
Příklad 7
Tento příklad popisuje imunizaci zvířat peptidovými epitopy BVH-3 a BV-11-2
Rekombinantní vektor pSCREEN-T (Novagen, Madison, WI) obsahující DNA fragment (nukleotidy 2421 až 2626 na sekvenci id. č. 5) kódující Mab 3A4 epitop (sekvence id. č. 24) byl elektroporací (zařízení Gene Pulser II, BIORAD Labs, Mississauga, Canada) transformován do E. coli Tuner (ÁDE3) pLyss [BL21 (F' ompT hsdSB (rB'mB') gal dcm lacYi pLyss (Cmx) ] (Novagen). V tomto kmenu je exprese fúzního proteinu kontrolována T7 promotérem, který je rozpoznáván T7 RNA polymerasou (přítomnou na ÁDE3 profágu, který sám je pod kontrolou lac promotérem indukovatelného isopropyl-β-D-thiogalaktopyranosidem (IPTG)). Plasmid pLysS snižuje expresi bazálního fúzního proteinu kódováním T7 lysozymu, který je přirozeným inhibitorem T7 RNA polymerasy.
Transformanty byly kultivovány při protřepávání 250 ot./min v bujónu LB kvasinkový extrakt 5 g/1, NaCl 5 g/1) glukosou, 100 pg/ml karbenicillinu a 34 pg/ml chloramfenikolu, dokud absorbance při 600 nm nedosáhla hodnoty 0,7. Přeexprimování T7gen 10 protein-His»Tag-3A4.1 fúzního proteinu pak bylo vyvoláno přidáním IPTG na konečnou koncentraci 1 mM a další kultivací při 25 °C a protřepávání 250 ot./min po dobu 3 hodin. Indukované buňky z 800 ml kultury byly stlačeny odstředěním a zmraženy při -70 °C. Fúzní protein byl čištěn z rozpustné frakce buněk afinitní chromatografii založenou na teplotě 37 °C a (pepton 10 g/1, doplněném 50 mM • · · · vazbě sekvence šesti histidinových zbytků (His-Tag) k dvojvazným kationtům (Ni2+) zmobilizovaných na Ni-NTA pryskyřici chelatujici kov (Qiagen, Mississauga, Canada). Stručně řečeno byly stlačené buňky rozehřátý a resuspendovány v Tris pufrovaném roztoku sacharosy (50 mM Tris, 25 % sacharosy, vyjádřeno jako hmotnost vztažená na objem) a po dobu 15 minut zmraženy při -70 °C. Buňky byly kultivovány po dobu 15 minut na ledu v přítomnosti 2 mg/ml lysozymu před rozrušením sonikací. Lyzát byl odstřeďován při 12 000 ot./min po dobu 30 minut a niklem obsazená Ni-NTA pryskyřice (QIAgen) byla přidána k roztoku nad pevnou látkou pro kultivaci přes noc při 4 °C za třepání při 100 ot./min. Po promytí pryskyřice pufrem obsahujícím 20 mM Tris, 500 mM NaCl, 20 mM imidazolu o pH 7,9, byl fúzní 3A4.1 protein eluován stejným pufrem doplněným o 250 mM imidazolu. Odstranění soli a imidazolu bylo provedeno dialýzou proti PBS při 4 °C. Koncentrace proteinu byla stanovena reagenční sadou pro BCA proteinovým test (Perce, Rockford, IL) a upravena na 760 pg/ml.
Pro vyhodnocení toho, zda imunizace epitopovou peptidovou sekvencí přispívá k ochraně před nemocí, byly skupiny šesti samic CBA/N (xid) myší (National Cancer Institute) imunizovány třikrát subkutánně ve třítýdenních intervalech afinitně čištěným T7genl0 protein-His*Tag-3A4.1 fúzním proteinem nebo jako kontrolou samotným adjuvans QuilA v PBS. Dvanáct až čtrnáct dnů po třetí imunizaci byl myším intravenózně podán S. pneumoniae WU2 kmen nebo intranasálně kmen P4241. Vzorky S. pneumoniae expoziční očkovací látky byly umístěny na čokoládové agarové desky, aby se zjistil počet CFU a ověřila podávaná dávka. Podávaná dávka je 300 CFU. Úmrtí byla zanamenávána po dobu 14 dnů a čtrnáctý den po podání byly přeživší myši usmrceny a vzorky jejich krve byly testovány na přítomnost S. pneumoniae. Protein 3A4.1 nebo jiný testovaný protein se označuje jako ochranný když je počet myší přeživších infekci nebo průměr počtu dnů do úmrtí je znatelně • φ · ·
6*9 vyšší ve skupině imunizované 3A4.1 v porovnání s kontrolní skupinou imunizovanou placebem.
Příklad 8
Tento příklad ilustruje zlepšení protilátkové reakce na pneumokoka pomocí BVH-3 fragmentů a jejich variant.
Celkové výsledky získané ze studií Mab eraktivity se zkrácenými genovými produkty, epitop exprimujícími koloniemi a živým intaktním pneumokokem uvedené v příkladech 2, 3 a 6 umožňují oddělit epitopy umístěné na povrchu a epitopy. Epitopy detekované Mab, k penumokokovým buňkám spadají vnitrní které se účinně váží do oblasti zahrnující aminokyseliny 223 až 1039 BVH-3 popsané v sekvenci id. č. 6. Existence ochranných epitopů v BVH-3-karboxylově polovině byla potvrzena prokázáním toho, že myši imunizované molekulou NEW1 byly chráněny před fatální infekcí kmenem P4241. Porovnání genové sekvence ukázalo, že v některých kmenech, oblast BVH-3 kódující aminokyseliny 244 až 420 popsané v sekvenci id. č. 6 chybí, což vede k názoru, že tato sekvence není užitečná pro ochranu před nemocí způsobenou takovými kmeny (sekvence id. č. 9 v porovnání se sekvencí id. č. 1). Dála byly BVH-3 fragmenty nebo jejich varianty navrženy tak, aby se vyvinula univerzální, vysoce účinná vakcína, která by byla cílená na imunitní reakci na všudypřítomné ochranné epitopy umístěné na povrchu. BVH-3 genové fragmenty označené jako NEW1 (kódující aminokyseliny 472 až 1039 ze sekvence id. č. 6) a NEW40 (kódující aminokyseliny 408 až 1039 ze sekvence id. č. 6) byly zesíleny z kmenu S. pneumoniae SP64 pomocí PCR za použití párů oligonukleotidů navržených pro zesílení příslušného genového fragmentu. Každý z primerů měl restrikční endonukleasové centrum na konci 5', což umožňovalo směrové klonování zesíleného produktu v rámci do naštěpeného plasmidového vektoru. PCR zesílené produkty byly naštěpeny restrikčními endonukleasami a ligovány do linearizovaného plasmidového
• · pET21 (Novagen) expersního vektoru, který byl naštěpen stejným způsobem. Pro konstrukci NEW 40 byly použity oligonukleotidové primery HAMJ489 (ccgaattccatatgcaaattgggcaaccgactc; Ndel) a HAMJ279 (cgccaagtctcgctatgaaatcagataaattc; HindlII). Klony byly před vložením do E. coli BL21 (ÁDE3) za účelem exprese zkrácených genových produktů nejprve stabilizovány v E. coli DH5oí. Varianty z NEW1 a NEW1 byly získány mutagenezí za použití sady Quickchange Site-Directed Mutagenesis od firmy Stratagene a oligonukleotidů obsahujících příslušnou mutaci. Přítomnost 6 histidinové značky na C-konci rekombinantních molekul usnadnila čištění proteinů pomocí chromatografie s niklem. Následující tabulky 12 a 13 popisují sekvence primerů použitých pro experimenty s mutagenezí a vzniklé variantní genové produkty. Experimenty s mutagenezí za použití sad primerů 39, 40, 46, 47 nebo 48 vedly k tichým mutacím a byly provedeny za účelem zlepšení exprese požadovaného genu nebo genového fragmentu, protože bylo pozorováno, že během exprese byly s BVH-3 genem a jeho fragmenty koexprimovány kratší produkty sekundární translace.
• ·
• ·
ΓΩ ο
• »
co | CO | CO | co H | ||
o | CO | 2 | |||
H | CO | 2 | CO | ||
CO | co | co | |||
cj | H | co | |||
O | H | H | |||
c | H | 2 | |||
o | CJ | 2 | CJ | ||
* | co | H | co | H | |
m | u | CO | (ď | H | |
CJ | 2 | CO | |||
Λ | co | H | 2 | H | |
H | H | CJ | CJ | ||
O | co | CJ | |||
CO | co | H | |||
co | CO | u | |||
H | CO | ||||
ιη | co | 2i | H | ||
O | CJ | ||||
3 | Eh | co | CO | ||
P | co | 2 | co | CO | |
Φ | H | 2 | u | CO | |
g | H | CJ | CJ | CJ | |
-rl | H | CJ | CJ | ||
P | CO | H | H | co | |
a | CO | E-J | c | H | |
co | H | H | |||
<u | co | CO | H | CO | |
υ | CJ | fp | CJ | ||
3 | H | CJ | CO | CO | |
Φ | co | CO | |||
> | co | H | |||
P | co | H | u | H | |
φ | cj | CO | H | ||
TO | co | CJ | |||
co | co | co | H | ||
fď | H | H | H | ||
2 | co | H | |||
co | H | CJ | |||
co | CO | H | CJ | ||
cj | CJ | H | |||
co | CO | H | H | ||
CJ | co | H | |||
CJ | CJ | ||||
• Ό | |||||
-r| | |||||
Φ υ rt | ι—1 | CM | CO | ||
>ó | CO | co | co | CO | |
Φ | CN | cn | cg | cg | |
P | |||||
Φ | |||||
TO | |||||
Φ | |||||
0 | |||||
(0 | 3 | CD | t> | CO | σ |
P | O | o | o | O | |
44 | Φ | CD | CD | CD | <0 |
g | b | t) | *3 | 13 | |
4J 3 Φ | Ή P a | i i | i | ||
ti | |||||
H | |||||
'3 | |||||
> | |||||
0 P φ g -H | da | C | co | ||
sa | 31 | ||||
P | |||||
04 |
co a
co <U '3 β
O e
0) β
a co
N
P o
'>1
P
CO
Ή
N »3
P
P
T3
O
P a
P o
'5l >
o
QO a
m
CQ
P
-rl
P >
P υ
m ι—I
P i—I b
'>1
QO
CJ '3
P
P £
N
0)
TO
Gen použitý pro mutagenezi | NEW1 1 | NEW1 | NEW4 0 | 0 ΐ>ΜΞΝ | cn •g, & W | NEW4 9 | NEW51 | NEW4 0 |
PCR primerová sada (viz tabulka 12) | 39 | 14, 17, 20, 22 | 9, 10, 11, 14, 17, 20, 22 | σ | 10 | 14 | 10, 17 | 14 |
Identifikace proteinu* | NEW1 | NEW1 550-SGDGTS-55 5 | NEW40 55-SGDSNS-60 144-SGDGTS-149 | NEW40 55-SGDHNH-60 | NEW40 55-SGDSNH-60 | NEW40 55-SGDHNH-60 144-SGDHHH-149 | NEW40 55-SGDSNH-60 144-SGDGHH-149 | NEW40 55-HGDHNH-60 144-SGDHHH-149 |
Gen/protein sekvence id. č. | 255 | CD tn cg | 257 | 258 | σ LD cg | 0 cd cg | 261 | 262 |
Označeni proteinu | •K -X 1—1 P 3 ε 1 r—1 5 M S | NEW35A | £řM3N | σ S W £ | 0 Lf) £ ω £ | NEW51 | NEW52 | NEW53 |
• · · ·
Gen použitý | 1 pro mutagenezi | NEW53 | NEW1 | co LO X x X | NEW56 | LO LD X w X | NEW53 | o 'φ X X X | NEW4 0 | NEW 6 3 | LO X X X | NEW 6 4 | o «Φ X X X | o V X X X | NEW105 | |||
'nJ | ||||||||||||||||||
ř> 0 p Φ e | N -rl | cm rd M | oo | CD | 45 | 45 | ||||||||||||
CQ | O | in | ’Φ | LO | CQ | CD | r- | CM | ||||||||||
Λ Pí o | (0 Ό (d m | rd P Λ n> | rd | CM | CN | sf LO | CM | CM | CM | CM | CM | rd | 4* rd Φ | |||||
X | ||||||||||||||||||
σ | Ch | σι | σ | σ | σ | cn | cn | σ | ||||||||||
v | M1 | sr | ||||||||||||||||
rd | Γ | rd | rd | rd | rd | rd | r-H | i—1 | ||||||||||
X | X | X | X | X | X | X | X | l | ||||||||||
x | X | X | X | X | X | X | X | |||||||||||
Ol | X | X | X | X | Ol | Ol | Ol | O << rd 1 | ||||||||||
x | LO | X | X | X | X | X | X | X | ||||||||||
H | o | LD | O | O | O | O | o | o | o | kD 1 | ||||||||
<1> | m| | LO | m| | m| | X | X | X | X | m| | 1 | ||||||||
4-J A | X | 'Φ | v | sř | ||||||||||||||
ti | X | •šř | ||||||||||||||||
X | rd | O| | rd | r—1 | rd | I—1 | rd | rd | rd | rd | ||||||||
Q | LO | LO | ||||||||||||||||
Φ o (0 u | o | O | O | tn | Lf) | O | O | o | O | O | O | O | ||||||
kD | X | lo | X | X | co | co | LO | LD | LO | kD | kD | |||||||
1 X | 1 O | 1 | NE | NE | 1 CO | | 1 X | ml | 1 X | ml | ml | 55- | ( | 1 | |||||
X | LD | X | X | X | X | X | X | X | ||||||||||
M-l | x | LT) | ml | X | m| | X | m| | X | X | O | ||||||||
Q | x | Q | X | Q | X | X | X | |||||||||||
CO | rd | O | O | O | O | O | O | o | X | |||||||||
β | m | NEW | X | X | X | X | X | X | X | ω | ||||||||
Φ Ό H | LTl | LD | L0 | 1O | m | LO | m | LO | X | X X | LO | |||||||
in | LD | LO | LO | LO | LO | LO | L0 | LO | ||||||||||
O | O | O | O | O | O | O | O | O | ||||||||||
v | št1 | 'φ | ||||||||||||||||
£ | & | X | X | X | X | X | X | X | ||||||||||
x | X | x | X | X | X | X | X | X | ||||||||||
X | X | X | X | X | X | X | X | X | ||||||||||
β | ||||||||||||||||||
•rl Φ -P 0 | Φ o β Φ > 44 Φ m | >0 | co | sr | LD | LD | r- | co | σ | o | 1—1 | CM | co | v | LD | LO | ||
P | kD | kD | LO | kD | LO | lo | lo | r- | t-~ | r- | O | Γ- | ||||||
X β Φ | id | CM | CM | CM | CM | CM | CM | CM | CM | CM | CM | CM | CM | CM | CM | |||
O | ||||||||||||||||||
* | * | |||||||||||||||||
* | * | |||||||||||||||||
Ή | P | CM | co | |||||||||||||||
β Φ >0 n> β N | β -rl Φ n 0 P | NEW 5 4 | NEW55 | NEW5 6 | 56-mut | 56-mut | NEW57 | NEW63 | NEW64 | NEW65 | LD LO X X X | NEW76 | NEW105 | NEW106 | NEW107 | |||
O | X | X | X | |||||||||||||||
x | X | |||||||||||||||||
X | X |
* Podtržená aminokyselina představuje úpravu v sekvenci proteinu. V konstruktech NEW105, NEW106 a NEW107 jsou vynechány nukleotidy/aminokyseliny.
** Tichá mutace, tj. polypeptid je stejný jako Newl.
• · · · • · · · · · *7S*
BALB/c (Charles River) v příkladu 1. Myši byly
Pro ochranné experimenty proti intranasálnímu podání virulentního kmenu S. pneumoniae P4241 byly použity skupiny sedmi nebo osmi samic myší imunizovaných postupem popsaným pozorovány 10 až 14 dnů po infikování. Údaje z tabulky 15 jasně ukazují, že molekula NEW35A byla z hlediska ochrany stejná jako původní NEWl. Zajímavé je, že bylo dosaženo vysokého stupně přežití ve skupinách imunizovaných NEW40 a NEW56, kdy přežilo 7 a 8 z osmi zvířat. Podobně i NEW25 obsahující aminokyseliny 233 až 1039 ochránil 7 z 8 zvířat před letální infekcí.
Tabulka 14
Ochrana pře experimentální pneumónií zprostředkovaná BVH-3 fragmenty nebo jejich varianty
Expe- | Imunogen | Živé : | Dny do smrti po infekci | |
riment | mrtvé | |||
1 | Quil A | 0 | : 8 | 4, 4, 4, 4, 4, 4, 4, 4, |
NEW 1 | 5 | : 3 | 5, 7, 7, >14, >14, >14, >14, >14 | |
NEW 35A | 5 | : 2 | 9, 10, >14, >14, >14, >14, >14 | |
NEW 40 | 7 | : 1 | 13, >14, >14, >14, >14, >14, >14, >14 | |
BVH-3M | 4 | : 4 | 7, 8, 10, 12, >14, >14, >14, >14 | |
2 | Quil A | 0 | : 8 | 3, 3, 4, 4, 4, 4, 4, 4 |
NEW 52 | 4 | : 4 | 7, 7, 8, 9, >10, >10, >10, >10, | |
NEW56 | 8 | : 0 | 8 x >10 | |
NEW 4 0 | 7 | : 1 | 6, >10, >10, >10, >10, >10, >10, >10 | |
3 | Quil A | 0 | : 8 | 3, 3, 4, 4, 4, 4, 4, 4 |
NEW25 | 7 | : 1 | 6, >13, >13, >13, >13, >13, >13, >13 |
Navíc cytometrická analýza vazebné kapacity sérových protilátek z vakcinovaných zvířat ukázala, že proitlátky NEW40 a NEW56 značily živý intaktní pneumokok účinněji než protilátky vytvořené proti BVH-3M (tabulka 15).
• · · · • · ••77··
Tabulka 15
Vazba protilátek z myšího séra na povrchu S. pneumoniae typ 3 kmen WU2 měřená průtokovou cytometrií
Antiséra | Index | fluorescence | ||
Experiment 1 | Experiment 2 | Experiment 3 | Průměr + standardní odchylka | |
BVH-3M | 9,2 | 11,4 | 14,5 | 11,7 + 1,5 |
NEW1 | 11,5 | 10,1 | nd* | 10,8 + 0,7 |
NEW3 5A | 14,3 | 12,9 | nd | 13,6 + 0,7 |
NEW4 0 | 20,4 | 19,1 | 20,2 | 19,9 + 0,4 |
NEW56 | nd | 16,7 | 20,2 | 18,5 + 1,8 |
NEW52 | nd | 16,6 | 19,3 | 18,0 + 1,4 |
Samotné adj uvans | 1,9 | 1,6 | 1,2 | 1,6 + 0,2 |
* nd: neprovedeno
Výsledky cytometrie vyjádřeny jako hodnota indexu fluorescence, kde index fluorescence je průměr hodnoty fluorescence pneumokoka upraveného testovaným sérem dělené výchozí hodnotou fluorescence pneumokoka upraveného samotným fluoresceinovým konjugátem. V těchto testech průtokové cytometrie byla všechna séra použita v naředění 1 : 50 a séra z myší imunizovaných BVH-3C fragmentem nebo samotným QuílA adjuvans poskytly hodnotu podobnou výchozí hodnotě.
Dohromady údaje o ochraně a vazbě pneumokokové protilátky ukázaly, že vakcinace za použití molekul NEW1 nebo NEW4 0 a jejich variantů směřuje imunitní reakci na konzervativní ochranné povrchové epitopy.
Příklad 9
Tento příklad popisuje klonování a expresi chimerního genu BVH-11-2 obsahujícího vynechávku, který kóduje chimerní
• « polypeptid odpovídající BVH-11-2 konzervativním ochranným povrchovým epitopům přítomným ve většině, pokud ne ve všech, kmenech S. pneumoníae.
BVH-11-2 genové fragmenty odpovídající 4 genovým oblastem, byly zesíleny PCR za použití párů oligonukleotidů připravených pro zesilování fragmentů pocházejících ze sekvence id. č. 5 v oblasti nukleotidů 1662 až 1742, 1806 až 2153, 2193 až 2414 a 2484 až 2627 z BVH-11-2 genu S. pneumoniae kmen Sp64.
Použité primery HAMJ490-491, HAMJ492-HAMJ493, HAMJ494-HAMJ495, HAMJ496-HAMJ354 měly restrikční endonukleasové centrum na konci 5', což umožňovalo směrové klonování zesíleného produktu v rámci do naštěpeného plasmidového vektoru pET21b(+) (tabulka 16). PCR zesílené produkty byly naštěpeny restrikčními endonukleasami a ligovány do linearizovaného plasmidového pSL301 vektoru, který byl naštěpen stejným způsobem s výjimkou PCR zesíleného fragmentu získaného s párem primerů HAMJ490-HAMJ491. HAMJ490-HAMJ491 PCR zesílený produkt byl čištěn z agarosového gelu za použití gelové extrakční sady QIAquick od firmy QIAgen (Chatsworth, CA) a ligován do pGEM-T plasmidového vektoru bez jakéhokoliv předchozího štěpení restrikční endonukleasou. Výsledné plasmidové konstrukty byly ověřeny nukleotidovou sekvenční analýzou. Rekombinantni plasmidy obsahující všechny čtyři byly naštěpeny restrikčními endonukleasami odpovídajícími 5' konci každého páru primerů použitého pro PCR zesílení. Fragmenty byly čištěny z agarosového gelu postupem, který již byl popsán výše a všechny byly ligovány do linearizovaného plasmidu pET21b (+) naštěpeného restrikčními enzymy Ndel a HindlII pro klonování v rámci čtyř různých oblastí BVH11-2 genu. Klony byly před vložením do E. coli BL21 (ÁDE3) za účelem exprese chimerní pneumokokové proteinové molekuly nejprve stabilizovány v E. coli DH5a.
Výsledná NEW43 genová sekvence (sekvence id. č. popsána na obrázku 33.
257 je φφ * φ
Odvozená aminokyselinová sekvence proteinu NEW43 (sekvence id. č. 258 je popsána na obrázku 34.
Tabulka 16
Seznam PCR oligonukleotidových primerů použitých pro konstrukci NEW43, VP43S a NEW86
Primer | Sekvence id. č. | Sekvence 5' - 3' | Pozice nukleotidu | Restrikční místa |
HAMJ490 | 259 | ccgaattccatatgcaaat tacctacactgatgatg | sekvence id. č. 5: 1662-1683 | Ndel |
HAMJ491 | 260 | ggactagtatcaaagatat aaccgtcttc | sekvence id. č. 5: 1742-1722 | Spěl |
HAMJ492 | 261 | ggactagttggattaaaaa agatagtttgtctg | sekvence id. č. 5: 1806-1830 | Spěl |
HAMJ493 | 262 | ttcccgcggttcgacatag taccttgacagtcg | sekvence id. č. 5: 2153-2131 | SacII |
HAMJ494 | 263 | ttcccgcggaacgctagtg accatgttcg | sekvence id. č. 5: 2193-2212 | SacII |
HAMJ495 | 264 | cggggtaccaggaatttca gcctcatctgtg | sekvence id. č. 5: 2414-2393 | KpnI |
HAMJ496 | 265 | cccggtacccctagtatta gacaaaatgctatggag | sekvence id. č. 5: 2484-2510 | KpnI |
HAMJ 354 | 65 | cgccaagcttctgtatagg agccggttgac | sekvence id. č. 5: 2627-2608 | HindlII |
HAMJ 583 | 266 | ggatcccgggaggtatgat taaactaccg | sekvence id. č. 5: 2039-2021 | Smál |
HAMJ 584 | 267 | catgcccgggaacatcaaa tttgagtggtttgac | sekvence id. č. 5: 2058-2081 | Smál |
HAMJ 610 | 268 | cttgatcgacatatgttgg caggcaagtacacaacag | sekvence id. č. 5: 1701-1722 | Ndel |
Tabulka 17
Seznam zkrácených BVH-11-2 fragmentů vytvořených z S.
• · • · « « • « · ·
pneumoniae SP64 pro konstrukci NEW43
PCR-primerová sada | Označení genového fragmentu | Odpovídaj ící aminokyseliny v sekvenci id. č. 8 | Klonuj ící vektor |
HAMJ490-HAMJ491 | NEW43a | 517-543 | pGEM-T |
HAMJ492-HAMJ493 | NEW43b | 565-680 | pSL301 |
HAMJ494-HAMJ495 | NEW43c | 694-767 | pSL301 |
HAMJ496-HAMJ354 | NEW43d | 791-838 | pSL301 |
Tabulka 18
Vlastnosti NEW86 a VP43S genů vytvořených z genu NEW43
PCR-primerová sada | Označení genu/proteinu | Identifikace |
HAMJ610-HAMJ354 | VP43S | NEW43 C'konec odpovídající zbytkům 15-272) |
HAMJ490-HAMJ583 HAMJ584-HAMJ354 | NEW86 | NEW43 109-_PG_-114 |
Molekuly odvozené od NEW43 označené VP43S a NEW86 byly vytvořeny zesílením genu a klonováním za použití PCR primerů popsaných v tabulkách 16 a 18 a pET21 expresního plasmidového vektoru. Varianty NEW43 byly vytvořeny mutagenezí za použití sady Quickchange Site-Directed Mutagenesis od firmy Stratagene a oligonukleotidů obsahujících příslušnou mutaci. Přítomnost 6 histidinové značky na C-konci rekombinantních molekul usnadnila čištění proteinů pomocí chromatografie s niklem. Následující tabulky 19 a 20 popisují sekvence primerů použitých pro experimenty s mutagenezí a vzniklé variantní genové produkty NEW4 3.
» 9 • 999 w · · · 9 ·
Tabulka 19
Seznam PCR oligonukleotidových primerových sad použitých gl • ·· • · pro místně cílenou mutagenezi na genu NEW43
Prime- | Identi- | Sek- | Sekvence primerů 5' ---> 3' |
rová | fikace | vence | |
sada | primerů | id. č. | |
1 | HAMJ 497 | 269 | AACGGTAGTTTAATCATACCTTCTTATGACCATTACCATAACATC |
HAMJ 498 | 270 | GATGTTATGGTAATGGTCATAAGAAGGTATGATTAAACTACCGTT | |
2 | HAMJ 499 | 271 | AATCATACCTTCTTATGACTCTTACCATAACATCAAATTTGAGTG |
HAMJ 500 | 272 | CACTCAAATTTGATGTTATGGTAAGAGTCATAAGAAGGTATGATT | |
3 | HAMJ 501 | 273 | TACCTTCTTATGACTCTTACTCTAACATCAAATTTGAGTGGTTTG |
HAMJ 502 | 274 | CAAACCACTCAAATTTGATGTTAGAGTAAGAGTCATAAGAAGGTA | |
26 | HAMJ 530 | 275 | AATCATACCTCATTATGACTCTTACCATAACATCAAATTTGAGTG |
HAMJ 531 | 276 | CACTCAAATTTGATGTTATGGTAAGAGTCATAATGAGGTATGATT | |
27 | HAMJ 532 | 277 | TACCTCATTATGACCATTACTCTAACATCAAATTTGAGTGGTTTG |
HAMJ 533 | 278 | CAAACCACTCAAATTTGATGTTAGAGTAATGGTCATAATGAGGTA | |
29 | HAMJ 569 | 279 | TACCTCATTATGACTCTTACTCTAACATCAAATTTGAGTGGTTTG |
HAMJ 570 | 280 | CAAACCACTCAAATTTGATGTTAGAGTAAGAGTCATAATGAGGTA | |
30 | HAMJ 571 | 281 | TACCTTCTTATGACCATTACTCTAACATCAAATTTGAGTGGTTTG |
HAMJ 572 | 282 | AAACCACTCAAATTTGATGTTAGAGTAATGGTCATAAGAAGGTA | |
31 | HAMJ 573 | 283 | AACGGTAGTTTAATCATACCTTCTAAAGACCATTACCATAACATC |
HAMJ 574 | 284 | GATGTTATGGTAATGGTCTTTAGAAGGTATGATTAAACTACCGTT | |
32 | HAMJ 575 | 285 | CGGTAGTTTAATCATACCTCATAAGGACTCTTACCATAACATCAAA |
HAMJ 576 | 286 | TTTGATGTTATGGTAAGAGTCCTTATGAGGTATGATTAAACTACCG | |
33 | HAMJ 577 | 287 | AACGGTAGTTTAATCATACCTGACCATTACCATAACATCAAATTTG |
HAMJ 578 | 288 | CAAATTTGATGTTATGGTAATGGTCAGGTATGATTAAACTACCGTT | |
34 | HAMJ 579 | 289 | AACGGTAGTTTAATCATACCTTACCATAACATCAAATTTGAGTGG |
HAMJ 580 | 290 | CCACTCAAATTTGATGTTATGGTAAGGTATGATTAAACTACCGTT | |
35 | HAMJ 581 | 291 | ACCGGTAGTTTAATCATACCTAACATCAAATTTGAGTGGTTTGAC |
HAMJ 582 | 292 | GTCAAACCACTCAAATTTGATGTTAGGTATGATTAAACTACCGTT |
4«4·
Tabulka 20
Seznam NEW43 variantních genových produktů vytvořených z .
• ·· • 44 · *
4 · · • 4 · < · ·
U82..' * » 4 • · ·
4 · • 4 pneumoniae SP64
Označení | Polypep- | Identifikace | PCR prime- | Gen |
polypep- | tidová | polypeptidu* | rová sada | použitý |
tidu | sekvence | (viz ta- | pro | |
id. č. | bulka 22) | mutagenezi | ||
NEW 60 | 293 | NEW43 109-SYDHYH-114 | 1 | NEW43 |
NEW61 | 294 | NEW43 109-HYDSYH-114 | 26 | NEW43 |
NEW62 | 295 | NEW43 109-HYDHYS-114 | 27 | NEW43 |
NEW80 | 296 | NEW43 109-SYDSYH-114 | 2 | NEW60 |
NEW81 | 297 | NEW43 109-SYDSYS-114 | 3 | NEW80 |
NEW 8 2 | 298 | NEW43 109-HYDSYS-114 | 29 | NEW61 |
NEW83 | 299 | NEW43 109-SYDHYS-114 | 30 | NEW 60 |
NEW 8 4 | 300 | NEW43 109-SKDHYH-114 | 31 | NEW 60 |
NEW85 | 301 | NEW43 109-HKDSYH-114 | 32 | NEW61 |
NEW88D1 | 302 | NEW43 109-_DHYH-114 | 33 | NEW43 |
NEW88D2 | 303 | NEW43 109- YH-114 | 34 | NEW88D1 |
NEW 8 8 | 304 | NEW43 109- -114 | 35 | NEW88D2 |
* Podtržené aminokyseliny představují změnu v sekvenci proteinu. Nukleotidy/aminokyseliny jsou vynechány v konstruktech NEW88D1, NEW88D2 a NEW88.
Skupiny sedmi nebo osmi samic myší BALB/c (Charles River) imunizovaných postupem popsaným v příkladu 1 byly použity pro zjištění ochrany proti intranasálnímu podání virulentního S. pneumoniae P4241 kmenu. Data z tabulky 21 jasně ukazují, že NEW 19, NEW43 a jejich varianty poskytují ochranu proti experimentální pneumonii.
·· ···· » · » ·»»
83..*
Tabulka 21
Ochrana zprostředkovaná NEW19 a NEW43 fragmenty nebo jejich varianty při experimentální pneumonii
Experiment | Imunogen | Živé : mrtvé | Průměr dnů přežití |
1 | Quil A | 0 : 8 | 4, 4, 4, 4, 4, 4, 4, 5 |
NEW 19 | 7 : 1 | 5, 7 x >14 | |
NEW 43 | 8 : 0 | 8 x >14 | |
2 | Quil A | 0 : 8 | 4, 4, 4, 4, 4, 5, 5, 5 |
NEW 43 | 7 : 1 | 8, 7 x >14 | |
NEW 8 0 | 6 : 2 | 5, 6, 6 x >14 | |
NEW 83 | 6 : 2 | 8, 10, 6 x >14 | |
3 | Quil A | 0 : 8 | 4, 4, 4, 4, 5, 5, 5, 5 |
NEW 43 | 7 : 1 | 5, 7 x >8 | |
NEW 88D1 | 5 : 3 | 5, 6, 6, 6 x >8 | |
NEW 88D2 | 5 : 3 | 6, 6, 6, 6 x >8 | |
NEW 88 | 7 : 1 | 6, 7 x >8 | |
3 | Quil A | 0 : 8 | 4, 4, 4, 5, 5, 5, 5, 6 |
NEW 60 | 8 : 0 | 8 x >8 | |
NEW 84 | 8 : 0 | 8 x >8 | |
NEW 85 | 5 : 3 | 5, 7, 7, 5 x >8 | |
NEW 86 | 5 : 3 | 5, 6, 6, 5 x > 8 |
Příklad 10
Tento příklad popisuje klonování a expresi chimerních genů kódujících chimerní protein odpovídající karboxy koncové oblasti BVH-3 nebo jeho varianty připojené, na karboxylovém konci nebo na aminokonci, k NEW43 nebo jeho variantům.
Chimerní geny obsahující BVH-3 zkrácený gen a NEW43 nebo NEW43 variantní gen byly vytvořeny postupem popsaným v příkladu 1. Polypeptidy kódované těmito chimerními geny jsou vypsány v tabulce 22. Stručně řečeno genové fragmenty, které jsou zahrnuty v chimerním genu byly zesíleny PCR za použití párů oligonukleotidů připravených tak, že primery měly restrikční endonukleasové místo na 5' konci, což umožňovalo • · • · · · • · · ·
S+. · ···· ····
S4 ·.
směrové klonování zesíleného produktu v rámci do naštěpených plasmidových vektorů (tabulka 23 a tabulka 24). PCR zesílené produkty byly naštěpeny restrikčními endonukleasami a ligovány do linearizovaného plasmidového pSL301 vektoru. Výsledný plasmidový konstrkt byl ověřen nukleotidovou sekvenční analýzou. Rekombinantní pSL301 plasmidy obsahující PCR produkt byly štěpeny tímtéž endonukleasovým restrikčním enzymem tak, aby se získaly DNA inserty. Výsledné insertní DNA fragmenty byly čištěny a inserty odpovídající danému chimernímu genu byly ligovány do pURV22-NdeI vektoru, aby se vytvořil chimerní gen. Exprimované rekombinantní proteiny byly čištěny z tekutin nad usazeninou získanou po odstředění sonikovaných teplem vyvolaných E. coli kultur za použití několikastupňového chromatografického čištění.
Tabulka 22
Seznam polypeptidů kódovaných chimerními geny obsahujícími
BVH-3 zkrácený variantní gen a NEW43 nebo NEW43 variantní gen
Označení polypeptidů | Sekvence id. č. | Identifikace |
VP 89 | 327 | M-New56 -GP- New43* |
VP 90 | 328 | M-New43 -GP- New56 |
VP 91 | 329 | M-New52 -GP- New43 |
VP 92 | 330 | M-New43 -GP- New52 |
VP 93 | 331 | M-New56 -GP- New60 |
VP 94 | 332 | M-New60 -GP- New56 |
VP 108 | 333 | M-New56 -GP- New88 |
VP109 | 334 | M-New88 -GP- New56 |
VP 110 | 335 | M-New60 -GP- Newl05 |
VP 111 | 336 | M-New60 -GP- Newl07 |
VP 112 | 337 | M-New88 -GP- Newl05 |
VP 113 | 338 | M-New88 -GP- Newl07 |
VP 114 | 339 | M-New80 -GP- Newl05 |
VP 115 | 340 | M-New80 -GP- Newl07 |
• · • · · ·
• · · · · · ’
Označeni polypeptidu | Sekvence id. č. | Identifikace |
VP 116 | 341 | M-New83 -GP- Newl05 |
VP 117 | 342 | M-New83 -GP- Newl07 |
VP 119 | 343 | M-New43S -GP- Newl05 |
VP 12 0 | 344 | M-New43S -GP- Newl07 |
VP 121 | 345 | M-New80S -GP- Newl05 |
VP 122 | 346 | M-New80S -GP- Newl07 |
VP 123 | 347 | M-New83S -GP- Newl05 |
VP 124 | 348 | M-New83S -GP- Newl07 |
* Aminokyseliny kódované pro chiméry jsou exprimovány jako genový produkt; byly přidány další aminokyseliny. M je methionin, G je glycin a P je prolin.
Tabulka 23
Seznam PCR oligonukleotidových příměrových párů připravených pro tvorbu chimerních genů kódujících polypeptidy vypsané v tabulce 22
Primerová sada | Identifikace PCR-primeru | Gen použity pro PCR zesílení | Odpovídaj ící pozice genového fragmentu na |
49 | HAMJ490-HAMJ471 | Variant New43 | N-konci |
50 | HAMJ564-HAMJ556 | Variant New43 | C-konci |
51 | HAMJ489-HAMJ359 | Variant New40 | N-konci |
52 | HAMJ559-HAMJ557 | Variant New40 | C-konci |
53 | HAMJ610-HAMJ471 | Variant New43S | N-konci |
• · · ·
Tabulka 24 sh.
Seznam PCR oligonukleotidových primerů připravených pro tvorbu chimerních genů kódujících polypeptidy vypsané v tabulce 22
Primer | Sekvence id. č. | Sekvence 5' - 3 ' | Restrikční místo |
HAMJ490 | 259 | ccgaattccatatgcaaattaccta cactgatgatg | Ndel |
HAMJ471 | 168 | atatgggcccctgtataggagccgg ttgactttc | Apal |
HAMJ564 | 327 | atatgggccccaaattacctacact gatgatgagattcagg | Apal |
HAMJ556 | 328 | ataagaatgcggccgcctactgtat aggagccggttgactttc | Notl |
HAMJ489 | 329 | ccgaattccatatgcaaattgggca accgactc | Ndel |
HAMJ359 | 173 | tcccgggccccgctatgaaatcaga taaattc | Apal |
HAMJ559 | 330 | atatgggccccaaattgggcaaccg actc | Apal |
HAMJ354 | 65 | cgccaagcttctgtataggagccgg ttgac | HindiII |
HAMJ610 | 268 | cttgatcgacatatgttggcaggca agtacacaacag | Ndel |
HAMJ557 | 331 | ataagaatgcggccgcttacgctat gaaatcagataaattc | Notl |
HAMJ279 | 35 | cgccaagcttcgctatgaaatcaga taaattc | HindiII |
Průmyslová využitelnost
Prostředky podle předkládaného vynálezu jsou průmyslově využitelné pro výrobu léčiv.
Seznam sekvencí <110> SHIRE BIOCHEM INC.
HAMEL, losée OUELLET, Catherine charland, Nathalie MARTIN, Denis BRODEUR, Bernard <120> STREPTOCOCCUS ANTIGENS <130> 12806-19PCT <140> PCT/CA01/00908 <141> 2001-06-19 <150> US 60/212,683 <151> 2000-06-20 <160> 384 <170> FastSEQ for Windows Version 4.0 <210> 1 <211> 3120 <212> DNA <213> BVH-3 <400> 1 atgaaattta gtaaaaaata tatagcagct ggatcagctg ttatcgtatc cttgagtcta 60 tgtgcctatg cactaaacca gcatcgttcg caggaaaata aggacaataa tcgtgtctct 120 tatgtggatg gcagccagtc aagtcagaaa agtgaaaact tgacaccaga ccaggttagc 180 cagaaagaag gaattcaggc tgagcaaatt gtaatcaaaa ttacagatca gggctatgta 240 acgtcacacg gtgaccacta tcattactat aatgggaaag ttccttatga tgccctcttt 300 agtgaagaac tcttgatgaa ggatccaaac tatcaactta aagacgctga tattgtcaat 360 gaagtcaagg gtggttatat catcaaggtc gatggaaaat attatgtcta cctgaaagat 420 gcagctcatg ctgataatgt tcgaactaaa gatgaaatca atcgtcaaaa acaagaacat 480 gtcaaagata atgagaaggt taactctaat gttgctgtag caaggtctca gggacgatat 540 acgacaaatg atggttatgt ctttaatcca gctgatatta tcgaagatac gggtaatgct 600 tatatcgttc ctcatggagg tcactatcac tacattccca aaagcgattt atctgctagt 660 gaattagcag cagctaaagc acatctggct ggaaaaaata tgcaaccgag tcagttaagc 720 tattcttcaa cagctagtga caataacacg caatctgtag caaaaggatc aactagcaag 780 ccagcaaata aatctgaaaa tctccagagt cttttgaagg aactctatga ttcacctagc 840 gcccaacgtt acagtgaatc agatggcctg gtctttgacc ctgctaagat tatcagtcgt 900 acaccaaatg gagttgcgat tccgcatggc gaccattacc actttattcc ttacagcaag 960 ctttctgctt tagaagaaaa gattgccaga atggtgccta tcagtggaac tggttctaca 1020 gtttctacaa atgcaaaacc taatgaagta gtgtctagtc taggcagtct ttcaagcaat 1080 ccttcttctt taacgacaag taaggagctc tcttcagcat ctgatggtta tatttttaat 1140 ccaaaagata tcgttgaaga aacggctaca gcttatattg taagacatgg tgatcatttc 1200 cattacattc caaaatcaaa tcaaattggg caaccgactc ttccaaacaa tagtctagca 1260 acaccttctc catctcttcc aatcaatcca ggaacttcac atgagaaaca tgaagaagat 1320 ggatacggat ttgatgctaa tcgtattatc gctgaagatg aatcaggttt tgtcatgagt 1380 cacggagacc acaatcatta tttcttcaag aaggacttga cagaagagca aattaaggct 1440 gcgcaaaaac atttagagga agttaaaact agtcataatg gattagattc tttgtcatct 1500 catgaacagg attatccagg taatgccaaa gaaatgaaag atttagataa aaaaatcgaa 1560 gaaaaaattg ctggcattat gaaacaatat ggtgtcaaac gtgaaagtat tgtcgtgaat 1620 aaagaaaaaa atgcgattat ttatccgcat ggagatcacc atcatgcaga tccgattgat 1680 gaacataaac cggttggaat tggtcattct cacagtaact atgaactgtt taaacccgaa 1740 gaaggagttg ctaaaaaaga agggaataaa gtttatactg gagaagaatt aacgaatgtt 1800 gttaatttgt taaaaaatag tacgtttaat aatcaaaact ttactctagc caatggtcaa 1860 aaacgcgttt cttttagttt tccgcctgaa ttggagaaaa aattaggtat caatatgcta 1920 gtaaaattaa taacaccaga tggaaaagta ttggagaaag tatctggtaa agtatttgga 1980 gaaggagtag ggaatattgc aaactttgaa ttagatcaac cttatttacc aggacaaaca 2040 tttaagtata ctatcgcttc aaaagattat ccagaagtaa gttatgatgg tacatttaca 2100 gttccaacct ctttagctta caaaatggcc agtcaaacga ttttctatcc tttccatgca 2160 ggggatactt atttaagagt gaaccctcaa tttgcagtgc ctaaaggaac tgatgcttta 2220
Μ gtcagagtgt ttgatgaatt tcatggaaat gcttatttag aaaataacta taaagttggt 2280 gaaatcaaat taccgattcc gaaattaaac caaggaacaa ccagaacggc cggaaataaa 2340 attcctgtaa ccttcatggc aaatgcttat ttggacaatc aatcgactta tattgtggaa 2400 gtacctatct tggaaaaaga aaatcaaact gataaaccaa gtattctacc acaatttaaa 2460 aggaataaag cacaagaaaa ctcaaaactt gatgaaaagg tagaagaacc aaagactagt 2520 gagaaggtag aaaaagaaaa actttctgaa actgggaata gtactagtaa ttcaacgtta 2580 gaagaagttc ctacagtgga tcctgtacaa gaaaaagtag caaaatttgc tgaaagttat 2640 gggatgaagc tagaaaatgt cttgtttaat atggacggaa caattgaatt atatttacca 2700 tcaggagaag tcattaaaaa gaatatggca gattttacag gagaagcacc tcaaggaaat 2760 ggtgaaaata aaccatctga aaatggaaaa gtatctactg gaacagttga gaaccaacca 2820 acagaaaata aaccagcaga ttctttacca gaggcaccaa acgaaaaacc tgtaaaacca 2880 gaaaactcaa cggataatgg aatgttgaat ccagaaggga atgtggggag tgaccctatg 2940 ttagatccag cattagagga agctccagca gtagatcctg tacaagaaaa attagaaaaa 3000 tttacagcta gttacggatt aggcttagat agtgttatat tcaatatgga tggaacgatt 3060 gaattaagat tgccaagtgg agaagtgata aaaaagaatt tatctgattt catagcgtaa 3120 <210> 2 <211> 5048 <212> DNA <213> BVH-3 <400> 2 aattccttgt cgggtaagtt ccgacccgca cgaaaggcgt aatgatttgg gcactgtctc 60 aacgagagac tcggtgaaat tttagtacct gtgaagatgc aggttacccg cgacaggacg 120 gaaagacccc atggagcttt actgcagttt gatattgagt gtctgtacca catgtacagg 180 ataggtagga gtctaagaga tcgggacgcc agtttcgaag gagacgctgt tgggatacta 240 cccttgtgtt atggccactc taacccagat aggtgatccc tatcggagac agtgtctgac 300 gggcagtttg actggggcgg tcgcctccta aaaggtaacg gaggcgccca aaggttccct 360 cagaatggtt ggaaatcatt cgcagagtgt aaaggtataa gggagcttga ctgcgagagc 420 tacaactcga gcagggacga aagtcgggct tagtgatccg gtggttccgt atggaagggc 480 catcgctcaa cggataaaag ctaccctggg gataacaggc ttatctcccc caagagttca 540 catcgacggg gaggtttggc acctcgatgt cggctcgtcg catcctgggg ctgtagtcgg 600 tcccaagggt tgggctgttc gcccattaaa gcggcacgcg agctgggttc agaacgtcgt 660 gagacagttc ggtccctatc cgtcgcgggc gtaggaaatt tgagaggatc tgctcctagt 720 acgagaggac cagagtggac ttaccgctgg tgtaccagtt gtcttgccaa aggcatcgct 780 gggtagctat gtagggaagg gataaacgct gaaagcatct aagtgtgaaa cccacctcaa 840 gatgagattt cccatgatta tatatcagta agagccctga gagatgatca ggtagatagg 900 ttagaagtgg aagtgtggcg acacatgtag cggactaata ctaatagctc gaggacttat 960 ccaaagtaac tgagaatatg aaagcgaacg gttttcttaa attgaataga tattcaattt 1020 tgagtaggta ttactcagag ttaagtgacg atagcctagg agatacacct gtacccatgc 1080 cgaacacaga agttaagccc tagaacgccg gaagtagttg ggggttgccc cctgtgagat 1140 agggaagtcg cttagctcta gggagtttag ctcagctggg agagcatctg ccttacaagc 1200 agagggtcag cggttcgatc ccgttaactc ccaaaggtcc cgtagtgtag cggttatcac 1260 gtcgccctgt cacggcgaag atcgcgggtt cgattcccgt cgggaccgtt taaggtaacg 1320 caagttattt tagactcgtt agctcagttg gtagagcaat tgacttttaa tcaatgggtc 1380 actggttcga gcccagtacg ggtcatatat gcgggtttgg cggaattcta atctctttga 1440 aatcatcttc tctcactttc caaaactcta ttacctctta ttataccaca tttcaatctt 1500 caacttccca gtaatataag cacctctggc gaaagaagtt tcaatgtcct aaagtaataa 1560 gtgaatccaa ttcaggaact ccaagaacaa aagaaacatc tggtgtcaca agtattggat 1620 ggcacagagt cacgtggtag tctgacccta gcagaaattt taaatagtaa actatttact 1680 ggttaattaa atggttaaat aaccggttta gaaaactatt taataaagta aaagaagttg 1740 agaaaaaact tcatcattta ttgaaatgag ggatttatga aatttagtaa aaaatatata 1800 gcagctggat cagctgttat cgtatccttg agtctatgtg cctatgcact aaaccagcat 1860 cgttcgcagg aaaataagga caataatcgt gtctcttatg tggatggcag ccagtcaagt 1920 cagaaaagtg aaaacttgac accagaccag gttagccaga aagaaggaat tcaggctgag 1980 caaattgtaa tcaaaattac agatcagggc tatgtaacgt cacacggtga ccactatcat 2040 tactataatg ggaaagttcc ttatgatgcc ctctttagtg aagaactctt gatgaaggat 2100 ccaaactatc aacttaaaga cgctgatatt gtcaatgaag tcaagggtgg ttatatcatc 2160 aaggtcgatg gaaaatatta tgtctacctg aaagatgcag ctcatgctga taatgttcga 2220 actaaagatg aaatcaatcg tcaaaaacaa gaacatgtca aagataatga gaaggttaac 2280 tctaatgttg ctgtagcaag gtctcaggga cgatatacga caaatgatgg ttatgtcttt 2340 aatccagctg atattatcga agatacgggt aatgcttata tcgttcctca tggaggtcac 2400 tatcactaca ttcccaaaag cgatttatct gctagtgaat tagcagcagc taaagcacat 2460 ctggctggaa aaaatatgca accgagtcag ttaagctatt cttcaacagc tagtgacaat 2520 aacacgcaat ctgtagcaaa aggatcaact agcaagccag caaataaatc tgaaaatctc 2580 cagagtcttt tgaaggaact ctatgattca cctagcgccc aacgttacag tgaatcagat 2640 ggcctggtct ttgaccctgc taagattatc agtcgtacac caaatggagt tgcgattccg 2700 catggcgacc attaccactt tattccttac agcaagcttt ctgctttaga agaaaagatt 2760 • · · ·
gccagaatgg gaagtagtgt gagctctctt gctacagctt attgggcaac aatccaggaa attatcgctg ttcaagaagg aaaactagtc gccaaagaaa caatatggtg ccgcatggag cattctcaca aataaagttt tttaataatc cctgaattgg aaagtattgg tttgaattag gattatccag atggccagtc cctcaatttg ggaaatgctt ttaaaccaag gcttatttgg caaactgata aaacttgatg tctgaaactg gtacaagaaa tttaatatgg atggcagatt ggaaaagtat ttaccagagg ttgaatccag ccagcagtag ttagatagtg gtgataaaaa atcaaaaatg tttattatta agttaatt tgcctatcag ctagtctagg cagcatctga atattgtaag cgactcttcc cttcacatga aagatgaatc acttgacaga ataatggatt tgaaagattt tcaaacgtga atcaccatca gtaactatga atactggaga aaaactttac agaaaaaatt agaaagtatc atcaacctta aagtaagtta aaacgatttt cagtgcctaa atttagaaaa gaacaaccag acaatcaatc aaccaagtat aaaaggtaga ggaatagtac aagtagcaaa acggaacaat ttacaggaga ctactggaac caccaaacga aagggaatgt atcctgtaca ttatattcaa agaatttatc aagttctctc atatataaaa tggaactggt cagtctttca tggttatatt acatggtgat aaacaatagt gaaacatgaa aggttttgtc agagcaaatt agattctttg agataaaaaa aagtattgtc tgcagatccg actgtttaaa agaattaacg tctagccaat aggtatcaat tggtaaagta tttaccagga tgatggtaca ctatcctttc aggaactgat taactataaa aacggccgga gacttatatt tctaccacaa agaaccaaag tagtaattca atttgctgaa tgaattatat agcacctcaa agttgagaac aaaacctgta ggggagtgac agaaaaatta tatggatgga tgatttcata aaaagttaga tttcttgaca tctacagttt agcaatcctt tttaatccaa catttccatt ctagcaacac gaagatggat atgagtcacg aaggctgcgc tcatctcatg atcgaagaaa gtgaataaag attgatgaac cccgaagaag aatgttgtta ggtcaaaaac atgctagtaa tttggagaag caaacattta tttacagttc catgcagggg gctttagtca gttggtgaaa aataaaattc gtggaagtac tttaaaagga actagtgaga acgttagaag agttatggga ttaccatcag ggaaatggtg caaccaacag aaaccagaaa cctatgttag gaaaaattta acgattgaat gcgtaaggaa aataaaactc tacaacttaa ctacaaatgc cttctttaac aagatatcgt acattccaaa cttctccatc acggatttga gagaccacaa aaaaacattt aacaggatta aaattgctgg aaaaaaatgc ataaaccggt gagttgctaa atttgttaaa gcgtttcttt aattaataac gagtagggaa agtatactat caacctcttt atacttattt gagtgtttga tcaaattacc ctgtaacctt ctatcttgga ataaagcaca aggtagaaaa aagttcctac tgaagctaga gagaagtcat aaaataaacc aaaataaacc actcaacgga atccagcatt cagctagtta taagattgcc tagcagtaga tgactttggg aaagaggtgg aaaacctaat gacaagtaag tgaagaaacg atcaaatcaa tcttccaatc tgctaatcgt tcattatttc agaggaagtt tccaggtaat cattatgaaa gattatttat tggaattggt aaaagaaggg aaatagtacg tagttttccg accagatgga tattgcaaac cgcttcaaaa agcttacaaa aagagtgaac tgaatttcat gattccgaaa catggcaaat aaaagaaaat agaaaactca agaaaaactt agtggatcct aaatgtcttg taaaaagaat atctgaaaat agcagattct taatggaatg agaggaagct cggattaggc aagtggagaa aaaagtctga agaatttcat aatatttact
2820
2880
2940
3000
3060
3120
3180
3240
3300
3360
3420
3480
3540
3600
3660
3720
3780
3840
3900
3960
4020
4080
4140
4200
4260
4320
4380
4440
4500
4560
4620
4680
4740
4800
4860
4920
4980
5040
5048 c210> 3 <211> 2523 <212> DNA <213> BVH-11 <400> 3 atgaaaatca ataaaaaata tctagctggg tcagtagcta cacttgtttt aagtgtctgt gcttatgaac taggtttgca tcaagctcaa actgtaaaag aaaataatcg tgtttcctat atagatggaa aacaagcgac gcaaaaaacg gagaatttga ctcctgatga ggttagcaag cgtgaaggaa tcaacgccga acaaatcgtc atcaagatta cggatcaagg ttatgtgacc tctcatggag accattatca ttactataat ggcaaggtcc cttatgatgc catcatcagt gaagagctcc tcatgaaaga tccgaattat cagttgaagg attcagacat tgtcaatgaa atcaagggtg gttatgtcat taaggtaaac ggtaaatact atgtttacct taaggatgca gctcatgcgg ataatgtccg tacaaaagaa gaaatcaatc ggcaaaaaca agaacatagt cagcatcgtg aaggagggac ttcagcaaac gatggtgcgg tagcctttgc acgttcacag ggacgctaca ccacagatga tggttatatc ttcaatgcat ctgatatcat cgaagatacg ggcgatgcct atatcgttcc tcatggagat cattaccatt acattcctaa gaatgagtta tcagctagcg agttggctgc tgcagaagcc ttcctatctg gtcgggaaaa tctgtcaaat ttaagaacct atcgccgaca aaatagcgat aacactccaa gaacaaactg ggtaccttct gtaagcaatc caggaactac aaatactaac acaagcaaca acagcaacac taacagtcaa gcaagtcaaa gtaatgacat tgatagtctc ttgaaacagc tctacaaact gcctttgagt caacgccatg tagaatctga tggccttatt ttcgacccag cgcaaatcac aagtcgaacc gccagaggtg tagctgtccc tcatggtaac cattaccact ttatccctta tgaacaaatg tctgaattgg aaaaacgaat tgctcgtatt attccccttc gttatcgttc aaaccattgg gtaccagatt caagaccaga agaaccaagt ccacaaccga ctccagaacc tagtccaagt ccgcaacctg caccaaatcc tcaaccagct ccaagcaatc caattgatga gaaattggtc
120
180
240
300
360
420
480
540
600
660
720
780
840
900
960
1020
1080
1140
1200 aaagaagctg ttcgaaaagt aggcgatggt tatatcccag ccaagaatct ttcagcagaa aagcaggaaa gtttatctca taagctagga cgagaatttt acaataaggc ttatgactta aataaaggtc gacaagttga ttttgaggct gtctcaagtg ataaagtcaa gttagtggat catccagaac gtttaggaaa accaaatgcg gtagccaagt tggcaggcaa gtacacaaca ataaccagtg atgaggggga tgcctatgta aaaaaagata gtttgtctga agctgagaga ggtttgaccc ctccttcgac agaccatcag gaagctatct acaaccgcgt gaaagcagct aatcttcaat atactgtaga agtcaaaaac taccataaca tcaaatttga gtggtttgac actcttgagg atcttttggc gactgtcaag cattcagata atggttttgg taacgctagc gctgatacca atcaaacgga aaaaccaagc gaagaaaccc ctcgagaaga gaaaccacaa gaggaaccag aagaagaatc accagaggaa gttgaagaaa aactgagaga ggctgaagat aagtccaatg ccaaagagac tctcacagga gacaacaata ctattatggc agaagctgaa taa <210> 4 <211> 2647 <212> DNA <213> BVH-11 <400> 4 cagagatctt agtgaatcaa atatacttaa aatatctagc tgggtcagta gctacacttg tgcatcaagc tcaaactgta aaagaaaata cgacgcaaaa aacggagaat ttgactcctg ccgaacaaat cgtcatcaag attacggatc atcattacta taatggcaag gtcccttatg aagatccgaa ttatcagttg aaggattcag tcattaaggt aaacggtaaa tactatgttt tccgtacaaa agaagaaatc aatcggcaaa ggacttcagc aaacgatggt gcggtagcct atgatggtta tatcttcaat gcatctgata ttcctcatgg agatcattac cattacattc ctgctgcaga agccttccta tctggtcggg gacaaaatag cgataacact ccaagaacaa ctacaaatac taacacaagc aacaacagca acattgatag tctcttgaaa cagctctaca ctgatggcct tattttcgac ccagcgcaaa tccctcatgg taaccattac cactttatcc gaattgctcg tattattccc cttcgttatc cagaagaacc aagtccacaa ccgactccag atcctcaacc agctccaagc aatccaattg aagtaggcga tggttatgtc tttgaggaga atctttcagc agaaacagca gcaggcattg ctcataagct aggagctaag aaaactgacc aggcttatga cttactagca agaattcacc ttgattttga ggctttggat aacctgttgg tcaagttagt ggatgatatt cttgccttct gaaaaccaaa tgcgcaaatt acctacactg gcaagtacac aacagaagac ggttatatct gggatgccta tgtaactcca catatgaccc ctgaagctga gagagcggca gcccaggctt cgacagacca tcaggattca ggaaatactg gcgtgaaagc agctaagaag gtgccacttg tagaagtcaa aaacggtagt ttaatcatac ttgagtggtt tgacgaaggc ctttatgagg tggcgactgt caagtactat gtcgaacatc ttggtaacgc tagcgaccat gttcaaagaa cggaaaaacc aagcgaggag aaacctcaga tatgtctttg aggagaatgg agtttctcgt 1260 acagcagcag gcattgatag caaactggcc 1320 gctaagaaaa ctgacctccc atctagtgat 1380 ctagcaagaa ttcaccaaga tttacttgat 1440 -ttggataacc tgttggaacg actcaaggat 1500 gatattcttg ccttcttagc tccgattcgt 1560 caaattacct acactgatga tgagattcaa 1620 gaagacggtt atatctttga tcctcgtgat 1680 actccacata tgacccatag ccactggatt 1740 gcggcagccc aggcttatgc taaagagaaa 1800 gattcaggaa atactgaggc aaaaggagca 1860 aagaaggtgc cacttgatcg tatgccttac 1920 ggtagtttaa tcatacctca ttatgaccat 1980 gaaggccttt atgaggcacc taaggggtat 2040 tactatgtcg aacatccaaa cgaacgtccg 2100 gaccatgttc aaagaaacaa aaatggtcaa 2160 gaggagaaac ctcagacaga aaaacctgag 2220 agcgagaaac cagagtctcc aaaaccaaca 2280 tcagaagaac ctcaggtcga gactgaaaag 2340 ttacttggaa aaatccagga tccaattatc 2400 ttaaaaaata atttactatt tggcacccag 2460 aaactattgg ctttattaaa ggagagtaag 2520
2523 gaaaagagga aagaatgaaa atcaataaaa 60 ttttaagtgt ctgtgcttat gaactaggtt 120 atcgtgtttc ctatatagat ggaaaacaag 180 atgaggttag caagcgtgaa ggaatcaacg 240 aaggttatgt gacctctcat ggagaccatt 300 atgccatcat cagtgaagag ctcctcatga 360 acattgtcaa tgaaatcaag ggtggttatg 420 accttaagga tgcagctcat gcggataatg 480 aacaagaaca tagtcagcat cgtgaaggag 540 ttgcacgttc acagggacgc tacaccacag 600 tcatcgaaga tacgggcgat gcctatatcg 660 ctaagaatga gttatcagct agcgagttgg 720 aaaatctgtc aaatttaaga acctatcgcc 780 actgggtacc ttctgtaagc aatccaggaa 840 acactaacag tcaagcaagt caaagtaatg 900 aactgccttt gagtcaacgc catgtagaat 960 tcacaagtcg aaccgccaga ggtgtagctg 1020 cttatgaaca aatgtctgaa ttggaaaaac 1080 gttcaaacca ttgggtacca gattcaagac 1140 aacctagtcc aagtccgcaa cctgcaccaa 1200 atgagaaatt ggtcaaagaa gctgttcgaa 1260 atggagtttc tcgttatatc ccagccaaga 1320 atagcaaact ggccaagcag gaaagtttat 1380 tcccatctag tgatcgagaa ttttacaata 1440 aagatttact tgataataaa ggtcgacaag 1500 aacgactcaa ggatgtctca agtgataaag 1560 tagctccgat tcgtcatcca gaacgtttag 1620 atgatgagat tcaagtagcc aagttggcag 1680 ttgatcctcg tgatataacc agtgatgagg 1740 atagccactg gattaaaaaa gatagtttgt 1800 atgctaaaga gaaaggtttg acccctcctt 1860 aggcaaaagg agcagaagct atctacaacc 1920 atcgtatgcc ttacaatctt caatatactg 1980 ctcattatga ccattaccat aacatcaaat 2040 cacctaaggg gtatactctt gaggatcttt 2100 caaacgaacg tccgcattca gataatggtt 2160 acaaaaatgg tcaagctgat accaatcaaa 2220 cagaaaaacc tgaggaagaa acccctcgag 2280 • · · ·
aagagaaacc acaaagcgag aaaccagagt ctccaaaacc aacagaggaa ccagaagaag 2340 aatcaccaga ggaatcagaa gaacctcagg tcgagactga aaaggttgaa gaaaaactga 2400 gagaggctga agatttactt ggaaaaatcc aggatccaat tatcaagtcc aatgccaaag 2460 agactctcac aggattaaaa aataatttac tatttggcac ccaggacaac aatactatta 2520 tggcagaagc tgaaaaacta ttggctttat taaaggagag taagtaaagg tagcagcatt 2580 ttctaactcc taaaaacagg ataggagaac gggaaaacga aaaatgagag cagaatgtga 2640 gttctag 2647 <210> 5 <211> 2639 <212> DNA <213> BVH-11-2 <400> 5 gggtcttaaa actctgaatc ctttagaggc agacccacaa aatgacaaga cctatttaga 60 aaatctggaa gaaaatatga gtgttctagč agaagaatta aagtgaggaa agaatgaaaa 120 tcaataaaaa atatctagca ggttcagtgg cagtccttgc cctaagtgtt tgttcctatg 180 aacttggtcg tcaccaagct ggtcaggtta agaaagagtc taatcgagtt tcttatatag 240 atggtgatca ggctggtcaa aaggcagaaa atttgacacc agatgaagtc agtaagagag 300 aggggatcaa cgccgaacaa attgttatca agattacgga tcaaggttat gtgacctctc 360 atggagacca ttatcattac tataatggca aggttcctta tgatgccatc atcagtgaag 420 aacttctcat gaaagatccg aattatcagt tgaaggattc agacattgtc aatgaaatca 480 agggtggcta tgtgattaag gtagacggaa aatactatgt ttaccttaaa gatgcggccc 540 atgcggacaa tattcggaca aaagaagaga ttaaacgtca gaagcaggaa cacagtcata 600 atcataactc aagagcagat aatgctgttg ctgcagccag agcccaagga cgttatacaa 660 cggatgatgg gtatatcttc aatgcatctg atatcattga ggacacgggt gatgcttata 720 tcgttcctca cggcgaccat taccattaca ttcctaagaa tgagttatca gctagcgagt 780 tagctgctgc agaagcctat tggaatggga agcagggatc tcgtccttct tcaagttcta 840 gttataatgc aaatccagtt caaccaagat tgtcagagaa ccacaatctg actgtcactc 900 caacttatca tcaaaatcaa ggggaaaaca tttcaagcct tttacgtgaa ttgtatgcta 960 aacccttatc agaacgccat gtagaatctg atggccttat tttcgaccca gcgcaaatca 1020 caagtcgaac cgccagaggt gtagctgtcc ctcatggtaa ccattaccac tttatccctt 1080 atgaacaaat gtctgaattg gaaaaacgaa ttgctcgtat tattcccctt cgttatcgtt 1140 caaaccattg ggtaccagat tcaagaccag aacaaccaag tccacaatcg actccggaac 1200 ctagtccaag tctgcaacct gcaccaaatc ctcaaccagc tccaagcaat ccaattgatg 1260 agaaattggt caaagaagct gttcgaaaag taggcgatgg ttatgtcttt gaggagaatg 1320 gagtttctcg ttatatccca gccaaggatc tttcagcaga aacagcagca ggcattgata 1380 gcaaactggc caagcaggaa agtttatctc ataagctagg agctaagaaa actgacctcc 1440 catctagtga tcgagaattt tacaataagg cttatgactt actagcaaga attcaccaag 1500 atttacttga taataaaggt cgacaagttg attttgaggt tttggataac ctgttggaac 1560 gactcaagga tgtctcaagt gataaagtca agttagtgga tgatattctt gccttcttag 1620 ctccgattcg tcatccagaa cgtttaggaa aaccaaatgc gcaaattacc tacactgatg 1680 atgagattca agtagccaag ttggcaggca agtacacaac agaagacggt tatatctttg 1740 atcctcgtga tataaccagt gatgaggggg atgcctatgt aactccacat atgacccata 1800 gccactggat taaaaaagat agtttgtctg aagctgagag agcggcagcc caggcttatg 1860 ctaaagagaa aggtttgacc cctccttcga cagaccacca ggattcagga aatactgagg 1920 caaaaggagc agaagctatc tacaaccgcg tgaaagcagc taagaaggtg ccacttgatc 1980 gtatgcctta caatcttcaa tatactgtag aagtcaaaaa cggtagttta atcatacctc 2040 attatgacca ttaccataac atcaaatttg agtggtttga cgaaggcctt tatgaggcac 2100 ctaaggggta tagtcttgag gatcttttgg cgactgtcaa gtactatgtc gaacatccaa 2160 acgaacgtcc gcattcagat aatggttttg gtaacgctag tgaccatgtt cgtaaaaata 2220 aggcagacca agatagtaaa cctgatgaag ataaggaaca tgatgaagta agtgagccaa 2280 ctcaccctga atctgatgaa aaagagaatc acgctggttt aaatccttca gcagataatc 2340 tttataaacc aagcactgat acggaagaga cagaggaaga agctgaagat accacagatg 2400 aggctgaaat tcctcaagta gagaattctg ttattaacgc taagatagca gatgcggagg 2460 ccttgctaga aaaagtaaca gatcctagta ttagacaaaa tgctatggag acattgactg 2520 gtctaaaaag tagtcttctt ctcggaacga aagataataa cactatttca gcagaagtag 2580 atagtctctt ggctttgtta aaagaaagtc aaccggctcc tatacagtag taaaatgaa 2639 <210> 6 <211> 1039 <212> PRT <213> BVH-3 <400> 6
Met Lys Phe Ser Lys Lys Tyr ile Ala Ala Gly Ser Ala val Ile val 15 10 15
Ser Leu Ser Leu Cys Ala Tyr Ala Leu Asn Gin His Arg Ser Gin Glu
25 30
AS Π | Lys | Asp 35 | Asn Asn Arg | Val | Ser Tyr val 40 | Asp Gly ser Gin ser 45 | Ser | ||||||||
Gin | Lys | Ser | Glu | Asn | Leu | Thr | Pro | Asp | Gin | val | ser | Gin | Lys | Glu | Gly |
50 | 55 | 60 | |||||||||||||
ile | Gin | Ala | Glu | Gin | Ile | Val | ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val |
65 | 70 | 75 | 80 | ||||||||||||
Thr | Ser | His | Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr |
85 | 90 | 95 | |||||||||||||
Asp | Ala | Leu | Phe | ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | pro | Asn | Tyr | Gin |
100 | 105 | 110 | |||||||||||||
Leu | Lys | Asp | Ala | Asp | Ile | Val | Asn | Glu | Val | Lys | Gly | Gly | Tyr | Ile | Ile |
115 | 120 | 125 | |||||||||||||
Lys | val | Asp | Gly | Lys | Tyr | Tyr | val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala |
130 | 135 | 140 | |||||||||||||
Asp | Asn | Val | Arg | Thr | Lys | Asp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Gl u | His |
145 | 150 | 155 | 160 | ||||||||||||
val | Lys | Asp | Asn | Glu | Lys | Val | Asn | Ser | Asn | val | Ala | val | Ala | Arg | Ser |
165 | 170 | 175 | |||||||||||||
Gin | Gly | Arg | Tyr | Thr | Thr | Asn | Asp | Gly | Tyr | val | Phe | Asn | Pro | Ala | Asp |
180 | 185 | 190 | |||||||||||||
Ile | Ile | Glu | Asp | Thr | Gly | Asn | Ala | Tyr | Ile | val | Pro | His | Gly Gly | Hi s | |
195 | Ile | 200 | 205 | ||||||||||||
Tyr | His | Tyr | Pro | Lys | ser | Asp | Leu | Ser | Ala | Ser | Glu | Leu | Ala | Ala | |
210 | 215 | 220 | |||||||||||||
Ala | Lys | Ala | His | Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser |
225 | 230 | 235 | 240 | ||||||||||||
Tyr | Ser | Ser | Thr | Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | val | Ala | Lys | Gly |
245 | 250 | 255 | |||||||||||||
Ser | Thr | Ser | Lys | Pro | Ala | Asn | Lys | ser | Glu | Asn | Leu | Gin | Ser | Leu | Leu |
260 | 265 | 270 | |||||||||||||
Lys | Glu | Leu | Tyr | Asp | Ser | Pro | ser | Ala | Gin | Arg | Tyr | Ser | Glu | Ser | Asp |
275 | 280 | 285 | |||||||||||||
Gly | Leu | Val | Phe | Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn | Gly |
290 | 295 | 300 | |||||||||||||
val | Ala | ile | Pro | HÍS | Gly | Asp | His | Tyr | His | Phe | Ile | Pro | Tyr | Ser | Lys |
305 | 310 | 315 | 320 | ||||||||||||
Leu | Ser | Ala | Leu | Glu | Glu | Lys | ile | Ala | Arg | Met | val | Pro | Ile | Ser | Gly |
325 | 330 | 335 | |||||||||||||
Thr | Gly | Ser | Thr | Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | val | Val | Ser |
340 | 345 | 350 | |||||||||||||
Ser | Leu | Gly | Ser | Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser | Lys |
355 | 360 | 365 | |||||||||||||
Glu | Leu | Ser | Ser | Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | Asp | ile |
370 | 375 | 380 | |||||||||||||
val | Glu | Glu | Thr | Ala | Thr | Ala | Tyr | ile | val | Arg | His | Gly | Asp | His | Phe |
385 | 390 | 395 | 400 | ||||||||||||
His | Tyr | Ile | Pro | Lys | Ser | Asn | Gin | ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn |
405 | 410 | 415 | |||||||||||||
Asn | Ser | Leu | Ala | Thr | Pro | Ser | Pro | Ser | Leu | Pro | ile | Asn | pro | Gly | Thr |
420 | 425 | 430 | |||||||||||||
Ser | His | Glu | Lys | His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg |
435 | 440 | 445 | |||||||||||||
ile | Ile | Ala | Glu | Asp | Glu | Ser | Gly | Phe | val | Met | Ser | His | Gly | Asp | His |
450 | 455 | 460 | |||||||||||||
Asn | HÍS | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala |
465 | 470 | 475 | 480 | ||||||||||||
Ala | Gin | Lys | His | Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp |
485 | 490 | 495 | |||||||||||||
Ser | Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met |
500 | 505 | 510 | |||||||||||||
Lys | Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys |
515 | 520 | 525 | |||||||||||||
Gin | Tyr | Gly | Val | Lys | Arg | Glu | Ser | Ile | val | Val | Asn | Lys | Glu | Lys | Asn |
530 | 535 | 540 | |||||||||||||
Ala | Ile | Ile | Tyr | pro | His | Gly | Asp | His | His | Hi s | Ala | Asp | Pro | ile | Asp |
545 | 550 | 555 | 560 | ||||||||||||
Glu | His | Lys | Pro | val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu |
565 | 570 | 575 | |||||||||||||
Phe | Lys | Pro | Glu | Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr |
580 | 585 | 590 | |||||||||||||
Thr | Gly | Glu | Glu | Leu | Thr | Asn | Val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr |
595 | 600 | 605 | |||||||||||||
Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser |
610 | 615 | 620 | |||||||||||||
Phe | Ser | phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu |
625 | 630 | 635 | 640 | ||||||||||||
Val | Lys | Leu | Ile | Thr | Pro | Asp | Gly | Lys | val | Leu | Glu | Lys | val | Ser | Gly |
645 | 650 | 655 | |||||||||||||
Lys | val | Phe | Gly | Glu | Gly | val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp |
660 | 665 | 670 | |||||||||||||
Gin | Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys |
675 | 680 | 685 | |||||||||||||
Asp | Tyr | Pro | Glu | val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | pro | Thr | Ser |
690 | 695 | 700 | |||||||||||||
Leu | Ala | Tyr | Lys | Met | Ala | Ser | Gin | Thr | ile | Phe | Tyr | Pro | Phe | His | Ala |
705 | 710 | 715 | 720 | ||||||||||||
Gly | Asp | Thr | Tyr | Leu | Arg | val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly |
725 | 730 | 735 | |||||||||||||
Thr | Asp | Ala | Leu | val | Arg | val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr |
740 | 745 | 750 | |||||||||||||
Leu | Glu | Asn | Asn | Tyr | Lys | val | Gly | Glu | Ile | Lys | Leu | pro | ile | pro | Lys |
755 | 760 | 765 | |||||||||||||
Leu | Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr |
770 | 775 | 780 | |||||||||||||
Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu |
785 | 790 | 795 | 800 | ||||||||||||
Val | Pro | Ile | Leu | Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu |
805 | 810 | 815 | |||||||||||||
Pro | Gin | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | ASP | Glu |
820 | 825 | 830 | |||||||||||||
Lys | val | Glu | Glu | Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu |
835 | 840 | 845 | |||||||||||||
Ser | Glu | Thr | Gly | Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro |
850 | 855 | 860 | |||||||||||||
Thr | val | Asp | Pro | val | Gin | Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr |
865 | 870 | 875 | 880 | ||||||||||||
Gly | Met | Lys | Leu | Glu | Asn | val | Leu | Phe | Asn | Met | Asp | Gly | Thr | ile | Glu |
885 | 890 | 895 | |||||||||||||
Leu | Tyr | Leu | Pro | Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | ASp | Phe |
900 | 905 | 910 | |||||||||||||
Thr | Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn |
915 | 920 | 925 | |||||||||||||
Gly | Lys | Val | Ser | Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys |
930 | 935 | 940 | |||||||||||||
Pro | Ala | Asp | Ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | val | Lys | Pro |
945 | 950 | 955 | 960 | ||||||||||||
Glu | Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly |
965 | 970 | 975 | |||||||||||||
Ser | Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp |
980 | 985 | 990 | |||||||||||||
pro | val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly |
995 | 1000 | 100 5 | |||||||||||||
Leu | ASP | Ser | val | Ile | Phe | Asn | Met | Asp | Gly | Thr | ile | Glu | Leu | Arg | Leu |
1010 | 1015 | 1020 | |||||||||||||
Pro | Ser | Gly | Glu | Val | Ile | Lys ) | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | |
1025 | 103Í | 1035 |
<210> 7 <211> 840 <212> PRT <213> BVH-11 <400> 7
Met Lys ile Asn Lys Lys Tyr Leu Ala Gly ser val Ala Thr Leu val 1 5 10 15 • « : ’ . . ·.....
«···· ·· ·· * ·
Leu | ser val cys Ala Tyr Glu Leu 20 | Gly Leu 25 | His | Gin | Ala | Gin 30 | Thr | Val | |||||||
Lys | Glu | Asn | Asn | Arg | val | Ser | Tyr | Ile | Asp | Gly | Lys | Gin | Ala | Thr | Gin |
35 | 40 | 45 | |||||||||||||
Lys | Thr | Gl u | Asn | Leu | Thr | Pro | Asp | Glu | val | Ser | Lys | Arg | Glu | Gly | ile |
50 | 55 | 60 | |||||||||||||
Asn | Ala | Gl u | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | val | Thr |
65 | 70 | 75 | 80 | ||||||||||||
Ser | His | Gly | Asp | Hi s | Tyr | Hi s | Tyr | Tyr | Asn | Gly | Lys | Val | Pro | Tyr | Asp |
85 | 90 | 95 | |||||||||||||
Ala | ile | Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu |
100 | 105 | 110 | |||||||||||||
Lys | Asp | Ser | Asp | Ile | val | Asn | Glu | ile | Lys | Gly Gly | Tyr | val | Ile | Lys | |
115 | 120 | 125 | |||||||||||||
Val | Asn | Gly | Lys | Tyr | Tyr | val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp |
130 | 135 | 140 | |||||||||||||
Asn | val | Arg | Thr | Lys | Glu | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | Ser |
145 | 150 | 155 | 160 | ||||||||||||
Gin | His | Arg | Glu | Gly | Gly | Thr | Ser | Al a | Asn | Asp | Gly | Ala | val | Ala | Phe |
165 | 170 | 175 | |||||||||||||
Ala | Arg | Ser | Gin | Gly | Arg | Tyr | Thr | Thr | ASp | Asp | Gly | Tyr | Ile | Phe | Asn |
180 | 185 | 190 | |||||||||||||
Ala | Ser | Asp | Ile | Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | Ile | Val | Pro | His |
195 | 200 | 205 | |||||||||||||
Gly | Asp | His | Tyr | His | Tyr | Ile | Pro | Lys | Asn | Glu | Leu | Ser | Ala | Ser | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Ala | Ala | Ala | Glu | Ala | Phe | Leu | Ser | Gly | Arg | Glu | Asn | Leu | Ser | Asn |
225 | 230 | 235 | 240 | ||||||||||||
Leu | Arg | Thr | Tyr | Arg | Arg | Gin | Asn | Ser | Asp | Asn | Thr | Pro | Arg | Thr | Asn |
245 | 250 | 255 | |||||||||||||
Trp | val | Pro | Ser | Val | Ser | Asn | Pro | Gly | Thr | Thr | Asn | Thr | Asn | Thr | ser |
260 | 265 | 270 | |||||||||||||
Asn | Asn | Ser | Asn | Thr | Asn | Ser | Gin | Ala | Ser | Gin | Ser | Asn | Asp | Ile | Asp |
275 | 280 | 285 | |||||||||||||
Ser | Leu | Leu | Lys | Gin | Leu | Tyr | Lys | Leu | Pro | Leu | ser | Gin | Arg | His | val |
290 | 295 | 300 | |||||||||||||
Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile | Thr | Ser | Arg | Thr |
305 | 310 | 315 | 320 | ||||||||||||
Ala | Arg | Gly | val | Ala | Val | Pro | His | Gly | Asn | His | Tyr | Hi s | Phe | Ile | Pro |
325 | 330 | 335 | |||||||||||||
Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | Ile | Pro |
340 | 345 | 350 | |||||||||||||
Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro | Glu | Glu |
355 | 360 | 365 | |||||||||||||
Pro | Ser | Pro | Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala |
370 | 375 | 380 | |||||||||||||
Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | pro | Ile | Asp | Glu | Lys | Leu | val |
385 | 390 | 395 | 400 | ||||||||||||
Lys | Glu | Ala | val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn |
405 | 410 | 415 | |||||||||||||
Gly | val | ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asn | Leu | Ser | Ala | Glu | Thr | Ala |
420 | 425 | 430 | |||||||||||||
Al a | Gly | Ile | ASp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | His | Lys |
Gly | 435 | 440 | 445 | ||||||||||||
Leu | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | |
450 | 455 | 460 | |||||||||||||
Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp |
465 | 470 | 475 | 480 | ||||||||||||
Asn | Lys | Gly | Arg | Gin | val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Gl u |
485 | 490 | 495 | |||||||||||||
Arg | Leu | Lys | Asp | Val | ser | Ser | Asp | Lys | val | Lys | Leu | Val | Asp | ASp | Ile |
500 | 505 | 510 | |||||||||||||
Leu | Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro |
515 | 520 | 525 | |||||||||||||
Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | val | Al a | Lys | Leu |
530 | 535 | 540 | |||||||||||||
Ala | Gly | Lys | Tyr | Thr | Thr | Glu | ASp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | Asp |
545 | 550 | 555 | 560 |
• · · ·
• • • · · | • · · • • · | • · • • · | • • · • · | • · · • · | • • · • · | ||||||||||
ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | pro | His | Met | Thr | His |
ile | 565 | 570 | 575 | ||||||||||||
Ser | His | Trp | Lys | Lys | Asp | ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | |
580 | 585 | 590 | |||||||||||||
Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp |
595 | 600 | 605 | |||||||||||||
His | Gin | ASp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | ile | Tyr |
610 | 615 | 620 | |||||||||||||
Asn | Arg | Val | Lys | Ala | Al a | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr |
625 | 630 | 635 | 640 | ||||||||||||
Asn | Leu | Gin | Tyr | Thr | val | Glu | val | Lys | Asn | Gly | Ser | Leu | Ile | ile | Pro |
645 | 650 | 655 | |||||||||||||
His | Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly |
660 | 665 | 670 | |||||||||||||
Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr |
675 | 680 | 685 | |||||||||||||
val | Lys | Tyr | Tyr | val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn |
690 | 695 | 700 | |||||||||||||
Gly | Phe | Gly | Asn | Ala | Ser | ASp | His | val | Gin | Arg | Asn | Lys | Asn | Gly | Gin |
705 | 710 | 715 | 720 | ||||||||||||
Ala | Asp | Thr | Asn | Gin | Thr | Glu | Lys | Pro | Ser | Glu | Glu | Lys | Pro | Gin | Thr |
725 | 730 | 735 | |||||||||||||
Glu | Lys | Pro | Glu | Glu | Glu | Thr | Pro | Arg | Glu | Glu | Lys | Pro | Gin | Ser | Glu |
740 | 745 | 750 | |||||||||||||
Lys | pro | Glu | Ser | Pro | Lys | Pro | Thr | Glu | Glu | Pro | Glu | Glu | Glu | Ser | Pro |
755 | 760 | 765 | |||||||||||||
Glu | Glu | Ser | Glu | Gl u | Pro | Gin | Val | Glu | Thr | Glu | Lys | val | Glu | Glu | Lys |
770 | 775 | 780 | |||||||||||||
Leu | Arg | Glu | Ala | Glu | Asp | Leu | Leu | Gly | Lys | Ile | Gin | Asp | Pro | ile | Ile |
785 | 790 | 795 | 800 | ||||||||||||
Lys | Ser | Asn | Ala | Lys | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Asn | Asn | Leu | Leu |
805 | 810 | 815 | |||||||||||||
Phe | Gly | Thr | Gin | Asp | Asn | Asn | Thr | Ile | Met | Ala | Glu | Ala | Glu | Lys | Leu |
820 | 825 | 830 | |||||||||||||
Leu | Ala | Leu | Leu | Lys | Glu | Ser | Lys |
835 840 <210> 8 <211> 838 <212> PRT <213> BVH-11-2
<400> 8 | |||||||||||||||
Met | Lys | ile | Asn | Lys | Lys | Tyr | Leu | Ala | Gly | Ser | val | Ala | val | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Leu | Ser | val | cys | Ser | Tyr | Glu | Leu | Gly | Arg | His | Gin | Ala | Gly | Gin | val |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Glu | ser | Asn | Arg | Val | Ser | Tyr | ile | Asp | Gly | Asp | Gin | Ala | Gly |
35 | 40 | 45 | |||||||||||||
Gin | Lys | Ala | Glu | Asn | Leu | Thr | Pro | Asp | Glu | Val | Ser | Lys | Arg | Glu | Gly |
50 | 55 | 60 | |||||||||||||
Ile | Asn | Ala | Glu | Gin | Ile | val | ile | Lys | ile | Thr | Asp | Gin | Gly | Tyr | val |
65 | 70 | 75 | 80 | ||||||||||||
Thr | Ser | His | Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | val | Pro | Tyr |
85 | 90 | 95 | |||||||||||||
Asp | Ala | Ile | Ile | Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin |
100 | 105 | 110 | |||||||||||||
Leu | Lys | Asp | Ser | Asp | Ile | Val | Asn | Glu | Ile | Lys | Gly | Gly | Tyr | Val | ile |
115 | 120 | 125 | |||||||||||||
Lys | val | ASp | Gly | Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala |
130 | 135 | 140 | |||||||||||||
Asp | Asn | ile | Arg | Thr | Lys | Glu | Glu | ile | Lys | Arg | Gin | Lys | Gin | Glu | His |
145 | 150 | 155 | 160 | ||||||||||||
Ser | His | Asn | His | Asn | Ser | Arg | Ala | Asp | Asn | Ala | val | Ala | Ala | Ala | Arg |
165 | 170 | 175 | |||||||||||||
Ala | Gin | Gly | Arg | Tyr | Thr | Thr | Asp | Asp | Gly | Tyr | Ile | Phe | Asn | Ala | Ser |
180 | 185 | 190 | |||||||||||||
Asp | Ile | Ile | Glu | Asp | Thr | Gly | Asp | Ala | Tyr | ile | val | Pro | His | Gly | Asp |
195 | 200 | 205 | |||||||||||||
HÍS | Tyr | His | Tyr | Ile | Pro | Lys | Asn | Glu | Leu | Ser | Ala | ser | Glu | Leu | Ala |
210 | 215 | 220 | |||||||||||||
Ala | Al a | Glu | Ala | Tyr | Trp | Asn | Gly | Lys | Gin | Gly | Ser | Arg | Pro | Ser | Ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Ser | Ser | Tyr | Asn | Ala | Asn | Pro | val | Gin | Pro | Arg | Leu | Ser | Glu | Asn |
245 | 250 | 255 | |||||||||||||
His | Asn | Leu | Thr | val | Thr | Pro | Thr | Tyr | His | Gin | Asn | Gin | Gly | Glu | Asn |
260 | 265 | 270 | |||||||||||||
Ile | Ser | Ser | Leu | Leu | Arg | Glu | Leu | Tyr | Ala | Lys | Pro | Leu | ser | Glu | Arg |
275 | 280 | 285 | |||||||||||||
His | Val | Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | ile | Thr | Ser |
290 | 295 | 300 | |||||||||||||
Arg | Thr | Ala | Arg | Gly | val | Ala | val | Pro | His | Gly | Asn | His | Tyr | Hi s | Phe |
305 | 310 | 315 | 320 | ||||||||||||
Ile | Pro | Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | ile |
325 | 330 | 335 | |||||||||||||
Ile | Pro | Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | Val | Pro | Asp | Ser | Arg | Pro |
340 | 345 | 350 | |||||||||||||
Glu | Gin | Pro | Ser | Pro | Gin | Ser | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Leu | Gin |
355 | 360 | 365 | |||||||||||||
Pro | Ala | Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp | Glu | Lys |
370 | 375 | 380 | |||||||||||||
Leu | val | Lys | Glu | Ala | Val | Arg | Lys | val | Gly | Asp | Gly | Tyr | Val | Phe | Glu |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Asn | Gly | val | Ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asp | Leu | Ser | Ala | Glu |
405 | 410 | 415 | |||||||||||||
Thr | Ala | Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser |
420 | 425 | 430 | |||||||||||||
His | Lys | Leu | Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu |
435 | 440 | 445 | |||||||||||||
Phe | Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Al a | Arg | ile | His | Gin | Asp | Leu |
450 | 455 | 460 | |||||||||||||
Leu | Asp | Asn | Lys | Gly | Arg | Gin | val | Asp | Phe | Glu | Val | Leu | ASp | Asn | Leu |
465 | 470 | 475 | 480 | ||||||||||||
Leu | Glu | Arg | Leu | Lys | Asp | val | Ser | Ser | Asp | Lys | Val | Lys | Leu | val | Asp |
485 | 490 | 495 | |||||||||||||
Asp | ile | Leu | Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly |
500 | 505 | 510 | |||||||||||||
Lys | Pro | Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | val | Ala |
515 | 520 | 525 | |||||||||||||
Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro |
530 | 535 | 540 | |||||||||||||
Arg | ASp | Ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His | Met |
545 | 550 | 555 | 560 | ||||||||||||
Thr | Hi S | Ser | His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg |
565 | 570 | 575 | |||||||||||||
Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser |
580 | 585 | 590 | |||||||||||||
Thr | ASp | His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala |
595 | 600 | 605 | |||||||||||||
Ile | Tyr | Asn | Arg | val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met |
610 | 615 | 620 | |||||||||||||
Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | val | Glu | val | Lys | Asn | Gly | Ser | Leu | ile |
625 | 630 | 635 | 640 | ||||||||||||
ile | Pro | His | Tyr | Asp | His | Tyr | His | Asn | ile | Lys | Phe | Glu | Trp | phe | Asp |
645 | 650 | 655 | |||||||||||||
Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu |
660 | 665 | 670 | |||||||||||||
Ala | Thr | val | Lys | Tyr | Tyr | val | Glu | Hi S | pro | Asn | Glu | Arg | Pro | His | Ser |
675 | 680 | 685 | |||||||||||||
Asp | Asn | Gly | Phe | Gly | Asn | Ala | Ser | Asp | Hi s | val | Arg | Lys | Asn | Lys | Ala |
690 | 695 | 700 | |||||||||||||
Asp | Gin | Asp | Ser | Lys | Pro | ASp | Glu | Asp | Lys | Glu | His | Asp | Glu | val | Ser |
705 | 710 | 715 | 720 | ||||||||||||
Glu | Pro | Thr | Hi s | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | HÍS | Ala | Gly | Leu |
• · ·
725 | |||||||
Asn Pro Ser Ala Asp Asn Leu 740 | Tyr Thr 760 | ||||||
Thr Glu Glu Glu Ala | Glu | Asp | |||||
755 | |||||||
val | Glu | Asn | Ser | Val | Ile | Asn | Ala |
770 | 775 | ||||||
Leu | Glu | Lys | val | Thr | Asp | Pro | Ser |
785 | 790 | ||||||
Leu | Thr | Gly | Leu | Lys | Ser | Ser | Leu |
805 | |||||||
Thr | Ile | Ser | Ala | Glu | val | Asp | ser |
820 | |||||||
Gin | Pro | Ala | Pro | ile | Gin | ||
835 |
730 Lys Pro 745 Thr Asp | Ser Thr Asp Thr 750 | 735 Glu Pro | Glu Gin | ||||
Glu Ala Glu 765 | Ile | ||||||
Lys | Ile | Ala | Asp | Ala | Glu | Ala | Leu |
780 | |||||||
ile | Arg | Gin | Asn | Ala | Met | Glu | Thr |
795 | 800 | ||||||
Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn |
810 | 815 | ||||||
Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser |
825 | 830 |
<210> 9 <211> 2528 <212> DNA <213> BVH-3 <400> 9 tgtgcctatg tatgtggatg cagaaagaag acgtcacacg agtgaagaac gaagtcaagg gcagctcatg gtcaaagata acgacaaatg tatatcgttc gaattagcag tattcttcaa gaagaagatg gtcatgagtc attaaggctg ttgtcatctc aaaatcgaag gtcgtgaata ccgattgatg aaacccgaag acgaatgttg aatggtcaaa aatatgctag gtatttggag ggacaaacat acatttacag ttccatgcag gatgctttag aaagttggtg ggaaataaaa attgtggaag caatttaaaa aagactagtg tcaacgttag gaaagttatg tatttaccat caaggaaatg aaccaaccaa gtaaaaccag gaccctatgt ttagaaaaat ggaacgattg tagcgtaa cactaaacca gcagccagtc gaattcaggc gtgatcacta tcttgatgaa gtggttatat ctgataatgt atgagaaggt atggttatgt ctcatggagg cagctaaagc caccttctcc gatacggatt acggagacca cgcaaaaaca atgaacagga aaaaaattgc aagaaaaaaa aacataaacc aaggagttgc ttaatttgtt aacgcgtttc taaaattaat aaggagtagg ttaagtatac ttccaacctc gggatactta tcagagtgtt aaatcaaatt ttcctgtaac tacctatctt ggaataaagc agaaggtaga aagaagttcc ggatgaagct cgggagaagt gtgaaaataa cagaaaataa aaaactcaac tagattcagc ttacagctag aattaagatt gcatcgttcg aagtcagaaa tgagcaaatt tcattactat ggatccaaac catcaaggtc tcgaactaaa taactctaat ctttaatcca tcactatcac acatctggct atctcttcca tgatgctaat caatcattat tttagaggaa ttatccaagt tggcattatg tgcgattatt ggttggaatt taaaaaagaa aaaaaatagt ttttagtttt aacaccagat gaatattgca tatcgcttca tttagcttac tttaagagtg tgatgaattt accgattccg cttcatggca ggaaaaagaa acaagaaaac aaaagaaaaa tacagtggat agaaaatgtc cattaaaaag accatctgaa accagcagat ggataatgga attagaggaa ttacggatta gccaagtgga caggaaaata agtgaaaact gtaatcaaaa aatgggaaag tatcaactta gatggaaaat gatgaaatca gttgctgtag gctgatatta tacattccca ggaaaaaata atcaatccag cgtattatcg ttcttcaaga gttaaaacta aatgccaaag aaacaatatg tatccgcatg ggtcattctc gggaataaag acgtttaata ccgcctgaat ggaaaagtat aactttgaat aaagattatc aaaatggcca aaccctcaat catggaaatg aaattaaacc aatgcttatt aatcaaactg tcaaaacttg ctttctgaaa cctgtacaag ttgtttaata aatatggcag aatggaaaag tctttaccag atgttgaatc gctccagcag ggcttagata gaagtgataa aggacaataa tgacaccaga ttacagatca ttccttatga aagacgctga attatgtcta atcgtcaaaa caaggtctca tcgaagatac aaagcgattt tgcaaccgag gaacttcaca ctgaagatga aggacttgac gtcataatgg aaatgaaaga gtgtcaaacg gagatcacca acagtaacta tttatactgg atcaaaactt tggagaaaaa tggagaaagt tagatcaacc cagaagtaag gtcaaacgat ttgcagtgcc cttatttaga aaggaacaac tggacaatca ataaaccaag atgaaaaggt ctgggaatag aaaaagtagc tggacggaac attttacagg tatctactgg aggcaccaaa cagaagggaa tagatcctgt gtgttatatt aaaagaattt tcgtgtctct ccaggttagc gggctatgta tgccctcttt tattgtcaat cctgaaagat acaagaacat gggacgatat gggtaatgct atctgctagt tcagttaagc tgagaaacat atcaggtttt agaagagcaa attagattct tttagataaa tgaaagtatt tcatgcagat tgaactgttt agaagaatta tactctagcc attaggtatc atctggtaaa ttatttacca ttatgatggt tttctatcct taaaggaact aaataactat cagaacggcc atcgacttat tattctacca agaagaacca tactagtaat aaaatttgct aattgaatta agaagcacct aacagttgag cgaaaaacct tgtggggagt acaagaaaaa caatatggat attgatctca
120
180
240
300
360
420
480
540
600
660
720
780
840
900
960
1020
1080
1140
1200
1260
1320
1380
1440
1500
1560
1620
1680
1740
1800
1860
1920
1980
2040
2100
2160
2220
2280
2340
2400
2460
2520
2528 <210> 10 • · * · <211> 840 <212> PRT <213> BVH-3 <400> 10
cys 1 | Ala Tyr Ala Leu Asn Gin 5 | His | Arg ser Gin 10 | Glu Asn | Lys | Asp 15 | Asn | ||||||||
Asn | Arg | Val | Ser | Tyr | Val | Asp | Gly | Ser | Gin | Ser | Ser | Gin | Lys | Ser | Glu |
20 | 25 | 30 | |||||||||||||
Asn | Leu | Thr | Pro | Asp | Gin | Val | Ser | Gin | Lys | Glu | Gly | Ile | Gin | Ala | Glu |
35 | 40 | 45 | |||||||||||||
Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr | Val | Thr | Ser | His | Gly |
50 | 55 | 60 | |||||||||||||
Asp | His | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | val | Pro | Tyr | Asp | Ala | Leu | Phe |
65 | 70 | 75 | 80 | ||||||||||||
Ser | Glu | Glu | Leu | Leu | Met | Lys | Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ala |
85 | 90 | 95 | |||||||||||||
Asp | Ile | val | Asn | Glu | Val | Lys | Gly Gly | Tyr | Ile | Ile | Lys | Val | Asp | Gly | |
100 | 105 | 110 | |||||||||||||
Lys | Tyr | Tyr | Val | Tyr | Leu | Lys | Asp | Ala | Ala | His | Ala | Asp | Asn | val | Arg |
115 | 120 | 125 | |||||||||||||
Thr | Lys | ASp | Glu | Ile | Asn | Arg | Gin | Lys | Gin | Glu | His | val | Lys | Asp | Asn |
130 | 135 | 140 | |||||||||||||
Glu | Lys | val | Asn | ser | Asn | Val | Ala | Val | Ala | Arg | Ser | Gin | Gly | Arg | Tyr |
145 | 150 | 155 | 160 | ||||||||||||
Thr | Thr | Asn | Asp | Gly | Tyr | val | Phe | Asn | Pro | Ala | Asp | Ile | ile | Glu | Asp |
165 | 170 | 175 | |||||||||||||
Thr | Gly | Asn | Ala | Tyr | Ile | val | Pro | His | Gly | Gly | His | Tyr | His | Tyr | Ile |
180 | 185 | 190 | |||||||||||||
Pro | Lys | Ser | Asp | Leu | ser | Ala | Ser | Glu | Leu | Ala | Ala | Ala | Lys | Ala | His |
195 | 200 | 205 | |||||||||||||
Leu | Ala | Gly | Lys | Asn | Met | Gin | Pro | Ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | Pro | ser | Leu | Pro | ile | Asn | Pro | Gly | Thr | Ser | Hi s | Glu | Lys | His |
225 | 230 | 235 | 240 | ||||||||||||
Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | ile | ile | Ala | Glu | ASp |
245 | 250 | 255 | |||||||||||||
Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His | Asn | His | Tyr | Phe | Phe |
260 | 265 | 270 | |||||||||||||
Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | ile | Lys | Ala | Ala | Gin | Lys | His | Leu |
275 | 280 | 285 | |||||||||||||
Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | ser | Hi s |
290 | 295 | 300 | |||||||||||||
Glu | Gin | Asp | Tyr | Pro | Ser | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys |
305 | 310 | 315 | 320 | ||||||||||||
Lys | ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys |
325 | 330 | 335 | |||||||||||||
Arg | Glu | ser | ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | ile | Tyr | Pro |
340 | 345 | 350 | |||||||||||||
Hi S | Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | Val |
355 | 360 | 365 | |||||||||||||
Gly | Ile | Gly | HÍS | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu |
370 | 375 | 380 | |||||||||||||
Gly | val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu |
385 | 390 | 395 | 400 | ||||||||||||
Thr | Asn | val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn |
405 | 410 | 415 | |||||||||||||
Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro | Pro |
420 | 425 | 430 | |||||||||||||
Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | val | Lys | Leu | ile | Thr |
435 | 440 | 445 | |||||||||||||
Pro | Asp | Gly | Lys | val | Leu | Glu | Lys | val | Ser | Gly | Lys | Val | Phe | Gly | Glu |
450 | 455 | 460 | |||||||||||||
Gly | val | Gly | Asn | ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro |
465 | 470 | 475 | 480 | ||||||||||||
Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | val |
485 | 490 | 495 | |||||||||||||
Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met |
• · » ·» «··«
55 | • · a ·· | • · | • · | • * | |||||||||||
500 | 505 | 510 | |||||||||||||
Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | ASp | Thr | Tyr | Leu |
515 | 520 | 525 | |||||||||||||
Arg | val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val |
530 | 535 | 540 | |||||||||||||
Arg | val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr |
545 | 550 | 555 | 560 | ||||||||||||
Lys | val | Gly | Glu | Ile | Lys | Leu | Pro | ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr |
565 | 570 | 575 | |||||||||||||
Thr | Arg | Thr | Ala | Gly | Asn | Lys | ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala |
580 | 585 | 590 | |||||||||||||
Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu | Glu |
595 | 600 | 605 | |||||||||||||
Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | ile | Leu | Pro | Gin | Phe | Lys | Arg |
610 | 615 | 620 | |||||||||||||
Asn | Lys | Ala | Gin | Glu | Asn | ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu | Pro |
625 | 630 | 635 | 640 | ||||||||||||
Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn |
645 | 650 | 655 | |||||||||||||
Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | Val | Asp | Pro | Val |
660 | 665 | 670 | |||||||||||||
Gin | Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu |
675 | 680 | 685 | |||||||||||||
Asn | val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser |
690 | 695 | 700 | |||||||||||||
Gly | Glu | val | ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro |
705 | 710 | 715 | 720 | ||||||||||||
Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | ser | Glu | Asn | Gly | Lys | val | Ser | Thr |
725 | 730 | 735 | |||||||||||||
Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu |
740 | 745 | 750 | |||||||||||||
Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | val | Lys | Pro | Glu | Asn | ser | Thr | Asp |
755 | 760 | 765 | |||||||||||||
Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu |
770 | 775 | 780 | |||||||||||||
Asp | Ser | Ala | Leu | Glu | Glu | Ala | Pro | Ala | val | Asp | Pro | Val | Gin | Glu | Lys |
785 | 790 | 795 | 800 | ||||||||||||
Leu | Glu | Lys | Phe | Thr | Ala | ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile |
805 | 810 | 815 | |||||||||||||
Phe | Asn | Met | Asp | Gly | Thr | ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val |
820 | 825 | 830 | |||||||||||||
ile | Lys | Lys | Asn | Leu | Leu | ile | Ser |
835 840 <210> 11 <211> 94 <212> PRT <213> unknown <220>
<223> 4D4.9 <400> 11
Asp | Gin | Gly | Tyr | val | Thr | Ser | HIS | Gly | Asp | His | Tyr | His | Tyr | Tyr | Asn |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | val | Pro | Tyr | Asp | Ala | Leu | Phe | Ser | Glu | Glu | Leu | Leu | Met | Lys |
20 | 25 | 30 | |||||||||||||
Asp | Pro | Asn | Tyr | Gin | Leu | Lys | Asp | Ala | Asp | ile | Val | Asn | Glu | val | Lys |
35 | 40 | 45 | |||||||||||||
Gly | Gly | Tyr | ile | Ile | Lys | val | Asp | Gly | Lys | Tyr | Tyr | val | Tyr | Leu | Lys |
50 | 55 | 60 | |||||||||||||
Asp | Ala | Ala | His | Ala | Asp | Asn | Val | Arg | Thr | Lys | Asp | Glu | ile | Asn | Arg |
65 | 70 | 75 | 80 | ||||||||||||
Gin | Lys | Gin | Glu | His | Val | Lys | Asp | Asn | Glu | Lys | val | Asn | Ser |
90 <210> 12 <211> 42 • ** ·· · · ·· ····
400 • · · · • · »« * Η » · * r » «· • · · • · · · ·· ·· «··« <212> PRT <213> Unknown <220>
<223> 7G11.7 <400> 12
Gly | ile | Gin | Ala | Glu | Gin | Ile | Val | Ile | Lys | Ile | Thr | Asp | Gin | Gly | Tyr |
1 | 5 | 10 | 15 | ||||||||||||
Val | Thr | Ser | His | Gly | Asp | Hi s | Tyr | His | Tyr | Tyr | Asn | Gly | Lys | val | Pro |
20 | 25 | 30 | |||||||||||||
Tyr | Asp | Ala | Leu | Phe | Ser | Glu | Glu | Leu | Leu | ||||||
35 | 40 |
<210> 13 <211> 39 <212> PRT <213> Unknown <220>
<223> 7G11.9 <400> 13
Thr | Ala | Tyr | Ile | Val | Arg | His | Gly | Asp | His | Phe | His | Tyr | ile | Pro | Lys |
1 | 5 | 10 | 15 | ||||||||||||
Ser | Asn | Gin | ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | ser | Leu | Ala | Thr |
20 | 25 | 30 | |||||||||||||
Pro | ser | Pro | Ser | Leu | Pro | Ile | |||||||||
35 |
<210> 14 <211> 36 <212> PRT <213> Unknown <220>
<223> 4D3.4 <400> 14
Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | val | Asp | Pro | Val | Gin |
1 | 5 | 10 | 15 | ||||||||||||
Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
20 | 25 | 30 | |||||||||||||
Val | Leu | Phe | Asn | ||||||||||||
35 |
<210> 15 <211> 24 <212> PRT <213> Unknown <220>
<223> 8Ε3.1 <400> 15
Met Asp Gly Thr ile Glu Leu Arg Leu Pro Ser Gly Glu val ile Lys 15 10 15
Lys Asn Leu Ser Asp Phe Ile Ala 20 <210> 16 <211> 35 <212> PRT <213> unknown <220>
<223> 1G2.2 «4 4 · 4444
4 4 4 4 <400> 16
Tyr | Gly | Leu | Gly | Leu | Asp | ser | Val | Ile | Phe | Asn | Met | Asp | Gly | Thr | ile |
1 | 5 | 10 | 15 | ||||||||||||
Glu | Leu | Arg | Leu | Pro | ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Leu | Ser | Asp |
20 | 25 | 30 | |||||||||||||
Phe | Ile | Ala | |||||||||||||
35 |
<210> 17 <211> 57 <212> PRT <213> unknown <220>
<223> 10C12.7 <400> 17
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | val | Gin | Glu | Lys | Leu |
1 | 5 | 10 | 15 | ||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | ser | val | Ile | Phe |
20 | 25 | 30 | |||||||||||||
Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val | Ile |
35 | 40 | 45 | |||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | |||||||
50 | 55 |
<210> 18 <211> 40 <212> PRT <213> Unknown <220>
<223> 14F6.3 <400> 18
Lys | val | Glu | Glu | Pro | Lys | Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu |
1 | 5 | 10 | 15 | ||||||||||||
Ser | Glu | Thr | Gly | Asn | ser | Thr | ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro |
20 | 25 | 30 | |||||||||||||
Thr | Val | Asp | Pro | Val | Gin | Glu | Lys | ||||||||
35 | 40 |
<210> 19 <211> 78 <212> PRT <213> Unknown <22O>
<223> B12D8.2 <400> 19
Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | ile | Met |
1 | 5 | 10 | 15 | ||||||||||||
Lys | Gin | Tyr | Gly | Val | Lys | Arg | Glu | ser | Ile | Val | Val | Asn | Lys | Glu | Lys |
20 | 25 | 30 | |||||||||||||
Asn | Ala | Ile | Ile | Tyr | Pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | ile |
35 | 40 | 45 | |||||||||||||
Asp | Glu | Hi S | Lys | Pro | val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu |
50 | 55 | 60 | |||||||||||||
Leu | Phe | Lys | Pro | Glu | Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | ||
65 | 70 | 75 |
<210> 20 <211> 51 <212> PRT <213> Unknown <220>
• ·
401 <223> 7F4.1 <400> 20
Ala | Ile | ile | Tyr | Pro | Hi s | Gly | Asp | His | His | HÍS | Ala | Asp | Pro | Ile | Asp |
1 | 5 | 10 | 15 | ||||||||||||
Glu | His | Lys | Pro | val | Gly | Ile | Gly | His | Ser | HÍS | Ser | Asn | Tyr | Glu | Leu |
20 | 25 | 30 | |||||||||||||
Phe | Lys | Pro | Glu | Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr |
35 | 40 | 45 | |||||||||||||
Thr | Gly | Glu | |||||||||||||
50 |
<210> 21 <211> 29 <212> PRT <213> Unknown <220>
<223> 1OD7.5 <400> 21
Ile Gin val Ala Lys Leu Ala Gly Lys Tyr Thr Thr Glu Asp Gly Tyr 15 10 15 ile Phe Asp Pro Arg Asp ile Thr Ser Asp Glu Gly Asp 20 25 <210> 22 <211> 86 <212> PRT <213> Unknown <22O>
<223> 10G9.3 and 10A2.2 and B11B8.1 <400> 22
Asp | Hi s | Gin | Asp | ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile |
1 | 5 | 10 | 15 | ||||||||||||
Tyr | Asn | Arg | Val | Lys | Ala | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro |
20 | 25 | 30 | |||||||||||||
Tyr | Asn | Leu | Gin | Tyr | Thr | val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile |
35 | 40 | 45 | |||||||||||||
Pro | His | Tyr | Asp | His | Tyr | His | Asn | ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu |
50 | 55 | 60 | |||||||||||||
Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala |
65 | 70 | 75 | 80 | ||||||||||||
Thr | val | Lys | Tyr | Tyr | val | ||||||||||
85 |
<210> 23 <211> 41 <212> PRT <213> Unknown <220>
<223> 11B8.4 <400> 23
Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Thr | Val | Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | Hi s | Ser | Asp |
20 | 25 | 30 | |||||||||||||
Asn | Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | |||||||
35 | 40 |
<210> 24 <211> 69 <212> PRT <213> Unknown • · · ·
<220>
<223> 3A4.1 <400> 24
Val | Glu | Asn | Ser | Val | ile | Asn | Ala | Lys | Ile | Ala | Asp | Ala | Glu | Ala | Leu |
1 | Glu | 5 | 10 | 15 | |||||||||||
Leu | Lys | val | Thr | Asp | Pro | Ser | ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | |
Thr | Gly | 20 | 25 | 30 | |||||||||||
Leu | Leu | Lys | Ser | ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | ||
35 | 40 | 45 | |||||||||||||
Thr | ile | ser | Ala | Glu | Val | Asp | ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser |
50 | 55 | 60 | |||||||||||||
Gin | Pro | Ala | pro | ile | |||||||||||
65 |
<210> 25 <211> 27 <212> DNA <213> Unknown <220>
<223> OCRR 479 <400> 25 cagtagatct gtgcctatgc actaaac 27 <210> 26 <211> 33 <212> DNA <213> Unknown <220>
<223> OCRR 480 <400> 26 gatctctaga ctactgctat tccttacgct atg 33 <210> 27 <211> 30 <212> DNA <213> Unknown <220>
<223> OCRR 497 <400> 27 atcactcgag cattacctgg ataatcctgt 30 <210> 28 <211> 26 <212> DNA <213> Unknown <220>
<223> OCRR 498 <400> 28 ctgctaagct tatgaaagat ttagat 26 <210> 29 <211> 24 <212> DNA <213> Unknown <220>
<223> OCRR 499 • · · · <400> 29 gatactcgag ctgctattcc ttac 24 <210> 30 <211> 28 <212> DNA <213> Unknown <220>
<223> HAM3 172 <400> 30 gaatctcgag ttaagctgct gctaattc 28 <210> 31 <211> 32 <212> DNA <213> unknown <220>
<223> HAM3 247 <400> 31 gacgctcgag cgctatgaaa tcagataaat tc 32 <210> 32 <211> 37 <212> DNA <213> Unknown <220>
<223> HAM3 248 <400> 32 gacgctcgag ggcattacct ggataatcct gttcatg 37 <210> 33 <211> 33 <212> DNA <213> Unknown <22O>
<223> HAM3 249 <400> 33 cagtagatct cttcatcatt tattgaaaag agg 33 <210> 34 <211> 40 <212> DNA <213> Unknown <220>
<223> HAM3 278 <400> 34 ttatttcttc catatggact tgacagaaga gcaaattaag 40 <210> 35 <211> 32 <212> DNA <213> Unknown <220>
<223> HAM3 279 <400> 35 cgccaagctt cgctatgaaa tcagataaat tc • · · · • · • · · ·
405* <210> 36 <211> 34 <212> DNA <213> Unknown <22O>
<223> HAMJ 280 <400> 36 cgccaagctt ttccacaata taagtcgatt gatt 34 <210> 37 <211> 40 <212> DNA <213> Unknown <220>
<223> HAMJ 281 <400> 37 ttatttcttc catatggaag tacctatctt ggaaaaagaa 40 <210> 38 <211> 37 <212> DNA <213> Unknown <220>
<223> HAMJ 300 <400> 38 ttatttcttc catatggtgc ctatgcacta aaccagc 37 <210> 39 <211> 40 <212> DNA <213> Unknown <22O>
<223> HAMJ 313 <400> 39 ataagaatgc ggccgcttcc acaatataag tcgattgatt 40 <210> 40 <211> 31 <212> DNA <213> unknown <220>
<223> OCRR 487 <400> 40 cagtagatct gtgcttatga actaggtttg c 31 <210> 41 <211> 32 <212> DNA <213> Unknown <220>
<223> OCRR 488 <400> 41 gatcaagctt gctgctacct ttacttactc tc 32 <210> 42 • · • · · · • ·
40C <211> 26 <212> DNA <213> Unknown <220>
<223> HAMJ 171 <400> 42 ctgagatatc cgttatcgtt caaacc 26 <210> 43 <211> 28 <212> DNA <213> unknown <220>
<223> HAMJ 251 <400> 43 ctgcaagctt ttaaagggga ataatacg 28 <210> 44 <211> 29 <212> DNA <213> Unknown <220>
<223> HAMJ 264 <400> 44 cagtagatct gcagaagcct tcctatctg 29 <210> 45 <211> 33 <212> DNA <213> unknown <220>
<223> HAMJ 282 <400> 45 tcgccaagct tcgttatcgt tcaaaccatt ggg 33 <210> 46 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 283 <400> 46 ataagaatgc ggccgcctta ctctccttta ataaagccaa tagtt 45 <210> 47 <211> 34 <212> DNA <213> Unknown <220>
<223> HAMJ 284 <400> 47 catgccatgg acattgatag tctcttgaaa cagc 34 <210> 48 <211> 37 <212> DNA • · · · • · · · dob <213> Unknown <220>
<223> HAMJ 285 <400> 48 cgccaagctt cttactctcc tttaataaag ccaatag 37 <210> 49 <211> 31 <212> DNA <213> unknown <220>
<223> HAMJ 286 <400> 49 cgacaagctt aacatggtcg ctagcgttac c 31 <210> 50 <211> 30 <212> DNA <213> Unknown <220>
<223> HAMJ 287 <400> 50 cataccatgg gcctttatga ggcacctaag 30 <210> 51 <211> 34 <212> DNA <213> Unknown <220>
<223> HAMJ 288 <400> 51 cgacaagctt aagtaaatct tcagcctctc tcag 34 <210> 52 <211> 31 <212> DNA <213> Unknown <220>
<223> HAMJ 289 <400> 52 gataccatgg ctagcgacca tgttcaaaga a 31 <210> 53 <211> 36 <212> DNA <213> Unknown <220>
<223> HAMJ 290 <400> 53 cgccaagctt atcatccact aacttgactt tatcac 36 <210> 54 <211> 33 <212> DNA <213> Unknown • · > ♦ » · • · ·
40S <220>
<223> HAMJ 291 <400> 54 cataccatgg atattcttgc cttcttagct ccg <210> 55 <211> 30 <212> DNA <213> Unknown <220>
<223> HAMJ 301 <400> 55 catgccatgg tgcttatgaa ctaggtttgc <210> 56 <211> 32 <212> DNA <213> Unknown <22O>
<223> HAMJ 302 <400> 56 cgccaagctt tagcgttacc aaaaccatta tc <210> 57 <211> 36 <212> DNA <213> Unknown <22O>
<223> HAMJ 160 <400> 57 gtattagatc tgttcctatg aacttggtcg tcacca <210> 58 <211> 28 <212> DNA <213> Unknown <22O>
<223> HAMJ 186 <400> 58 cgcctctaga ctactgtata ggagccgg <210> 59 <211> 34 <212> DNA <213> Unknown <220>
<223> HAMJ 292 <400> 59 catgccatgg aaaacatttc aagcctttta cgtg <210> 60 <211> 34 <212> DNA <213> Unknown <220>
<223> HAMJ 293 • · · 9 · · • ·
<400> 60 cgacaagctt ctgtatagga gccggttgac tttc 34 <210> 61 <211> 34 <212> DNA <213> Unknown <220>
<223> HAMJ 294 <400> 61 catgccatgg ttcgtaaaaa taaggcagac caag 34 <210> 62 <211> 30 <212> DNA <213> Unknown <22O>
<223> HAMJ 297 <400> 62 catgccatgg aagcctattg gaatgggaag 30 <210> 63 <211> 31 <212> DNA <213> Unknown <22O>
<223> HAMJ 352 <400> 63 catgccatgg aagcctattg gaatgggaag c 31 <210> 64 <211> 31 <212> DNA <213> Unknown <220>
<223> HAMJ 353 <400> 64 cgccaagctt gtaggtaatt tgcgcatttg g 31 <210> 65 <211> 30 <212> DNA <213> Unknown <22O>
<223> HAMJ 354 <400> 65 cgccaagctt ctgtatagga gccggttgac 30 <210> 66 <211> 32 <212> DNA <213> Unknown <220>
<223> HAMJ 355 <400> 66 <· ·· ν· «· 9 9f • ·· ’
I ♦*
4Ί0 catgccatgg atattcttgc cttcttagct cc 32 <210> 67 <211> 38 <212> DNA <213> unknown <220>
<223> HAMJ 404 <400> 67 ttatttcttc catatgcatg gtgatcattt ccattaca 38 <210> 68 <211> 34 <212> DNA <213> Unknown <220>
<223> HAMJ 464 <400> 68 gatgcatatg aatatgcaac cgagtcagtt aagc 34 <210> 69 <211> 31 <212> DNA <213> Unknown <220>
<223> HAMJ 465 <400> 69 gatgctcgag agcatcaaat ccgtatccat c 31 <210> 70 <211> 31 <212> DNA <213> Unknown <220>
<223> HAMJ 466 <400> 70 gatgcatatg gatcatttcc attacattcc a 31 <210> 71 <211> 30 <212> DNA <213> Unknown <220>
<223> HAMJ 467 <400> 71 gacaagcttg gcattacctg gataatcctg 30 <210> 72 <211> 31 <212> DNA <213> Unknown <220>
<223> HAMJ 352 <400> 72 catgccatgg aagcctattg gaatgggaag c • · · · · · • · · · · • · · · · · · • · · · • · · · · · · 44Ί <210> 73 <211> 38 <212> DNA <213> Unknown <220>
<223> HAMJ 470 <400> 73 ataagaatgc ggccgccgct atgaaatcag ataaattc <210> 74 <400> 74 000 <210> 75 <400> 75 000 <210> 76 <400> 76 000 <210> 77 <400> 77 000 <210> 78 <400> 78 000 <210> 79 <400> 79 000 <210> 80 <400> 80 000 <210> 81 <400> 81 000 <210> 82 <400> 82 000 <210> 83 <400> 83 000 <210> 84 <400> 84 000 <210> 85
<400> 85 000 <210> 86 <400> 86 000 <210> 87 <400> 87
000 | |
<210> | 88 |
<400> 000 | 88 |
<210> | 89 |
<400> 000 | 89 |
<210> | 90 |
<400> 000 | 90 |
<210> | 91 |
<400> 000 | 91 |
<210> | 92 |
<400> 000 | 92 |
<210> | 93 |
<400> 000 | 93 |
<210> | 94 |
<400> 000 | 94 |
<210> | 95 |
<400> 000 | 95 |
<210> | 96 |
<400> 000 | 96 |
<210> | 97 |
<400> 000 | 97 |
<210> | 98 |
<400> 000 | 98 |
• · · ·
443 <210> 99 <400> 99 000 <210> 100 <400> 100 000 <210> 101 <400> 101 000 <210> 102 <400> 102 000 <210> 103 <400> 103 000 <210> 104 <400> 104 000 <210> 105 <400> 105 000 <210> 106 <400> 106 000 <210> 107 <400> 107 000 <210> 108 <400> 108 000 <210> 109 <400> 109 000 <210> 110 <400> 110 000 <210> 111 <400> 111 000 <210> 112 <400> 112 • ·· ·· ···· ·· ···· • · · · · · · · · ·
000 <210> 113 <400> 113 000 <210> 114 <400> 114 000 <210> 115 <400> 115 000 <210> 116 <400> 116 000 <210> 117 <400> 117 000 <210> 118 <400> 118 000 <210> 119 <400> 119 000 <210> 120 <400> 120 000 <210> 121 <400> 121 000 <210> 122 <400> 122 000 <210> 123 <400> 123 000 <210> 124 <400> 124 000 <210> 125 <400> 125
000 <210> 126
<400> 126 000 <210> 127 <400> 127 000 <210> 128 <400> 128 000
<210> 129 | |
<400> 000 | 129 |
<210> | 130 |
<400> 000 | 130 |
<210> | 131 |
<400> 000 | 131 |
<210> | 132 |
<400> 000 | 132 |
<210> | 133 |
<400> 000 | 133 |
<2io> : | 134 |
<400> 134 000 <210> 135 <400> 135 000
<210> | 136 |
<400> 000 | 136 |
<210> | 137 |
<400> 000 | 137 |
<210> | 138 |
<400> 000 | 138 |
<210> | 139 |
<400> 000 | 139 |
I « · · I
44C
<210> | 140 |
<400> 000 | 140 |
<210> | 141 |
<400> 000 | 141 |
<210> | 142 |
<400> 000 | 142 |
<210> | 143 |
<400> | 143 |
000 <210> 144 <400> 144 000 <210> 145 <400> 145 000 <210> 146 <400> 146 000 <210> 147 <400> 147 000 <210> 148 <400> 148 000 <210> 149 <400> 149 000 <210> 150 <400> 150 000 <210> 151 <400> 151 000 <210> 152 <400> 152
000 <210> 153 ·« ·· ···· ♦ · ♦ · * <400> 153 000 <210> 154 <400> 154 000 <210> 155 <400> 155 000 <210> 156 <400> 156 000 <210> 157 <400> 157
000 <210> 158 <400> 158
000 <210> 159 <400> 159
000 <210> 160 <400> 160
000 <210> 161 <400> 161
000 <210> 162 <400> 162
000 <210> 163 <211> 22 <212> PRT <213> unknown <220>
<223> Mab H11-B-11B8 target epitope <400> 163
Gly Leu Tyr Glu Ala Pro Lys Gly Tyr Ser Leu Glu Asp Leu Leu Ala 15 10 15
Thr val Lys Tyr Tyr Val 20 <210> 164 <400> 164
000 <210> 165 <400> 165 000 <210> 166 <400> 166 000 <210> 167 <400> 167 000 <210> 168 <211> 34 <212> DNA <213> Unknown <220>
<223> HAMJ 471 <400> 168 atatgggccc ctgtatagga gccggttgac tttc 34 <210> 169 <211> 34 <212> DNA <213> unknown <220>
<223> HAMJ 472 <400> 169 atatgggccc aatatgcaac cgagtcagtt aagc 34 <210> 170 <211> 31 <212> DNA <213> Unknown <22O>
<223> HAMJ 350 <400> 170 atatgggccc aacatggtcg ctagcgttac c 31 <210> 171 <211> 34 <212> DNA <213> Unknown <22O>
<223> HAMJ 351 <400> 171 tcccgggccc gacttgacag aagagcaaat taag 34 <210> 172 <211> 34 <212> DNA <213> Unknown <220>
<223> HAMJ 358 <400> 172 catgccatgg gacttgacag aagagcaaat taag 34 • · <210> 173 <211> 32 <212> DNA <213> Unknown <220>
<223> HAMJ 359 <400> 173 tcccgggccc cgctatgaaa tcagataaat tc 32 <210> 174 <211> 35 <212> DNA <213> Unknown <220>
<223> HAMJ 403 <400> 174 atatgggccc gacattgata gtctcttgaa acagc 35 <210> 175 <211> 31 <212> DNA <213> Unknown <22O>
<223> HAMJ 361 <400> 175 cgccaagctt aacatggtcg ctagcgttac c 31 <210> 176 <211> 37 <212> DNA <213> Unknown <220>
<223> HAMJ 483 <400> 176 atatgggccc cttactctcc tttaataaag ccaatag 37 <210> 177 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 513 <400> 177 gaatcaggtt ttgtcatgag ttccggagac cacaatcatt atttc 45 <210> 178 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 514 <400> 178 gaaataatga ttgtggtctc cggaactcat gacaaaacct gattc 45 <210> 179 • ·
49/0 <211> 43 <212> DNA <213> Unknown <220>
<223> HAMJ 515 <400> 179 gtcatgagtt ccggagactc caatcattat ttcttcaaga agg 43 <210> 180 <211> 43 <212> DNA <213> Unknown <220>
<223> HAMJ 516 <400> 180 ccttcttgaa gaaataatga ttggagtctc cggaactcat gac 43 <210> 181 <211> 44 <212> DNA <213> Unknown <22O>
<223> HAMJ 517 <400> 181 atgagttcgg agactccaat tcttatttct tcaagaagga cttg 44 <210> 182 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 518 <400> 182 caagtccttc ttgaagaaat aagaattgga gtctccggaa ctcat 45 <210> 183 <211> 35 <212> DNA <213> Unknown <220>
<223> CHÁN 51 <400> 183 gcgattattt atccgtctgg agatcaccat catgc 35 <210> 184 <211> 35 <212> DNA <213> Unknown <220>
<223> CHÁN 52 <400> 184 gcatgatggt gatctccaga cggataaata atcgc 35 <210> 185 <211> 30 <212> DNA
<213> Unknown <220>
<223> CHÁN 53 <400> 185 ccgtctggag atggccatca tgcagatccg 30 <210> 186 <211> 30 <212> DNA <213> Unknown <220>
<223> CHÁN 54 <400> 186 cggatctgca tgatggccat ctccagacgg 30 <210> 187 <211> 34 <212> DNA <213> Unknown <220>
<223> CHÁN 47 <400> 187 ccgcagggag ataagcgtca tgcagatccg attg 34 <210> 188 <211> 34 <212> DNA <213> Unknown <220>
<223> CHÁN 48 <400> 188 caatcggatc tgcatgacgc ttatctccct gcgg 34 <210> 189 <211> 34 <212> DNA <213> Unknown <220>
<223> CHÁN 55 <400> 189 ccgtctggag atggcactca tgcagatccg attg 34 <210> 190 <211> 34 <212> DNA <213> Unknown <220>
<223> CHÁN 56 <400> 190 caatcggatc tgcatgagtg ccatctccag acgg 34 <210> 191 <211> 37 <212> DNA <213> Unknown • « · ♦ ♦ · •χπ.
<220>
<223> CHAN 57 <400> 191 ccgtctggag atggcacttc tgcagatccg attgatg 37 <210> 192 <211> 37 <212> DNA <213> Unknown <220>
<223> CHAN 58 <400> 192 catcaatcgg atctgcagaa gtgccatctc cagacgg 37 <210> 193 <211> 30 <212> DNA <213> Unknown <220>
<223> HAMJ 523 <400> 193 ccgcatggag atggccatca tgcagatccg 30 <210> 194 <211> 30 <212> DNA <213> Unknown <220>
<223> HAMJ 524 <400> 194 cggatctgca tgatggccat ctccatgcgg 30 <210> 195 <211> 43 <212> DNA <213> Unknown <220>
<223> HAMJ 526 <400> 195 gtcatgagtc acggagactc caatcattat ttcttcaaga agg 43 <210> 196 <211> 43 <212> DNA <213> Unknown <22O>
<223> HAMJ 527 <400> 196 ccttcttgaa gaaataatga ttggagtctc cgtgactcat gac 43 <210> 197 <211> 45 <212> DNA <213> unknown <220>
<223> HAMJ 528 .:. ..· ·· ··
ΛΜ>
<400> 197 atgagtcacg gagaccacaa ttcttatttc ttcaagaagg acttg 45 <210> 198 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 529 <400> 198 caagtccttc ttgaagaaat aagaattgtg gtctccgtga ctcat 45 <210> 199 <211> 45 <212> DNA <213> Unknown <22O>
<223> HAMJ 569 <400> 199 tacctcatta tgactcttac tctaacatca aatttgagtg gtttg 45 <210> 200 <211> 45 <212> DNA <213> Unknown <22O>
<223> HAMJ 570 <400> 200 caaaccactc aaatttgatg ttagagtaag agtcataatg aggta 45 <210> 201 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 571 <400> 201 taccttctta tgaccattac tctaacatca aatttgagtg gtttg 45 <210> 202 <211> 44 <212> DNA <213> Unknown <220>
<223> HAMJ 572 <400> 202 aaaccactca aatttgatgt tagagtaatg gtcataagaa ggta 44 <210> 203 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 573 <400> .203 • · • · « ·
9 9 9
aacggtagtt taatcatacc ttctaaagac cattaccata acatc 45 <210> 204 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 574 <400> 204 gatgttatgg taatggtctt tagaaggtat gattaaacta ccgtt 45 <210> 205 <211> 46 <212> DNA <213> Unknown <220>
<223> HAMJ 575 <400> 205 cggtagttta atcatacctc ataaggactc ttaccataac atcaaa 46 <210> 206 <211> 46 <212> DNA <213> unknown <220>
<223> HAMJ 576 <400> 206 tttgatgtta tggtaagagt ccttatgagg tatgattaaa ctaccg 46 <210> 207 <211> 46 <212> DNA <213> Unknown <22O>
<223> HAMJ 577 <400> 207 aacggtagtt taatcatacc tgaccattac cataacatca aatttg 46 <210> 208 <211> 46 <212> DNA <213> Unknown <220>
<223> HAMJ 578 <400> 208 caaatttgat gttatggtaa tggtcaggta tgattaaact accgtt 46 <210> 209 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 579 <400> 209 aacggtagtt taatcatacc ttaccataac atcaaatttg agtgg 45
• · · · ·· ··
415 <210> 210 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 580 <400> 210 ccactcaaat ttgatgttat ggtaaggtat gattaaacta ccgtt 45 <210> 211 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 581 <400> 211 accggtagtt taatcatacc taacatcaaa tttgagtggt ttgac 45 <210> 212 <211> 45 <212> DNA <213> Unknown <22O>
<223> HAMJ 582 <400> 212 gtcaaaccac tcaaatttga tgttaggtat gattaaacta ccgtt 45 <210> 213 <211> 35 <212> DNA <213> Unknown <220>
<223> HAMJ 536 <400> 213 cctatgtaac tccacatata acccatagcc actgg 35 <210> 214 <211> 35 <212> DNA <213> Unknown <220>
<223> HAMJ 537 <400> 214 ccagtggcta tgggttatat gtggagttac atagg 35 <210> 215 <211> 36 <212> DNA <213> Unknown <220>
<223> HAMJ 550 <400> 215 cgtgaaagta ttgtcgtaaa taaagaaaaa aatgcg 36 <210> 216 <211> 36
4tC <212> DNA <213> Unknown <220>
<223> HAMJ 551 <400> 216 cgcatttttt tctttattta cgacaatact ttcacg 36 <210> 217 <211> 49 <212> DNA <213> Unknown <220>
<223> HAMJ 586 <400> 217 catgaagaag atggttacgg tttcgatgct aaccgtatta tcgctgaag 49 <210> 218 <211> 48 <212> DNA <213> Unknown <220>
<223> HAMJ 587 <400> 218 ‘ cttcagcgat aatacggtta gcatcgaaac cgtaaccatc ttcttctg 48 <210> 219 <211> 42 <212> DNA <213> Unknown <220>
<223> HAMJ 588 <400> 219 gaatcaggtt ttgtcatgag tgaccacaat cattatttct tc 42 <210> 220 <211> 42 <212> DNA <213> Unknown <220>
<223> HAMJ 589 <400> 220 gaagaaataa tgattgtggt cactcatgac aaaacctgat tc 42 <210> 221 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 590 <400> 221 gaagatgaat caggttttgt catgagtaat cattatttct tcaag 45 <210> 222 <211> 45 <212> DNA <213> Unknown
<220>
<223> HAMJ 591 <400> 222 cttgaagaaa taatgattac tcatgacaaa acctgattca tcttc 45 <210> 223 <211> 45 <212> DNA <213> Unknown <22O>
<223> HAMJ 592 <400> 223 gaagatgaat caggttttgt catgagttat ttcttcaaga aggac 45 <210> 224 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 593 <400> 224 gtccttcttg aagaaataac tcatgacaaa acctgattca tcttc 45 <210> 225 <211> 42 <212> DNA <213> Unknown <22O>
<223> HAMJ 594 <400> 225 aaaatgcgat tatttatccg caccatcatg cagatccgat tg 42 <210> 226 <211> 42 <212> DNA <213> Unknown <22O>
<223> HAMJ 595 <400> 226 caatcggatc tgcatgatgg tgcggataaa taatcgcatt tt 42 <210> 227 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 600 <400> 227 aaaatgcgat tatttatccg gcagatccga ttgatgaaca taaac 45 <210> 228 <211> 45 <212> DNA <213> Unknown <220>
• 9 · · · · • · · · · ·
41» <223> HAMJ 601 <400> 228 gtttatgttc atcaatcgga tctgccggat aaataatcgc atttt 45 <210> 229 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 604 <400> 229 gatgctaacc gtataatcgc cgaagacgaa tcaggttttg tcatg 45 <210> 230 <211> 45 <212> DNA <213> Unknown <22O>
<223> HAMJ 605 <400> 230 catgacaaaa cctgattcgt cttcggcgat tatacggtta gcatc 45 <210> 231 <211> 43 <212> DNA <213> Unknown <220>
<223> HAMJ 606 <400> 231 cgccgaagac gaatccggct ttgtaatgag tcacggagac tcc 43 <210> 232 <211> 43 <212> DNA <213> Unknown <22O>
<223> HAMJ 607 <400> 232 ggagtctccg tgactcatta caaagccgga ttcgtcttcg gcg 43 <210> 233 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 608 <400> 233 catctcatga acaggattat cccggcaacg ccaaagaaat gaaag 45 <210> 234 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 609 • » ♦ · * · • · · · · · <400> 234 ctttcatttc tttggcgttg ccgggataat cctgttcatg agatg <210> 235 <211> 569 <212> PRT <213> Unknown <220>
<223> NEW 1 <400> 235
Met 1 | Asp Leu Thr | Glu Glu Gin Ile Lys Ala | Ala Gin Lys | His | Leu 15 | Glu | |||||||||
5 | 10 | ||||||||||||||
Glu | val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | HiS | Glu |
20 | 25 | 30 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
35 | 40 | 45 | |||||||||||||
ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg |
50 | 55 | 60 | |||||||||||||
Glu | Ser | ile | val | val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | pro | His |
65 | 70 | 75 | 80 | ||||||||||||
Gly | Asp | His | His | His | Ala | ASp | Pro | Ile | Asp | Glu | His | Lys | Pro | val | Gly |
85 | 90 | 95 | |||||||||||||
Ile | Gly | His | Ser | His | ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
100 | 105 | 110 | |||||||||||||
val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
115 | 120 | 125 | |||||||||||||
Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
130 | 135 | 140 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
145 | 150 | 155 | 160 | ||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | val | Lys | Leu | Ile | Thr | Pro |
165 | 170 | 175 | |||||||||||||
Asp | Gly | Lys | val | Leu | Glu | Lys | val | Ser | Gly | Lys | val | Phe | Gly | Glu | Gly |
180 | 185 | 190 | |||||||||||||
val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
195 | 200 | 205 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | val | ser |
210 | 215 | 220 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
245 | 250 | 255 | |||||||||||||
Val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val | Arg |
260 | 265 | 270 | |||||||||||||
val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
275 | 280 | 285 | |||||||||||||
Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
290 | 295 | 300 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
305 | 310 | 315 | 320 | ||||||||||||
Leu | Asp | Asn | Gin | Ser | Thr | Tyr | ile | val | Gl u | Val | pro | ile | Leu | Glu | Lys |
325 | 330 | 335 | |||||||||||||
Gl u | Asn | Gin | Thr | Asp | Lys | Pro | ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
340 | 345 | 350 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | ASp | Glu | Lys | val | Glu | Glu | Pro | Lys |
355 | 360 | 365 | |||||||||||||
Thr | Ser | Glu | Lys | Val | Gl u | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser |
370 | 375 | 380 | |||||||||||||
Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | val | Asp | Pro | Val | Gin |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
405 | 410 | 415 | |||||||||||||
Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Gl u | Leu | Tyr | Leu | Pro | Ser | Gly |
420 | 425 | 430 | |||||||||||||
Gl u | val | ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
435 | 440 | 445 |
«« * • · • » · • « • · · ·· ·· ·· ····
Gly Asn 450 | Gly Glu | Asn | Lys | Pro Ser Glu Asn Gly Lys Val | Ser | Thr | Gly | ||||||||
455 | 460 | ||||||||||||||
Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro |
465 | 470 | 475 | 480 | ||||||||||||
Glu | Ala | pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
Gly | 485 | 490 | 495 | ||||||||||||
Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu | Asp | |
500 | 505 | 510 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu | Lys | Leu |
515 | 520 | 525 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | Phe |
530 | 535 | 540 | |||||||||||||
Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val | ile |
545 | 550 | 555 | 560 | ||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | |||||||
565 |
<210> | 236 |
<400> 000 | 236 |
<210> | 237 |
<400> 000 | 237 |
<210> | 238 |
<400> 000 | 238 |
<210> | 239 |
<400> 000 | 239 |
<210> | 240 |
<400> 000 | 240 |
<210> | 241 |
<400> 000 | 241 |
<210> | 242 |
<400> 000 | 242 |
<210> | 243 |
<400> 000 | 243 |
<210> | 244 |
<400> 000 | 244 |
<210> | 245 |
<400> 000 | 245 |
<210> 246 η · · · * * ·· ♦»··
♦ * • · * • · · · • · · »· ··
<400> 000 | 246 |
<210> | 247 |
<400> 000 | 247 |
<210> | 248 |
<400> 000 | 248 |
<210> | 249 |
<400> 000 | 249 |
<210> | 250 |
<400> 000 | 250 |
<210> | 251 |
<400> 000 | 251 |
<210> | 252 |
<400> 000 | 252 |
<210> | 253 |
<400> 000 | 253 |
<210> | 254 |
<400> 000 | 254 |
<210> <211> <212> <213> | 255 569 PRT Unknown |
<220> <223> | NEW 1 |
<400> | 255 |
Met | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
1 | 5 | 10 | 15 | ||||||||||||
Glu | val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu |
20 | 25 | 30 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Al a | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
35 | 40 | 45 | |||||||||||||
Ile | Glu | Glu | Lys | ile | Ala | Gly | ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg |
50 | 55 | 60 | |||||||||||||
Glu | Ser | Ile | val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | His |
65 | 70 | 75 | 80 | ||||||||||||
Gly | Asp | His | His | Hi s | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | val | Gly |
85 | 90 | 95 | |||||||||||||
Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
100 | 105 | 110 | |||||||||||||
Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
• · · · a ·
115 | 120 | 125 | |||||||||||||
Asn | val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
130 | 135 | 140 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | ser | Phe | Ser | Phe | Pro | Pro | Glu |
145 | 150 | 155 | 160 | ||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr | Pro |
165 | 170 | 175 | |||||||||||||
Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | val | Phe | Gly | Glu | Gly |
180 | 185 | 190 | |||||||||||||
val | Gly | Asn | ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
195 | 200 | 205 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | val | Ser |
210 | 215 | 220 | |||||||||||||
Tyr | ASp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Gin | Thr | ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
245 | 250 | 255 | |||||||||||||
Val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg |
260 | 265 | 270 | |||||||||||||
Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
275 | 280 | 285 | |||||||||||||
val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
290 | 295 | 300 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | ile | Pro | Val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
305 | 310 | 315 | 320 | ||||||||||||
Leu | Asp | Asn | Gin | Ser | Thr | Tyr | ile | val | Glu | val | Pro | ile | Leu | Glu | Lys |
325 | 330 | 335 | |||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | ile | Leu | pro | Gin | Phe | Lys | Arg | Asn |
340 | 345 | 350 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu | Pro | Lys |
355 | 360 | 365 | |||||||||||||
Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser |
370 | 375 | 380 | |||||||||||||
Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro | Val | Gin |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
405 | 410 | 415 | |||||||||||||
val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
420 | 425 | 430 | |||||||||||||
Gl u | val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
435 | 440 | 445 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | ser | Glu | Asn | Gly | Lys | val | Ser | Thr | Gly |
450 | 455 | 460 | |||||||||||||
Thr | val | Glu | Asn | Gl n | Pro | Thr | Glu | Asn | Lys | Pro | Al a | Asp | Ser | Leu | Pro |
465 | 470 | 475 | 480 | ||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
485 | 490 | 495 | |||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met | Leu | Asp |
500 | 505 | 510 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Al a | Val | Asp | Pro | val | Gin | Gl u | Lys | Leu |
515 | 520 | 525 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | Phe |
530 | 535 | 540 | |||||||||||||
Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val | Ile |
545 | 550 | 555 | 560 | ||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | |||||||
565 |
<210> 256 <211> 569 <212> PRT <213> Unknown <220>
<223> NEW 35A <400> 256
Met Asp Leu Thr Glu Glu Gin ile Lys Ala Ala Gin Lys His Leu Glu • · · · • « • · · ·
1 | 5 | 10 | 15 | ||||||||||||
Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | ser | Ser | His | Glu |
Gin | 20 | 25 | 30 | ||||||||||||
Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | |
35 | 40 | 45 | |||||||||||||
Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg |
50 | 55 | 60 | |||||||||||||
Glu | Ser | Ile | val | val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | ile | Tyr | Pro | Ser |
65 | 70 | 75 | 80 | ||||||||||||
Gly | Asp | Gly | Thr | Ser | Ala | Asp | Pro | ile | Asp | Glu | His | Lys | Pro | Val | Gly |
85 | 90 | 95 | |||||||||||||
Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
100 | 105 | 110 | |||||||||||||
val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
115 | 120 | 125 | |||||||||||||
Asn | val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
130 | 135 | 140 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
145 | 150 | 155 | 160 | ||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr | Pro |
165 | 170 | 175 | |||||||||||||
Asp | Gly | Lys | val | Leu | Glu | Lys | val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly |
180 | 185 | 190 | |||||||||||||
val | Gly | Asn | ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
195 | 200 | 205 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | val | Ser |
210 | 215 | 220 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | ser | Leu | Ala | Tyr | Lys | Met | Ala |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Gin | Thr | Ile | Phe | Tyr | Pro | phe | Hi s | Al a | Gly | Asp | Thr | Tyr | Leu | Arg |
245 | 250 | 255 | |||||||||||||
Val | Asn | Pro | Gl n | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg |
260 | 265 | 270 | |||||||||||||
Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
275 | 280 | 285 | |||||||||||||
Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
290 | 295 | 300 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | ile | Pro | Val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
305 | 310 | 315 | 320 | ||||||||||||
Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | ile | Leu | Glu | Lys |
325 | 330 | 335 | |||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
340 | 345 | 350 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | ser | Lys | Leu | Asp | Glu | Lys | val | Glu | Glu | Pro | Lys |
355 | 360 | 365 | |||||||||||||
Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser |
370 | 375 | 380 | |||||||||||||
Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | Val | Asp | Pro | Val | Gin |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
405 | 410 | 415 | |||||||||||||
val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
420 | 425 | 430 | |||||||||||||
Glu | val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
435 | 440 | 445 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | ser | Thr | Gly |
450 | 455 | 460 | |||||||||||||
Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro |
465 | 470 | 475 | 480 | ||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
485 | 490 | 495 | |||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu | Asp |
500 | 505 | 510 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | val | Gin | Glu | Lys | Leu |
515 | 520 | 525 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | val | Ile | Phe |
530 | 535 | 540 | |||||||||||||
Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val | Ile |
• · · ·
ns
545 550 ' 555 _
Lys Lys Asn Leu Ser Asp Phe Ile Ala
565 <210> 257 <211> 819 <212> DNA <213> Unknown <220>
<223> NEW43 gene <400> 257 atgcaaatta cctacactga tgatgagatt caggtagcca agttggcagg acagaagacg gttatatctt tgatactagt tggattaaaa aagatagttt gagagagcgg cagcccaggc ttatgctaaa gagaaaggtt tgacccctcc caccaggatt caggaaatac tgaggcaaaa ggagcagaag ctatctacaa gcagctaaga aggtgccact tgatcgtatg ccttacaatc ttcagtatac aaaaacggta gtttaatcat acctcattat gaccattacc ataacatcaa tttgacgaag gcctttatga ggcacctaag gggtatagtc ttgaggatct gtcaagtact atgtcgaacc gcggaacgct agtgaccatg ttcgtaaaaa caagatagta aacctgatga agataaggaa catgatgaag taagtgagcc gaatctgatg aaaaagagaa tcacgctggt ttaaatcctt cagcagataa ccaagcactg atacggaaga gacagaggaa gaagctgaag ataccacaga attcctggta cccctagtat tagacaaaat gctatggaga cattgactgg agtcttcttc tcggaacgaa agataataac actatttcag cagaagtaga gctttgttaa aagaaagtca accggctcct atacagtag
560 caagtacaca gtctgaagct ttcgacagac ccgcgtgaaa tgtagaagtc atttgagtgg tttggcgact taaggcagac aactcaccct tctttataaa tgaggctgaa tctaaaaagt tagtctcttg
120
180
240
300
360
420
480
540
600
660
720
780
819 <210> 258 <211> 272 <212> PRT <213> Unknown <22O>
<223> NEW43 polypeptide <400> 258
Met | Gin | ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | ile | Tyr | Asn | Arg | val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | val | Lys | Asn | Gly | Ser | Leu | Ile | ile | pro | His | Tyr | ASp | His |
100 | 105 | 110 | |||||||||||||
Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
val | Glu | Pro | Arg | Asn | Ala | Ser | Asp | His | val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu | val | Ser | Glu |
165 | 170 | 175 | |||||||||||||
Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | Hi S | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | ASp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
245 250 255
Asp Ser Leu Leu Ala Leu Leu Lys Glu ser Gin Pro Ala Pro Ile Gin
260 265 270 <210> 259 <211> 36 <212> DNA <213> Unknown <22O>
<223> HAMJ 490 <400> 259
ccgaattcca tatgcaaatt | acctacactg | atgatg | |
<210> | 260 | ||
<211> | 29 | ||
<212> | DNA | ||
<213> | Unknown | ||
<220> | |||
<223> | HAMJ 491 | ||
<400> | 260 | ||
ggactagtat caaagatata | accgtcttc | ||
<210> | 261 | ||
<211> | 33 | ||
<212> | DNA | ||
<213> | Unknown | ||
<220> | |||
<223> | HAMJ 492 | ||
<400> | 261 | ||
ggactagttg gattaaaaaa | gatagtttgt | ctg | |
<210> | 262 | ||
<211> | 32 | ||
<212> | DNA | ||
<213> | Unknown | ||
<220> | |||
<223> | HAMJ 493 | ||
<400> | 262 | ||
ttcccgcggt tcgacatagt | acttgacagt | cg | |
<210> | 263 | ||
<211> | 29 | ||
<212> | DNA | ||
<213> | Unknown | ||
<22O> | |||
<223> | HAMJ 494 | ||
<400> | 263 | ||
ttcccgcgga acgctagtga | ccatgttcg | ||
<210> | 264 | ||
<211> | 31 | ||
<212> | DNA | ||
<213> | Unknown |
<22O>
<223> HAMJ 495 <400> 264 • · · · • · · ·
Ί3( cggggtacca ggaatttcag cctcatctgt g 31 <210> 265 <211> 36 <212> DNA <213> Unknown <220>
<223> HAMJ 496 <400> 265 cccggtaccc ctagtattag acaaaatgct atggag 36 <210> 266 <211> 29 <212> DNA <213> Unknown <22O>
<223> HAMJ 583 <400> 266 ggatcccggg aggtatgatt aaactaccg 29 <210> 267 <211> 34 <212> DNA <213> Unknown <220>
<223> HAMJ 584 <400> 267 catgcccggg aacatcaaat ttgagtggtt tgac 34 <210> 268 <211> 37 <212> DNA <213> Unknown <220>
<223> HAMJ 610 <400> 268 cttgatcgac atatgttggc aggcaagtac acaacag 37 <210> 269 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 497 <400> 269 aacggtagtt taatcatacc ttcttatgac cattaccata acatc 45 <210> 270 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 498 <400> 270 gatgttatgg taatggtcat aagaaggtat gattaaacta ccgtt • ·· ·
• · · • · · • · • · · | • · • · « · • · · • · * · | |
<210> 271 <211> 45 <212> DNA <213> Unknown <220> <223> HAMJ 499 <400> 271 aatcatacct tcttatgact cttaccataa | catcaaattt | gagtg |
<210> 272 <211> 45 <212> DNA <213> Unknown <22O> <223> HAMJ 500 <400> 272 cactcaaatt tgatgttatg gtaagagtca | taagaaggta | tgatt |
<210> 273 <211> 45 <212> DNA <213> Unknown <220> <223> HAMJ 501 <400> 273 taccttctta tgactcttac tctaacatca | aatttgagtg | gtttg |
<210> 274 <211> 45 <212> DNA <213> Unknown <220> <223> HAMJ 502 <400> 274 caaaccactc aaatttgatg ttagagtaag | agtcataaga | aggta |
<210> 275 <211> 45 <212> DNA <213> Unknown <220> <223> HAMJ 530 <400> 275 aatcatacct cattatgact cttaccataa | catcaaattt | gagtg |
<210> 276 <211> 45 <212> DNA <213> Unknown <220> <223> HAMJ 531 <400> 276 cactcaaatt tgatgttatg gtaagagtca | taatgaggta | tgatt |
<210> 277 <211> 45 «« ·· • «
m | • » • · • · · • · • · | |
<212> DNA <213> Unknown <220> <223> HAMJ 532 <400> 277 tacctcatta tgaccattac tctaacatca | aatttgagtg | gtttg |
<210> 278 <211> 45 <212> DNA <213> Unknown <22O> <223> HAMJ 533 <400> 278 caaaccactc aaatttgatg ttagagtaat | ggtcataatg | aggta |
<210> 279 <211> 45 <212> DNA <213> Unknown <220> <223> HAMJ 569 <400> 279 tacctcatta tgactcttac tctaacatca | aatttgagtg | gtttg |
<210> 280 <211> 45 <212> DNA <213> Unknown <220> <223> HAMJ 570 <400> 280 caaaccactc aaatttgatg ttagagtaag | agtcataatg | aggta |
<210> 281 <211> 45 <212> DNA <213> unknown <22O> <223> HAMJ 571 <400> 281 taccttctta tgaccattac tctaacatca | aatttgagtg | gtttg |
<210> 282 <211> 44 <212> DNA <213> unknown <220> <223> HAMJ 572 <400> 282 aaaccactca aatttgatgt tagagtaatg | gtcataagaa | ggta |
• « <210> 283 <211> 45 <212> DNA <213> Unknown ··· · <22Ο>
<223> HAMJ 573 <400> 283 aacggtagtt taatcatacc ttctaaagac cattaccata acatc <210> 284 <211> 45 <212> DNA <213> Unknown <22O>
<223> HAMJ 574 <400> 284 gatgttatgg taatggtctt tagaaggtat gattaaacta ccgtt <210> 285 <211> 46 <212> DNA <213> Unknown <22O>
<223> HAMJ 575 <400> 285 cggtagttta atcatacctc ataaggactc ttaccataac atcaaa <210> 286 <211> 46 <212> DNA <213> Unknown <220>
<223> HAMJ 576 <400> 286 tttgatgtta tggtaagagt ccttatgagg tatgattaaa ctaccg <210> 287 <211> 46 <212> DNA <213> Unknown <220>
<223> HAMJ 577 <400> 287 aacggtagtt taatcatacc tgaccattac cataacatca aatttg <210> 288 <211> 46 <212> DNA <213> Unknown <220>
<223> HAMJ 578 <400> 288 caaatttgat gttatggtaa tggtcaggta tgattaaact accgtt <210> 289 <211> 45 <212> DNA <213> unknown <22O>
• · « · • · 9 99· • 4
<223> HAMJ 579 <400> 289 aacggtagtt taatcatacc ttaccataac atcaaatttg agtgg 45 <210> 290 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 580 <400> 290 ccactcaaat ttgatgttat ggtaaggtat gattaaacta ccgtt 45 <210> 291 <211> 45 <212> DNA <213> Unknown <22O>
<223> HAMJ 581 <400> 291 accggtagtt taatcatacc taacatcaaa tttgagtggt ttgac 45 <210> 292 <211> 45 <212> DNA <213> Unknown <220>
<223> HAMJ 582 <400> 292 gtcaaaccac tcaaatttga tgttaggtat gattaaacta ccgtt 45 <210> 293 <211> 272 <212> PRT <213> Unknown <22O>
<223> NEW 60 <400> 293
Met | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | ser | Trp | ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Al a | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Al a | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | Ser | Tyr | Asp | His |
100 | 105 | 110 | |||||||||||||
Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
val | Glu | Pro | Arg | Asn | Ala | Ser | Asp | His | val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 |
·« ···* «· »···
4Μ
Gin Asp Ser Lys Pro | Asp | Glu | Asp Lys | Glu 170 | His Asp Glu | val | Ser 175 | Glu | |||||||
165 | |||||||||||||||
Pro | Thr | HIS | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Al a | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | Ile | Gin |
260 | 265 | 270 |
<210> 294 <211> 272 <212> PRT <213> Unknown <22Ο>
<223> NEW 61 <400> 294
Met | Gin | ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | Ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr | ASp | Ser |
100 | 105 | 110 | |||||||||||||
Tyr | Hi s | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
val | Glu | Pro | Arg | Asn | Ala | ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | Hi S | Asp | Glu | val | Ser | Glu |
165 | 170 | 175 | |||||||||||||
Pro | Thr | Hi s | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | HIS | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | ser | Gin | Pro | Ala | pro | Ile | Gin |
260 | 265 | 270 |
<210> 295 <211> 272 <212> PRT <213> Unknown <220>
<223> NEW 62 • · · · • · • · ·
• · • · · · · mi | • · | • · | *· ·· | ||||||||||||
<400> 295 | Ala | ||||||||||||||
Met | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | ile | Gin | Val | Ala | Lys | Leu | |
1 | 5 | 10 | 15 | Ile | |||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | ser | Trp | |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | val | Lys |
65 | 70 | 75 | Gin | 80 | |||||||||||
Ala | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Tyr | |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr | ASp | His |
100 | 105 | 110 | |||||||||||||
Tyr | Ser | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Al a | Thr | val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
Val | Glu | Pro | Arg | Asn | Al a | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | ASp | Glu | Val | Ser | Glu |
165 | 170 | 175 | |||||||||||||
Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | HÍS | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | ASp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
225 | 230 | 235 | 240 | ||||||||||||
ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | ser | Ala | Glu | val |
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | Ile | Gin |
260 265 270 <210> 296 <211> 272 <212> PRT <213> Unknown <220>
<223> NEW 80 <400> 296
Met | Gin | ile | Thr | Tyr | Thr | Asp | Asp | Glu | ile | Gin | val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | ile | Phe | ASP | Thr | Ser | Trp | Ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Al a | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | val | Lys |
65 | 70 | 75 | Gin | 80 | |||||||||||
Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Tyr | |
85 | 90 | 95 | |||||||||||||
Thr | Val | Glu | val | Lys | Asn | Gly | Ser | Leu | ile | ile | Pro | Ser | Tyr | ASp | Ser |
100 | 105 | 110 | |||||||||||||
Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
val | Glu | Pro | Arg | Asn | Ala | Ser | ASp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | Glu | 155 | 160 | |||||||||||
Gin | Asp | Ser | Lys | Pro | Asp | Glu | ASp | Lys | His | Asp | Glu | Val | Ser | Glu |
• · · · • · · ·
165 | • Lys 185 | • v • · · · 170 | • · His | • · Ala | • · Gly 190 | • · 175 Leu | Asn | ||||||||
Pro | Thr | His | Pro Glu ser Asp Glu 180 | Glu | Asn | ||||||||||
Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Gl u | Ser | Gin | Pro | Ala | Pro | Ile | Gin |
260 265 270 <210> 297 <211> 272 <212> PRT <213> Unknown <220>
<223> NEW 81 <400> 297
Met | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | Ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | val | Lys | Asn | Gly | Ser | Leu | Ile | ile | Pro | ser | Tyr | Asp | Ser |
100 | 105 | 110 | |||||||||||||
Tyr | ser | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
val | Glu | Pro | Arg | Asn | Ala | Ser | Asp | His | val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | Ser | Lys | Pro | ASp | Glu | Asp | Lys | Glu | His | Asp | Glu | Val | ser | Glu |
165 | 170 | 175 | |||||||||||||
Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | Hi s | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | val |
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | Ile | Gin |
260 | 265 | 270 |
<210> 298 <211> 272 <212> PRT <213> Unknown <220>
<223> NEW 82 • · · ·
• · • · · · · | • * | • · | • · * ♦ | ||||||||||||
<400> 298 | |||||||||||||||
Met | Gin | ile | Thr Tyr | Thr | Asp | Asp | Glu | Ile | Gin | val | Ala | Lys | Leu | Ala | |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | ile | Tyr | Asn | Arg | val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | val | Lys | Asn | Gly | Ser | Leu | Ile | ile | Pro | His | Tyr | ASp | Ser |
100 | 105 | 110 | |||||||||||||
Tyr | Ser | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
val | Glu | Pro | Arg | Asn | Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu | val | Ser | Glu |
165 | 170 | 175 | |||||||||||||
Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | Ile | Gin |
260 265 270 <210> 299 <211> 272 <212> PRT <213> Unknown <22O>
<223> NEW 83 <400> 299
Met | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | ile | Gin | val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | Ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Al a | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | ile | Tyr | Asn | Arg | val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Al a | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | val | Lys | Asn | Gly | Ser | Leu | Ile | ile | Pro | Ser | Tyr | Asp | His |
100 | 105 | 110 | |||||||||||||
Tyr | Ser | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
val | Glu | Pro | Arg | Asn | Ala | Ser | Asp | His | val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | Hi S | Asp | Glu | val | Ser | Glu |
165 | 170 | 175 |
«
· | • · | • < » | » · · • · | • • · | • · | • · | |||||||||
Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | ser | Gin | Pro | Ala | Pro | Ile | Gin |
260 265 270 <210> 300 <211> 272 <212> PRT <213> Unknown <220>
<223> NEW 84 <400> 300
Met | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | Ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | Val | Glu | val | Lys | Asn | Gly | ser | Leu | Ile | Ile | Pro | Ser | Lys | ASp | His |
100 | 105 | 110 | |||||||||||||
Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
Val | Glu | Pro | Arg | Asn | Ala | Ser | Asp | His | val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | Hi S | Asp | Glu | val | ser | Glu |
165 | 170 | 175 | |||||||||||||
Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | HÍS | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
225 | 230 | 235 | 240 | ||||||||||||
ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Al a | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | pro | Ile | Gin |
260 | 265 | 270 |
<210> 301 <211> 272 <212> PRT <213> Unknown <220>
<223> NEW 85 <400> 301 • · · ·
me | • • · | • · · • • | • · • · • · | » · • · | • • ♦ | • · • · | I | ||||||||
Met | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | Ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | ile | Tyr | Asn | Arg | Val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Lys | Asp | Ser |
100 | 105 | 110 | |||||||||||||
Tyr | His | Asn | ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | Ser | Leu | Glu | ASp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
Val | Glu | Pro | Arg | Asn | Ala | Ser | Asp | His | val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | Ser | Lys | Pro | ASp | Glu | Asp | Lys | Glu | His | Asp | Glu | val | Ser | Glu |
165 | 170 | 175 | |||||||||||||
Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | val |
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | Ile | Gin |
260 265 270 <210> 302 <211> 270 <212> PRT <213> Unknown <220>
<223> NEW 88D1 <400> 302
Met | Gin | ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | Hi 5 | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Al a | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | val | Lys | Asn | Gly | Ser | Leu | Ile | ile | Pro | Asp | His | Tyr | His |
100 | 105 | 110 | |||||||||||||
Asn | ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys |
115 | 120 | 125 | |||||||||||||
Gly | Tyr | ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | val | Lys | Tyr | Tyr | val | Glu |
130 | 135 | 140 | |||||||||||||
Pro | Arg | Asn | Ala | Ser | Asp | His | val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu | val | Ser | Glu | Pro | Thr |
165 | 170 | 175 | |||||||||||||
His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn | Pro | Ser |
• ·
180 | |||||||
Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser |
195 | 200 | ||||||
Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu |
210 | 215 | ||||||
Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr |
225 | 230 | ||||||
Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn |
245 | |||||||
Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser |
260 |
• · • · · J *···· · ··: · : . · · · ··..·
44¾ | • · | » | • · | « · | « · | ||
185 | 190 | ||||||
Thr | ASp | Thr | Glu | Glu | Thr | Glu | Glu |
205 | |||||||
Ala | Glu | ile | Pro | Gly | Thr | Pro | Ser |
- | 220 | ||||||
Leu | Thr | Gly | Leu | Lys | Ser | Ser | Leu |
235 | 240 | ||||||
Thr | Ile | Ser | Ala | Glu | val | Asp | Ser |
250 | 255 | ||||||
Gin | Pro | Ala | Pro | ile | Gin | ||
265 | 270 |
<210> 303 <211> 268 <212> PRT <213> Unknown <220>
<223> NEW 88D2 <400> 303
Met | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | ile | Phe | Asp | Thr | Ser | Trp | Ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | val | Lys | Asn | Gly | Ser | Leu | ile | Ile | Pro | Tyr | Hi s | Asn | Ile |
100 | 105 | 110 | |||||||||||||
Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr |
115 | 120 | 125 | |||||||||||||
Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | val | Lys | Tyr | Tyr | val | Glu | Pro | Arg |
130 | 135 | 140 | |||||||||||||
Asn | Ala | Ser | Asp | Hi s | val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys |
145 | 150 | 155 | 160 | ||||||||||||
Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu | val | Ser | Glu | Pro | Thr | His | Pro |
165 | 170 | 175 | |||||||||||||
Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp |
180 | 185 | 190 | |||||||||||||
Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala |
195 | 200 | 205 | |||||||||||||
Glu | Asp | Thr | Thr | Asp | Glu | Ala | Gl u | ile | Pro | Gly | Thr | Pro | Ser | Ile | Arg |
210 | 215 | 220 | |||||||||||||
Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | ser | Ser | Leu | Leu | Leu |
225 | 230 | 235 | 240 | ||||||||||||
Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | val | Asp | Ser | Leu | Leu |
245 | 250 | 255 | |||||||||||||
Al a | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | Ile | Gin | ||||
260 | 265 |
<210> 304 <211> 266 <212> PRT <213> Unknown <220>
<223> NEW 88 <400> 304 • ·
Met | Gin | ile | Thr | Tyr | Thr | Asp | Asp | blU | Ile | Gin | val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | Asn | Ile | Lys | Phe |
100 | 105 | 110 | |||||||||||||
Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu |
115 | 120 | 125 | |||||||||||||
Glu | Asp | Leu | Leu | Ala | Thr | val | Lys | Tyr | Tyr | val | Glu | Pro | Arg | Asn | Ala |
130 | 135 | 140 | |||||||||||||
Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Glu | Asp | Lys | Glu | His | Asp | Glu | val | Ser | Glu | Pro | Thr | His | Pro | Glu | Ser |
165 | 170 | 175 | |||||||||||||
Asp | Glu | Lys | Glu | Asn | Hi S | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn | Leu |
180 | 185 | 190 | |||||||||||||
Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu | Asp |
195 | 200 | 205 | |||||||||||||
Thr | Thr | ASp | Glu | Ala | Glu | Ile | Pro | Gly | Thr | Pro | Ser | Ile | Arg | Gin | Asn |
210 | 215 | 220 | |||||||||||||
Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr |
225 | 230 | 235 | 240 | ||||||||||||
Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val | ASp | Ser | Leu | Leu | Ala | Leu |
245 | 250 | 255 | |||||||||||||
Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | ile | Gin | ||||||
260 | 265 |
<210> 305 <400> 305 000 <210> 306 <400> 306 000 <210> 307 <400> 307 000 <210> 308 <400> 308 000 <210> 309 <400> 309 000 <210> 310 <400> 310 000 <210> 311 <400> 311
000
<210> | 312 |
<400> 000 | 312 |
<210> | 313 |
<400> 000 | 313 |
<210> | 314 |
<400> 000 | 314 |
<210> | 315 |
<400> 000 | 315 |
<210> | 316 |
<400> 000 | 316 |
<210> | 317 |
<400> 000 | 317 |
<210> | 318 |
<400> 000 | 318 |
<210> | 319 |
<400> 000 | 319 |
<210> | 320 |
<400> 000 | 320 |
<210> | 321 |
<400> 000 | 321 |
<210> | 322 |
<400> 000 | 322 |
<210> | 323 |
<400> 000 | 323 |
<210> | 324 |
<400> | 324 |
000 <210> 325 • · · ·
ISO <400> 325 000 <210> 326 <400> 326 000 <210> 327 <211> 41 <212> DNA <213> unknown <220>
<223> HAMJ 564 <400> 327 atatgggccc caaattacct acactgatga tgagattcag g <210> 328 <211> 43 <212> DNA <213> Unknown <220>
<223> HAMJ 556 <400> 328 ataagaatgc ggccgcctac tgtataggag ccggttgact ttc <210> 329 <211> 33 <212> DNA <213> Unknown <220>
<223> HAMJ 489 <400> 329 ccgaattcca tatgcaaatt gggcaaccga ctc <210> 330 <211> 29 <212> DNA <213> Unknown <220>
<223> HAMJ 559 <400> 330 atatgggccc caaattgggc aaccgactc <210> 331 <211> 41 <212> DNA <213> Unknown <220>
<223> HAMJ 557 <400> 331 ataagaatgc ggccgcttac gctatgaaat cagataaatt c <211> 906 <212> PRT <210> 332 ·« ·· 4 ·
<213> Unknown <220>
<223> VP 94 | |||
<400> 332 | |||
Met | Gin | Ile | Thr |
1 Gly | Lys | Tyr | Thr |
Lys | Lys | Asp | 20 Ser |
Ala | Lys | 35 Glu | Lys |
Gly | 50 Asn | Thr | Glu |
65 Ala | Ala | Lys | Lys |
Thr | val | Glu | val |
Tyr | His | Asn | 100 Ile |
Pro | Lys | 115 Gly | Tyr |
val | 130 Glu | Pro | Arg |
145 Gin | Asp | Ser | Lys |
Pro | Thr | His | Pro |
Pro | Ser | Ala | 180 Asp |
Glu | Glu | 195 Glu | Ala |
Pro | 210 Ser | ile | Arg |
225 Ser | Leu | Leu | Leu |
Asp | Ser | Leu | Leu |
Gly | Pro | Gin | 260 Ile |
Pro | Ser | 275 Pro | Ser |
Glu | 290 Glu | Asp | Gly |
305 Glu | Ser | Gly | Phe |
Lys | Lys | Asp | Leu |
Glu | Glu | val | 340 Lys |
Glu | Gin | 355 Asp | Tyr |
Lys | 370 Ile | Glu | Glu |
385 Arg | Glu | Ser | Ile |
Ser | Gly | Asp | His |
Gly | Ile | Gly | 420 His |
Gly | val | 435 Ala | Lys |
Thr | 450 Asn | Val | Val |
465 Phe | Thr | Leu | Ala |
Tyr | Thr | Asp | Asp |
5 | |||
Thr | Glu | Asp | Gly |
Leu | Ser | Glu | Ala |
Gly | Leu | Thr | 40 Pro |
Ala | Lys | 55 Gly | Ala |
Val | 70 Pro | Leu | Asp |
85 | |||
Lys | Asn | Gly | ser |
Lys | Phe | Glu | Trp |
Ser | Leu | Glu | 120 Asp |
Asn | Ala | 135 Ser | Asp |
Pro | 150 Asp | Glu | ASp |
165 | |||
Glu | Ser | Asp | Glu |
Asn | Leu | Tyr | Lys |
Glu | Asp | Thr | 200 Thr |
Gin | Asn | 215 Ala | Met |
Gly | 230 Thr | Lys | Asp |
245 | |||
Ala | Leu | Leu | Lys |
Gly | Gin | Pro | Thr |
Leu | Pro | Ile | 280 Asn |
Tyr | Gly | 295 Phe | Asp |
Val | 310 Met | Ser | His |
325 | |||
Thr | Glu | Glu | Gin |
Thr | Ser | His | Asn |
Pro | Gly | Asn | 360 Ala |
Lys | Ile | 375 Ala | Gly |
val | 390 Val | Asn | Lys |
405 | |||
His | Hi s | Ala | Asp |
Ser | His | Ser | Asn |
Lys | Glu | Gly | 440 Asn |
Asn | Leu | 455 Leu | Lys |
Asn | 470 Gly | Gin | Lys |
485 |
Glu | Ile 10 | Gin | val |
Tyr 25 | Ile | Phe | Asp |
Glu | Arg | Al a | Ala |
Pro | Ser | Thr | Asp 60 |
Glu | Ala | ile 75 | Tyr |
Arg | Met 90 | Pro | Tyr |
Leu 105 | Ile | ile | Pro |
Phe | Asp | Glu | Gly |
Leu | Leu | Ala | Thr 140 |
Hi s | val | Arg 155 | Lys |
Lys | Glu 170 | His | Asp |
Lys 185 | Glu | Asn | His |
Pro | Ser | Thr | Asp |
Asp | Glu | Ala | Glu 220 |
Glu | Thr | Leu 235 | Thr |
Asn | Asn 250 | Thr | Ile |
Glu 265 | Ser | Gin | Pro |
Leu | Pro | Asn | Asn |
Pro | Gly | Thr | Ser 300 |
Ala | Asn | Arg 315 | Ile |
Gly | Asp 330 | Ser | Asn |
Ile 345 | Lys | Ala | Ala |
Gly | Leu | Asp | ser |
Lys | Glu | Met | Lys 380 |
Ile | Met | Lys 395 | Gin |
Glu | Lys 410 | Asn | Ala |
Pro 425 | Ile | Asp | Glu |
Tyr | Gl u | Leu | Phe |
Lys | Val | Tyr | Thr 460 |
Asn | Ser | Thr 475 | Phe |
Arg | val 490 | Ser | Phe |
Ala | Lys | Leu 15 | Ala |
Thr | Ser 30 | Trp | ile |
Ala 45 | Gin | Al a | Tyr |
His | Gin | Asp | Ser |
Asn | Arg | val | Lys 80 |
Asn | Leu | Gin 95 | Tyr |
Ser | Tyr 110 | ASp | His |
Leu 125 | Tyr | Glu | Ala |
val | Lys | Tyr | Tyr |
Asn | Lys | Ala | Asp 160 |
Glu | val | Ser 175 | Glu |
Ala | Gly 190 | Leu | Asn |
Thr 205 | Glu | Glu | Thr |
Ile | Pro | Gly | Thr |
Gly | Leu | Lys | Ser 240 |
Ser | Ala | Glu 255 | val |
Ala | Pro 270 | Ile | Gin |
Ser 285 | Leu | Ala | Thr |
His | Glu | Lys | His |
Ile | Ala | Glu | Asp 320 |
His | Tyr | Phe 335 | Phe |
Gin | Lys 350 | His | Leu |
Leu 365 | ser | Ser | His |
Asp | Leu | Asp | Lys |
Tyr | Gly | Val | Lys 400 |
Ile | ile | Tyr 415 | Pro |
His | Lys 430 | Pro | val |
Lys 445 | Pro | Glu | Gl u |
Gly | Glu | Glu | Leu |
Asn | Asn | Gin | Asn 480 |
Ser | Phe | Pro 495 | Pro |
Glu | Leu | Glu | Lys | Lys | Leu | Gly | ile | Asn | Met | Leu | val | Lys | Leu | Ile | Thr |
500 | 505 | 510 | |||||||||||||
Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | val | Phe | Gly | Glu |
515 | 520 | 525 | |||||||||||||
Gly | val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val |
545 | 550 | 555 | 560 | ||||||||||||
Ser | Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met |
565 | 570 | 575 | |||||||||||||
Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | Hi S | Ala | Gly | Asp | Thr | Tyr | Leu |
580 | 585 | 590 | |||||||||||||
Arg | val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val |
595 | 600 | 605 | |||||||||||||
Arg | val | Phe | Asp | Glu | phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr |
610 | 615 | 620 | |||||||||||||
Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr |
625 | 630 | 635 | 640 | ||||||||||||
Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala |
645 | 650 | 655 | |||||||||||||
Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu | Glu |
660 | 665 | 670 | |||||||||||||
Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg |
675 | 680 | 685 | |||||||||||||
Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | val | Glu | Glu | Pro |
690 | 695 | 700 | |||||||||||||
Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn |
705 | 710 | 715 | 720 | ||||||||||||
Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | val | Asp | Pro | Val |
725 | 730 | 735 | |||||||||||||
Gin | Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu |
740 | 745 | 750 | |||||||||||||
Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser |
755 | 760 | 765 | |||||||||||||
Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro |
770 | 775 | 780 | |||||||||||||
Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | val | Ser | Thr |
785 | 790 | 795 | 800 | ||||||||||||
Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu |
805 | 810 | 815 | |||||||||||||
Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | pro | Glu | Asn | Ser | Thr | Asp |
820 | 825 | 830 | |||||||||||||
Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu |
835 | 840 | 845 | |||||||||||||
Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | val | Asp | Pro | Val | Gin | Glu | Lys |
850 | 855 | 860 | |||||||||||||
Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | val | Ile |
865 | 870 | 875 | 880 | ||||||||||||
Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val |
885 | 890 | 895 | |||||||||||||
Ile | Lys | Lys | Asn | Leu | Ser | Asp | Phe | ile | Ala | ||||||
900 | 905 |
<210> 333 <211> 900 <212> PRT <213> Unknown <22O>
<223> VP 108 <400> 333
Met | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr | Pro |
1 | 5 | 10 | 15 | ||||||||||||
Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | Asp | Glu |
>153
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | val | Met | Ser | His | Gly | Asp | ser | Asn | His | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Glu | val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | ser | His | Glu |
85 | 90 | 95 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
100 | 105 | 110 | |||||||||||||
Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg |
115 | 120 | 125 | |||||||||||||
Glu | ser | Ile | val | val | Asn | Lys | Glu | Lys | Asn | Ala | ile | Ile | Tyr | Pro | Ser |
130 | 135 | 140 | |||||||||||||
Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
Ile | Gly | His | ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | 170 | 175 | |||||||||||||
Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | phe | Asn | Asn | Gin | Asn | Phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | val | Lys | Leu | Ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
Asp | Gly | Lys | val | Leu | Glu | Lys | val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
Val | Gly | Asn | ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser |
275 | 280 | 285 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala |
290 | 295 | 300 | |||||||||||||
Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
305 | 310 | 315 | 320 | ||||||||||||
Val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Al a | Leu | val | Arg |
325 | 330 | 335 | |||||||||||||
val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
340 | 345 | 350 | |||||||||||||
Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
355 | 360 | 365 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
370 | 375 | 380 | |||||||||||||
Leu | Asp | Asn | Gin | Ser | Thr | Tyr | ile | val | Glu | val | Pro | Ile | Leu | Glu | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
405 | 410 | 415 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | ser | Lys | Leu | Asp | Glu | Lys | val | Glu | Glu | Pro | Lys |
420 | 425 | 430 | |||||||||||||
Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | ser |
435 | 440 | 445 | |||||||||||||
Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | Val | Asp | Pro | Val | Gin |
450 | 455 | 460 | |||||||||||||
Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
465 | 470 | 475 | 480 | ||||||||||||
Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
485 | 490 | 495 | |||||||||||||
Glu | val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
500 | 505 | 510 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly |
515 | 520 | 525 | |||||||||||||
Thr | val | Glu | Asn | Gl n | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | Pro | val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | ser | Asp | Pro | Met | Leu | Asp |
565 | 570 | 575 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | val | Asp | Pro | val | Gin | Glu | Lys | Leu |
• · * ·
• ·« • · · · · • · · · • · · · · ·
580 | 585 | 590 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | ser | val | Ile | Phe |
595 | 600 | 605 | |||||||||||||
Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val | Ile |
610 | 615 | 620 | |||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Al a | Gly | Pro | Gin | Ile | Thr | Tyr | Thr |
625 | 630 | 635 | 640 | ||||||||||||
Asp | Asp | Glu | ile | Gin | val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu |
645 | 650 | 655 | |||||||||||||
Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser |
660 | 665 | 670 | |||||||||||||
Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Al a | Tyr | Ala | Lys | Glu | Lys | Gly | Leu |
675 | 680 | 685 | |||||||||||||
Thr | Pro | Pro | ser | Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys |
690 | 695 | 700 | |||||||||||||
Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys | Ala | Ala | Lys | Lys | val | Pro |
705 | 710 | 715 | 720 | ||||||||||||
Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | Val | Glu | val | Lys | Asn |
725 | 730 | 735 | |||||||||||||
Gly | Ser | Leu | Ile | Ile | Pro | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly |
740 | 745 | 750 | |||||||||||||
Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr |
755 | 760 | 765 | |||||||||||||
val | Lys | Tyr | Tyr | Val | Glu | Pro | Arg | Asn | Ala | Ser | Asp | His | val | Arg | Lys |
770 | 775 | 780 | |||||||||||||
Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | ASp |
785 | 790 | 795 | 800 | ||||||||||||
Glu | val | Ser | Glu | Pro | Thr | His | Pro | Glu | ser | Asp | Glu | Lys | Glu | Asn | His |
805 | 810 | 815 | |||||||||||||
Al a | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp |
820 | 825 | 830 | |||||||||||||
Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu |
835 | 840 | 845 | |||||||||||||
Ile | Pro | Gly | Thr | Pro | Ser | ile | Arg | Gl n | Asn | Ala | Met | Glu | Thr | Leu | Thr |
850 | 855 | 860 | |||||||||||||
Gly | Leu | Lys | Ser | ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile |
865 | 870 | 875 | 880 | ||||||||||||
Ser | Ala | Glu | Val | Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Gl u | ser | Gin | Pro |
885 | 890 | 895 | |||||||||||||
Al a | Pro | Ile | Gin |
900 <210> 334 <211> 900 <212> PRT <213> Unknown <220>
<223> VP 109 | |||||||||||||||
<400> 334 | |||||||||||||||
Met | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | ile | Gin | val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | ser | Trp | ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Gl u | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | ile | Tyr | Asn | Arg | val | Lys |
65 | Ala | 70 | 75 | 80 | |||||||||||
Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr | |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | val | Lys | Asn | Gly | ser | Leu | Ile | ile | Pro | Asn | ile | Lys | Phe |
100 | 105 | 110 | |||||||||||||
Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu |
115 120 125 r ·« · • ·· • · * *
Glu Asp Leu Leu 130 | Ala Thr val 135 | Lys | Tyr Ťyr val Glu Pro Arg Asn 140 | Ala | |||||||||||
ser | Asp | Hl s | val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Glu | Asp | Lys | Glu | Hi s | Asp | Glu | val | Ser | Glu | Pro | Thr | His | Pro | Glu | ser |
165 | 170 | 175 | |||||||||||||
Asp | Glu | Lys | Glu | Asn | HÍS | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn | Leu |
180 | 185 | 190 | |||||||||||||
Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu | Asp |
195 | 200 | 205 | |||||||||||||
Thr | Thr | Asp | Glu | Ala | Glu | ile | Přo | Gly | Thr | Pro | Ser | Ile | Arg | Gin | Asn |
210 | 215 | 220 | |||||||||||||
Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr |
225 | 230 | 235 | 240 | ||||||||||||
Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val | ASp | Ser | Leu | Leu | Ala | Leu |
245 | 250 | 255 | |||||||||||||
Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | ile | Gin | Gly | Pro | Gin | Ile | Gly | Gin |
260 | 265 | 270 | |||||||||||||
Pro | Thr | Leu | Pro | Asn | Asn | ser | Leu | Ala | Thr | Pro | Ser | Pro | Ser | Leu | Pro |
275 | 280 | 285 | |||||||||||||
Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu | Glu | Asp | Gly | Tyr | Gly |
290 | 295 | 300 | |||||||||||||
Phe | Asp | Ala | Asn | Arg | ile | Ile | Ala | Glu | Asp | Glu | Ser | Gly | Phe | val | Met |
305 | 310 | 315 | 320 | ||||||||||||
Ser | HIS | Gly | Asp | Ser | Asn | His | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu |
325 | 330 | 335 | |||||||||||||
Glu | Gin | ile | Lys | Ala | Ala | Gin | Lys | Hi s | Leu | Glu | Glu | val | Lys | Thr | Ser |
340 | 345 | 350 | |||||||||||||
His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr | Pro | Gly |
355 | 360 | 365 | |||||||||||||
Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | ile | Glu | Glu | Lys | ile |
370 | 375 | 380 | |||||||||||||
Ala | Gly | ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg | Glu | Ser | ile | val | val |
385 | 390 | 395 | 400 | ||||||||||||
Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | Ser | Gly | Asp | His | His | Hi s |
405 | 410 | 415 | |||||||||||||
Ala | Asp | Pro | ile | Asp | Glu | His | Lys | Pro | Val | Gly | Ile | Gly | His | Ser | His |
420 | 425 | 430 | |||||||||||||
Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly | Val | Ala | Lys | Lys | Glu |
435 | 440 | 445 | |||||||||||||
Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn | Val | val | Asn | Leu |
450 | 455 | 460 | |||||||||||||
Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly |
465 | 470 | 475 | 480 | ||||||||||||
Gin | Lys | Arg | val | Ser | Phe | ser | Phe | Pro | Pro | Gl u | Leu | Glu | Lys | Lys | Leu |
485 | 490 | 495 | |||||||||||||
Gly | Ile | Asn | Met | Leu | val | Lys | Leu | ile | Thr | Pro | Asp | Gly | Lys | Val | Leu |
500 | 505 | 510 | |||||||||||||
Glu | Lys | Val | Ser | Gly | Lys | val | Phe | Gly | Glu | Gly | Val | Gly | Asn | Ile | Ala |
515 | 520 | 525 | |||||||||||||
Asn | Phe | Gl u | Leu | ASp | Gin | Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr |
530 | 535 | 540 | |||||||||||||
Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser | Tyr | Asp | Gly | Thr | Phe |
545 | 550 | 555 | 560 | ||||||||||||
Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala | Ser | Gin | Thr | Ile | Phe |
565 | 570 | 575 | |||||||||||||
Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg | Val | Asn | Pro | Gin | Phe |
580 | 585 | 590 | |||||||||||||
Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg | val | Phe | Asp | Glu | Phe |
595 | 600 | 605 | |||||||||||||
His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | Val | Gly | Glu | Ile | Lys |
610 | 615 | 620 | |||||||||||||
Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly | Asn |
625 | 630 | 635 | 640 | ||||||||||||
Lys | Ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser |
645 | 650 | 655 | |||||||||||||
Thr | Tyr | Ile | val | Glu | Val | Pro | Ile | Leu | Glu | Lys | Glu | Asn | Gin | Thr | Asp |
660 | 665 | 670 |
♦ » * »·*
Lys Pro Ser | Ile | Leu Pro | Gin Phe 680 | Lys Arg Asn Lys Ala Gin Glu Asn 685 | |||||||||||
675 | |||||||||||||||
Ser | Lys | Leu | Asp | Glu | Lys | val | Glu | Glu | Pro | Lys | Thr | ser | Glu | Lys | val |
690 | 695 | 700 | |||||||||||||
Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser | Thr | Ser | Asn | Ser | Thr |
705 | 710 | 715 | 720 | ||||||||||||
Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro | Val | Gin | Glu | Lys | Val | Ala | Lys |
725 | 730 | 735 | |||||||||||||
Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn | Val | Leu | Phe | Asn | Met |
740 | 745 | 750 | |||||||||||||
Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly | Glu | val | ile | Lys | Lys |
755 | 760 | 765 | |||||||||||||
Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn |
770 | 775 | 780 | |||||||||||||
Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly | Thr | val | Glu | Asn | Gin |
785 | 790 | 795 | 800 | ||||||||||||
Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu |
805 | 810 | 815 | |||||||||||||
Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | ASp | Asn | Gly | Met | Leu | Asn | Pro |
820 | 825 | 830 | |||||||||||||
Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu |
835 | 840 | 845 | |||||||||||||
Ala | Pro | Ala | val | Asp | Pro | val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Ala |
850 | 855 | 860 | |||||||||||||
Ser | Tyr | Gly | Leu | Gly | Leu | ASp | Ser | Val | ile | Phe | Asn | Met | Asp | Gly | Thr |
865 | Glu | 870 | 875 | 880 | |||||||||||
Ile | Leu | Arg | Leu | Pro | ser | Gly | Glu | val | ile | Lys | Lys | Asn | Leu | Ser | |
885 | 890 | 895 | |||||||||||||
Asp | Phe | Ile | Ala | ||||||||||||
900 |
<210> 335 <211> 900 <212> PRT <213> Unknown <220>
<223> VP 110
<400> 3: | 35 | ||||||||||||||
Met | Gin | ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Al a |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Al a | ile | Tyr | Asn | Arg | Val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | Val | Glu | val | Lys | Asn | Gly | Ser | Leu | ile | ile | Pro | Ser | Tyr | Asp | His |
100 | 105 | 110 | |||||||||||||
Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
val | Glu | Pro | Arg | Asn | Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | ASp | Glu | Val | Ser | Glu |
165 | 170 | 175 | |||||||||||||
Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr |
195 | 200 | 205 |
• · • · · ·
4 | sť' | • · • · · • • · | • • · • • ' | • · • « • · | • · ' • « | • • · * * | • • « * | ||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | Ile | Gin |
260 | 265 | 270 | |||||||||||||
Gly | Pro | Gin | ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr |
275 | 280 | 285 | |||||||||||||
Pro | ser | Pro | Ser | Leu | Pro | ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His |
290 | 295 | 300 | |||||||||||||
Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | Asp |
305 | 310 | 315 | 320 | ||||||||||||
Glu | Ser | Gly | Phe | Val | Met | ser | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu |
325 | 330 | 335 | |||||||||||||
Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu | Glu | val | Lys | Thr | Ser |
340 | 345 | 350 | |||||||||||||
His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr | Pro | Gly |
355 | 360 | 365 | |||||||||||||
Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | ile | Glu | Glu | Lys | Ile |
370 | 375 | 380 | |||||||||||||
Ala | Gly | ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg | Glu | Ser | Ile | Val | val |
385 | 390 | 395 | 400 | ||||||||||||
Asn | Lys | Glu | Lys | Asn | Ala | ile | ile | Tyr | Pro | His | Gly | Asp | His | His | His |
405 | 410 | 415 | |||||||||||||
Ala | ASp | Pro | Ile | Asp | Glu | His | Lys | Pro | val | Gly | Ile | Gly | His | Ser | Hi s |
420 | 425 | 430 | |||||||||||||
Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly | Val | Ala | Lys | Lys | Gl u |
435 | 440 | 445 | |||||||||||||
Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn | Val | val | Asn | Leu |
450 | 455 | 460 | |||||||||||||
Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu | Al a | Asn | Gly |
465 | 470 | 475 | 480 | ||||||||||||
Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys | Leu |
485 | 490 | 495 | |||||||||||||
Gly | ile | Asn | Met | Leu | val | Lys | Leu | Ile | Thr | Pro | Asp | Gly | Lys | Val | Leu |
500 | 505 | 510 | |||||||||||||
Glu | Lys | val | ser | Gly | Lys | val | Phe | Gly | Glu | Gly | val | Gly | Asn | Ile | Ala |
515 | 520 | 525 | |||||||||||||
Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr |
530 | 535 | 540 | |||||||||||||
Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | val | Ser | Tyr | Asp | Gly | Thr | Phe |
545 | 550 | 555 | 560 | ||||||||||||
Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala | Ser | Gin | Thr | Ile | Phe |
565 | 570 | 575 | |||||||||||||
Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg | Val | Asn | Pro | Gin | Phe |
580 | 585 | 590 | |||||||||||||
Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val | Arg | val | Phe | Asp | Glu | Phe |
595 | 600 | 605 | |||||||||||||
His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | Val | Gly | Glu | Ile | Lys |
610 | 615 | 620 | |||||||||||||
Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly | Asn |
625 | 630 | 635 | 640 | ||||||||||||
Lys | Ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser |
645 | 650 | 655 | |||||||||||||
Thr | Tyr | ile | val | Glu | val | Pro | Ile | Leu | Glu | Lys | Glu | Asn | Gin | Thr | Asp |
660 | 665 | 670 | |||||||||||||
Lys | Pro | Ser | ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu | Asn |
675 | 680 | 685 | |||||||||||||
ser | Lys | Leu | Asp | Glu | Lys | val | Glu | Glu | Pro | Lys | Thr | Ser | Glu | Lys | Val |
690 | 695 | 700 | |||||||||||||
Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser | Thr | ser | Asn | Ser | Thr |
705 | 710 | 715 | 720 | ||||||||||||
Leu | Glu | Glu | val | Pro | Thr | Val | Asp | Pro | val | Gin | Glu | Lys | val | Ala | Lys |
725 | 730 | 735 | |||||||||||||
Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn | val | Leu | Phe | Asn | Met |
740 | 745 | 750 |
« · · · ·· ··· ·
Asp Gly Thr Ile Glu Leu Tyr Leu Pro šer Gly Glu val ile Lys Lys 755 760 765
Asn Met Ala Asp Phe Thr Gly Glu Ala Pro Gin Gly Asn Gly Glu Asn 770 775 780
Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly | Thr | Val | Glu | Asn | Gin |
785 | 790 | 795 | 800 | ||||||||||||
Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu |
805 | 810 | 815 | |||||||||||||
Lys | Pro | val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro |
820 | 825 | 830 | |||||||||||||
Glu | Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu |
835 | 840 | 845 | |||||||||||||
Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Ala |
850 | 855 | 860 | |||||||||||||
Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | Phe | Asn | Met | Asp | Gly | Thr |
865 | 870 | 875 | 880 | ||||||||||||
Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val | Ile | Lys | Lys | Asn | Leu | Ser |
885 | 890 | 895 | |||||||||||||
Asp | Phe | ile | Ala |
900 <210> 336 <211> 894 <212> PRT <213> Unknown <22O>
<223> VP 111 <400> 336
Met Gin Ile Thr Tyr Thr Asp Asp Glu Ile Gin val Ala Lys Leu Ala | |||||||||||||||
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | ile | Phe | Asp | Thr | Ser | Trp | Ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | ile | Tyr | Asn | Arg | Val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Al a | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | val | Lys | Asn | Gly | Ser | Leu | ile | ile | Pro | Ser | Tyr | Asp | His |
100 | 105 | 110 | |||||||||||||
Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
val | Glu | Pro | Arg | Asn | Ala | Ser | ASp | His | val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu | val | Ser | Glu |
165 | 170 | 175 | |||||||||||||
Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | ile | Gin |
260 | 265 | 270 | |||||||||||||
Gly | Pro | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr |
275 | 280 | 285 | |||||||||||||
Pro | Ser | Pro | Ser | Leu | Pro | ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His |
• · • · · · • · · · • · · · • ·
4S5
290 | 295 | 300 | |||||||||||||
Glu | Glu | Asp | Gly Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | Asp | |
305 | 310 | 315 | 320 | ||||||||||||
Glu | Ser | Gly | Phe | val | Met | Ser | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu |
325 | 330 | 335 | |||||||||||||
Glu | Gin | Ile | Lys | Ala | Ala | Gl n | Lys | His | Leu | Glu | Glu | Val | Lys | Thr | ser |
340 | 345 | 350 | |||||||||||||
His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr | Pro | Gly |
355 | 360 | 365 | |||||||||||||
Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys | Ile |
370 | 375 | 380 | |||||||||||||
Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val | Lys | Arg | Glu | Ser | Ile | Val | val |
385 | 390 | 395 | 400 | ||||||||||||
Asn | Lys | Glu | Lys | Asn | Ala | ile | ile | Tyr | Pro | Ala | Asp | Pro | Ile | Asp | Glu |
405 | 410 | 415 | |||||||||||||
His | Lys | Pro | val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe |
420 | 425 | 430 | |||||||||||||
Lys | Pro | Glu | Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr |
435 | 440 | 445 | |||||||||||||
Gly | Glu | Glu | Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe |
450 | 455 | 460 | |||||||||||||
Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe |
465 | 470 | 475 | 480 | ||||||||||||
Ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | val |
485 | 490 | 495 | |||||||||||||
Lys | Leu | ile | Thr | Pro | Asp | Gly | Lys | val | Leu | Glu | Lys | Val | Ser | Gly | Lys |
500 | 505 | 510 | |||||||||||||
val | Phe | Gly | Glu | Gly | val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin |
515 | 520 | 525 | |||||||||||||
Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | ile | Ala | Ser | Lys | Asp |
530 | 535 | 540 | |||||||||||||
Tyr | Pro | Glu | val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu |
545 | 550 | 555 | 560 | ||||||||||||
Al a | Tyr | Lys | Met | Ala | Ser | Gin | Thr | ile | Phe | Tyr | Pro | Phe | His | Ala | Gly |
565 | 570 | 575 | |||||||||||||
Asp | Thr | Tyr | Leu | Arg | val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr |
580 | 585 | 590 | |||||||||||||
Asp | Ala | Leu | Val | Arg | val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu |
595 | 600 | 605 | |||||||||||||
Gl u | Asn | Asn | Tyr | Lys | val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu |
610 | 615 | 620 | |||||||||||||
Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | val | Thr | Phe |
625 | 630 | 635 | 640 | ||||||||||||
Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | val | Glu | val |
645 | 650 | 655 | |||||||||||||
Pro | Ile | Leu | Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro |
660 | 665 | 670 | |||||||||||||
Gin | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys |
675 | 680 | 685 | |||||||||||||
Val | Glu | Glu | Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser |
690 | 695 | 700 | |||||||||||||
Glu | Thr | Gly | Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr |
705 | 710 | 715 | 720 | ||||||||||||
Val | Asp | Pro | val | Gin | Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | ser | Tyr | Gly |
725 | 730 | 735 | |||||||||||||
Met | Lys | Leu | Glu | Asn | val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu |
740 | 745 | 750 | |||||||||||||
Tyr | Leu | Pro | Ser | Gly | Glu | val | ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr |
755 | 760 | 765 | |||||||||||||
Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly |
770 | 775 | 780 | |||||||||||||
Lys | Val | Ser | Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro |
785 | 790 | 795 | 800 | ||||||||||||
Al a | Asp | Ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | val | Lys | Pro | Glu |
805 | 810 | 815 | |||||||||||||
Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser |
820 | 825 | 830 |
·· · ·
ASp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | val | Asp | Pro |
835 | 840 | 845 | |||||||||||||
val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu |
850 | 855 | 860 | |||||||||||||
Asp | Ser | val | ile | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro |
865 | 870 | 875 | 880 | ||||||||||||
Ser | Gly | Glu | Val | ile | Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | ||
885 | 890 |
<210> 337 <211> 894 <212> PRT <213> Unknown <220>
<223> VP 112 <400> 337
Met 1 | Gin | Ile | Thr | Tyr 5 | Thr | Asp Asp | Glu ile Gin val Ala Lys Leu | Ala | |||||||
10 | 15 | ||||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Al a | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | ile | Tyr | Asn | Arg | val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | Asn | ile | Lys | Phe |
100 | 105 | 110 | |||||||||||||
Glu | Trp | Phe | ASp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | ser | Leu |
115 | 120 | 125 | |||||||||||||
Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr | Val | Glu | Pro | Arg | Asn | Ala |
130 | 135 | 140 | |||||||||||||
Ser | Asp | Hi s | Val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Glu | Asp | Lys | Glu | His | Asp | Glu | val | ser | Glu | Pro | Thr | His | Pro | Glu | Ser |
165 | 170 | 175 | |||||||||||||
Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn | Leu |
180 | 185 | 190 | |||||||||||||
Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu | Asp |
195 | 200 | 205 | |||||||||||||
Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr | Pro | Ser | Ile | Arg | Gin | Asn |
210 | 215 | 220 | |||||||||||||
Al a | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr |
225 | 230 | 235 | 240 | ||||||||||||
Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | val | Asp | Ser | Leu | Leu | Ala | Leu |
245 | 250 | 255 | |||||||||||||
Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | ile | Gin | Gly | Pro | Gin | Ile | Gly | Gin |
260 | 265 | 270 | |||||||||||||
Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr | Pro | Ser | Pro | Ser | Leu | Pro |
275 | 280 | 285 | |||||||||||||
Ile | Asn | Pro | Gly | Thr | ser | His | Glu | Lys | His | Glu | Glu | Asp | Gly | Tyr | Gly |
290 | 295 | 300 | |||||||||||||
Phe | Asp | Ala | Asn | Arg | ile | Ile | Ala | Glu | Asp | Glu | Ser | Gly | Phe | val | Met |
305 | 310 | 315 | 320 | ||||||||||||
Ser | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala |
325 | 330 | 335 | |||||||||||||
Gin | Lys | Hi s | Leu | Glu | Glu | val | Lys | Thr | Ser | His | Asn | Gly | Leu | ASp | Ser |
340 | 345 | 350 | |||||||||||||
Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys |
355 | 360 | 365 | |||||||||||||
Asp | Leu | Asp | Lys | Lys | Ile | Glu | Gl u | Lys | Ile | Ala | Gly | ile | Met | Lys | Gin |
370 | 375 | 380 | |||||||||||||
Tyr | Gly | val | Lys | Arg | Glu | Ser | ile | val | val | Asn | Lys | Glu | Lys | Asn | Ala |
• ·
385 | 390 | 395 | 400 | ||||||||||||
Ile | Ile | Tyr | Pro | His | Gly | Asp | HÍS | His | His | Ala | Asp | Pro | ile | Asp | Glu |
405 | 410 | 415 | |||||||||||||
Hi s | Lys | Pro | val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe |
420 | 425 | 430 | |||||||||||||
Lys | Pro | Glu | Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr |
435 | 440 | 445 | |||||||||||||
Gly | Glu | Glu | Leu | Thr | Asn | val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe |
450 | 455 | 460 | |||||||||||||
Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe |
465 | 470 | 475 | 480 | ||||||||||||
Ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val |
485 | 490 | 495 | |||||||||||||
Lys | Leu | Ile | Thr | Pro | Asp | Gly | Lys | val | Leu | Glu | Lys | Val | Ser | Gly | Lys |
500 | 505 | 510 | |||||||||||||
val | Phe | Gly | Glu | Gly | val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin |
515 | 520 | 525 | |||||||||||||
Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp |
530 | 535 | 540 | |||||||||||||
Tyr | Pro | Glu | val | Ser | Tyr | ASp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu |
545 | 550 | 555 | 560 | ||||||||||||
Ala | Tyr | Lys | Met | Ala | Ser | Gin | Thr | Ile | phe | Tyr | pro | Phe | His | Ala | Gly |
565 | 570 | 575 | |||||||||||||
Asp | Thr | Tyr | Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | val | pro | Lys | Gly | Thr |
580 | 585 | 590 | |||||||||||||
ASp | Ala | Leu | Val | Arg | Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu |
595 | 600 | 605 | |||||||||||||
Glu | Asn | Asn | Tyr | Lys | Val | Gly | Glu | Ile | Lys | Leu | pro | ile | Pro | Lys | Leu |
610 | 615 | 620 | |||||||||||||
Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | pro | Val | Thr | Phe |
625 | 630 | 635 | 640 | ||||||||||||
Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | ile | val | Glu | Val |
645 | 650 | 655 | |||||||||||||
Pro | Ile | Leu | Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | ile | Leu | Pro |
660 | 665 | 670 | |||||||||||||
Gl n | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys |
675 | 680 | 685 | |||||||||||||
Val | Glu | Glu | Pro | Lys | Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu | ser |
690 | 695 | 700 | |||||||||||||
Glu | Thr | Gly | Asn | Ser | Thr | Ser | Asn | ser | Thr | Leu | Glu | Glu | val | Pro | Thr |
705 | 710 | 715 | 720 | ||||||||||||
Val | Asp | Pro | val | Gin | Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly |
725 | 730 | 735 | |||||||||||||
Met | Lys | Leu | Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu |
740 | 745 | 750 | |||||||||||||
Tyr | Leu | Pro | Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr |
755 | 760 | 765 | |||||||||||||
Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly |
770 | 775 | 780 | |||||||||||||
Lys | Val | ser | Thr | Gly | Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro |
785 | 790 | 795 | 800 | ||||||||||||
Ala | Asp | ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | val | Lys | Pro | Glu |
805 | 810 | 815 | |||||||||||||
Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser |
820 | 825 | Ala | 830 | ||||||||||||
Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu | Pro | Ala | val | Asp | Pro | |
835 | 840 | 845 | |||||||||||||
val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Al a | Ser | Tyr | Gly | Leu | Gly | Leu |
850 | 855 | 860 | |||||||||||||
Asp | Ser | val | Ile | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro |
865 | 870 | 875 | 880 | ||||||||||||
Ser | Gly | Glu | Val | ile | Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | ||
885 | 890 |
<210> 338 <211> 888 <212> PRT • «
-tet <213> Unknown <22O>
<223> VP 113 <400> 338
Met 1 | Gin Ile | Thr Tyr Thr Asp 5 | Asp | Glu | ile Gin 10 | val | Ala | Lys | Leu 15 | Ala | |||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | Ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Gl u | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | Asn | ile | Lys | Phe |
100 | 105 | 110 | |||||||||||||
Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu |
115 | 120 | 125 | |||||||||||||
Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr | val | Glu | Pro | Arg | Asn | Ala |
130 | 135 | 140 | |||||||||||||
Ser | ASp | His | val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Glu | ASP | Lys | Glu | Hi s | ASp | Glu | val | Ser | Glu | Pro | Thr | His | Pro | Glu | Ser |
165 | 170 | 175 | |||||||||||||
Asp | Glu | Lys | Glu | Asn | Hi S | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn | Leu |
180 | 185 | 190 | |||||||||||||
Tyr | Lys | pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu | Asp |
195 | 200 | 205 | |||||||||||||
Thr | Thr | ASp | Glu | Ala | Glu | Ile | Pro | Gly | Thr | Pro | Ser | ile | Arg | Gin | Asn |
210 | 215 | 220 | |||||||||||||
Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr |
225 | 230 | 235 | 240 | ||||||||||||
Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | val | Asp | Ser | Leu | Leu | Ala | Leu |
245 | 250 | 255 | |||||||||||||
Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | Ile | Gin | Gly | Pro | Gin | Ile | Gly | Gin |
260 | 265 | 270 | |||||||||||||
Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr | Pro | Ser | Pro | Ser | Leu | Pro |
275 | 280 | 285 | |||||||||||||
Ile | Asn | Pro | Gly | Thr | Ser | Hi s | Glu | Lys | His | Glu | Glu | ASp | Gly | Tyr | Gly |
290 | 295 | 300 | |||||||||||||
Phe | Asp | Ala | Asn | Arg | ile | Ile | Ala | Glu | Asp | Glu | Ser | Gly | Phe | Val | Met |
305 | 310 | 315 | 320 | ||||||||||||
Ser | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala |
325 | 330 | 335 | |||||||||||||
Gin | Lys | His | Leu | Glu | Glu | val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | ser |
340 | 345 | 350 | |||||||||||||
Leu | ser | ser | His | Glu | Gin | Asp | Tyr | pro | Gly | Asn | Ala | Lys | Glu | Met | Lys |
355 | 360 | 365 | |||||||||||||
Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys | ile | Ala | Gly | Ile | Met | Lys | Gin |
370 | 375 | 380 | |||||||||||||
Tyr | Gly | Val | Lys | Arg | Glu | Ser | Ile | val | val | Asn | Lys | Glu | Lys | Asn | Ala |
385 | 390 | 395 | 400 | ||||||||||||
Ile | Ile | Tyr | Pro | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | Val | Gly | Ile |
405 | 410 | 415 | |||||||||||||
Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly | val |
420 | 425 | 430 | |||||||||||||
Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn |
435 | 440 | 445 | |||||||||||||
Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr |
450 | 455 | 460 | |||||||||||||
Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | ser | Phe | Ser | Phe | Pro | Pro | Glu | Leu |
465 | 470 | 475 | 480 | ||||||||||||
Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | val | Lys | Leu | Ile | Thr | Pro | ASp |
485 | 490 | 495 |
• 9 « ·
xcř ·' | • | • · | • | • · | « * | ||||||||
Gly Lys | Val | Leu | Glu | Lys | val | Ser | Gly Lys val | Phe | Gly Glu Gly | val | |||
500 | 505 | 510 | |||||||||||
Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp Gin Pro | Tyr | Leu | Pro Gly | Gin | |
515 | 520 | 525 | |||||||||||
Thr | Phe | Lys | Tyr | Thr | ile | Ala | Ser | Lys Asp Tyr | Pro | Glu | val | Ser | Tyr |
530 | 535 | 540 | |||||||||||
Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser Leu Ala | Tyr | Lys | Met | Ala | Ser |
545 | 550 | 555 | 560 | ||||||||||
Gin | Thr | ile | Phe | Tyr | Pro | Phe | His | Ala Gly Asp | Thr | Tyr | Leu | Arg | Val |
565 | 570 | 575 | |||||||||||
Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly Thr Asp | Ala | Leu | val | Arg | Val |
580 | 585 | 590 | |||||||||||
Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr Leu Glu | Asn | Asn | Tyr | Lys | val |
595 | 600 | 605 | |||||||||||
Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys Leu Asn | Gin | Gly | Thr | Thr | Arg |
610 | 615 | 620 | |||||||||||
Thr | Ala | Gly | Asn | Lys | Ile | Pro | val | Thr Phe Met | Ala | Asn | Ala | Tyr | Leu |
625 | 630 | 635 | 640 | ||||||||||
Asp | Asn | Gin | Ser | Thr | Tyr | Ile | val | Glu Val Pro | Ile | Leu | Glu | Lys | Glu |
645 | 650 | 655 | |||||||||||
Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu Pro Gin | Phe | Lys | Arg | Asn | Lys |
660 | 665 | 670 | |||||||||||
Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu Lys Val | Glu | Glu | Pro | Lys | Thr |
675 | 680 | 685 | |||||||||||
Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu Ser Glu | Thr | Gly | Asn | Ser | Thr |
690 | 695 | 700 | |||||||||||
Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro Thr val | Asp | Pro | val | Gin | Glu |
705 | 710 | 715 | 720 | ||||||||||
Lys | val | Ala | Lys | Phe | Al a | Glu | Ser | Tyr Gly Met | Lys | Leu | Glu | Asn | val |
725 | 730 | 735 | |||||||||||
Leu | Phe | Asn | Met | ASp | Gly | Thr | Ile | Glu Leu Tyr | Leu | Pro | Ser | Gly | Glu |
740 | 745 | 750 | |||||||||||
Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe Thr Gly | Glu | Ala | Pro | Gin | Gly |
755 | 760 | 765 | |||||||||||
Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn Gly Lys | val | Ser | Thr | Gly | Thr |
770 | 775 | 780 | |||||||||||
Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys Pro Ala | Asp | ser | Leu | Pro | Glu |
785 | 790 | 795 | 800 | ||||||||||
Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro Glu Asn | Ser | Thr | Asp | Asn | Gly |
805 | 810 | 815 | |||||||||||
Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly Ser Asp | Pro | Met | Leu | ASp | Pro |
820 | 825 | 830 | |||||||||||
Ala | Leu | Glu | Glu | Ala | Pro | Ala | val | Asp Pro val | Gin | Glu | Lys | Leu | Glu |
835 | 840 | 845 | |||||||||||
Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly Leu Asp | Ser | val | Ile | Phe | Asn |
850 | 855 | 860 | |||||||||||
Met | ASp | Gly | Thr | Ile | Glu | Leu | Arg | Leu Pro ser | Gly | Glu | val | ile | Lys |
865 | 870 | 875 | 880 | ||||||||||
Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | ||||||
885 |
<210> 339 <211> 900 <212> PRT <213> Unknown <220>
<223> VP 114 <400> 339
Met Gin ile Thr Tyr Thr Asp Asp Glu Ile Gin val Ala Lys Leu Ala 15 10 15
Gly Lys Tyr Thr Thr Glu Asp Gly Tyr Ile Phe Asp Thr Ser Trp ile 20 25 30
Lys Lys Asp ser Leu Ser Glu Ala Glu Arg Ala Ala Ala Gin Ala Tyr 35 40 45
Ala Lys Glu Lys Gly Leu Thr Pro Pro Ser Thr Asp His Gin Asp ser • 4 • ·
4 | • « | • | • · | • · | |||||||||||
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | pro | Ser | Tyr | Asp | Ser |
100 | 105 | 110 | |||||||||||||
Tyr | His | Asn | ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
val | Glu | Pro | Arg | Asn | Ala | ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | Hi S | Asp | Glu | val | ser | Glu |
His | 165 | 170 | 175 | ||||||||||||
Pro | Thr | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn | |
180 | 185 | 190 | |||||||||||||
Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | val |
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | ser | Gin | Pro | Ala | Pro | Ile | Gin |
260 | 265 | 270 | |||||||||||||
Gly | Pro | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | ser | Leu | Ala | Thr |
275 | 280 | 285 | |||||||||||||
Pro | ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | Hi S | Glu | Lys | His |
290 | 295 | 300 | |||||||||||||
Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | Asp |
305 | 310 | 315 | 320 | ||||||||||||
Glu | Ser | Gly | Phe | Val | Met | Ser | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu |
325 | 330 | 335 | |||||||||||||
Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu | Glu | val | Lys | Thr | Ser |
340 | 345 | 350 | |||||||||||||
His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr | Pro | Gly |
355 | 360 | 365 | |||||||||||||
Asn | Ala | Lys | Gl u | Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys | Ile |
370 | 375 | 380 | |||||||||||||
Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg | Glu | Ser | ile | Val | val |
385 | 390 | 395 | 400 | ||||||||||||
Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | Hi S | Gly | Asp | His | His | His |
405 | 410 | 415 | |||||||||||||
Ala | Asp | Pro | ile | Asp | Glu | His | Lys | Pro | Val | Gly | Ile | Gly | His | Ser | His |
420 | 425 | 430 | |||||||||||||
Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly | Val | Ala | Lys | Lys | Glu |
435 | 440 | 445 | |||||||||||||
Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn | Val | Val | Asn | Leu |
450 | 455 | 460 | |||||||||||||
Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly |
465 | 470 | 475 | 480 | ||||||||||||
Gin | Lys | Arg | val | ser | Phe | ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys | Leu |
485 | 490 | 495 | |||||||||||||
Gly | ile | Asn | Met | Leu | Val | Lys | Leu | ile | Thr | Pro | Asp | Gly | Lys | val | Leu |
500 | 505 | 510 | |||||||||||||
Glu | Lys | Val | Ser | Gly | Lys | val | phe | Gly | Glu | Gly | val | Gly | Asn | Ile | Ala |
515 | 520 | 525 | |||||||||||||
Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr |
530 | 535 | 540 | |||||||||||||
Thr | ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser | Tyr | Asp | Gly | Thr | Phe |
545 | 550 | 555 | 560 | ||||||||||||
Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala | Ser | Gin | Thr | Ile | Phe |
565 | 570 | 575 | |||||||||||||
Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg | Val | Asn | Pro | Gin | Phe |
580 | 585 | 590 | |||||||||||||
Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg | Val | Phe | Asp | Gl u | Phe |
• · · ·
595 | 600 | 605 | |||||||||||||
His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | val | Gly | Glu | ile | Lys |
610 | 615 | 620 | |||||||||||||
Leu | Pro | ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly | Asn |
625 | 630 | 635 | 640 | ||||||||||||
Lys | ile | Pro | Val | Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser |
645 | 650 | 655 | |||||||||||||
Thr | Tyr | ile | val | Glu | val | Pro | ile | Leu | Glu | Lys | Glu | Asn | Gin | Thr | Asp |
660 | 665 | 670 | |||||||||||||
Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu | Asn |
675 | 680 | 685 | |||||||||||||
Ser | Lys | Leu | Asp | Glu | Lys | val | Glu | Glu | Pro | Lys | Thr | Ser | Glu | Lys | Val |
690 | 695 | 700 | |||||||||||||
Glu | Lys | Glu | Lys | Leu | ser | Glu | Thr | Gly | Asn | Ser | Thr | Ser | Asn | Ser | Thr |
705 | 710 | 715 | 720 | ||||||||||||
Leu | Glu | Glu | Val | Pro | Thr | val | Asp | Pro | val | Gin | Glu | Lys | Val | Ala | Lys |
725 | 730 | 735 | |||||||||||||
Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn | Val | Leu | Phe | Asn | Met |
740 | 745 | 750 | |||||||||||||
Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly | Glu | val | Ile | Lys | Lys |
755 | 760 | 765 | |||||||||||||
Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn |
770 | 775 | 780 | |||||||||||||
Lys | Pro | ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly | Thr | Val | Glu | Asn | Gin |
785 | 790 | 795 | 800 | ||||||||||||
Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu |
805 | 810 | 815 | |||||||||||||
Lys | Pro | val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro |
820 | 825 | 830 | |||||||||||||
Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu |
835 | 840 | 845 | |||||||||||||
Al a | Pro | Ala | val | Asp | Pro | val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Ala |
850 | 855 | 860 | |||||||||||||
Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | val | ile | Phe | Asn | Met | Asp | Gly | Thr |
865 | 870 | 875 | 880 | ||||||||||||
Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val | ile | Lys | Lys | Asn | Leu | Ser |
885 | 890 | 895 | |||||||||||||
Asp | Phe | ile | Ala |
900 <210> 340 <211> 894 <212> PRT <213> Unknown <220>
<223> VP 115 <400> 340
Met | Gin | ile | Thr | Tyr | Thr | Asp | Asp | Glu | ile | Gin | val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Al a | ile | Tyr | Asn | Arg | val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | val | Lys | Asn | Gly | Ser | Leu | Ile | ile | Pro | Ser | Tyr | Asp | Ser |
100 | 105 | 110 | |||||||||||||
Tyr | His | Asn | ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
130 135 140
Val | Glu | Pro | Arg | Asn | Ala | Ser |
145 Gin | Asp | Ser | Lys | Pro | 150 ASp | Glu |
Pro | Thr | His | Pro | 165 Glu | Ser | Asp |
Pro | Ser | Ala | 180 Asp | Asn | Leu | Tyr |
Glu | Glu | 195 Glu | Ala | Glu | Asp | Thr |
Pro | 210 ser | Ile | Arg | Gin | Asn | 215 Ala |
225 Ser | Leu | Leu | Leu | Gly | 230 Thr | Lys |
Asp | ser | Leu | Leu | 245 Ala | Leu | Leu |
Gly | Pro | Gin | 260 Ile | Gly | Gin | Pro |
Pro | Ser | 275 Pro | Ser | Leu | Pro | Ile |
Glu | 290 Glu | Asp | Gly | Tyr | Gly | 295 Phe |
305 Glu | Ser | Gly | Phe | val | 310 Met | Ser |
Glu | Gin | ile | Lys | 325 Ala | Ala | Gin |
His | Asn | Gly | 340 Leu | Asp | Ser | Leu |
Asn | Ala | 355 Lys | Glu | Met | Lys | Asp |
Ala | 370 Gly | Ile | Met | Lys | Gin | 375 Tyr |
385 Asn | Lys | Glu | Lys | Asn | 390 Ala | ile |
His | Lys | Pro | Val | 405 Gly | ile | Gly |
Lys | Pro | Glu | 420 Glu | Gly | val | Ala |
Gly | Glu | 435 Glu | Leu | Thr | Asn | Val |
Asn | 450 Asn | Gin | Asn | Phe | Thr | 455 Leu |
465 Ser | Phe | Pro | Pro | Glu | 470 Leu | Glu |
Lys | Leu | Ile | Thr 500 Glu | 485 Pro | Asp | Gly |
val | Phe | Gly 515 Leu | Gly | val | Gly | |
Pro | Tyr | Pro | Gly | Gin | Thr | |
Tyr | 530 Pro | Glu | Val | Ser | Tyr | 535 ASp |
545 Ala | Tyr | Lys | Met | Ala | 550 Ser | Gin |
Asp | Thr | Tyr | Leu | 565 Arg | val | Asn |
Asp | Ala | Leu | 580 val | Arg | Val | Phe |
Glu | Asn | 595 Asn | Tyr | Lys | Val | Gly |
Asn | 610 Gin | Gly | Thr | Thr | Arg | 615 Thr |
625 Met | Ala | Asn | Ala | Tyr | 630 Leu | Asp |
Pro | Ile | Leu | Glu | 645 Lys | Gl u | Asn |
Gin | Phe | Lys | 660 Arg | Asn | Lys | Ala |
675 |
• · 4CC | • · • • • · • · · | • · • · » « · • · | » · · • • • • » • · | • · * • • · • • · | • · 9 · • · « · • · • · | • · · · • • • · • « | |
HÍS | Val | Arg 155 | Lys | Asn | Lys | Ala | Asp 160 |
Lys | Glu 170 | Hi S | Asp | Glu | val | Ser 175 | Glu |
Lys 185 | Glu | Asn | HÍS | Ala | Gly 190 | Leu | Asn |
Pro | Ser | Thr | Asp | Thr 205 | Glu | Glu | Thr |
Asp | Glu | Ala | Glu 220 | Ile | Pro | Gly | Thr |
Glu | Thr | Leu 235 | Thr | Gly | Leu | Lys | Ser 240 |
Asn | Asn 250 | Thr | Ile | Ser | Ala | Glu 255 | Val |
Glu 265 | Ser | Gin | Pro | Ala | Pro 270 | Ile | Gin |
Leu | Pro | Asn | Asn | Ser 285 | Leu | Ala | Thr |
Pro | Gly | Thr | Ser 300 | His | Glu | Lys | His |
Ala | Asn | Arg 315 | Ile | Ile | Ala | Glu | Asp 320 |
Phe | Phe 330 | Lys | Lys | Asp | Leu | Thr 335 | Glu |
His 345 | Leu | Glu | Glu | val | Lys 350 | Thr | Ser |
Ser | His | Glu | Gin | Asp 365 | Tyr | Pro | Gly |
Asp | Lys | Lys | Ile 380 | Glu | Glu | Lys | Ile |
val | Lys | Arg 395 | Glu | Ser | ile | val | Val 400 |
Tyr | Pro 410 | Ala | Asp | Pro | Ile | Asp 415 | Glu |
Ser 425 | His | Ser | Asn | Tyr | Glu 430 | Leu | Phe |
Lys | Glu | Gly | Asn | Lys 445 | val | Tyr | Thr |
Asn | Leu | Leu | Lys 460 | Asn | Ser | Thr | Phe |
Asn | Gly | Gin 475 | Lys | Arg | Val | Ser | Phe 480 |
Lys | Leu 490 | Gly | ile | Asn | Met | Leu 495 | val |
val 505 | Leu | Glu | Lys | val | Ser 510 | Gly | Lys |
Ile | Ala | Asn | Phe | Glu 525 | Leu | Asp | Gin |
Lys | Tyr | Thr | ile 540 | Ala | Ser | Lys | Asp |
Thr | Phe | Thr 555 | val | Pro | Thr | Ser | Leu 560 |
Ile | Phe 570 | Tyr | Pro | Phe | His | Ala 575 | Gly |
Gin 585 | Phe | Ala | Val | Pro | Lys 590 | Gly | Thr |
Glu | Phe | Hi s | Gly | Asn 605 | Ala | Tyr | Leu |
ile | Lys | Leu | Pro 620 | ile | Pro | Lys | Leu |
Gly | Asn | Lys 635 | Ile | Pro | Val | Thr | Phe 640 |
Gin | Ser 650 | Thr | Tyr | ile | val | Glu 655 | val |
Thr 665 | Asp | Lys | Pro | Ser | ile 670 | Leu | Pro |
Glu | Asn | Ser | Lys | Leu 685 | ASp | Glu | Lys |
« · • · · ·
4 | iÝ | ► · · | « · | • | • · | • · | |||||||||
Val | Glu | Glu | Pro | Lys | Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu | Ser |
690 | 695 | 700 | |||||||||||||
Glu | Thr | Gly | Asn | Ser | Thr | Ser | Asn | ser | Thr | Leu | Glu | Glu | Val | Pro | Thr |
705 | 710 | 715 | 720 | ||||||||||||
Val | Asp | Pro | val | Gin | Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly |
725 | 730 | 735 | |||||||||||||
Met | Lys | Leu | Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu |
740 | 745 | 750 | |||||||||||||
Tyr | Leu | Pro | Ser | Gly | Glu | val | ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr |
755 | 760 | 765 | |||||||||||||
Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly |
770 | 775 | 780 | |||||||||||||
Lys | Val | Ser | Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro |
785 | 790 | 795 | 800 | ||||||||||||
Ala | Asp | Ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu |
805 | 810 | 815 | |||||||||||||
Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser |
820 | 825 | 830 | |||||||||||||
Asp | Pro | Met | Leu | Asp | pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro |
835 | 840 | 845 | |||||||||||||
val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Ala | ser | Tyr | Gly | Leu | Gly | Leu |
850 | 855 | 860 | |||||||||||||
Asp | Ser | val | ile | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro |
865 | 870 | 875 | 880 | ||||||||||||
ser | Gly | Glu | val | ile | Lys | Lys | Asn | Leu | Ser | ASp | Phe | Ile | Ala |
885 890 <210> 341 <211> 900 <212> PRT <213> Unknown <220>
<223> VP 116 <400> 341
Met | Gin | ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | Ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | Val | Glu | Val | Lys | Asn | Gly | ser | Leu | Ile | ile | Pro | ser | Tyr | Asp | His |
100 | 105 | 110 | |||||||||||||
Tyr | Ser | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
val | Glu | Pro | Arg | Asn | Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | Hi S | ASp | Glu | Val | Ser | Glu |
165 | 170 | 175 | |||||||||||||
Pro | Thr | Hi s | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | HÍS | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
Pro | Ser | Ala | ASp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | ile | Ser | Ala | Glu | val |
• · · · • · · ·
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | Ile | Gin |
260 | 265 | 270 | |||||||||||||
Gly | Pro | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr |
275 | 280 | 285 | |||||||||||||
Pro | ser | Pro | ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His |
290 | 295 | 300 | |||||||||||||
Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | ile | Ile | Ala | Glu | Asp |
305 | 310 | 315 | 320 | ||||||||||||
Glu | Ser | Gly | Phe | Val | Met | Ser | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu |
325 | 330 | 335 | |||||||||||||
Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu | Glu | val | Lys | Thr | Ser |
340 | 345 | 350 | |||||||||||||
His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | Hi s | Glu | Gin | Asp | Tyr | Pro | Gly |
355 | 360 | 365 | |||||||||||||
Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys | Ile |
370 | 375 | 380 | |||||||||||||
Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val | Lys | Arg | Glu | ser | Ile | Val | Val |
385 | 390 | 395 | 400 | ||||||||||||
Asn | Lys | Glu | Lys | Asn | Ala | ile | Ile | Tyr | Pro | His | Gly | Asp | His | His | His |
405 | 410 | 415 | |||||||||||||
Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | val | Gly | Ile | Gly | His | Ser | His |
420 | 425 | 430 | |||||||||||||
Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly | val | Ala | Lys | Lys | Glu |
435 | 440 | 445 | |||||||||||||
Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn | Val | Val | Asn | Leu |
450 | 455 | 460 | |||||||||||||
Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly |
465 | 470 | 475 | 480 | ||||||||||||
Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys | Leu |
485 | 490 | 495 | |||||||||||||
Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | ile | Thr | Pro | Asp | Gly | Lys | Val | Leu |
500 | 505 | 510 | |||||||||||||
Glu | Lys | val | Ser | Gly | Lys | val | Phe | Gly | Glu | Gly | val | Gly | Asn | Ile | Ala |
515 | 520 | 525 | |||||||||||||
Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr |
530 | 535 | 540 | |||||||||||||
Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser | Tyr | Asp | Gly | Thr | Phe |
545 | 550 | 555 | 560 | ||||||||||||
Thr | val | Pro | Thr | Ser | Leu | Al a | Tyr | Lys | Met | Ala | ser | Gin | Thr | Ile | Phe |
565 | 570 | 575 | |||||||||||||
Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg | val | Asn | Pro | Gin | Phe |
580 | 585 | 590 | |||||||||||||
Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg | val | Phe | Asp | Glu | Phe |
595 | 600 | 605 | |||||||||||||
Hi s | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | val | Gly | Glu | Ile | Lys |
610 | 615 | 620 | |||||||||||||
Leu | Pro | ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly | Asn |
625 | 630 | 635 | 640 | ||||||||||||
Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser |
645 | 650 | 655 | |||||||||||||
Thr | Tyr | Ile | val | Glu | Val | Pro | ile | Leu | Glu | Lys | Glu | Asn | Gin | Thr | Asp |
660 | 665 | 670 | |||||||||||||
Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu | Asn |
675 | 680 | 685 | |||||||||||||
Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu | Pro | Lys | Thr | ser | Glu | Lys | val |
690 | 695 | 700 | |||||||||||||
Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser | Thr | ser | Asn | Ser | Thr |
705 | 710 | 715 | 720 | ||||||||||||
Leu | Glu | Glu | val | Pro | Thr | Val | Asp | Pro | val | Gin | Glu | Lys | val | Ala | Lys |
725 | 730 | 735 | |||||||||||||
Phe | Ala | Glu | ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn | Val | Leu | Phe | Asn | Met |
740 | 745 | 750 | |||||||||||||
Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly | Glu | Val | Ile | Lys | Lys |
755 | 760 | 765 | |||||||||||||
Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn |
770 | 775 | 780 | |||||||||||||
Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly | Thr | val | Glu | Asn | Gin |
785 | 790 | 795 | 800 | ||||||||||
Pro Thr Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu |
805 | 810 | 815 | |||||||||||
Lys Pro val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro |
820 | 825 | 830 | |||||||||||
Glu Gly Asn | Val | Gly | Ser | Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu |
835 | 840 | 845 | |||||||||||
Ala Pro Ala | Val | Asp | Pro | val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Ala |
850 | 855 | 860 | |||||||||||
ser Tyr Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | Phe | Asn | Met | ASp | Gly | Thr |
865 | 870 | 875 | 880 | ||||||||||
Ile Glu Leu | Arg | Leu | Pro | Ser | Gly | Glu | val | Ile | Lys | Lys | Asn | Leu | Ser |
885 | 890 | 895 | |||||||||||
Asp Phe ile | Ala | ||||||||||||
900 | |||||||||||||
<210> 342 | |||||||||||||
<211> 894 <212> PRT | |||||||||||||
<213> Unknown | |||||||||||||
<220> | |||||||||||||
<223> VP 117 |
<400> 342 | |||||||||||||||
Met | Gin | Ile | Thr | Tyr | Thr | ASp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | ASp | Gly | Tyr | ile | Phe | Asp | Thr | Ser | Trp | ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Al a | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | ile | Tyr | Asn | Arg | val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Al a | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | val | Lys | Asn | Gly | Ser | Leu | Ile | ile | Pro | Ser | Tyr | ASp | His |
100 | 105 | 110 | |||||||||||||
Tyr | Ser | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
Val | Glu | Pro | Arg | Asn | Ala | Ser | Asp | Hi s | val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu | val | Ser | Glu |
165 | 170 | 175 | |||||||||||||
Pro | Thr | His | Pro | Gl u | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | ser | Thr | Asp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | ile | Gin |
260 | 265 | 270 | |||||||||||||
Gly | Pro | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr |
275 | 280 | 285 | |||||||||||||
Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His |
290 | 295 | 300 | |||||||||||||
Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | ile | Ala | Glu | Asp |
305 | 310 | 315 | 320 |
• · · · φ · · · · · · · • · · · · ♦ ··· • · · · · · · · * · · • · ··»· · · · ····· ·· ·· * · ··
-íio
Glu | Ser Gly Phe val 325 | Met | Ser Tyr pne Phe 330 | Lys Lys Asp Leu | Thr 335 | Glu | |||||||||
Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu | Glu | val | Lys | Thr | Ser |
340 | 345 | 350 | |||||||||||||
His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr | Pro | Gly |
355 | 360 | 365 | |||||||||||||
Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys | ile |
370 | 375 | 380 | |||||||||||||
Ala | Gly | ile | Met | Lys | Gin | Tyr | Gly | Val | Lys | Arg | Glu | Ser | Ile | Val | Val |
385 | 390 | 395 | 400 | ||||||||||||
Asn | Lys | Glu | Lys | Asn | Ala | ile | ile | Tyr | Pro | Ala | Asp | Pro | Ile | Asp | Glu |
405 | 410 | 415 | |||||||||||||
Hi S | Lys | Pro | Val | Gly | ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe |
420 | 425 | 430 | |||||||||||||
Lys | Pro | Glu | Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr |
435 | 440 | 445 | |||||||||||||
Gly | Glu | Glu | Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe |
450 | 455 | 460 | |||||||||||||
Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe |
465 | 470 | 475 | 480 | ||||||||||||
Ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | val |
485 | 490 | 495 | |||||||||||||
Lys | Leu | ile | Thr | Pro | Asp | Gly | Lys | val | Leu | Glu | Lys | val | Ser | Gly | Lys |
500 | 505 | 510 | |||||||||||||
val | Phe | Glv | Glu | Gly | val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin |
515 | 520 | 525 | |||||||||||||
Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp |
530 | 535 | 540 | |||||||||||||
Tyr | Pro | Glu | val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu |
545 | 550 | 555 | 560 | ||||||||||||
Ala | Tyr | Lys | Met | Ala | Ser | Gin | Thr | ile | Phe | Tyr | Pro | Phe | His | Ala | Gly |
565 | 570 | 575 | |||||||||||||
Asp | Thr | Tyr | Leu | Arg | val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr |
580 | 585 | 590 | |||||||||||||
Asp | Ala | Leu | val | Arg | val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu |
595 | 600 | 605 | |||||||||||||
Glu | Asn | Asn | Tyr | Lys | val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | pro | Lys | Leu |
610 | 615 | 620 | |||||||||||||
Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | val | Thr | Phe |
625 | 630 | 635 | 640 | ||||||||||||
Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | val | Glu | Val |
645 | 650 | 655 | |||||||||||||
Pro | Ile | Leu | Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro |
660 | 665 | 670 | |||||||||||||
Gin | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys |
675 | 680 | 685 | |||||||||||||
Val | Glu | Glu | Pro | Lys | Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu | Ser |
690 | 695 | 700 | |||||||||||||
Glu | Thr | Gly | Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr |
705 | 710 | 715 | 720 | ||||||||||||
Val | Asp | Pro | val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | ser | Tyr | Gly |
725 | 730 | 735 | |||||||||||||
Met | Lys | Leu | Glu | Asn | val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu |
740 | 745 | 750 | |||||||||||||
Tyr | Leu | Pro | Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr |
755 | 760 | 765 | |||||||||||||
Gly | Gl u | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly |
770 | 775 | 780 | |||||||||||||
Lys | val | ser | Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro |
785 | 790 | 795 | 800 | ||||||||||||
Ala | Asp | Ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | val | Lys | Pro | Glu |
805 | 810 | 815 | |||||||||||||
Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser |
820 | 825 | 830 | |||||||||||||
Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | val | Asp | Pro |
835 | 840 | 845 | |||||||||||||
Val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Al a | Ser | Tyr | Gly | Leu | Gly | Leu |
850 | 855 | 860 |
·· ··
4M
Asp Ser Val Ile Phe Asn Met Asp Gly Ťhr ile Glu Leu Arg Leu Pro 865 870 875 880
Ser Gly Glu Val Ile Lys Lys Asn Leu Ser Asp Phe Ile Ala
885 890 <210> 343 <211> 901 <212> PRT <213> Unknown <220>
<223> VP 119 <400> 343
Met Gin ile Thr Tyr | Thr Asp Asp | Glu Ile Gin Val Ala Lys Leu | Ala | ||||||||||||
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | Ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | ile | Tyr | Asn | Arg | val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Al a | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | Val | Glu | val | Lys | Asn | Gly | Ser | Leu | ile | ile | Pro | His | Tyr | Asp | HÍ 5 |
100 | 105 | 110 | |||||||||||||
Tyr | Hi S | Asn | ile | Lys | Phe | Gl u | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
val | Glu | Pro | Arg | Asn | Ala | Ser | Asp | His | val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | ASp | Glu | Val | Ser | Glu |
165 | 170 | 175 | |||||||||||||
Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | Hi S | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | ASp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | Ile | Gin |
260 | 265 | 270 | |||||||||||||
Ser | Gly | Pro | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
275 | 280 | 285 | |||||||||||||
Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys |
290 | 295 | 300 | |||||||||||||
His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | ile | ile | Ala | Glu |
305 | 310 | 315 | 320 | ||||||||||||
ASP | Glu | Ser | Gly | Phe | val | Met | Ser | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr |
325 | 330 | 335 | |||||||||||||
Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | HÍS | Leu | Glu | Glu | val | Lys | Thr |
340 | 345 | 350 | |||||||||||||
Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr | Pro |
355 | 360 | 365 | |||||||||||||
Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys |
370 | 375 | 380 | |||||||||||||
ile | Ala | Gly | ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg | Glu | Ser | Ile | val |
385 | 390 | 395 | 400 | ||||||||||||
Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | His | Gly | Asp | His | His |
405 | 410 | 415 |
• · · ·
HiS | Ala Asp | Pro Ile 420 | Asp | Glu | His | Lys Pro 425 | Val | Gly | ile | Gly 430 | His | ser | |||
His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly | val | Ala | Lys | Lys |
435 | 440 | 445 | |||||||||||||
Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Gl u | Glu | Leu | Thr | Asn | val | val | Asn |
450 | 455 | 460 | |||||||||||||
Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn |
465 | 470 | 475 | 480 | ||||||||||||
Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys |
485 | 490 | 495 | |||||||||||||
Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr | Pro | Asp | Gly | Lys | val |
500 | 505 | 510 | |||||||||||||
Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly | Val | Gly | Asn | Ile |
515 | 520 | 525 | |||||||||||||
Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys |
530 | 535 | 540 | |||||||||||||
Tyr | Thr | ile | Ala | ser | Lys | Asp | Tyr | Pro | Glu | val | Ser | Tyr | Asp | Gly | Thr |
545 | 550 | 555 | 560 | ||||||||||||
Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala | Ser | Gin | Thr | Ile |
565 | 570 | 575 | |||||||||||||
phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg | Val | Asn | Pro | Gin |
580 | 585 | 590 | |||||||||||||
phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg | val | Phe | Asp | Glu |
595 | 600 | 605 | |||||||||||||
phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | val | Gly | Glu | Ile |
610 | 615 | 620 | |||||||||||||
Lys | Leu | Pro | ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly |
625 | 630 | 635 | 640 | ||||||||||||
Asn | Lys | ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin |
645 | 650 | 655 | |||||||||||||
Ser | Thr | Tyr | ile | Val | Glu | Val | Pro | Ile | Leu | Glu | Lys | Gl u | Asn | Gin | Thr |
660 | 665 | 670 | |||||||||||||
Asp | Lys | Pro | ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu |
675 | 680 | 685 | |||||||||||||
Asn | Ser | Lys | Leu | Asp | Glu | Lys | val | Glu | Glu | Pro | Lys | Thr | ser | Glu | Lys |
690 | 695 | 700 | |||||||||||||
val | Glu | Lys | Glu | Lys | Leu | Ser | Gl u | Thr | Gly | Asn | Ser | Thr | ser | Asn | Ser |
705 | 710 | 715 | 720 | ||||||||||||
Thr | Leu | Glu | Glu | val | Pro | Thr | val | Asp | Pro | Val | Gin | Glu | Lys | val | Ala |
725 | 730 | 735 | |||||||||||||
Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn | val | Leu | Phe | Asn |
740 | 745 | 750 | |||||||||||||
Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | pro | Ser | Gly | Glu | val | ile | Lys |
755 | 760 | 765 | |||||||||||||
Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu |
770 | 775 | 780 | |||||||||||||
Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | ser | Thr | Gly | Thr | Val | Glu | Asn |
785 | 790 | 795 | 800 | ||||||||||||
Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro | Glu | Ala | pro | Asn |
805 | 810 | 815 | |||||||||||||
Glu | Lys | Pro | val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn |
820 | 825 | 830 | |||||||||||||
Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu |
835 | 840 | 845 | |||||||||||||
Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr |
850 | 855 | 860 | |||||||||||||
Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | ser | val | ile | Phe | Asn | Met | Asp | Gly |
865 | 870 | 875 | 880 | ||||||||||||
Thr | ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val | Ile | Lys | Lys | Asn | Leu |
885 | 890 | 895 | |||||||||||||
Ser | Asp | Phe | Ile | Ala | |||||||||||
900 |
<210> 344 <211> 895 <212> PRT <213> Unknown • · · ·
I · · « • · · ·
4W <220>
<223> VP 120
<400> 344 | Thr Tyr Thr 5 | Asp | Asp | Glu | ile Gin val 10 | Ala | Lys | Leu 15 | Ala | ||||||
Met 1 | Gin ile | ||||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | Ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | Val | pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | Hi s | Tyr | Asp | His |
100 | 105 | 110 | |||||||||||||
Tyr | His | Asn | ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
val | Glu | Pro | Arg | Asn | Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu | val | Ser | Glu |
165 | 170 | 175 | |||||||||||||
Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | val |
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | Ile | Gin |
260 | 265 | 270 | |||||||||||||
Ser | Gly | Pro | Gin | ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | ser | Leu | Ala |
275 | 280 | 285 | |||||||||||||
Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys |
290 | 295 | 300 | |||||||||||||
His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Gl u |
305 | 310 | 315 | 320 | ||||||||||||
Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr |
325 | 330 | 335 | |||||||||||||
Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu | Glu | val | Lys | Thr |
340 | 345 | 350 | |||||||||||||
Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr | Pro |
355 | 360 | 365 | |||||||||||||
Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys |
370 | 375 | 380 | |||||||||||||
Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg | Glu | ser | ile | Val |
385 | 390 | 395 | 400 | ||||||||||||
Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | ile | Tyr | Pro | Ala | Asp | Pro | ile | Asp |
405 | 410 | 415 | |||||||||||||
Gl u | His | Lys | Pro | Val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu |
420 | 425 | 430 | |||||||||||||
Phe | Lys | ΡΓΟ | Gl u | Glu | Gly | val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr |
435 | 440 | 445 | |||||||||||||
Thr | Gly | Glu | Glu | Leu | Thr | Asn | val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr |
450 | 455 | 460 | |||||||||||||
Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser |
465 | 470 | 475 | 480 | ||||||||||||
Phe | Ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu |
485 | 490 | 495 | |||||||||||||
val | Lys | Leu | Ile | Thr | Pro | Asp | Gly | Lys | val | Leu | Glu | Lys | val | ser | Gly |
• « · · · · • · · ·
• • · | v • · · | • | • · | • | « · | • · | |||||||||
500 | 505 | 510 | |||||||||||||
Lys | Val | Phe | Gly Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | |
515 | 520 | 525 | |||||||||||||
Gin | Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys |
530 | 535 | 540 | |||||||||||||
Asp | Tyr | Pro | Glu | Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser |
545 | 550 | 555 | 560 | ||||||||||||
Leu | Ala | Tyr | Lys | Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala |
565 | 570 | 575 | |||||||||||||
Gly | Asp | Thr | Tyr | Leu | Arg | val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly |
580 | 585 | 590 | |||||||||||||
Thr | Asp | Ala | Leu | val | Arg | val | Phe | ASp | Glu | Phe | His | Gly | Asn | Ala | Tyr |
595 | 600 | 605 | |||||||||||||
Leu | Glu | Asn | Asn | Tyr | Lys | val | Gly | Glu | ile | Lys | Leu | Pro | Ile | Pro | Lys |
610 | 615 | 620 | |||||||||||||
Leu | Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr |
625 | 630 | 635 | 640 | ||||||||||||
Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | val | Glu |
645 | 650 | 655 | |||||||||||||
val | pro | Ile | Leu | Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu |
660 | 665 | 670 | |||||||||||||
Pro | Gin | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu |
675 | 680 | 685 | |||||||||||||
Lys | Val | Glu | Glu | Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu |
690 | 695 | 700 | |||||||||||||
Ser | Glu | Thr | Gly | Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro |
705 | 710 | 715 | 720 | ||||||||||||
Thr | Val | Asp | Pro | Val | Gin | Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr |
725 | 730 | 735 | |||||||||||||
Gly | Met | Lys | Leu | Glu | Asn | val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu |
740 | 745 | 750 | |||||||||||||
Leu | Tyr | Leu | Pro | Ser | Gly | Glu | val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe |
755 | 760 | 765 | |||||||||||||
Thr | Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn |
770 | 775 | 780 | |||||||||||||
Gly | Lys | Val | Ser | Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys |
785 | 790 | 795 | 800 | ||||||||||||
Pro | Ala | Asp | Ser | Leu | Pro | Glu | Ala | Pro | Asn | Gl U | Lys | Pro | Val | Lys | Pro |
805 | 810 | 815 | |||||||||||||
Gl u | Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly |
820 | 825 | 830 | |||||||||||||
Ser | Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp |
835 | 840 | 845 | |||||||||||||
Pro | val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly |
850 | 855 | 860 | |||||||||||||
Leu | Asp | Ser | Val | Ile | Phe | Asn | Met | Asp | Gly | Thr | ile | Glu | Leu | Arg | Leu |
865 | 870 | 875 | 880 | ||||||||||||
Pro | Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala |
885 890 895 <210> 345 <211> 901 <212> PRT <213> Unknown <220>
<223> VP 121 | |||||||||||||||
<400> 345 | |||||||||||||||
Met | Gin | ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | ile | Phe | Asp | Thr | ser | Trp | Ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Al a | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
55 60 « « 9 · * · »9 · · · ·
Λ5 | • · 9 | • · · · | ·· »· | ||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala Ile | Tyr | Asn | Arg | val | Lys | |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | val | Lys | Asn | Gly | Ser | Leu | ile | Ile | Pro | Ser | Tyr | Asp | Ser |
100 | 105 | 110 | |||||||||||||
Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
val | Glu | Pro | Arg | Asn | Al a | Ser | Asp | His | val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | Ser | Lys | Pro | Asp | Glu | ASp | Lys | Glu | His | Asp | Glu | Val | Ser | Glu |
165 | 170 | 175 | |||||||||||||
Pro | Thr | Hi s | Pro | Gl u | Ser | Asp | Glu | Lys | Glu | Asn | HÍS | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
Pro | ser | Ala | ASp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
245 | 250 | 255 | |||||||||||||
Asp | ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | ile | Gin |
260 | 265 | 270 | |||||||||||||
Ser | Gly | Pro | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
275 | 280 | 285 | |||||||||||||
Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys |
290 | 295 | 300 | |||||||||||||
Hi s | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Al a | Asn | Arg | Ile | Ile | Ala | Glu |
305 | 310 | 315 | 320 | ||||||||||||
Asp | Glu | Ser | Gly | Phe | Val | Met | Ser | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr |
325 | 330 | 335 | |||||||||||||
Glu | Glu | Gin | ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu | Glu | Val | Lys | Thr |
340 | 345 | 350 | |||||||||||||
Ser | Hi s | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr | Pro |
355 | 360 | 365 | |||||||||||||
Gly | Asn | Al a | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys |
370 | 375 | 380 | |||||||||||||
Ile | Ala | Gly | ile | Met | Lys | Gin | Tyr | Gly | Val | Lys | Arg | Glu | Ser | Ile | Val |
385 | 390 | 395 | 400 | ||||||||||||
Val | Asn | Lys | Glu | Lys | Asn | Ala | ile | Ile | Tyr | Pro | His | Gly | Asp | His | Hi S |
405 | 410 | 415 | |||||||||||||
His | Ala | Asp | pro | Ile | Asp | Glu | His | Lys | Pro | Val | Gly | Ile | Gly | His | Ser |
420 | 425 | 430 | |||||||||||||
His | Ser | Asn | Tyr | Gl u | Leu | Phe | Lys | Pro | Glu | Glu | Gly | val | Ala | Lys | Lys |
435 | 440 | 445 | |||||||||||||
Gl u | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn | Val | val | Asn |
450 | 455 | 460 | |||||||||||||
Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn |
465 | 470 | 475 | 480 | ||||||||||||
Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys |
485 | 490 | 495 | |||||||||||||
Leu | Gly | Ile | Asn | Met | Leu | val | Lys | Leu | Ile | Thr | Pro | Asp | Gly | Lys | Val |
500 | 505 | 510 | |||||||||||||
Leu | Glu | Lys | val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly | Val | Gly | Asn | Ile |
515 | 520 | 525 | |||||||||||||
Al a | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys |
530 | 535 | 540 | |||||||||||||
Tyr | Thr | Ile | Ala | Ser | Lys | ASp | Tyr | Pro | Glu | Val | Ser | Tyr | Asp | Gly | Thr |
545 | 550 | 555 | 560 | ||||||||||||
Phe | Thr | val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala | Ser | Gin | Thr | Ile |
565 | 570 | 575 | |||||||||||||
Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg | Val | Asn | Pro | Gin |
580 | 585 | 590 | |||||||||||||
Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg | val | phe | Asp | Glu |
595 | 600 | 605 |
* · · · ···» • “ * » · ♦: : : i z · * : · **.?-* k ··· ·
• · • » « · 9 •06 | • · · • » « · | ||||||||||||||
Phe | His | Gly | Asn | Ala Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | val | Gly | Glu | Ile | |
610 | 615 | 620 | |||||||||||||
Lys | Leu | Pro | ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly |
625 | 630 | 635 | 640 | ||||||||||||
Asn | Lys | ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin |
645 | 650 | 655 | |||||||||||||
Ser | Thr | Tyr | ile | val | Glu | val | Pro | Ile | Leu | Glu | Lys | Glu | Asn | Gin | Thr |
660 | 665 | 670 | |||||||||||||
Asp | Lys | Pro | Ser | ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu |
675 | 680 | 685 | |||||||||||||
Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu | Pro | Lys | Thr | Ser | Glu | Lys |
690 | 695 | 700 | |||||||||||||
Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser | Thr | Ser | Asn | Ser |
705 | 710 | 715 | 720 | ||||||||||||
Thr | Leu | Glu | Glu | val | Pro | Thr | Val | Asp | Pro | val | Gin | Glu | Lys | Val | Ala |
725 | 730 | 735 | |||||||||||||
Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn | val | Leu | Phe | Asn |
740 | 745 | 750 | |||||||||||||
Met | Asp | Gly | Thr | ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly | Glu | val | ile | Lys |
755 | 760 | 765 | |||||||||||||
Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu |
770 | 775 | 780 | |||||||||||||
Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | val | ser | Thr | Gly | Thr | val | Glu | Asn |
785 | 790 | 795 | 800 | ||||||||||||
Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | ser | Leu | Pro | Glu | Ala | Pro | Asn |
805 | 810 | 815 | |||||||||||||
Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn |
820 | 825 | 830 | |||||||||||||
Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu |
835 | 840 | 845 | |||||||||||||
Glu | Ala | Pro | Al a | val | Asp | Pro | Val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr |
850 | 855 | 860 | |||||||||||||
Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | val | ile | Phe | Asn | Met | Asp | Gly |
865 | 870 | 875 | 880 | ||||||||||||
Thr | ile | Glu | Leu | Arg | Leu | Pro | ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Leu |
885 | 890 | 895 | |||||||||||||
Ser | Asp | Phe | ile | Ala |
900 <210> 346 <211> 895 <212> PRT <213> Unknown <220>
<223> VP 122 <400> 346
Met | Gin | ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | Ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | HÍS | Gin | Asp | ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | ile | Tyr | Asn | Arg | val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | Val | Glu | val | Lys | Asn | Gly | Ser | Leu | Ile | ile | Pro | Ser | Tyr | Asp | Ser |
100 | 105 | 110 | |||||||||||||
Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
val | Glu | Pro | Arg | Asn | Ala | Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp |
4» ♦ ·» · « · · · * · ··« ·* ·* ··
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu | val | Ser | Glu |
165 | 170 | 175 | |||||||||||||
Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | ile | Ser | Ala | Gl u | val |
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | Ile | Gin |
260 | 265 | 270 | |||||||||||||
Ser | Gly | Pro | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala |
275 | 280 | 285 | |||||||||||||
Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys |
290 | 295 | 300 | |||||||||||||
His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | ile | Ile | Ala | Glu |
305 | 310 | 315 | 320 | ||||||||||||
Asp | Glu | Ser | Gly | Phe | val | Met | Ser | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr |
325 | 330 | 335 | |||||||||||||
Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu | Glu | Val | Lys | Thr |
340 | 345 | 350 | |||||||||||||
Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | ser | Ser | His | Glu | Gin | Asp | Tyr | Pro |
355 | 360 | 365 | |||||||||||||
Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile | Gl u | Glu | Lys |
370 | 375 | 380 | |||||||||||||
Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg | Glu | Ser | Ile | val |
385 | 390 | 395 | 400 | ||||||||||||
Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | Ala | Asp | Pro | Ile | Asp |
405 | 410 | 415 | |||||||||||||
Gl u | His | Lys | Pro | val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu |
420 | 425 | 430 | |||||||||||||
Phe | Lys | Pro | Glu | Glu | Gly | val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr |
435 | 440 | 445 | |||||||||||||
Thr | Gly | Glu | Glu | Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr |
450 | 455 | 460 | |||||||||||||
Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser |
465 | 470 | 475 | 480 | ||||||||||||
Phe | Ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu |
485 | 490 | 495 | |||||||||||||
Val | Lys | Leu | Ile | Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | ser | Gly |
500 | 505 | 510 | |||||||||||||
Lys | val | Phe | Gly | Glu | Gly | val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp |
515 | 520 | 525 | |||||||||||||
Gin | Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys |
530 | 535 | 540 | |||||||||||||
Asp | Tyr | Pro | Glu | val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser |
545 | 550 | 555 | 560 | ||||||||||||
Leu | Ala | Tyr | Lys | Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala |
565 | 570 | 575 | |||||||||||||
Gly | Asp | Thr | Tyr | Leu | Arg | Val | Asn | Pro | Gl n | Phe | Ala | val | pro | Lys | Gly |
580 | 585 | 590 | |||||||||||||
Thr | Asp | Ala | Leu | val | Arg | Val | Phe | Asp | Gl u | Phe | His | Gly | Asn | Ala | Tyr |
595 | 600 | 605 | |||||||||||||
Leu | Glu | Asn | Asn | Tyr | Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys |
610 | 615 | 620 | |||||||||||||
Leu | Asn | Gl n | Gly | Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | val | Thr |
625 | 630 | 635 | 640 | ||||||||||||
Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu |
645 | 650 | 655 | |||||||||||||
val | Pro | Ile | Leu | Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu |
660 | 665 | 670 | |||||||||||||
Pro | Gin | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu |
675 | 680 | 685 | |||||||||||||
Lys | val | Glu | Glu | pro | Lys | Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu |
• · · · • · · · ··«· · · · * · ·
9 · · · • 9 · | • « • · • · | 9 9 9 | • • 9 9 9 1 | • • » | |||||||||||
9 9 9 · | • • | ||||||||||||||
690 | 695 | 700 | |||||||||||||
Ser | Glu | Thr | Gly | Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro |
705 | 710 | 715 | 720 | ||||||||||||
Thr | Val | Asp | Pro | val | Gin | Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | ser | Tyr |
725 | 730 | 735 | |||||||||||||
Gly | Met | Lys | Leu | Glu | Asn | val | Leu | Phe | Asn | Met | Asp | Gly | Thr | ile | Glu |
740 | 745 | 750 | |||||||||||||
Leu | Tyr | Leu | Pro | Ser | Gly | Glu | Val | ile | Lys | Lys | Asn | Met | Ala | Asp | Phe |
755 | 760 | 765 | |||||||||||||
Thr | Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn |
770 | 775 | 780 | |||||||||||||
Gly | Lys | Val | Ser | Thr | Gly | Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys |
785 | 790 | 795 | 800 | ||||||||||||
Pro | Al a | Asp | ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | val | Lys | Pro |
805 | 810 | 815 | |||||||||||||
Glu | Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly |
820 | 825 | 830 | |||||||||||||
Ser | Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp |
835 | 840 | 845 | |||||||||||||
Pro | Val | Gin | Glu | Lys | Leu | Glu | Lys | phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly |
850 | 855 | 860 | |||||||||||||
Leu | Asp | Ser | val | ile | Phe | Asn | Met | Asp | Gly | Thr | ile | Glu | Leu | Arg | Leu |
865 | 870 | 875 | 880 | ||||||||||||
Pro | Ser | Gly | Glu | val | Ile | Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala |
885 890 895 <210> 347 <211> 895 <212> PRT <213> Unknown <22O>
<223> VP 123 <400> 347
Met | Gin | ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Gl u | Asp | Gly | Tyr | ile | Phe | Asp | Thr | Ser | Trp | ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Al a | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Gl u | val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | Asn | Ile | Lys | Phe |
100 | 105 | 110 | |||||||||||||
Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu |
115 | 120 | 125 | |||||||||||||
Glu | Asp | Leu | Leu | Ala | Thr | val | Lys | Tyr | Tyr | val | Glu | Pro | Arg | Asn | Ala |
130 | 135 | 140 | |||||||||||||
Ser | Asp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Glu | Asp | Lys | Glu | His | Asp | Glu | val | Ser | Glu | Pro | Thr | His | Pro | Glu | Ser |
165 | 170 | 175 | |||||||||||||
Asp | Glu | Lys | Glu | Asn | Hi S | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn | Leu |
180 | 185 | 190 | |||||||||||||
Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu | Asp |
195 | 200 | 205 | |||||||||||||
Thr | Thr | ASp | Glu | Al a | Glu | ile | Pro | Gly | Thr | Pro | Ser | Ile | Arg | Gin | Asn |
210 | 215 | 220 | |||||||||||||
Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr |
225 | 230 | 235 | 240 | ||||||||||||
Lys | Asp | Asn | Asn | Thr | ile | Ser | Ala | Glu | val | Asp | Ser | Leu | Leu | Ala | Leu |
245 | 250 | 255 |
• · ···· ·· · · · ·
• « O? | • · · • • « | • · • • · | • • · • « | • · · • · | • • · • · 4 | • t · | |||||||||
Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | Ile | Gl n | ser | Gly | Pro | Gin | Ile | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr | Pro | Ser | Pro | Ser | Leu |
275 | 280 | 285 | |||||||||||||
Pro | ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | Hi s | Glu | Glu | Asp | Gly | Tyr |
290 | 295 | 300 | |||||||||||||
Gly | Phe | Asp | Ala | Asn | Arq | Ile | Ile | Ala | Glu | Asp | Glu | Ser | Gly | Phe | val |
305 | 310 | 315 | 320 | ||||||||||||
Met | ser | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | ile | Lys | Ala |
325 | 330 | 335 | |||||||||||||
Al a | Gin | Lys | His | Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp |
340 | 345 | 350 | |||||||||||||
Ser | Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met |
355 | 360 | 365 | |||||||||||||
Lys | Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys |
370 | 375 | 380 | |||||||||||||
Gin | Tyr | Gly | Val | Lys | Arg | Glu | Ser | ile | val | val | Asn | Lys | Glu | Lys | Asn |
385 | 390 | 395 | 400 | ||||||||||||
Ala | ile | ile | Tyr | pro | His | Gly | Asp | His | His | His | Ala | Asp | Pro | ile | Asp |
405 | 410 | 415 | |||||||||||||
Glu | His | Lys | Pro | val | Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu |
420 | 425 | 430 | |||||||||||||
Phe | Lys | Pro | Glu | Glu | Gly | val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr |
435 | 440 | 445 | |||||||||||||
Thr | Gly | Glu | Glu | Leu | Thr | Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr |
450 | 455 | 460 | |||||||||||||
Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser |
465 | 470 | 475 | 480 | ||||||||||||
Phe | Ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu |
485 | 490 | 495 | |||||||||||||
val | Lys | Leu | Ile | Thr | Pro | Asp | Gly | Lys | Val | Leu | Gl u | Lys | Val | Ser | Gly |
500 | 505 | 510 | |||||||||||||
Lys | val | Phe | Gly | Glu | Gly | val | Gly | Asn | ile | Al a | Asn | Phe | Glu | Leu | Asp |
515 | 520 | 525 | |||||||||||||
Gin | Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys |
530 | 535 | 540 | |||||||||||||
Asp | Tyr | Pro | Glu | val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | ser |
545 | 550 | 555 | 560 | ||||||||||||
Leu | Ala | Tyr | Lys | Met | Ala | Ser | Gin | Thr | ile | Phe | Tyr | Pro | Phe | His | Ala |
565 | 570 | 575 | |||||||||||||
Gly | Asp | Thr | Tyr | Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly |
580 | 585 | 590 | |||||||||||||
Thr | Asp | Ala | Leu | val | Arg | val | Phe | ASp | Glu | Phe | His | Gly | Asn | Ala | Tyr |
595 | 600 | 605 | |||||||||||||
Leu | Glu | Asn | Asn | Tyr | Lys | val | Gly | Glu | ile | Lys | Leu | Pro | Ile | Pro | Lys |
610 | 615 | 620 | |||||||||||||
Leu | Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | val | Thr |
625 | 630 | 635 | 640 | ||||||||||||
Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | val | Glu |
645 | 650 | 655 | |||||||||||||
val | Pro | ile | Leu | Gl u | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | ser | ile | Leu |
660 | 665 | 670 | |||||||||||||
Pro | Gin | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu |
675 | 680 | 685 | |||||||||||||
Lys | Val | Glu | Glu | Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu |
690 | 695 | 700 | |||||||||||||
Ser | Glu | Thr | Gly | Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro |
705 | 710 | 715 | 720 | ||||||||||||
Thr | Val | Asp | Pro | val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr |
725 | 730 | 735 | |||||||||||||
Gly | Met | Lys | Leu | Gl u | Asn | val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu |
740 | 745 | 750 | |||||||||||||
Leu | Tyr | Leu | Pro | Ser | Gly | Glu | val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe |
755 | 760 | 765 | |||||||||||||
Thr | Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn |
770 | 775 | 780 | |||||||||||||
Gly | Lys | val | Ser | Thr | Gly | Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys |
785 | 790 | 795 | 800 |
• · · · · | • · « « | « · « · | |||||||||||||
Pro | Ala | Asp | Ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | val | Lys | Pro |
805 | 810 | 815 | |||||||||||||
Glu | Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly |
820 | 825 | 830 | |||||||||||||
Ser | Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp |
835 | 840 | 845 | |||||||||||||
Pro | Val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly |
850 | 855 | 860 | |||||||||||||
Leu | Asp | ser | Val | ile | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu |
865 | 870 | 875 | 880 | ||||||||||||
Pro | Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn | Leu | ser | Asp | Phe | ile | Ala |
885 890 895 <210> 348 <211> 889 <212> PRT <213> Unknown <220>
<223> VP 124 <400> 348
Met Gin Ile Thr Tyr Thr | Asp | Asp | Glu Ile Gin val Ala Lys Leu | Ala | |||||||||||
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | Hi S | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | ile | Tyr | Asn | Arg | val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | val | Glu | val | Lys | Asn | Gly | ser | Leu | Ile | ile | Pro | Asn | Ile | Lys | Phe |
100 | 105 | 110 | |||||||||||||
Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu |
115 | 120 | 125 | |||||||||||||
Glu | Asp | Leu | Leu | Ala | Thr | val | Lys | Tyr | Tyr | val | Glu | Pro | Arg | Asn | Ala |
130 | 135 | 140 | |||||||||||||
Ser | Asp | His | val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | ASp | Ser | Lys | Pro | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Glu | Asp | Lys | Glu | His | Asp | Glu | val | Ser | Glu | Pro | Thr | His | Pro | Glu | Ser |
165 | 170 | 175 | |||||||||||||
Asp | Glu | Lys | Glu | Asn | Hi S | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn | Leu |
180 | 185 | 190 | |||||||||||||
Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu | Asp |
195 | 200 | 205 | |||||||||||||
Thr | Thr | Asp | Glu | Ala | Glu | ile | Pro | Gly | Thr | Pro | Ser | Ile | Arg | Gin | Asn |
210 | 215 | 220 | |||||||||||||
Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser | ser | Leu | Leu | Leu | Gly | Thr |
225 | 230 | 235 | 240 | ||||||||||||
Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | val | ASp | Ser | Leu | Leu | Al a | Leu |
245 | 250 | 255 | |||||||||||||
Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | Ile | Gin | ser | Gly | Pro | Gin | ile | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr | Pro | Ser | Pro | Ser | Leu |
275 | 280 | 285 | |||||||||||||
Pro | ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | Hi S | Glu | Glu | Asp | Gly | Tyr |
290 | 295 | 300 | |||||||||||||
Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | Asp | Glu | Ser | Gly | Phe | Val |
305 | 310 | 315 | 320 | ||||||||||||
Met | Ser | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gl n | ile | Lys | Ala |
325 | 330 | 335 | |||||||||||||
Ala | Gin | Lys | His | Leu | Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp |
340 | 345 | 350 | |||||||||||||
Ser | Leu | Ser | ser | His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met |
4 | • • · • 1«· | • * • · • · · • • · | • · · · « • « V · · • · · * · · a | • • a « · 1 • 1 | • · * • • • · • · | • · · • • • • · | |||||||||
355 | 360 | 365 | |||||||||||||
Lys | Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys | ile | Ala | Gly | ile | Met | Lys |
370 | 375 | 380 | |||||||||||||
Gin | Tyr | Gly | Val | Lys | Arg | Glu | Ser | ile | val | val | Asn | Lys | Glu | Lys | Asn |
385 | 390 | 395 | 400 | ||||||||||||
Ala | ile | ile | Tyr | Pro | Ala | Asp | Pro | ile | Asp | Glu | His | Lys | Pro | val | Gly |
405 | 410 | 415 | |||||||||||||
Ile | Gly | His | Ser | Hi S | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
420 | 425 | 430 | |||||||||||||
Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
435 | 440 | 445 | |||||||||||||
Asn | Val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
450 | 455 | 460 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gl n | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
465 | 470 | 475 | 480 | ||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr | Pro |
485 | 490 | 495 | |||||||||||||
Asp | Gly | Lys | val | Leu | Glu | Lys | Val | Ser | Gly | Lys | val | Phe | Gly | Glu | Gly |
500 | 505 | 510 | |||||||||||||
val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
515 | 520 | 525 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser |
530 | 535 | 540 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala |
545 | 550 | 555 | 560 | ||||||||||||
Ser | Gin | Thr | ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
565 | 570 | 575 | |||||||||||||
val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val | Arg |
580 | 585 | 590 | |||||||||||||
val | phe | Asp | Glu | Phe | Hi s | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
595 | 600 | 605 | |||||||||||||
val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
610 | 615 | 620 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
625 | 630 | 635 | 640 | ||||||||||||
Leu | Asp | Asn | Gin | Ser | Thr | Tyr | ile | val | Glu | Val | Pro | Ile | Leu | Glu | Lys |
645 | 650 | 655 | |||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
660 | 665 | 670 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | ASp | Glu | Lys | Val | Glu | Glu | Pro | Lys |
675 | 680 | 685 | |||||||||||||
Thr | ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser |
690 | 695 | 700 | |||||||||||||
Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | val | Asp | Pro | val | Gin |
705 | 710 | 715 | 720 | ||||||||||||
Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
725 | 730 | 735 | |||||||||||||
Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
740 | 745 | 750 | |||||||||||||
Gl u | val | ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
755 | 760 | 765 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly |
770 | 775 | 780 | |||||||||||||
Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | ser | Leu | Pro |
785 | 790 | 795 | 800 | ||||||||||||
Gl u | Ala | Pro | Asn | Glu | Lys | Pro | val | Lys | Pro | Glu | Asn | ser | Thr | Asp | Asn |
805 | 810 | 815 | |||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | pro | Met | Leu | Asp |
820 | 825 | 830 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | val | Asp | Pro | val | Gin | Glu | Lys | Leu |
835 | 840 | 845 | |||||||||||||
Glu | Lys | Phe | Thr | Al a | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | Phe |
850 | 855 | 860 | |||||||||||||
Asn | Met | Asp | Gly | Thr | ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val | Ile |
865 | 870 | 875 | 880 | ||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | |||||||
885 |
• · · ·
<210> | 349 |
<211> <212> <213> | 633 PRT Unknown |
<220> <223> | NEW 42 |
<400> | 349 |
Met 1 | Gin Ile Gly Gin 5 | Pro | Thr Leu Pro Asn Asn Ser Leu Ala Thr | Pro | |||||||||||
10 | 15 | ||||||||||||||
Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | Val | Met | Ser | ser | Gly | Asp | Ser | Asn | Ser | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | Asp | Leu | Thr | Glu | Gl u | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu |
85 | 90 | 95 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
100 | 105 | 110 | |||||||||||||
Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg |
115 | 120 | 125 | |||||||||||||
Glu | Ser | Ile | val | val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | Ser |
130 | 135 | 140 | |||||||||||||
Gly | Asp | Gly | Thr | Ser | Ala | Asp | Pro | ile | Asp | Glu | His | Lys | Pro | val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
Ile | Gly | His | ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | 170 | 175 | |||||||||||||
val | Ala | Lys | Lys | Gl u | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | ile | Asn | Met | Leu | val | Lys | Leu | Ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
Asp | Gly | Lys | val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gl n | Pro | Tyr | Leu | Pro | Gly |
260 | 265 | 270 | |||||||||||||
Gl n | Thr | Phe | Lys | Tyr | Thr | ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser |
275 | 280 | 285 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | ser | Leu | Ala | Tyr | Lys | Met | Ala |
290 | 295 | 300 | |||||||||||||
Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
305 | 310 | 315 | 320 | ||||||||||||
val | Asn | Pro | Gin | phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg |
325 | 330 | 335 | |||||||||||||
Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
340 | 345 | 350 | |||||||||||||
Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
355 | 360 | 365 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
370 | 375 | 380 | |||||||||||||
Leu | Asp | Asn | Gin | ser | Thr | Tyr | ile | val | Glu | Val | Pro | Ile | Leu | Glu | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
405 | 410 | 415 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | val | Glu | Glu | Pro | Lys |
420 | 425 | 430 | |||||||||||||
Thr | ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | ser |
435 | 440 | 445 | |||||||||||||
Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | val | Asp | Pro | val | Gin |
450 | 455 | 460 |
• ·· ·· ···· ·· ···· .·· ·· ·· · ·· ·
•til | • · | • · | • | • · | » | ||||||||||
Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
465 | 470 | 475 | 480 | ||||||||||||
Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | pro | Ser | Gly |
485 | 490 | 495 | |||||||||||||
Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
500 | 505 | 510 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly |
515 | 520 | 525 | |||||||||||||
Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met | Leu | ASp |
565 | 570 | 575 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu | Lys | Leu |
580 | 585 | 590 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | Phe |
595 | 600 | 605 | |||||||||||||
Asn | Met | ASp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val | ile |
610 | 615 | 620 | |||||||||||||
Lys | Lys | Asn | Leu | ser | Asp | Phe | Ile | Ala |
625 630 <210> 350 <211> 633 <212> PRT <213> unknown <220>
<223> NEW 49 <400> 350
Met Gin Ile Gly Gin Pro Thr Leu Pro Asn Asn Ser Leu Ala Thr Pro | |||||||||||||||
1 | 5 | 10 | 15 | ||||||||||||
Ser | pro | Ser | Leu | Pro | ile | Asn | Pro | Gly | Thr | ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | ASp | Glu |
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | Val | Met | Ser | Ser | Gly | Asp | His | Asn | His | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | ASp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Glu | val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | ser | Ser | His | Glu |
85 | 90 | 95 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
100 | 105 | 110 | |||||||||||||
Ile | Glu | Glu | Lys | Ile | Ala | Gly | ile | Met | Lys | Gin | Tyr | Gly | Val | Lys | Arg |
115 | 120 | 125 | |||||||||||||
Glu | Ser | Ile | val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | ile | Tyr | Pro | His |
130 | 135 | 140 | |||||||||||||
Gly | Asp | His | His | His | Ala | Asp | Pro | ile | Asp | Glu | His | Lys | Pro | Val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
Ile | Gly | His | Ser | His | ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | 170 | 175 | |||||||||||||
val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | val | Lys | Leu | Ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
Asp | Gly | Lys | Val | Leu | Glu | Lys | val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | ile | Ala | ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser |
• · ···· ·· ····
* · · · • · • · · · * 4?U | • · • • | • • · • · | v · • » | · • · 1 • · | • • • · |
275 280 | 285 | ||||
Tyr Asp Gly Thr Phe Thr Val Pro Thr Ser Leu | Ala | Tyr | Lys | Met | Ala |
290 295 | 300 | ||||
Ser Gin Thr Ile Phe Tyr Pro Phe His Ala Gly | Asp | Thr | Tyr | Leu | Arg |
305 310 315 | 320 | ||||
Val Asn Pro Gin Phe Ala val Pro Lys Gly Thr | Asp | Ala | Leu | val | Arg |
325 330 | 335 | ||||
val Phe Asp Glu Phe His Gly Asn Ala Tyr Leu | Glu | Asn | Asn | Tyr | Lys |
340 345 | 350 | ||||
Val Gly Glu Ile Lys Leu Pro Ile Pro Lys Leu | Asn | Gin | Gly | Thr | Thr |
355 360 | 365 | ||||
Arg Thr Ala Gly Asn Lys Ile Pro val Thr Phe | Met | Ala | Asn | Ala | Tyr |
370 375 | 380 | ||||
Leu Asp Asn Gin ser Thr Tyr ile val Glu val | Pro | ile | Leu | Glu | Lys |
385 390 395 | 400 | ||||
Glu Asn Gin Thr Asp Lys Pro Ser Ile Leu Pro | Gin | Phe | Lys | Arg | Asn |
405 410 | 415 | ||||
Lys Ala Gin Glu Asn Ser Lys Leu Asp Glu Lys | val | Glu | Glu | Pro | Lys |
420 425 | 430 | ||||
Thr Ser Glu Lys val Glu Lys Glu Lys Leu Ser | Glu | Thr | Gly | Asn | Ser |
435 440 | 445 | ||||
Thr Ser Asn Ser Thr Leu Glu Glu val Pro Thr | val | ASp | Pro | val | Gin |
450 455 | 460 | ||||
Glu Lys Val Ala Lys Phe Ala Glu Ser Tyr Gly | Met | Lys | Leu | Glu | Asn |
465 470 475 | 480 | ||||
Val Leu Phe Asn Met Asp Gly Thr ile Glu Leu | Tyr | Leu | Pro | Ser | Gly |
485 490 | 495 | ||||
Glu val Ile Lys Lys Asn Met Ala Asp Phe Thr | Gly | Gl u | Ala | Pro | Gin |
500 505 | 510 | ||||
Gly Asn Gly Glu Asn Lys Pro Ser Glu Asn Gly | Lys | val | Ser | Thr | Gly |
515 520 | 525 | ||||
Thr val Glu Asn Gin Pro Thr Glu Asn Lys Pro | Ala | Asp | ser | Leu | Pro |
530 535 | 540 | ||||
Glu Ala Pro Asn Glu Lys Pro Val Lys Pro Glu | Asn | Ser | Thr | Asp | Asn |
545 550 555 | 560 | ||||
Gly Met Leu Asn Pro Glu Gly Asn Val Gly Ser | Asp | Pro | Met | Leu | ASp |
565 570 | 575 | ||||
Pro Ala Leu Glu Glu Ala Pro Ala val Asp Pro | Val | Gin | Glu | Lys | Leu |
580 585 | 590 | ||||
Glu Lys Phe Thr Ala Ser Tyr Gly Leu Gly Leu | Asp | Ser | val | ile | Phe |
595 600 | 605 | ||||
Asn Met Asp Gly Thr Ile Glu Leu Arg Leu Pro | Ser | Gly | Glu | Val | ile |
610 615 | 620 | ||||
Lys Lys Asn Leu Ser Asp Phe Ile Ala | |||||
625 630 | |||||
<210> 351 | |||||
<211> 633 | |||||
<212> PRT | |||||
<213> Unknown | |||||
<220> | |||||
<223> NEW 50 | |||||
<400> 351 | |||||
Met Gin ile Gly Gin Pro Thr Leu Pro Asn Asn | Ser | Leu | Ala | Thr | Pro |
15 10 | 15 | ||||
Ser Pro ser Leu Pro Ile Asn Pro Gly Thr Ser | His | Glu | Lys | His | Glu |
20 25 | 30 | ||||
Glu Asp Gly Tyr Gly Phe Asp Ala Asn Arg ile | Ile | Ala | Glu | Asp | Gl u |
35 40 | 45 | ||||
Ser Gly phe val Met Ser Ser Gly Asp ser Asn | His | Tyr | Phe | Phe | Lys |
50 55 | 60 | ||||
Lys Asp Leu Thr Glu Glu Gin Ile Lys Ala Ala | Gl n | Lys | His | Leu | Glu |
65 70 75 | 80 | ||||
Glu val Lys Thr Ser His Asn Gly Leu Asp Ser | Leu | Ser | Ser | His | Gl u |
85 90 | 95 |
·· ·· ···· ·· · ···
• · · · m··' | • · • | • • · | • · 4 • | 1 · » · · | • • | |
Gin Asp Tyr Pro Gly Asn Ala Lys Glu Met Lys 100 105 | Asp | Leu | Asp 110 | Lys | Lys | |
Ile Glu Glu Lys Ile 115 | Ala Gly Ile Met Lys Gin 120 | Tyr | Gly 125 | val | Lys | Arg |
Glu ser Ile Val val 130 | Asn Lys Glu Lys Asn Ala 135 | ile 140 | ile | Tyr | Pro | His |
Gly Asp His His His 145 | Ala Asp Pro ile Asp Glu 150 155 | His | Lys | Pro | val | Gly 160 |
Ile Gly His Ser His 165 | Ser Asn Tyr Glu Leu Phe 170 | Lys | Pro | Glu | Glu 175 | Gly |
val Ala Lys Lys Glu 180 | Gly Asn Lys val Tyr Thr 185 | Gly | Glu | Glu 190 | Leu | Thr |
Asn val Val Asn Leu 195 | Leu Lys Asn Ser Thr Phe 200 | Asn | Asn 205 | Gin | Asn | Phe |
Thr Leu Ala Asn Gly 210 | Gin Lys Arg val ser Phe 215 | Ser 220 | Phe | Pro | Pro | Glu |
Leu Glu Lys Lys Leu 225 | Gly Ile Asn Met Leu Val 230 235 | Lys | Leu | ile | Thr | Pro 240 |
Asp Gly Lys val Leu 245 | Glu Lys Val ser Gly Lys 250 | val | Phe | Gly | Glu 255 | Gly |
val Gly Asn Ile Ala 260 | Asn Phe Glu Leu Asp Gin 265 | Pro | Tyr | Leu 270 | Pro | Gly |
Gin Thr Phe Lys Tyr 275 | Thr Ile Ala Ser Lys Asp 280 | Tyr | Pro 285 | Glu | Val | Ser |
Tyr Asp Gly Thr Phe 290 | Thr val Pro Thr ser Leu 295 | Ala 300 | Tyr | Lys | Met | Ala |
Ser Gin Thr Ile Phe 305 | Tyr Pro Phe His Ala Gly 310 315 | Asp | Thr | Tyr | Leu | Arg 320 |
val Asn Pro Gin Phe 325 | Ala Val Pro Lys Gly Thr 330 | Asp | Ala | Leu | val 335 | Arg |
Val Phe Asp Glu Phe 340 | His Gly Asn Ala Tyr Leu 345 | Glu | Asn | Asn 350 | Tyr | Lys |
val Gly Glu ile Lys 355 | Leu Pro Ile Pro Lys Leu 360 | Asn | Gin 365 | Gly | Thr | Thr |
Arg Thr Ala Gly Asn 370 | Lys ile Pro Val Thr Phe 375 | Met 380 | Ala | Asn | Ala | Tyr |
Leu Asp Asn Gin Ser 385 | Thr Tyr Ile val Glu val 390 395 | Pro | Ile | Leu | Gl u | Lys 400 |
Glu Asn Gin Thr Asp 405 | Lys Pro Ser Ile Leu Pro 410 | Gin | Phe | Lys | Arg 415 | Asn |
Lys Ala Gin Glu Asn 420 | Ser Lys Leu Asp Glu Lys 425 | Val | Glu | Glu 430 | Pro | Lys |
Thr Ser Glu Lys Val 435 | Glu Lys Glu Lys Leu Ser 440 | Glu | Thr 445 | Gly | Asn | Ser |
Thr ser Asn Ser Thr 450 | Leu Glu Glu Val Pro Thr 455 | val 460 | Asp | Pro | val | Gin |
Glu Lys Val Ala Lys 465 | Phe Ala Glu Ser Tyr Gly 470 475 | Met | Lys | Leu | Glu | Asn 480 |
val Leu Phe Asn Met 485 | Asp Gly Thr Ile Glu Leu 490 | Tyr | Leu | Pro | Ser 495 | Gly |
Glu Val Ile Lys Lys 500 | Asn Met Ala Asp Phe Thr 505 | Gly | Glu | Ala 510 | Pro | Gin |
Gly Asn Gly Glu Asn 515 | Lys Pro Ser Glu Asn Gly 520 | Lys | val 525 | Ser | Thr | Gly |
Thr Val Glu Asn Gin 530 | Pro Thr Glu Asn Lys Pro 535 | Ala 540 | Asp | Ser | Leu | Pro |
Glu Ala Pro Asn Glu 545 | Lys Pro val Lys Pro Glu 550 555 | Asn | Ser | Thr | Asp | Asn 560 |
Gly Met Leu Asn Pro 565 | Glu Gly Asn Val Gly Ser 570 | Asp | Pro | Met | Leu 575 | ASp |
Pro Ala Leu Glu Glu 580 | Ala Pro Ala val Asp Pro 585 | val | Gin | Glu 590 | Lys | Leu |
Glu Lys Phe Thr Ala 595 | Ser Tyr Gly Leu Gly Leu 600 | Asp | Ser 605 | Val | Ile | Phe |
Asn Met Asp Gly Thr 610 Lys Lys Asn Leu Ser 625 | Ile Glu Leu Arg Leu Pro 615 Asp Phe ile Ala 630 | Ser 620 | Gly | Glu | Val | Ile |
• « · · ···· ·· · ·* ··· · · · ···
• · | • · | • · | • · | ||||||||||||
<210> 352 | |||||||||||||||
<211> 633 | |||||||||||||||
<212> PRT | |||||||||||||||
<213> Unknown | |||||||||||||||
<220> | |||||||||||||||
<223> NEW 51 | |||||||||||||||
<400> 352 | |||||||||||||||
Met | Gin | ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr | Pro |
1 | 5 | 10 | 15 | ||||||||||||
ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | val | Met | Ser | Ser | Gly | Asp | His | Asn | His | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | Asp | Leu | Thr | Glu | Glu | Gin | ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Glu | val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | ser | Leu | Ser | Ser | His | Glu |
85 | 90 | 95 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
100 | 105 | 110 | |||||||||||||
ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg |
115 | 120 | 125 | |||||||||||||
Glu | Ser | Ile | val | val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | Ser |
130 | 135 | 140 | |||||||||||||
Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | Val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | 170 | 175 | |||||||||||||
Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | val | Lys | Leu | Ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
ASp | Gly | Lys | val | Leu | Glu | Lys | val | ser | Gly | Lys | Val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | val | ser |
275 | 280 | 285 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala |
290 | 295 | 300 | |||||||||||||
Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Al a | Gly | Asp | Thr | Tyr | Leu | Arg |
305 | 310 | 315 | 320 | ||||||||||||
Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val | Arg |
325 | 330 | 335 | |||||||||||||
val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
340 | 345 | 350 | |||||||||||||
val | Gly | Glu | Ile | Lys | Leu | Pro | ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
355 | 360 | 365 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | val | Thr | phe | Met | Ala | Asn | Ala | Tyr |
370 | 375 | 380 | |||||||||||||
Leu | Asp | Asn | Gin | Ser | Thr | Tyr | ile | val | Glu | Val | Pro | ile | Leu | Glu | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
405 | 410 | 415 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | val | Glu | Glu | Pro | Lys |
420 | 425 | 430 | |||||||||||||
Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser |
435 | 440 | 445 | |||||||||||||
Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | val | Asp | Pro | val | Gin |
····· · · · · · ♦ • ···· ····
• · · · · 4ΙΊ | • · · · | • · · · | |||||||||||||
450 | 455 | 460 | |||||||||||||
Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
465 | 470 | 475 | 480 | ||||||||||||
Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | pro | Ser | Gly |
485 | 490 | 495 | |||||||||||||
Glu | val | ile | Lys | Lys | Asn | Met | Ala | ASp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
500 | 505 | 510 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | val | Ser | Thr | Gly |
515 | 520 | 525 | |||||||||||||
Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | ASp | Ser | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu | Asp |
565 | 570 | 575 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | val | Asp | Pro | val | Gin | Glu | Lys | Leu |
580 | 585 | 590 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | Phe |
595 | 600 | 605 | |||||||||||||
Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | ser | Gly | Glu | Val | Ile |
610 | 615 | 620 | |||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | ile | Ala |
625 630 <210> 353 <211> 633 <212> PRT <213> Unknown <22O>
<223> NEW 52 <400> 353
Met | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr | pro |
1 | 5 | 10 | 15 | ||||||||||||
Ser | Pro | ser | Leu | Pro | ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Al a | Asn | Arg | ile | Ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | Val | Met | Ser | Ser | Gly | Asp | Ser | Asn | Hi s | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | Asp | Leu | Thr | Glu | Glu | Gin | ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu |
85 | 90 | 95 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
100 | 105 | 110 | |||||||||||||
Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val | Lys | Arg |
115 | 120 | 125 | |||||||||||||
Glu | Ser | Ile | val | val | Asn | Lys | Glu | Lys | Asn | Ala | ile | Ile | Tyr | Pro | Ser |
130 | 135 | 140 | |||||||||||||
Gly | Asp | Gly | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
Ile | Gly | His | Ser | Hi s | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | 170 | 175 | |||||||||||||
val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Gl u | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
Asp | Gly | Lys | val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
Val | Gly | Asn | ile | Ala | Asn | Phe | Glu | Leu | ASp | Gin | Pro | Tyr | Leu | Pro | Gly |
260 265 270 • «· ·· ··♦· ·· ···· « · · · · · · ·· ·
• • • · · 4Π | • · · • · | Φ · • · | • • · | • · · | • • · | • • B · | |||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp Tyr | Pro | Glu | val | Ser | |
275 | 280 | 285 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala |
290 | 295 | 300 | |||||||||||||
ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
305 | 310 | 315 | 320 | ||||||||||||
val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg |
325 | 330 | 335 | |||||||||||||
Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
340 | 345 | 350 | |||||||||||||
val | Gly | Glu | Ile | Lys | Leu | pro | ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
355 | 360 | 365 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
370 | 375 | 380 | |||||||||||||
Leu | Asp | Asn | Gin | Ser | Thr | Tyr | ile | val | Glu | val | Pro | ile | Leu | Glu | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | ser | ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
405 | 410 | 415 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | val | Glu | Glu | Pro | Lys |
420 | 425 | 430 | |||||||||||||
Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | ser |
435 | 440 | 445 | |||||||||||||
Thr | ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | val | Asp | Pro | val | Gin |
450 | 455 | 460 | |||||||||||||
Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
465 | 470 | 475 | 480 | ||||||||||||
val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
485 | 490 | 495 | |||||||||||||
Glu | val | Ile | Lys | Lys | Asn | Met | Ala | ASp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
500 | 505 | 510 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | val | Ser | Thr | Gly |
515 | 520 | 525 | |||||||||||||
Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | ASp | Ser | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu | ASp |
565 | 570 | 575 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu | Lys | Leu |
580 | 585 | 590 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | Phe |
595 | 600 | 605 | |||||||||||||
Asn | Met | ASp | Gly | Thr | ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val | Ile |
610 | 615 | 620 | |||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala |
625 630 <210> 354 <211> 633 <212> PRT <213> Unknown <22O>
<223> NEW 53 <400> 354
Met | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | ser | Leu | Ala | Thr | Pro |
1 | 5 | 10 | 15 | ||||||||||||
Ser | Pro | ser | Leu | Pro | ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | Val | Met | ser | His | Gly | Asp | His | Asn | His | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | ASp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu |
• · ·« ··*· ·· · ··· • ····· · ··· · · • · ···· ···· ··· ·· ·· ·· · · · ·
4Í%
85 | 90 | 95 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
100 | 105 | 110 | |||||||||||||
Ile | Glu | Glu | Lys | Ile | Ala | Gly | ile | Met | Lys | Gl n | Tyr | Gly | Val | Lys | Arg |
115 | 120 | 125 | |||||||||||||
Glu | Ser | Ile | val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | Ser |
130 | 135 | 140 | |||||||||||||
Gly | Asp | His | His | His | Ala | ASp | Pro | ile | ASp | Glu | His | Lys | Pro | val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | 170 | 175 | |||||||||||||
Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
Asp | Gly | Lys | val | Leu | Glu | Lys | val | ser | Gly | Lys | val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
val | Gly | Asn | ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | val | Ser |
275 | 280 | 285 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala |
290 | 295 | 300 | |||||||||||||
ser | Gin | Thr | ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
305 | 310 | 315 | 320 | ||||||||||||
val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg |
325 | 330 | 335 | |||||||||||||
val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
340 | 345 | 350 | |||||||||||||
val | Gly | Glu | Ile | Lys | Leu | Pro | ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
355 | 360 | 365 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
370 | 375 | 380 | |||||||||||||
Leu | ASP | Asn | Gin | Ser | Thr | Tyr | Ile | val | Glu | Val | Pro | Ile | Leu | Glu | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
405 | 410 | 415 | |||||||||||||
Lys | Al a | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu | Pro | Lys |
420 | 425 | 430 | |||||||||||||
Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu | Ser | Gl u | Thr | Gly | Asn | Ser |
435 | 440 | 445 | |||||||||||||
Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro | Val | Gin |
450 | 455 | 460 | |||||||||||||
Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
465 | 470 | 475 | 480 | ||||||||||||
val | Leu | Phe | Asn | Met | ASp | Gly | Thr | ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
485 | 490 | 495 | |||||||||||||
Glu | val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
500 | 505 | 510 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | val | Ser | Thr | Gly |
515 | 520 | 525 | |||||||||||||
Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | Pro | val | Lys | pro | Glu | Asn | Ser | Thr | Asp | Asn |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu | Asp |
565 | 570 | 575 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | val | Gin | Glu | Lys | Leu |
580 | 585 | 590 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | Phe |
595 | 600 | 605 | |||||||||||||
Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val | Ile |
610 | 615 | 620 | |||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala |
• ·· · · · · * · ·· ···· ···· ·· · ·· · >no
625 630 <210> 355 <211> 633 <212> PRT <213> Unknown <22O>
<223> NEW 54 <400> 355
Met 1 | Gin | Ile | Gly Gin 5 | Pro Thr Leu Pro Asn 10 | Asn | Ser Leu | Ala | Thr 15 | Pro | ||||||
Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His | Asn | His | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Glu | val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu |
85 | 90 | 95 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
100 | 105 | 110 | |||||||||||||
Ile | Glu | Glu | Lys | Ile | Ala | Gly | ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg |
115 | 120 | 125 | |||||||||||||
Glu | Ser | Ile | val | val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | Ser |
130 | 135 | 140 | |||||||||||||
Gly | ASp | Gly | His | Hi s | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
Ile | Gly | Hi s | ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | 170 | 175 | |||||||||||||
val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | Val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | ser | Phe | Ser | Phe | Pro | Pro | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | val | Lys | Leu | Ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
Asp | Gly | Lys | val | Leu | Glu | Lys | Val | Ser | Gly | Lys | val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
val | Gly | Asn | Ile | Al a | Asn | Phe | Glu | Leu | ASp | Gl n | Pro | Tyr | Leu | Pro | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | val | Ser |
275 | 280 | 285 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala |
290 | 295 | 300 | |||||||||||||
Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
305 | 310 | 315 | 320 | ||||||||||||
val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg |
325 | 330 | 335 | |||||||||||||
Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
340 | 345 | 350 | |||||||||||||
val | Gly | Glu | Ile | Lys | Leu | Pro | ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
355 | 360 | 365 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
370 | 375 | 380 | |||||||||||||
Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | val | Glu | Val | Pro | Ile | Leu | Glu | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
405 | 410 | 415 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | val | Glu | Glu | Pro | Lys |
420 | 425 | 430 | |||||||||||||
Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | ser |
435 | 440 | 445 |
• ·· ·« -»· · · ·· ···· • · · · · · · · · ·
Thr Ser Asn 450 | Ser | Thr Leu Glu Glu 455 | val | pro | Thr | val 460 | Asp | Pro | Val | Gin | |||||
Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
465 | 470 | 475 | 480 | ||||||||||||
Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
485 | 490 | 495 | |||||||||||||
Glu | val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
500 | 505 | 510 | |||||||||||||
Gly | Asn | Gly | Gl u | Asn | Lys | Pro | ser | Glu | Asn | Gly | Lys | val | Ser | Thr | Gly |
515 | 520 | 525 | |||||||||||||
Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Gl u | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu | Asp |
565 | 570 | 575 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | val | Asp | Pro | val | Gin | Glu | Lys | Leu |
580 | 585 | 590 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | ile | Phe |
595 | 600 | 605 | |||||||||||||
Asn | Met | Asp | Gly | Thr | ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val | Ile |
610 | 615 | 620 | |||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | ile | Ala | |||||||
625 | 630 |
<210> 356 <211> 569 <212> PRT <213> Unknown <220>
<223> NEW 55 <400> 356
Met | Asp | Leu | Thr | Gl u | Glu | Gin | ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
1 | 5 | 10 | 15 | ||||||||||||
Glu | val | Lys | Thr | Ser | His | Asn | Gly | Leu | ASP | Ser | Leu | Ser | Ser | His | Glu |
20 | 25 | 30 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
35 | 40 | 45 | |||||||||||||
ile | Glu | Gl u | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg |
50 | 55 | 60 | |||||||||||||
Glu | ser | Ile | val | val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | His |
65 | 70 | 75 | 80 | ||||||||||||
Gly | Asp | Gly | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | Val | Gly |
85 | 90 | 95 | |||||||||||||
Ile | Gly | His | Ser | Hi S | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
100 | 105 | 110 | |||||||||||||
val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
115 | 120 | 125 | |||||||||||||
Asn | val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
130 | 135 | 140 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
145 | 150 | 155 | 160 | ||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | ile | Asn | Met | Leu | val | Lys | Leu | Ile | Thr | Pro |
165 | 170 | 175 | |||||||||||||
Asp | Gly | Lys | val | Leu | Glu | Lys | Val | Ser | Gly | Lys | val | Phe | Gly | Glu | Gly |
180 | 185 | 190 | |||||||||||||
val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
195 | 200 | 205 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser |
210 | 215 | 220 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
245 | 250 | 255 | |||||||||||||
val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg |
···«· · · · · ·
« · » · * «i | * · | • · · · | |||||||||||||
260 | 265 | 270 | |||||||||||||
val | Phe | ASp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
275 | 280 | 285 | |||||||||||||
val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
290 | 295 | 300 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
305 | 310 | 315 | 320 | ||||||||||||
Leu | Asp | Asn | Gin | ser | Thr | Tyr | Ile | val | Glu | val | Pro | Ile | Leu | Glu | Lys |
325 | 330 | 335 | |||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
340 | 345 | 350 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | ASp | Glu | Lys | Val | Glu | Glu | Pro | Lys |
355 | 360 | 365 | |||||||||||||
Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser |
370 | 375 | 380 | |||||||||||||
Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | val | Asp | Pro | val | Gin |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
405 | 410 | 415 | |||||||||||||
Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
420 | 425 | 430 | |||||||||||||
Glu | val | ile | Lys | Lys | Asn | Met | Ala | ASp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
435 | 440 | 445 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly |
450 | 455 | 460 | |||||||||||||
Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro |
465 | 470 | 475 | 480 | ||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
485 | 490 | 495 | |||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu | Asp |
500 | 505 | 510 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | val | Asp | Pro | Val | Gin | Glu | Lys | Leu |
515 | 520 | 525 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | phe |
530 | 535 | 540 | |||||||||||||
Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val | ile |
545 | 550 | 555 | 560 | ||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala |
565 <210> 357 <211> 633 <212> PRT <213> Unknown <220>
<223> NEW 56 <400> 357
Met | Gin | ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr | Pro |
1 | 5 | 10 | 15 | ||||||||||||
Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | val | Met | Ser | His | Gly | Asp | Ser | Asn | His | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | Hi s | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Glu | val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu |
85 | 90 | 95 | |||||||||||||
Gin | Asp | Tyr | pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
100 | 105 | 110 | |||||||||||||
Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg |
115 | 120 | 125 | |||||||||||||
Gl u | Ser | Ile | Val | val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | ile | Tyr | Pro | Ser |
130 135 140 ♦· ··*· «»· » » * *19 ««··? · 9 9 · * · * · ···* τ··* ··· »» ·· ·· ·· ··
Gly | Asp | HIS | His | Hi s | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
Ile | Gly | Hi S | Ser | Hi s | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | 170 | 175 | |||||||||||||
val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | ile | Asn | Met | Leu | val | Lys | Leu | ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
Asp | Gly | Lys | val | Leu | Glu | Lys | val | Ser | Gly | Lys | val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
val | Gly | Asn | ile | Ala | Asn | Phe | Glu | Leu | ASp | Gin | pro | Tyr | Leu | Pro | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | val | ser |
275 | 280 | 285 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala |
290 | 295 | 300 | |||||||||||||
Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
305 | 310 | 315 | 320 | ||||||||||||
val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val | Arg |
325 | 330 | 335 | |||||||||||||
Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
340 | 345 | 350 | |||||||||||||
val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
355 | 360 | 365 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
370 | 375 | 380 | |||||||||||||
Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | val | Glu | val | Pro | ile | Leu | Glu | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
405 | 410 | 415 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu | Pro | Lys |
420 | 425 | 430 | |||||||||||||
Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser |
435 | 440 | 445 | |||||||||||||
Thr | Ser | Asn | ser | Thr | Leu | Glu | Glu | val | Pro | Thr | val | Asp | Pro | Val | Gin |
450 | 455 | 460 | |||||||||||||
Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
465 | 470 | 475 | 480 | ||||||||||||
Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
485 | 490 | 495 | |||||||||||||
Glu | Val | ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
500 | 505 | 510 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | val | Ser | Thr | Gly |
515 | 520 | 525 | |||||||||||||
Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | Pro | val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu | Asp |
565 | 570 | 575 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | Val | Gin | Glu | Lys | Leu |
580 | 585 | 590 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | val | Ile | Phe |
595 | 600 | 605 | |||||||||||||
Asn | Met | ASp | Gly | Thr | ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val | ile |
610 | 615 | 620 | |||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | |||||||
625 | 630 |
<210> 358 <211> 633 <212> PRT <213> Unknown
<220>
<223> NEW 56 <400> 358
Met 1 | Gin | ile Gly | Gin Pro Thr 5 | Leu Pro Asn Asn Ser 10 | Leu Ala | Thr 15 | Pro | ||||||||
ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
ser | Gly | Phe | val | Met | ser | His | Gly | Asp | Ser | Asn | His | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | Asp | Leu | Thr | Glu | Glu | Gin | ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Glu | val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu |
85 | 90 | 95 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
100 | 105 | 110 | |||||||||||||
ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg |
115 | 120 | 125 | |||||||||||||
Glu | Ser | Ile | Val | val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | ile | Tyr | Pro | Ser |
130 | 135 | 140 | |||||||||||||
Gly | Asp | His | His | His | Ala | ASp | Pro | Ile | Asp | Glu | His | Lys | Pro | Val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | 170 | 175 | |||||||||||||
val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
Val | Gly | Asn | ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | val | Ser |
275 | 280 | 285 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala |
290 | 295 | 300 | |||||||||||||
Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | ASp | Thr | Tyr | Leu | Arg |
305 | 310 | 315 | 320 | ||||||||||||
Val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg |
325 | 330 | 335 | |||||||||||||
val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
340 | 345 | 350 | |||||||||||||
Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
355 | 360 | 365 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
370 | 375 | 380 | |||||||||||||
Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | val | Glu | val | Pro | Ile | Leu | Glu | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
405 | 410 | 415 | |||||||||||||
Lys | Al a | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | val | Glu | Glu | Pro | Lys |
420 | 425 | 430 | |||||||||||||
Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser |
435 | 440 | 445 | |||||||||||||
Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | Val | Asp | Pro | Val | Gin |
450 | 455 | 460 | |||||||||||||
Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
465 | 470 | 475 | 480 | ||||||||||||
val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
485 | 490 | 495 | |||||||||||||
Glu | val | Ile | Lys | Lys | Asn | Met | Ala | asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
• · • · · ·
• • · | • • * | • · 1 · « | • « ► | • · • · | • • · | ||||||||||
500 | 505 | 510 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly |
515 | 520 | 525 | |||||||||||||
Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | ser | Asp | Pro | Met | Leu | ASp |
565 | 570 | 575 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | Val | ASp | Pro | Val | Gin | Glu | Lys | Leu |
580 | 585 | 590 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | val | Ile | Phe |
595 | 600 | 605 | |||||||||||||
Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | ser | Gly | Glu | Val | ile |
610 | 615 | 620 | |||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala |
625 630 <210> 359 <211> 633 <212> PRT <213> Unknown <220>
<223> NEW 56 <400> 359
Met | Gin | Ile | Gly | Gin | Pro | Thr | Leu | pro | Asn | Asn | Ser | Leu | Ala | Thr | Pro |
1 | 5 | 10 | 15 | ||||||||||||
Ser | Pro | Ser | Leu | Pro | ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | Ser | Asn | His | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Gl u | val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | ser | His | Glu |
85 | 90 | 95 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
100 | 105 | 110 | |||||||||||||
ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg |
115 | 120 | 125 | |||||||||||||
Glu | Ser | Ile | val | val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | Ser |
130 | 135 | 140 | |||||||||||||
Gly | Asp | Hi s | His | His | Ala | ASp | Pro | Ile | Asp | Glu | His | Lys | Pro | Val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
Ile | Gly | His | ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | 170 | 175 | |||||||||||||
val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | val | val | Asn | Leu | Leu | Lys | Asn | ser | Thr | Phe | Asn | Asn | Gin | Asn | phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | ile | Asn | Met | Leu | val | Lys | Leu | ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
Asp | Gly | Lys | Val | Leu | Glu | Lys | val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser |
275 | 280 | 285 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala |
290 | 295 | 300 | |||||||||||||
Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | Hi s | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
305 | 310 | 315 | 320 |
• · • · · ·
Val Asn Pro Gin Phe | Ala | Val | Pro | Lys Gly 330 | Thr | Asp Ala Leu | Val 335 | Arg | |||||||
325 | |||||||||||||||
val | Phe | Asp | Gl u | Phe | His | Gly | Asn | Al a | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
340 | 345 | 350 | |||||||||||||
Val | Gly | Glu | Ile | Lys | Leu | Pro | ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
355 | 360 | 365 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
370 | 375 | 380 | |||||||||||||
Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | val | Glu | val | Pro | Ile | Leu | Glu | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
405 | 410 | 415 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu | Pro | Lys |
420 | 425 | 430 | |||||||||||||
Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser |
435 | 440 | 445 | |||||||||||||
Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | Val | Asp | Pro | val | Gin |
450 | 455 | 460 | |||||||||||||
Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
465 | 470 | 475 | 480 | ||||||||||||
Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
485 | 490 | 495 | |||||||||||||
Glu | val | ile | Lys | Lys | Asn | Met | Al a | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
500 | 505 | 510 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly |
515 | 520 | 525 | |||||||||||||
Thr | Val | Gl u | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met | Leu | Asp |
565 | 570 | 575 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Al a | val | Asp | Pro | val | Gin | Glu | Lys | Leu |
580 | 585 | 590 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | val | ile | Phe |
595 | 600 | 605 | |||||||||||||
Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val | Ile |
610 | 615 | 620 | |||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | ile | Ala | |||||||
625 | 630 |
<210> 360 <211> 633 <212> PRT <213> Unknown <220>
<223> NEW 57 <400> 360
Met | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr | Pro |
1 | 5 | 10 | 15 | ||||||||||||
Ser | Pro | Ser | Leu | Pro | ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | ile | Ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | Val | Met | Ser | Hi s | Gly | Asp | His | Asn | Ser | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | ASp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | Hi s | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu |
Gin | 85 | 90 | 95 | ||||||||||||
Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | |
Ile | 100 | 105 | 110 | ||||||||||||
Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg | |
115 | 120 | 125 | |||||||||||||
Glu | Ser | Ile | val | val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | ser |
• · · ·
130 | 135 | 140 | |||||||||||||
Gly | Asp | His | His | His | Ala | ASp | Pro | Ile | Asp | Glu | His | Lys | Pro | Val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | - | 170 | 175 | ||||||||||||
val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | val | Lys | Leu | Ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
Asp | Gly | Lys | val | Leu | Glu | Lys | val | Ser | Gly | Lys | val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
val | Gly | Asn | ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | ser | Lys | Asp | Tyr | Pro | Glu | val | ser |
275 | 280 | 285 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala |
290 | 295 | 300 | |||||||||||||
Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | Hi s | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
305 | 310 | 315 | 320 | ||||||||||||
val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg |
325 | 330 | 335 | |||||||||||||
val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
340 | 345 | 350 | |||||||||||||
val | Gly | Glu | Ile | Lys | Leu | Pro | ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
355 | 360 | 365 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
370 | 375 | 380 | |||||||||||||
Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | val | Glu | val | Pro | Ile | Leu | Glu | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | pro | Ser | ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
405 | 410 | 415 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu | Pro | Lys |
420 | 425 | 430 | |||||||||||||
Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser |
435 | 440 | 445 | |||||||||||||
Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | val | Asp | Pro | Val | Gin |
450 | 455 | 460 | |||||||||||||
Gl u | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
465 | 470 | 475 | 480 | ||||||||||||
val | Leu | Phe | Asn | Met | Asp | Gly | Thr | ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
485 | 490 | 495 | |||||||||||||
Glu | val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
500 | 505 | 510 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | val | Ser | Thr | Gly |
515 | 520 | 525 | |||||||||||||
Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | ASP | ser | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | ser | Asp | Pro | Met | Leu | Asp |
565 | 570 | 575 | |||||||||||||
Pro | Ala | Leu | Gl u | Glu | Ala | Pro | Ala | val | ASp | pro | val | Gin | Glu | Lys | Leu |
580 | 585 | 590 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | val | Ile | Phe |
595 | 600 | 605 | |||||||||||||
Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val | Ile |
610 | 615 | 620 | |||||||||||||
Lys | Lys | Asn | Leu | ser | Asp | Phe | Ile | Ala | |||||||
625 | 630 |
<210> 361 <211> 633 <212> PRT « ·
<213> Unknown <220>
<223> NEW 63 <400> 361
Met Gin Ile Gly Gin Pro Thr Leu Pro Asn Asn Ser Leu Ala Thr | Pro | ||||||||||||||
1 | 5 | 10 | 15 | ||||||||||||
Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | Ser | Asn | His | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Glu | val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu |
85 | 90 | 95 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
100 | 105 | 110 | |||||||||||||
Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val | Lys | Arg |
115 | 120 | 125 | |||||||||||||
Glu | Ser | Ile | val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | His |
130 | 135 | 140 | |||||||||||||
Gly | Asp | His | His | His | Ala | Asp | Pro | ile | Asp | Glu | His | Lys | Pro | val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
ile | Gly | His | Ser | Hi s | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | 170 | 175 | |||||||||||||
val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | ser | Phe | ser | Phe | Pro | Pro | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
val | Gly | Asn | ile | Ala | Asn | Phe | Glu | Leu | ASp | Gin | Pro | Tyr | Leu | Pro | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Thr | phe | Lys | Tyr | Thr | ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | val | Ser |
275 | 280 | 285 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | ser | Leu | Ala | Tyr | Lys | Met | Ala |
290 | 295 | 300 | |||||||||||||
ser | Gin | Thr | ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
305 | 310 | 315 | 320 | ||||||||||||
val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg |
325 | 330 | 335 | |||||||||||||
val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
340 | 345 | 350 | |||||||||||||
val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
355 | 360 | 365 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
370 | 375 | 380 | |||||||||||||
Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | val | Glu | val | Pro | Ile | Leu | Glu | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
405 | 410 | 415 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | val | Glu | Glu | Pro | Lys |
420 | 425 | 430 | |||||||||||||
Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu | ser | Glu | Thr | Gly | Asn | Ser |
435 | 440 | 445 | |||||||||||||
Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | Val | Asp | Pro | val | Gin |
450 | 455 | 460 | |||||||||||||
Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
465 | 470 | 475 | 480 | ||||||||||||
Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
485 | 490 | 495 |
• · · · • · · · «♦ · ♦ · · · • · · · *
“M | Λ | • · | • · | • | • · | • | |||||||||
Glu | Val | ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
500 | 505 | 510 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly |
515 | 520 | 525 | |||||||||||||
Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met | Leu | ASp |
565 | 570 | 575 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | val | ASp | Pro | val | Gin | Glu | Lys | Leu |
580 | 585 | 590 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | Phe |
595 | 600 | 605 | |||||||||||||
Asn | Met | ASp | Gly | Thr | ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val | Ile |
610 | 615 | 620 | |||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala |
625 630 <210> 362 <211> 633 <212> PRT <213> unknown <220>
<223> NEW 64 <400> 362
Met Gin Ile Gly Gin Pro Thr Leu Pro Asn Asn Ser Leu Ala Thr Pro | |||||||||||||||
1 | 5 | 10 | 15 | ||||||||||||
Ser | Pro | Ser | Leu | Pro | ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | ile | ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | His | Asn | Ser | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | Asp | Leu | Thr | Glu | Glu | Gin | ile | Lys | Ala | Ala | Gin | Lys | Hi s | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Glu | val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | Hi s | Glu |
85 | 90 | 95 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
100 | 105 | 110 | |||||||||||||
Ile | Glu | Glu | Lys | ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg |
115 | 120 | 125 | |||||||||||||
Glu | Ser | Ile | Val | val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | Hi s |
130 | 135 | 140 | |||||||||||||
Gly | Asp | Hi s | His | Hi s | Ala | Asp | Pro | ile | Asp | Glu | His | Lys | Pro | val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
Ile | Gly | Hi s | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | 170 | 175 | |||||||||||||
Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Gl u |
210 | 215 | 220 | |||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | val | Lys | Leu | ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
Asp | Gly | Lys | val | Leu | Glu | Lys | Val | ser | Gly | Lys | Val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
val | Gly | Asn | ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | val | Ser |
275 | 280 | 285 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala |
290 | 295 | 300 | |||||||||||||
Ser | Gin | Thr | ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | ASp | Thr | Tyr | Leu | Arg |
• · · • · · · « · · • · · · 1 • · « · · · · 200 | • * • • < • • · | • · · a » · 1 · • « • · a • · | a • « • · • | • · · • • • • · • · | • a • • • « | |
305 | 310 315 | 320 | ||||
val Asn | Pro Gin Phe Ala Val Pro Lys Gly Thr | Asp | Ala | Leu | val | Arg |
325 330 | 335 | |||||
val Phe | Asp Glu Phe His Gly Asn Ala Tyr Leu | Glu | Asn | Asn | Tyr | Lys |
340 345 | 350 | |||||
val Gly | Glu Ile Lys Leu Pro Ile Pro Lys Leu | Asn | Gin | Gly | Thr | Thr |
355 360 | 365 | |||||
Arg Thr | Ala Gly Asn Lys ile Pro val Thr Phe | Met | Ala | Asn | Ala | Tyr |
370 | 375 | 380 | ||||
Leu Asp | Asn Gin Ser Thr Tyr Ile val Glu val | Pro | ile | Leu | Glu | Lys |
385 | 390 395 | 400 | ||||
Glu Asn | Gin Thr Asp Lys Pro Ser Ile Leu Pro | Gin | Phe | Lys | Arg | Asn |
405 410 | 415 | |||||
Lys Ala | Gin Glu Asn Ser Lys Leu Asp Glu Lys | val | Glu | Glu | Pro | Lys |
420 425 | 430 | |||||
Thr Ser | Glu Lys val Glu Lys Glu Lys Leu Ser | Glu | Thr | Gly | Asn | Ser |
435 440 | 445 | |||||
Thr Ser | Asn Ser Thr Leu Glu Glu val Pro Thr | Val | Asp | Pro | val | Gin |
450 | 455 | 460 | ||||
Glu Lys | Val Ala Lys Phe Ala Glu Ser Tyr Gly | Met | Lys | Leu | Glu | Asn |
465 | 470 475 | 480 | ||||
Val Leu | Phe Asn Met Asp Gly Thr Ile Glu Leu | Tyr | Leu | Pro | Ser | Gly |
485 490 | 495 | |||||
Glu Val | Ile Lys Lys Asn Met Ala Asp Phe Thr | Gly | Glu | Ala | Pro | Gin |
500 505 | 510 | |||||
Gly Asn | Gly Glu Asn Lys Pro Ser Glu Asn Gly | Lys | val | Ser | Thr | Gly |
515 520 | 525 | |||||
Thr val | Glu Asn Gin Pro Thr Glu Asn Lys Pro | Ala | Asp | ser | Leu | Pro |
530 | 535 | 540 | ||||
Glu Ala | Pro Asn Glu Lys Pro Val Lys Pro Glu | Asn | Ser | Thr | Asp | Asn |
545 | 550 555 | 560 | ||||
Gly Met | Leu Asn Pro Glu Gly Asn Val Gly Ser | Asp | Pro | Met | Leu | Asp |
565 570 | 575 | |||||
Pro Ala | Leu Glu Glu Ala Pro Ala Val Asp Pro | val | Gin | Glu | Lys | Leu |
580 585 | 590 | |||||
Glu Lys | Phe Thr Ala Ser Tyr Gly Leu Gly Leu | Asp | Ser | Val | ile | Phe |
595 600 | 605 | |||||
Asn Met | Asp Gly Thr Ile Glu Leu Arg Leu Pro | Ser | Gly | Glu | val | Ile |
610 | 615 | 620 | ||||
Lys Lys | Asn Leu Ser Asp Phe Ile Ala | |||||
625 | 630 | |||||
<210> 363 | ||||||
<211> 633 | ||||||
<212> PRT | ||||||
<213> Unknown | ||||||
<220> | ||||||
<223> NEW 65 | ||||||
<400> 363 | ||||||
Met Gin | Ile Gly Gin Pro Thr Leu Pro Asn Asn | Ser | Leu | Ala | Thr | Pro |
1 | 5 10 | 15 | ||||
Ser Pro | Ser Leu Pro Ile Asn Pro Gly Thr Ser | His | Glu | Lys | His | Glu |
20 25 | 30 | |||||
Glu Asp | Gly Tyr Gly Phe Asp Ala Asn Arg ile | Ile | Ala | Glu | Asp | Glu |
35 40 | 45 | |||||
Ser Gly | Phe Val Met Ser His Gly Asp Ser Asn | His | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | ||||
Lys Asp | Leu Thr Glu Glu Gin ile Lys Ala Ala | Gin | Lys | His | Leu | Glu |
65 | 70 75 | 80 | ||||
Glu Val | Lys Thr Ser His Asn Gly Leu Asp Ser | Leu | Ser | Ser | His | Glu |
85 90 | 95 | |||||
Gin Asp | Tyr Pro Gly Asn Ala Lys Glu Met Lys | Asp | Leu | Asp | Lys | Lys |
100 105 | 110 | |||||
Ile Glu | Glu Lys ile Ala Gly ile Met Lys Gin | Tyr | Gly | val | Lys | Arg |
115 120 125 • ·
2,o<
Glu | Ser Ile 130 | val val | Asn | Lys Glu Lys Asn 135 | Ala | ile ile 140 | Tyr | Pro | His | ||||||
Gly | Asp | Gly | HIS | Hi s | Ala | ASp | Pro | Ile | Asp | Glu | His | Lys | Pro | val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | 170 | 175 | |||||||||||||
Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | pro | Pro | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
Asp | Gly | Lys | val | Leu | Glu | Lys | val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
val | Gly | Asn | ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | val | Ser |
275 | 280 | 285 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | ser | Leu | Ala | Tyr | Lys | Met | Ala |
290 | 295 | 300 | |||||||||||||
Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
305 | 310 | 315 | 320 | ||||||||||||
val | Asn | Pro | Gin | Phe | Al a | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg |
325 | 330 | 335 | |||||||||||||
val | Phe | Asp | Glu | Phe | Hi s | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
340 | 345 | 350 | |||||||||||||
val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
355 | 360 | 365 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
370 | 375 | 380 | |||||||||||||
Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | val | Pro | ile | Leu | Glu | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
405 | 410 | 415 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu | Pro | Lys |
420 | 425 | 430 | |||||||||||||
Thr | Ser | Gl u | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser |
435 | 440 | 445 | |||||||||||||
Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | Val | Asp | Pro | Val | Gin |
450 | 455 | 460 | |||||||||||||
Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
465 | 470 | 475 | 480 | ||||||||||||
Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
485 | 490 | 495 | |||||||||||||
Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
500 | 505 | 510 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly |
515 | 520 | 525 | |||||||||||||
Thr | val | Gl u | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | Pro | val | Lys | Pro | Glu | Asn | ser | Thr | Asp | Asn |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu | ASp |
565 | 570 | 575 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | val | ASp | Pro | val | Gin | Glu | Lys | Leu |
580 | 585 | 590 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | val | Ile | Phe |
595 | 600 | 605 | |||||||||||||
Asn | Met | ASp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val | Ile |
610 | 615 | 620 | |||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | |||||||
625 | 630 |
<210> 364 <211> 633 • · • · • * « w ’ · « ’ • · · · · «* · · · · • · · · · · 1 • · · · • · · · · * lot <212> PRT <213> Unknown <220>
<223> NEW 66 <400> 364
Met Gin Ile Gly Gin | Pro Thr Leu Pro Asn 10 | Asn Ser Leu | Ala | Thr 15 | Pro | ||||||||||
1 | 5 | ||||||||||||||
Ser | Pro | Ser | Leu | Pro | ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | Val | Met | Ser | Hi s | Gly | Asp | Hi s | Asn | Ser | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | ASp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu |
85 | 90 | 95 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
100 | 105 | 110 | |||||||||||||
Ile | Glu | Glu | Lys | ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg |
115 | 120 | 125 | |||||||||||||
Glu | Ser | ile | val | Val | Asn | Lys | Glu | Lys | Asn | Ala | ile | ile | Tyr | Pro | His |
130 | 135 | 140 | |||||||||||||
Gly | Asp | Gly | His | His | Ala | Asp | Pro | ile | Asp | Glu | His | Lys | Pro | val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
ile | Gly | His | ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | 170 | 175 | |||||||||||||
Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | Val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | ile | Asn | Met | Leu | val | Lys | Leu | Ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
Asp | Gly | Lys | val | Leu | Glu | Lys | val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
Val | Gly | Asn | ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | ile | Al a | Ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser |
275 | 280 | 285 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | ser | Leu | Ala | Tyr | Lys | Met | Ala |
290 | 295 | 300 | |||||||||||||
Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | ASp | Thr | Tyr | Leu | Arg |
305 | 310 | 315 | 320 | ||||||||||||
Val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg |
325 | 330 | 335 | |||||||||||||
val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
340 | 345 | 350 | |||||||||||||
Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
355 | 360 | 365 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
370 | 375 | 380 | |||||||||||||
Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | val | Glu | Val | Pro | ile | Leu | Glu | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Asn | Gl n | Thr | Asp | Lys | Pro | ser | ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
405 | 410 | 415 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu | Pro | Lys |
420 | 425 | 430 | |||||||||||||
Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser |
435 | 440 | 445 | |||||||||||||
Thr | Ser | Asn | ser | Thr | Leu | Glu | Glu | val | Pro | Thr | Val | Asp | Pro | val | Gin |
450 | 455 | 460 | |||||||||||||
Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
465 | 470 | 475 | 480 | ||||||||||||
val | Leu | Phe | Asn | Met | Asp | Gly | Thr | ile | Glu | Leu | Tyr | Leu | ΡΓΟ | Ser | Gly |
• ·
485 | 490 | 495 | |||||||||||||
Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
500 | 505 | 510 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | val | Ser | Thr | Gly |
515 | 520 | 525 | |||||||||||||
Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | ASP | Ser | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp | pro | Met | Leu | Asp |
565 | 570 | 575 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | val | Asp | Pro | Val | Gin | Glu | Lys | Leu |
580 | 585 | 590 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | val | ile | Phe |
595 | 600 | 605 | |||||||||||||
Asn | Met | ASp | Gly | Thr | ile | Gl u | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val | Ile |
610 | 615 | 620 | |||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | |||||||
625 | 630 |
<210> 365 <211> 633 <212> PRT <213> Unknown <220>
<223> NEW 76 <400> 365
Met Gin Ile Gly Gin Pro Thr Leu Pro Asn Asn Ser Leu Ala Thr Pro | |||||||||||||||
1 | 5 | 10 | 15 | ||||||||||||
Ser | Pro | Ser | Leu | Pro | ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | Hi s | Asn | Ser | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | ASp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Glu | val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu |
85 | 90 | 95 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
100 | 105 | 110 | |||||||||||||
Ile | Glu | Glu | Lys | Ile | Ala | Gly | ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg |
115 | 120 | 125 | |||||||||||||
Glu | Ser | Ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | Ser |
130 | 135 | 140 | |||||||||||||
Gly | ASp | Gly | His | His | Ala | Asp | Pro | ile | Asp | Glu | Hi S | Lys | Pro | val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
ile | Gly | Hi s | ser | Hi s | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | - | 170 | 175 | ||||||||||||
Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | val | Val | Asn | Leu | Leu | Lys | Asn | ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
Asp | Gly | Lys | val | Leu | Gl u | Lys | val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | val | Ser |
275 | 280 | 285 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala |
290 | 295 | 300 |
• · · ·
• · · • · • | • • » · · · • » * | • · • · 1» · • · • · | • • • • · • · | • • » • • | • • · • • · • · | • • • | |||||||||
Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | Hi S | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
305 | 310 | 315 | 320 | ||||||||||||
val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg |
325 | 330 | 335 | |||||||||||||
val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
340 | 345 | 350 | |||||||||||||
val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
355 | 360 | 365 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
370 | 375 | 380 | |||||||||||||
Leu | ASp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | val | Pro | Ile | Leu | Glu | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Asn | Gl n | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
405 | 410 | 415 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu | Pro | Lys |
420 | 425 | 430 | |||||||||||||
Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser |
435 | 440 | 445 | |||||||||||||
Thr | ser | Asn | Ser | Thr | Leu | Glu | Glu | Val | Pro | Thr | val | Asp | Pro | Val | Gin |
450 | 455 | 460 | |||||||||||||
Glu | Lys | Val | Al a | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
465 | 470 | 475 | 480 | ||||||||||||
val | Leu | Phe | Asn | Met | Asp | Gly | Thr | ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
485 | 490 | 495 | |||||||||||||
Glu | val | ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
500 | 505 | 510 | |||||||||||||
Gly | Asn | Gly | Gl u | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | val | Ser | Thr | Gly |
515 | 520 | 525 | |||||||||||||
Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | Pro | val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu | Asp |
565 | 570 | 575 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | val | Asp | Pro | val | Gin | Glu | Lys | Leu |
580 | 585 | 590 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | Phe |
595 | 600 | 605 | |||||||||||||
Asn | Met | ASp | Gly | Thr | ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val | ile |
610 | 615 | 620 | |||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala |
625 630 <210> 366 <211> 627 <212> PRT <213> Unknown <220>
<223> NEW 105 <400> 366
Met | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr | Pro |
1 | 5 | 10 | 15 | ||||||||||||
Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | ile | ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | Val | Met | Ser | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu |
50 | 55 | 60 | |||||||||||||
Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu | Glu | val | Lys | Thr | Ser | His |
65 | 70 | 75 | 80 | ||||||||||||
Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn |
85 | 90 | 95 | |||||||||||||
Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala |
100 | 105 | 110 | |||||||||||||
Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val | Lys | Arg | Glu | Ser | Ile | val | Val | Asn |
• · • · • · · · • · · <
• ·· ·· ··
0,05
115 120 125
Lys Glu Lys Asn Ala ile ile Tyr Pro His Gly Asp His His His Ala
130 135 140
Asp Pro Ile Asp Glu His Lys Pro Val Gly Ile Gly His ser His Ser
145 150 - 155 160
Asn Tyr Glu Leu Phe Lys Pro Glu Glu Gly val Ala Lys Lys Glu Gly
165 170 175
Asn Lys Val Tyr Thr Gly Glu Glu Leu Thr Asn Val val Asn Leu Leu
180 185 190
Lys Asn Ser Thr Phe Asn Asn Gin Asn Phe Thr Leu Ala Asn Gly Gin
195 200 205
Lys Arg val ser Phe ser Phe Pro Pro Glu Leu Glu Lys Lys Leu Gly
210 215 220 ile Asn Met Leu Val Lys Leu Ile Thr Pro Asp Gly Lys val Leu Glu
225 230 235 240
Lys Val ser Gly Lys Val Phe Gly Glu Gly Val Gly Asn Ile Ala Asn
245 250 255
Phe Glu Leu Asp Gin Pro Tyr Leu Pro Gly Gin Thr Phe Lys Tyr Thr
260 265 270
Ile Ala Ser Lys Asp Tyr Pro Glu Val Ser Tyr Asp Gly Thr Phe Thr
275 280 285
val | pro Thr ser Leu 290 | Ala Tyr Lys Met Ala ser Gin Thr ile Phe | Tyr | ||||||||||||
295 | 300 | ||||||||||||||
Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg | val | Asn | Pro | Gin | Phe | Ala |
305 | 310 | 315 | 320 | ||||||||||||
Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val | Arg | val | Phe | Asp | Glu | Phe | His |
325 | 330 | 335 | |||||||||||||
Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | val | Gly | Glu | Ile | Lys | Leu |
340 | 345 | 350 | |||||||||||||
Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys |
355 | 360 | 365 | |||||||||||||
Ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr |
370 | 375 | 380 | |||||||||||||
Tyr | ile | val | Glu | val | Pro | Ile | Leu | Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser |
405 | 410 | 415 | |||||||||||||
Lys | Leu | Asp | Glu | Lys | val | Glu | Glu | Pro | Lys | Thr | Ser | Glu | Lys | val | Glu |
420 | 425 | 430 | |||||||||||||
Lys | Glu | Lys | Leu | ser | Glu | Thr | Gly | Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu |
435 | 440 | 445 | |||||||||||||
Glu | Glu | Val | Pro | Thr | val | Asp | Pro | val | Gin | Glu | Lys | val | Ala | Lys | Phe |
450 | 455 | 460 | |||||||||||||
Ala | Glu | ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn | val | Leu | Phe | Asn | Met | Asp |
465 | 470 | 475 | 480 | ||||||||||||
Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly | Glu | Val | Ile | Lys | Lys | Asn |
485 | 490 | 495 | |||||||||||||
Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys |
500 | 505 | 510 | |||||||||||||
Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly | Thr | Val | Glu | Asn | Gin | Pro |
515 | 520 | 525 | |||||||||||||
Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys |
530 | 535 | 540 | |||||||||||||
Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Asn | val | Gly | ser | Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala |
565 | 570 | 575 | |||||||||||||
Pro | Al a | val | Asp | pro | Val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser |
580 | 585 | 590 | |||||||||||||
Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | Phe | Asn | Met | Asp | Gly | Thr | Ile |
595 | 600 | 605 | |||||||||||||
Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val | Ile | Lys | Lys | Asn | Leu | Ser | Asp |
610 | 615 | 620 | |||||||||||||
Phe | Ile | Ala | |||||||||||||
625 |
<210> 367 • · · · · ·
«· ·· • · · · • · · · • · · · · ·
-Krt ···’ <211> 627 <212> PRT <213> Unknown <220>
<223> NEW 106 <400> 367
Met 1 | Gin Ile Gly Gin Pro Thr 5 | Leu Pro | Asn Asn ser 10 | Leu | Ala | Thr 15 | Pro | ||||||||
Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | val | Met | Ser | His | Gly | Asp | His | Asn | His | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Glu | val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu |
85 | 90 | 95 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
100 | 105 | 110 | |||||||||||||
ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val | Lys | Arg |
115 | 120 | 125 | |||||||||||||
Glu | Ser | Ile | Val | val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | Ala |
130 | 135 | 140 | |||||||||||||
Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | val | Gly | Ile | Gly | Hi s | Ser | His | Ser |
145 | 150 | 155 | 160 | ||||||||||||
Asn | Tyr | Glu | Leu | Phe | Lys | pro | Glu | Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly |
165 | 170 | 175 | |||||||||||||
Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn | Val | val | Asn | Leu | Leu |
180 | 185 | 190 | |||||||||||||
Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gl n |
195 | 200 | 205 | |||||||||||||
Lys | Arg | Val | Ser | Phe | ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly |
210 | 215 | 220 | |||||||||||||
Ile | Asn | Met | Leu | val | Lys | Leu | ile | Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu |
225 | 230 | 235 | 240 | ||||||||||||
Lys | Val | Ser | Gly | Lys | val | Phe | Gly | Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn |
245 | 250 | 255 | |||||||||||||
Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr |
260 | 265 | 270 | |||||||||||||
Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr |
275 | 280 | 285 | |||||||||||||
Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala | Ser | Gin | Thr | Ile | Phe | Tyr |
290 | 295 | 300 | |||||||||||||
pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg | val | Asn | Pro | Gin | Phe | Ala |
305 | 310 | 315 | 320 | ||||||||||||
Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val | Arg | val | Phe | Asp | Glu | Phe | His |
325 | 330 | 335 | |||||||||||||
Gly | Asn | Al a | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | val | Gly | Glu | Ile | Lys | Leu |
340 | 345 | 350 | |||||||||||||
Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys |
355 | 360 | 365 | |||||||||||||
Ile | Pro | Val | Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr |
370 | 375 | 380 | |||||||||||||
Tyr | Ile | Val | Glu | val | Pro | Ile | Leu | Glu | Lys | Glu | Asn | Gin | Thr | Asp | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu | Asn | ser |
405 | 410 | 415 | |||||||||||||
Lys | Leu | Asp | Glu | Lys | Val | Glu | Glu | Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu |
420 | 425 | 430 | |||||||||||||
Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu |
435 | 440 | 445 | |||||||||||||
Glu | Glu | val | Pro | Thr | Val | Asp | Pro | val | Gin | Glu | Lys | val | Ala | Lys | Phe |
450 | 455 | 460 | |||||||||||||
Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn | val | Leu | Phe | Asn | Met | Asp |
465 | 470 | 475 | 480 |
φ · · · φ φ
Gly | Thr ile Glu | Leu 485 | Tyr Leu Pro ser Gly Glu val 490 | Ile | Lys | Lys 495 | Asn | ||||||||
Met | Ala | Asp | Phe | Thr | Gly | Glu | Al a | Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys |
500 | 505 | 510 | |||||||||||||
Pro | ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly | Thr | val | Glu | Asn | Gin | Pro |
515 | 520 | 525 | |||||||||||||
Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys |
530 | 535 | 540 | |||||||||||||
Pro | val | Lys | Pro | Glu | Asn | Ser | Thr | ASp | Asn | Gly | Met | Leu | Asn | Pro | Glu |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu | ASp | Pro | Ala | Leu | Glu | Glu | Ala |
565 | 570 | 575 | |||||||||||||
Pro | Ala | val | Asp | Pro | val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Ala | ser |
580 | 585 | 590 | |||||||||||||
Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | Phe | Asn | Met | Asp | Gly | Thr | Ile |
595 | 600 | 605 | |||||||||||||
Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val | Ile | Lys | Lys | Asn | Leu | Ser | Asp |
610 | 615 | 620 | |||||||||||||
Phe | ile | Ala |
625 <210> 368 <211> 621 <212> PRT <213> Unknown <220> ' <223> NEW 107 <400> 368
Met | Gin | ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr | Pro |
1 | 5 | 10 | 15 | ||||||||||||
Ser | Pro | Ser | Leu | Pro | ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | Val | Met | ser | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu |
50 | 55 | 60 | |||||||||||||
Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu | Glu | Val | Lys | Thr | ser | His |
65 | 70 | 75 | 80 | ||||||||||||
Asn | Gly | Leu | Asp | Ser | Leu | ser | Ser | His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn |
85 | 90 | 95 | |||||||||||||
Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | ile | Glu | Glu | Lys | Ile | Ala |
100 | 105 | 110 | |||||||||||||
Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg | Glu | Ser | ile | val | Val | Asn |
115 | 120 | 125 | |||||||||||||
Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | Ala | Asp | Pro | Ile | Asp | Glu | His |
130 | 135 | 140 | |||||||||||||
Lys | Pro | Val | Gly | ile | Gly | Hi S | ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys |
145 | 150 | 155 | 160 | ||||||||||||
Pro | Glu | Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly |
165 | 170 | 175 | |||||||||||||
Glu | Glu | Leu | Thr | Asn | val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn |
180 | 185 | 190 | |||||||||||||
Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser |
195 | 200 | 205 | |||||||||||||
Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | ile | Asn | Met | Leu | val | Lys |
210 | 215 | 220 | |||||||||||||
Leu | Ile | Thr | Pro | Asp | Gly | Lys | val | Leu | Glu | Lys | Val | Ser | Gly | Lys | val |
225 | 230 | 235 | 240 | ||||||||||||
Phe | Gly | Glu | Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro |
245 | 250 | 255 | |||||||||||||
Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | ile | Ala | Ser | Lys | Asp | Tyr |
260 | 265 | 270 | |||||||||||||
Pro | Glu | val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser | Leu | Ala |
275 280 285
Tyr Lys Met Ala Ser 290 | Gin Thr ile 295 | Phe | Tyr | Pro | Phe His 300 | Ala | Gly | Asp | |||||||
Thr | Tyr | Leu | Arg | val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp |
305 | 310 | 315 | 320 | ||||||||||||
Ala | Leu | Val | Arg | val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu |
325 | 330 | 335 | |||||||||||||
Asn | Asn | Tyr | Lys | Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn |
340 | 345 | 350 | |||||||||||||
Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | ile | Pro | val | Thr | Phe | Met |
355 | 360 | 365 | |||||||||||||
Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | ile | val | Glu | val | Pro |
370 | Glu | 375 | 380 | ||||||||||||
ile | Leu | Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | |
385 | 390 | 395 | 400 | ||||||||||||
Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val |
405 | 410 | 415 | |||||||||||||
Glu | Glu | Pro | Lys | Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu | Ser | Glu |
420 | 425 | 430 | |||||||||||||
Thr | Gly | Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | val |
435 | 440 | 445 | |||||||||||||
Asp | Pro | Val | Gin | Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met |
450 | 455 | 460 | |||||||||||||
Lys | Leu | Glu | Asn | val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr |
465 | 470 | 475 | 480 | ||||||||||||
Leu | Pro | Ser | Gly | Glu | Val | ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly |
485 | 490 | 495 | |||||||||||||
Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys |
500 | 505 | 510 | |||||||||||||
val | Ser | Thr | Gly | Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala |
515 | 520 | 525 | |||||||||||||
Asp | Ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn |
530 | 535 | 540 | |||||||||||||
Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp |
545 | 550 | 555 | 560 | ||||||||||||
Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | val | Asp | Pro | Val |
565 | 570 | 575 | |||||||||||||
Gin | Glu | Lys | Leu | Gl u | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp |
580 | 585 | 590 | |||||||||||||
Ser | Val | ile | Phe | Asn | Met | Asp | Gly | Thr | ile | Glu | Leu | Arg | Leu | Pro | Ser |
595 | 600 | 605 | |||||||||||||
Gly | Glu | Val | Ile | Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | |||
610 | 615 | 620 |
<210> 369 <211> 906 <212> PRT <213> Unknown <220>
<223> VP 89 <400> 369
Met | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr | Pro |
1 | 5 | 10 | 15 | ||||||||||||
Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | Ser | Asn | His | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | ASp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu |
Gin | 85 | 90 | 95 | ||||||||||||
Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | |
100 | 105 | 110 | |||||||||||||
Ile | Glu | Glu | Lys | Ile | Al a | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val | Lys | Arg |
« » · · * · • · · ·
to^
115 | 120 | 125 | |||||||||||||
Glu | Ser | ile | Val | val | Asn | Lys | Glu | Lys | Asn | Ala | ile | Ile | Tyr | Pro | Ser |
130 | 135 | 140 | |||||||||||||
Gly | Asp | His | His | His | Ala | Asp | Pro | ile | Asp | Glu | His | Lys | Pro | val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
Ile | Gly | His | Ser | His | ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | 170 | 175 | |||||||||||||
val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | val | Lys | Leu | ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
ASp | Gly | Lys | Val | Leu | Glu | Lys | val | Ser | Gly | Lys | val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser |
275 | 280 | 285 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala |
290 | 295 | 300 | |||||||||||||
Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
305 | 310 | 315 | 320 | ||||||||||||
Val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val | Arg |
325 | 330 | 335 | |||||||||||||
val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
340 | 345 | 350 | |||||||||||||
val | Gly | Glu | Ile | Lys | Leu | Pro | ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
355 | 360 | 365 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
370 | 375 | 380 | |||||||||||||
Leu | Asp | Asn | Gin | ser | Thr | Tyr | ile | val | Glu | Val | Pro | ile | Leu | Glu | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | ser | Ile | Leu | Pro | Gl n | Phe | Lys | Arg | Asn |
405 | 410 | 415 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Gl u | Lys | Val | Glu | Glu | Pro | Lys |
420 | 425 | 430 | |||||||||||||
Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser |
435 | 440 | 445 | |||||||||||||
Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | val | Asp | Pro | val | Gin |
450 | 455 | 460 | |||||||||||||
Gl u | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
465 | 470 | 475 | 480 | ||||||||||||
Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
485 | 490 | 495 | |||||||||||||
Glu | Val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
500 | 505 | 510 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | val | Ser | Thr | Gly |
515 | 520 | 525 | |||||||||||||
Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | ASp | Ser | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Glu | Ala | Pro | Asn | Gl u | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu | ASp |
565 | 570 | 575 | |||||||||||||
Pro | Al a | Leu | Glu | Glu | Ala | Pro | Ala | val | Asp | Pro | val | Gin | Glu | Lys | Leu |
580 | 585 | 590 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | ile | Phe |
595 | 600 | 605 | |||||||||||||
Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val | ile |
610 | 615 | 620 | |||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | ile | Ala | Gly | Pro | Gin | Ile | Thr | Tyr | Thr |
625 | 630 | 635 | 640 | ||||||||||||
Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu |
645 | 650 | 655 | |||||||||||||
Asp | Gly | Tyr | Ile | Phe | Asp | Thr | ser | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser |
• • · • • • · · | • · v · • · • · · • • « | • · • • • · « • · | ♦ · · • ♦ · • • · | • • · • • · · • · | • · · • • • • · • · | ·· · • • • • • · | |||||||||
660 | 665 | ··' | 670 | ||||||||||||
Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu |
675 | 680 | 685 | |||||||||||||
Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys |
690 | 695 | - | 700 | ||||||||||||
Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | val | Lys | Ala | Ala | Lys | Lys | val | pro |
705 | 710 | 715 | 720 | ||||||||||||
Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | val | Glu | val | Lys | Asn |
725 | 730 | 735 | |||||||||||||
Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr | Asp | His | Tyr | His | Asn | ile | Lys | Phe |
740 | 745 | 750 | |||||||||||||
Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | ser | Leu |
755 | 760 | 765 | |||||||||||||
Glu | Asp | Leu | Leu | Ala | Thr | val | Lys | Tyr | Tyr | Val | Glu | Pro | Arg | Asn | Ala |
770 | 775 | 780 | |||||||||||||
Ser | Asp | His | val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | ser | Lys | Pro | Asp |
785 | 790 | 795 | 800 | ||||||||||||
Glu | Asp | Lys | Glu | His | ASp | Glu | Val | Ser | Glu | Pro | Thr | His | Pro | Glu | ser |
805 | 810 | 815 | |||||||||||||
Asp | Glu | Lys | Glu | Asn | HÍS | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn | Leu |
820 | 825 | 830 | |||||||||||||
Tyr | Lys | Pro | Ser | Thr | ASp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu | Asp |
835 | 840 | 845 | |||||||||||||
Thr | Thr | ASp | Glu | Ala | Glu | ile | Pro | Gly | Thr | Pro | Ser | Ile | Arg | Gin | Asn |
850 | 855 | 860 | |||||||||||||
Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr |
865 | 870 | 875 | 880 | ||||||||||||
Lys | Asp | Asn | Asn | Thr | ile | Ser | Ala | Glu | val | ASp | Ser | Leu | Leu | Ala | Leu |
885 | 890 | 895 | |||||||||||||
Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | ile | Gin |
900 905 <210> 370 <211> 906 <212> PRT <213> Unknown <220>
<223> VP 90 <400> 370
Met | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | Val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | ile | Phe | Asp | Thr | ser | Trp | Ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Gl u | Ala | Ile | Tyr | Asn | Arg | Val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Al a | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | Val | Glu | val | Lys | Asn | Gly | Ser | Leu | ile | ile | Pro | His | Tyr | Asp | His |
100 | 105 | 110 | |||||||||||||
Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
Val | Glu | Pro | Arg | Asn | Ala | Ser | Asp | Hi s | val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu | Val | ser | Glu |
165 | 170 | 175 | |||||||||||||
Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | HÍS | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr |
195 200 205 • · • * ·
2/M
Glu Glu 210 | Glu | Ala Glu Asp | Thr Thr Asp Glu Ala 215 | Glu Ile 220 | Pro | Gly | Thr | ||||||||
Pro | Ser | Ile | Arg | Gin | Asn | Al a | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | val |
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | Ile | Gin |
260 | 265 | 270 | |||||||||||||
Gly | Pro | Gin | ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr |
275 | 280 | 285 | |||||||||||||
Pro | ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His |
290 | 295 | 300 | |||||||||||||
Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Al a | Asn | Arg | Ile | Ile | Ala | Glu | Asp |
305 | 310 | 315 | 320 | ||||||||||||
Glu | ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp | Ser | Asn | His | Tyr | Phe | Phe |
325 | 330 | 335 | |||||||||||||
Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu |
340 | 345 | 350 | |||||||||||||
Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His |
355 | 360 | 365 | |||||||||||||
Glu | Gin | ASp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys |
370 | 375 | 380 | |||||||||||||
Lys | ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Arg | Glu | Ser | Ile | val | val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | ile | Tyr | Pro |
405 | 410 | 415 | |||||||||||||
Ser | Gly | Asp | His | His | Hi s | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | val |
420 | 425 | 430 | |||||||||||||
Gly | ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | pro | Glu | Glu |
435 | 440 | 445 | |||||||||||||
Gly | Val | Al a | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu |
450 | 455 | 460 | |||||||||||||
Thr | Asn | Val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn |
465 | 470 | 475 | 480 | ||||||||||||
Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | Val | ser | Phe | Ser | Phe | pro | Pro |
485 | 490 | 495 | |||||||||||||
Glu | Leu | Glu | Lys | Lys | Leu | Gly | ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr |
500 | 505 | 510 | |||||||||||||
Pro | Asp | Gly | Lys | Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | val | Phe | Gly | Glu |
515 | 520 | 525 | |||||||||||||
Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val |
545 | 550 | 555 | 560 | ||||||||||||
Ser | Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met |
565 | 570 | 575 | |||||||||||||
Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu |
580 | 585 | 590 | |||||||||||||
Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val |
595 | 600 | 605 | |||||||||||||
Arg | val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr |
610 | 615 | 620 | |||||||||||||
Lys | val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr |
625 | 630 | 635 | 640 | ||||||||||||
Thr | Arg | Thr | Ala | Gly | Asn | Lys | ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala |
645 | 650 | 655 | |||||||||||||
Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | val | Glu | val | Pro | ile | Leu | Glu |
660 | 665 | 670 | |||||||||||||
Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg |
675 | 680 | 685 | |||||||||||||
Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | val | Glu | Glu | Pro |
690 | 695 | 700 | |||||||||||||
Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn |
705 | 710 | 715 | 720 | ||||||||||||
Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | Val | Asp | Pro | val |
725 | 730 | 735 | |||||||||||||
Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu |
740 | 745 | 750 |
·· ·« »-»··
Asn val | Leu 755 | Phe Asn | Met Asp Gly Thr Ile Glu Leu Tyr Leu Pro | Ser | |||||||||||
760 | 765 | ||||||||||||||
Gly | Glu | val | ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro |
770 | 775 | 780 | |||||||||||||
Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Gl u | Asn | Gly | Lys | val | Ser | Thr |
785 | 790 | 795 | 800 | ||||||||||||
Gly | Thr | val | Glu | Asn | Gin | Pro | Thr | Gl u | Asn | Lys | Pro | Ala | Asp | Ser | Leu |
805 | 810 | 815 | |||||||||||||
Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp |
820 | 825 | 830 | |||||||||||||
Asn | Gly | Met | Leu | Asn | Pro | Gl u | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met | Leu |
835 | 840 | 845 | |||||||||||||
Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | val | Asp | Pro | val | Gin | Glu | Lys |
850 | 855 | 860 | |||||||||||||
Leu | Glu | Lys | Phe | Thr | Ala | ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | val | Ile |
865 | 870 | 875 | 880 | ||||||||||||
Phe | Asn | Met | Asp | Gly | Thr | ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val |
885 | 890 | 895 | |||||||||||||
Ile | Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | ||||||
900 | 905 |
<210> 371 <211> 906 <212> PRT <213> Unknown <220>
<223> VP 91 <400> 371
Met Gin Ile Gly Gin Pro Thr Leu Pro Asn Asn Ser Leu Ala Thr Pro | |||||||||||||||
1 | 5 | 10 | 15 | ||||||||||||
Ser | Pro | ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Gl u | Asp | Gly | Tyr | Gly | Phe | Asp | Al a | Asn | Arg | Ile | ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | Val | Met | Ser | Ser | Gly | Asp | Ser | Asn | His | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu |
85 | 90 | 95 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
100 | 105 | 110 | |||||||||||||
Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val | Lys | Arg |
115 | 120 | 125 | |||||||||||||
Glu | Ser | Ile | Val | val | Asn | Lys | Glu | Lys | Asn | Ala | ile | ile | Tyr | Pro | Ser |
130 | 135 | 140 | |||||||||||||
Gly | ASp | Gly | His | His | Ala | ASp | Pro | ile | Asp | Gl u | His | Lys | Pro | val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
Ile | Gly | Hi s | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | 170 | 175 | |||||||||||||
val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Al a | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | val | Lys | Leu | Ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
ASp | Gly | Lys | val | Leu | Glu | Lys | val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | val | Ser |
275 | 280 | 285 |
Tyr Asp | Gly | Thr | Phe Thr Val 295 | Pro | Thr | Ser | Leu Ala 300 | Tyr | Lys | Met | Ala | ||||
290 | |||||||||||||||
Ser | Gin | Thr | ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
305 | 310 | 315 | 320 | ||||||||||||
Val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg |
325 | 330 | 335 | |||||||||||||
val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
340 | 345 | 350 | |||||||||||||
val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
355 | 360 | 365 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
370 | 375 | 380 | |||||||||||||
Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | val | Glu | val | Pro | Ile | Leu | Glu | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
405 | 410 | 415 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | val | Glu | Glu | Pro | Lys |
420 | 425 | 430 | |||||||||||||
Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser |
435 | 440 | 445 | |||||||||||||
Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | val | Asp | Pro | val | Gin |
450 | 455 | 460 | |||||||||||||
Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
465 | 470 | 475 | 480 | ||||||||||||
val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
485 | 490 | 495 | |||||||||||||
Glu | val | ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
500 | 505 | 510 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly |
515 | 520 | 525 | |||||||||||||
Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | ASp | Ser | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | Pro | val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu | Asp |
565 | 570 | 575 | |||||||||||||
Pro | Al a | Leu | Glu | Glu | Ala | Pro | Ala | val | Asp | Pro | val | Gin | Glu | Lys | Leu |
580 | 585 | 590 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | Ile | Phe |
595 | 600 | 605 | |||||||||||||
Asn | Met | Asp | Gly | Thr | ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val | Ile |
610 | 615 | 620 | |||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | Gly | Pro | Gin | Ile | Thr | Tyr | Thr |
625 | 630 | 635 | 640 | ||||||||||||
Asp | Asp | Glu | ile | Gin | val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu |
645 | 650 | 655 | |||||||||||||
Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser |
660 | 665 | 670 | |||||||||||||
Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu |
675 | 680 | 685 | |||||||||||||
Thr | Pro | Pro | ser | Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys |
690 | 695 | 700 | |||||||||||||
Gly | Ala | Glu | Ala | ile | Tyr | Asn | Arg | val | Lys | Ala | Ala | Lys | Lys | Val | Pro |
705 | 710 | 715 | 720 | ||||||||||||
Leu | Asp | Arg | Met | pro | Tyr | Asn | Leu | Gin | Tyr | Thr | val | Glu | val | Lys | Asn |
725 | 730 | 735 | |||||||||||||
Gly | Ser | Leu | ile | Ile | Pro | His | Tyr | Asp | His | Tyr | His | Asn | ile | Lys | Phe |
740 | 745 | 750 | |||||||||||||
Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu |
755 | 760 | 765 | |||||||||||||
Glu | Asp | Leu | Leu | Ala | Thr | val | Lys | Tyr | Tyr | Val | Glu | Pro | Arg | Asn | Ala |
770 | 775 | 780 | |||||||||||||
Ser | ASp | His | Val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro | Asp |
785 | 790 | 795 | 800 | ||||||||||||
Glu | Asp | Lys | Glu | His | Asp | Glu | val | Ser | Glu | Pro | Thr | Hi s | Pro | Glu | Ser |
805 | 810 | 815 | |||||||||||||
Asp | Glu | Lys | Glu | Asn | HÍS | Ala | Gly | Leu | Asn | Pro | Ser | Al a | Asp | Asn | Leu |
820 | 825 | 830 |
• · · ·
Tyr Lys Pro 835 | Ser Thr Asp Thr Glu Glu Thr 840 | Glu Glu Glu Ala Glu 845 Pro Ser ile Arg Gin 860 | ASp Asn Thr 880 | ||||||||||||
Thr Thr 850 | Asp Glu | Glu Ala Thr Leu | Glu ile Pro Gly 855 | Thr Ser | |||||||||||
Ala 865 | Met | Thr 870 | Gly Leu | Lys | Ser 875 | Leu | Leu | Leu | Gly | ||||||
Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | val | Asp | Ser | Leu | Leu | Al a | Leu |
885 | 890 | 895 | |||||||||||||
Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | ile | Gin | ||||||
900 | 905 |
<210> 372 <211> 906 <212> PRT <213> Unknown <22O>
<223> VP 92 <400> 372
Met Gin Ile Thr Tyr | Thr | Asp | Asp Glu Ile Gin val 10 | Ala | Lys | Leu 15 | Ala | ||||||||
1 | 5 | ||||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | ile | Phe | Asp | Thr | Ser | Trp | ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Ala | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | Val | Glu | val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr | Asp | His |
100 | 105 | 110 | |||||||||||||
Tyr | Hi s | Asn | ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Gl u | Ala |
115 | 120 | 125 | |||||||||||||
Pro | Lys | Gly | Tyr | ser | Leu | Glu | ASp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr |
130 | 135 | 140 | |||||||||||||
val | Glu | Pro | Arg | Asn | Ala | Ser | Asp | His | val | Arg | Lys | Asn | Lys | Ala | Asp |
145 | 150 | 155 | 160 | ||||||||||||
Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu | val | Ser | Glu |
165 | 170 | 175 | |||||||||||||
Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | HIS | Ala | Gly | Leu | Asn |
180 | 185 | 190 | |||||||||||||
Pro | Ser | Ala | ASp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr |
195 | 200 | 205 | |||||||||||||
Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr |
210 | 215 | 220 | |||||||||||||
Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | ser |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val |
245 | 250 | 255 | |||||||||||||
Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | ser | Gin | Pro | Ala | Pro | Ile | Gin |
260 | 265 | 270 | |||||||||||||
Gly | Pro | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr |
275 | 280 | 285 | |||||||||||||
Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly | Thr | ser | His | Glu | Lys | His |
290 | 295 | 300 | |||||||||||||
Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | Ile | Ile | Ala | Glu | Asp |
305 | 310 | 315 | 320 | ||||||||||||
Glu | Ser | Gly | Phe | Val | Met | Ser | Ser | Gly | Asp | Ser | Asn | His | Tyr | Phe | Phe |
325 | 330 | 335 | |||||||||||||
Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu |
340 | 345 | 350 | |||||||||||||
Glu | Glu | Val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His |
355 | 360 | 365 |
• · · ·
Glu Gin Asp Tyr Pro Gly 370 | Asn Ala 375 | Lys Glu | Meť | Lys Asp Leu Asp Lys 380 | |||||||||||
Lys | Ile | Glu | Glu | Lys | ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Arg | Glu | Ser | ile | Val | Val | Asn | Lys | Glu | Lys | Asn | Ala | ile | Ile | Tyr | Pro |
405 | 410 | 415 | |||||||||||||
Ser | Gly | Asp | Gly | His | His | Ala | Asp | Pro | ile | Asp | Glu | His | Lys | Pro | val |
420 | 425 | 430 | |||||||||||||
Gly | Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu |
435 | 440 | 445 | |||||||||||||
Gly | Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu |
450 | 455 | 460 | |||||||||||||
Thr | Asn | val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn |
465 | 470 | 475 | 480 | ||||||||||||
Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro |
485 | 490 | 495 | |||||||||||||
Glu | Leu | Glu | Lys | Lys | Leu | Gly | ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr |
500 | 505 | 510 | |||||||||||||
Pro | Asp | Gly | Lys | val | Leu | Glu | Lys | Val | Ser | Gly | Lys | val | Phe | Gly | Glu |
515 | 520 | 525 | |||||||||||||
Gly | Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Gly | Gin | Thr | Phe | Lys | Tyr | Thr | ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val |
545 | 550 | 555 | 560 | ||||||||||||
Ser | Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met |
565 | 570 | 575 | |||||||||||||
Ala | Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu |
580 | 585 | 590 | |||||||||||||
Arg | val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val |
595 | 600 | 605 | |||||||||||||
Arg | val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr |
610 | 615 | 620 | |||||||||||||
Lys | val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr |
625 | 630 | 635 | 640 | ||||||||||||
Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | Val | Thr | Phe | Met | Ala. | Asn | Ala |
645 | 650 | 655 | |||||||||||||
Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu | Glu |
660 | 665 | 670 | |||||||||||||
Lys | Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gl n | Phe | Lys | Arg |
675 | 680 | 685 | |||||||||||||
Asn | Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | val | Glu | Glu | Pro |
690 | 695 | 700 | |||||||||||||
Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn |
705 | 710 | 715 | 720 | ||||||||||||
Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | val | Asp | Pro | val |
725 | 730 | 735 | |||||||||||||
Gin | Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu |
740 | 745 | 750 | |||||||||||||
Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | pro | ser |
755 | 760 | 765 | |||||||||||||
Gly | Glu | val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro |
770 | 775 | 780 | |||||||||||||
Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr |
785 | 790 | 795 | 800 | ||||||||||||
Gly | Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu |
805 | 810 | 815 | |||||||||||||
Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | val | Lys | Pro | Glu | Asn | Ser | Thr | Asp |
820 | 825 | 830 | |||||||||||||
Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu |
835 | 840 | 845 | |||||||||||||
Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | val | Asp | Pro | Val | Gin | Glu | Lys |
850 | 855 | 860 | |||||||||||||
Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | val | ile |
865 | 870 | 875 | 880 | ||||||||||||
Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val |
885 | 890 | 895 | |||||||||||||
ile | Lys | Lys | Asn | Leu | Ser | Asp | Phe | ile | Ala | ||||||
900 | 905 |
• · · · <210> 373 <211> 906 <212> PRT <213> Unknown <220>
<223> VP 93 <400> 373
Met 1 | Gin Ile Gly Gin 5 | Pro Thr | Leu Pro Asn Asn Ser Leu Ala Thr | Pro | |||||||||||
10 | 15 | ||||||||||||||
Ser | Pro | ser | Leu | Pro | ile | Asn | Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu |
20 | 25 | 30 | |||||||||||||
Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn | Arg | ile | Ile | Ala | Glu | Asp | Glu |
35 | 40 | 45 | |||||||||||||
Ser | Gly | Phe | Val | Met | Ser | Hi s | Gly | Asp | Ser | Asn | His | Tyr | Phe | Phe | Lys |
50 | 55 | 60 | |||||||||||||
Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Glu | val | Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | ser | Leu | Ser | Ser | His | Glu |
85 | 90 | 95 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys |
100 | 105 | 110 | |||||||||||||
Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | Val | Lys | Arg |
115 | 120 | 125 | |||||||||||||
Glu | ser | Ile | val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | Ser |
130 | 135 | 140 | |||||||||||||
Gly | Asp | His | His | Hi s | Ala | Asp | Pro | ile | Asp | Glu | His | Lys | Pro | val | Gly |
145 | 150 | 155 | 160 | ||||||||||||
Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
165 | 170 | 175 | |||||||||||||
Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
180 | 185 | 190 | |||||||||||||
Asn | val | Val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
195 | 200 | 205 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
210 | 215 | 220 | |||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | val | Lys | Leu | Ile | Thr | Pro |
225 | 230 | 235 | 240 | ||||||||||||
Asp | Gly | Lys | val | Leu | Glu | Lys | Val | ser | Gly | Lys | val | Phe | Gly | Glu | Gly |
245 | 250 | 255 | |||||||||||||
val | Gly | Asn | Ile | Al a | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
260 | 265 | 270 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser |
275 | 280 | 285 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala |
290 | 295 | 300 | |||||||||||||
Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | Hi s | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
305 | 310 | 315 | 320 | ||||||||||||
val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val | Arg |
325 | 330 | 335 | |||||||||||||
Val | Phe | Asp | Glu | Phe | Hi s | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
340 | 345 | 350 | |||||||||||||
Val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
355 | 360 | 365 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
370 | 375 | 380 | |||||||||||||
Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | Val | Pro | Ile | Leu | Glu | Lys |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
405 | 410 | 415 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | val | Glu | Glu | Pro | Lys |
420 | 425 | 430 | |||||||||||||
Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser |
435 | 440 | 445 | |||||||||||||
Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | val | Asp | Pro | Val | Gin |
450 | 455 | 460 | |||||||||||||
Glu | Lys | val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
465 | 470 | 475 | 480 | ||||||||||||
val | Leu | Phe | Asn | Met | ASp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
485 | 490 | 495 | |||||||||||||
Glu | val | Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
500 | 505 | 510 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | val | Ser | Thr | Gly |
515 | 520 | 525 | |||||||||||||
Thr | val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro |
530 | 535 | 540 | |||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
545 | 550 | 555 | 560 | ||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu | Asp |
565 | 570 | 575 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala | val | Asp | Pro | val | Gin | Glu | Lys | Leu |
580 | 585 | 590 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | ile | Phe |
595 | 600 | 605 | |||||||||||||
Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val | Ile |
610 615 620
Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | Gly | Pro | Gin | ile | Thr | Tyr | Thr |
625 | 630 | 635 | 640 | ||||||||||||
Asp | Asp | Glu | ile | Gin | Val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu |
645 | 650 | 655 | |||||||||||||
Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser |
660 | 665 | 670 | |||||||||||||
Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu |
675 | 680 | 685 | |||||||||||||
Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys |
690 | 695 | 700 | |||||||||||||
Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys | Ala | Ala | Lys | Lys | val | Pro |
705 | 710 | 715 | 720 | ||||||||||||
Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | Val | Gl u | val | Lys | Asn |
725 | 730 | 735 | |||||||||||||
Gly | Ser | Leu | ile | ile | Pro | Ser | Tyr | Asp | His | Tyr | His | Asn | ile | Lys | Phe |
740 | 745 | 750 | |||||||||||||
Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu |
755 | 760 | 765 | |||||||||||||
Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr | Val | Glu | Pro | Arg | Asn | Ala |
770 | 775 | 780 | |||||||||||||
Ser | Asp | His | val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | ser | Lys | Pro | Asp |
785 | 790 | 795 | 800 | ||||||||||||
Gl u | Asp | Lys | Glu | His | Asp | Glu | val | Ser | Glu | Pro | Thr | His | Pro | Glu | Ser |
805 | 810 | 815 | |||||||||||||
Asp | Glu | Lys | Glu | Asn | Hi S | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn | Leu |
820 | 825 | 830 | |||||||||||||
Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu | Asp |
835 | 840 | 845 | |||||||||||||
Thr | Thr | Asp | Glu | Ala | Gl u | ile | Pro | Gly | Thr | Pro | Ser | Ile | Arg | Gin | Asn |
850 | 855 | 860 | |||||||||||||
Al a | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | ser | Ser | Leu | Leu | Leu | Gly | Thr |
865 | 870 | 875 | 880 | ||||||||||||
Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val | Asp | Ser | Leu | Leu | Ala | Leu |
885 | 890 | 895 | |||||||||||||
Leu | Lys | Glu | Ser | Gin | Pro | Ala | pro | ile | Gin |
900 905 <210> 374 <211> 259 <212> PRT <213> Unknown <220>
<223> VP43S <400> 374
Met | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | phe | Asp | Thr |
1 | 5 | 10 | 15 | ||||||||||||
Ser | Trp | ile | Lys | Lys | Asp | ser | Leu | Ser | Glu | Al a | Glu | Arg | Ala | Ala | Ala |
20 | 25 | 30 | |||||||||||||
Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His |
35 | 40 | 45 | |||||||||||||
Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Al a | Glu | Ala | ile | Tyr | Asn |
50 | 55 | 60 | |||||||||||||
Arg | val | Lys | Al a | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | pro | Tyr | Asn |
65 | 70 | 75 | 80 | ||||||||||||
Leu | Gin | Tyr | Thr | Val | Glu | val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His |
85 | 90 | 95 | |||||||||||||
Tyr | Asp | His | Tyr | His | Asn | ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu |
100 | 105 | 110 | |||||||||||||
Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | val |
115 | 120 | 125 | |||||||||||||
Lys | Tyr | Tyr | val | Glu | Pro | Arg | Asn | Al a | ser | Asp | His | val | Arg | Lys | Asn |
130 | 135 | 140 | |||||||||||||
Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp | Glu |
145 | 150 | 155 | 160 | ||||||||||||
val | Ser | Glu | Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | HÍS | Ala |
165 | 170 | 175 | |||||||||||||
Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr |
180 | 185 | 190 | |||||||||||||
Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile |
195 | 200 | 205 | |||||||||||||
Pro | Gly | Thr | Pro | Ser | ile | Arg | Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly |
210 | 215 | 220 | |||||||||||||
Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser |
225 | 230 | 235 | 240 | ||||||||||||
Ala | Glu | val | Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala |
245 | 250 | 255 | |||||||||||||
Pro | ile | Gin |
<210> 375 <211> 268 <212> PRT <213> Unknown <220>
<223> NEW 86 <400> 375
Met | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | val | Ala | Lys | Leu | Ala |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Thr | Ser | Trp | ile |
20 | 25 | 30 | |||||||||||||
Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr |
35 | 40 | 45 | |||||||||||||
Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser |
50 | 55 | 60 | |||||||||||||
Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg | Val | Lys |
65 | 70 | 75 | 80 | ||||||||||||
Al a | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr |
85 | 90 | 95 | |||||||||||||
Thr | Val | Glu | Val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | Pro | Gly | Asn | Ile |
100 | 105 | 110 | |||||||||||||
Lys | Phe | Glu | Trp | Phe | Asp | Gl u | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr |
115 | 120 | 125 | |||||||||||||
Ser | Leu | Glu | Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr | val | Glu | Pro | Arg |
130 | 135 | 140 | |||||||||||||
Asn | Ala | Ser | Asp | His | val | Arg | Lys | Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys |
145 | 150 | 155 | 160 | ||||||||||||
Pro | Asp | Glu | Asp | Lys | Glu | Hi s | Asp | Glu | val | Ser | Glu | Pro | Thr | His | Pro |
·· · · ···· • · · · ·
165 | 170 | 175 | |||||||||||||
Glu | Ser | Asp | Glu | Lys | Glu | Asn | His | Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp |
180 | 185 | 190 | |||||||||||||
Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala |
195 | 200 | 205 | |||||||||||||
Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro | Gly | Thr | Pro | Ser | Ile | Arg |
210 | 215 | 220 | |||||||||||||
Gin | Asn | Ala | Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu |
225 | 230 | 235 | 240 | ||||||||||||
Gly | Thr | Lys | Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | val | Asp | Ser | Leu | Leu |
245 | 250 | 255 | |||||||||||||
Ala | Leu | Leu | Lys | Glu | Ser | Gin | Pro | Ala | Pro | Ile | Gin | ||||
260 | 265 |
<210> 376 <211> 999 <212> PRT <213> Unknown <220>
<223> NEW 17 <221> VARIANT <222> (1)...(1) <223> Xaa = Methionine or nothing <221> VARIANT <222> (430)...(430) <223> xaa = Glycine or nothing <221> VARIANT <222> (431)...(431) <223> Xaa = Proline or nothing <400> 376
Xaa | Asp | Ile | Asp | Ser | Leu | Leu | Lys | Gin | Leu | Tyr | Lys | Leu | Pro | Leu | Ser |
1 | 5 | 10 | 15 | ||||||||||||
Gin | Arg | His | Val | Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile |
20 | 25 | 30 | |||||||||||||
Thr | Ser | Arg | Thr | Ala | Arg | Gly | val | Ala | Val | Pro | Hi S | Gly | Asn | His | Tyr |
35 | 40 | 45 | |||||||||||||
His | Phe | Ile | Pro | Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | ile | Ala |
50 | 55 | 60 | |||||||||||||
Arg | Ile | Ile | Pro | Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | val | Pro | Asp | Ser |
65 | 70 | 75 | 80 | ||||||||||||
Arg | Pro | Gl u | Glu | Pro | Ser | Pro | Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser |
85 | 90 | 95 | |||||||||||||
Pro | Gin | Pro | Ala | Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | ile | Asp |
100 | 105 | 110 | |||||||||||||
Glu | Lys | Leu | val | Lys | Glu | Ala | val | Arg | Lys | val | Gly | Asp | Gly | Tyr | val |
115 | 120 | 125 | |||||||||||||
Phe | Glu | Glu | Asn | Gly | Val | ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asn | Leu | Ser |
130 | 135 | 140 | |||||||||||||
Al a | Glu | Thr | Ala | Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser |
145 | 150 | 155 | 160 | ||||||||||||
Leu | Ser | His | Lys | Leu | Gly | Al a | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp |
165 | 170 | 175 | |||||||||||||
Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin |
180 | 185 | 190 | |||||||||||||
Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg | Gin | val | Asp | Phe | Glu | Ala | Leu | Asp |
195 | 200 | 205 | |||||||||||||
Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp | val | Ser | Ser | Asp | Lys | Val | Lys | Leu |
210 | 215 | 220 | |||||||||||||
val | Asp | Asp | Ile | Leu | Al a | Phe | Leu | Ala | Pro | ile | Arg | His | Pro | Glu | Arg |
225 | 230 | 235 | 240 | ||||||||||||
Leu | Gly | Lys | Pro | Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin |
245 250 255
Val Ala Lys Leu Ala Gly Lys Tyr Thr Thr Glu Asp Gly Tyr Ile | Phe | ||||||||||||||
260 | 265 | 270 | |||||||||||||
Asp | Pro | Arg | Asp | Ile | Thr | Ser | ASp | Glu | Gly | Asp | Ala | Tyr | val | Thr | pro |
275 | 280 | - | 285 | Ala | |||||||||||
His | Met | Thr | His | Ser | His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | |
290 | 295 | 300 | |||||||||||||
Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro |
305 | 310 | 315 | 320 | ||||||||||||
Pro | Ser | Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala |
325 | 330 | 335 | |||||||||||||
Glu | Ala | Ile | Tyr | Asn | Arg | val | Lys | Ala | Ala | Lys | Lys | val | Pro | Leu | Asp |
340 | 345 | 350 | |||||||||||||
Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | val | Glu | val | Lys | Asn | Gly | Ser |
355 | 360 | 365 | |||||||||||||
Leu | ile | ile | Pro | His | Tyr | Asp | Hi S | Tyr | His | Asn | ile | Lys | Phe | Glu | Trp |
370 | 375 | 380 | |||||||||||||
Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp |
385 | 390 | 395 | 400 | ||||||||||||
Leu | Leu | Ala | Thr | val | Lys | Tyr | Tyr | val | Glu | His | Pro | Asn | Glu | Arg | Pro |
405 | 410 | 415 | |||||||||||||
His | Ser | Asp | Asn | Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | Val | xaa | Xaa | Asp |
420 | 425 | 430 | |||||||||||||
Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu | Glu | Val |
435 | 440 | 445 | |||||||||||||
Lys | Thr | Ser | His | Asn | Gly | Leu | Asp | ser | Leu | Ser | Ser | His | Glu | Gin | Asp |
450 | 455 | 460 | |||||||||||||
Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | ile | Glu |
465 | 470 | 475 | 480 | ||||||||||||
Glu | Lys | Ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg | Glu | Ser |
485 | 490 | 495 | |||||||||||||
Ile | val | val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | His | Gly | Asp |
500 | 505 | 510 | |||||||||||||
His | Hi s | His | Ala | ASp | Pro | ile | Asp | Glu | His | Lys | Pro | val | Gly | Ile | Gly |
515 | 520 | 525 | |||||||||||||
Hi s | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly | val | Ala |
530 | 535 | 540 | |||||||||||||
Lys | Lys | Glu | Gly | Asn | Lys | Val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn | val |
545 | 550 | 555 | 560 | ||||||||||||
val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu |
565 | 570 | 575 | |||||||||||||
Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu | Leu | Glu |
580 | 585 | 590 | |||||||||||||
Lys | Lys | Leu | Gly | Ile | Asn | Met | Leu | Val | Lys | Leu | Ile | Thr | Pro | Asp | Gly |
595 | 600 | 605 | |||||||||||||
Lys | val | Leu | Glu | Lys | Val | Ser | Gly | Lys | val | Phe | Gly | Glu | Gly | Val | Gly |
610 | 615 | 620 | |||||||||||||
Asn | ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly | Gin | Thr |
625 | 630 | 635 | 640 | ||||||||||||
Phe | Lys | Tyr | Thr | ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser | Tyr | Asp |
645 | 650 | 655 | |||||||||||||
Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Al a | Tyr | Lys | Met | Ala | Ser | Gin |
660 | 665 | 670 | |||||||||||||
Thr | ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg | val | Asn |
675 | 680 | 685 | |||||||||||||
Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg | val | Phe |
690 | 695 | 700 | |||||||||||||
Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Gl u | Asn | Asn | Tyr | Lys | val | Gly |
705 | 710 | 715 | 720 | ||||||||||||
Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg | Thr |
725 | 730 | 735 | |||||||||||||
Ala | Gly | Asn | Lys | Ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp |
740 | 745 | 750 | |||||||||||||
Asn | Gin | Ser | Thr | Tyr | Ile | val | Glu | Val | Pro | Ile | Leu | Glu | Lys | Glu | Asn |
755 | 760 | 765 | |||||||||||||
Gin | Thr | Asp | Lys | Pro | Ser | ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn | Lys | Ala |
770 | 775 | 780 | |||||||||||||
Gin | Glu | Asn | Ser | Lys | Leu | Asp | Glu | Lys | Val | Gl u | Glu | Pro | Lys | Thr | Ser |
• ·
Φ • · · · · | * · ·· ·· 14 | • · · · | |||||||||||||
785 | 790 | 795 | 800 | ||||||||||||
Gl u | Lys | val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | ser | Thr | Ser |
805 | 810 | 815 | |||||||||||||
Asn | Ser | Thr | Leu | Glu | Glu | val | Pro | Thr | Val | Asp | pro | val | Gin | Glu | Lys |
820 | 825 | 830 | |||||||||||||
Val | Ala | Lys | Phe | Ala | Gl u | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn | val | Leu |
835 | 840 | 845 | |||||||||||||
Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly | Glu | val |
850 | 855 | 860 | |||||||||||||
Ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Gl u | Ala | Pro | Gin | Gly | Asn |
865 | 870 | 875 | 880 | ||||||||||||
Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | val | Ser | Thr | Gly | Thr | Val |
885 | 890 | 895 | |||||||||||||
Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | Ser | Leu | Pro | Glu | Ala |
900 | 905 | 910 | |||||||||||||
Pro | Asn | Glu | Lys | Pro | val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn | Gly | Met |
915 | 920 | 925 | |||||||||||||
Leu | Asn | Pro | Glu | Gly | Asn | Val | Gly | Ser | Asp | Pro | Met | Leu | Asp | Pro | Ala |
930 | 935 | 940 | |||||||||||||
Leu | Glu | Glu | Ala | Pro | Ala | Val | Asp | Pro | val | Gin | Glu | Lys | Leu | Glu | Lys |
945 | 950 | 955 | 960 | ||||||||||||
Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | Val | ile | Phe | Asn | Met |
965 | 970 | 975 | |||||||||||||
Asp | Gly | Thr | ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | val | ile | Lys | Lys |
980 | 985 | 990 | |||||||||||||
Asn | Leu | Ser | Asp | Phe | Ile | Ala |
995 <210> 377 <211> 999 <212> PRT <213> Unknown
<22O> <223> | NEW 20 | |
<221> | VARIANT | |
<222> | (i)...(1) | |
<223> | Xaa = Methionine | or nothing |
<221> | VARIANT | |
<222> | (570)...(570) | |
<223> | Xaa = Glycine or | nothi ng |
<221> VARIANT <222> (571)...(571)
<22: | 3> Xaa = | Pro' | line | or i | noth' | ing | |||||||||
<400> 377 | |||||||||||||||
Xaa | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu |
1 | 5 | 10 | 15 | ||||||||||||
Glu | val | Lys | Thr | Ser | Hi s | Asn | Gly | Leu | Asp | Ser | Leu | Ser | ser | His | Glu |
20 | 25 | 30 | |||||||||||||
Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | ASp | Lys | Lys |
35 | 40 | 45 | |||||||||||||
Ile | Glu | Gl u | Lys | Ile | Ala | Gly | ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg |
50 | 55 | 60 | |||||||||||||
Glu | Ser | Ile | val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | His |
65 | 70 | 75 | 80 | ||||||||||||
Gly | Asp | His | His | His | Ala | Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | val | Gly |
85 | 90 | 95 | |||||||||||||
Ile | Gly | His | Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly |
100 | 105 | 110 | |||||||||||||
Val | Ala | Lys | Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr |
115 | 120 | 125 | |||||||||||||
Asn | val | val | Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe |
• · · · llX
130 | 135 | 140 | |||||||||||||
Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu |
145 | 150 | 155 | 160 | ||||||||||||
Leu | Glu | Lys | Lys | Leu | Gly | ile | Asn | Met | Leu | val | Lys | Leu | ile | Thr | Pro |
165 | 170 | 175 | |||||||||||||
Asp | Gly | Lys | Val | Leu | Glu | Lys | val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly |
180 | 185 | 190 | |||||||||||||
Val | Gly | Asn | Ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly |
195 | 200 | 205 | |||||||||||||
Gin | Thr | Phe | Lys | Tyr | Thr | ile | Ala | Ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser |
210 | 215 | 220 | |||||||||||||
Tyr | Asp | Gly | Thr | Phe | Thr | Val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala |
225 | 230 | 235 | 240 | ||||||||||||
Ser | Gin | Thr | Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg |
245 | 250 | 255 | |||||||||||||
val | Asn | Pro | Gin | Phe | Ala | val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val | Arg |
260 | 265 | 270 | |||||||||||||
Val | Phe | Asp | Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys |
275 | 280 | 285 | |||||||||||||
val | Gly | Glu | Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr |
290 | 295 | 300 | |||||||||||||
Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr |
305 | 310 | 315 | 320 | ||||||||||||
Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile | Val | Glu | val | Pro | Ile | Leu | Glu | Lys |
325 | 330 | 335 | |||||||||||||
Glu | Asn | Gin | Thr | Asp | Lys | Pro | Ser | Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn |
340 | 345 | 350 | |||||||||||||
Lys | Ala | Gin | Glu | Asn | ser | Lys | Leu | Asp | Gl u | Lys | Val | Glu | Glu | Pro | Lys |
355 | 360 | 365 | |||||||||||||
Thr | Ser | Glu | Lys | val | Glu | Lys | Glu | Lys | Leu | Ser | Glu | Thr | Gly | Asn | ser |
370 | 375 | 380 | |||||||||||||
Thr | Ser | Asn | Ser | Thr | Leu | Gl u | Glu | Val | Pro | Thr | Val | Asp | Pro | val | Gin |
385 | 390 | 395 | 400 | ||||||||||||
Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu | Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn |
405 | 410 | 415 | |||||||||||||
val | Leu | Phe | Asn | Met | Asp | Gly | Thr | Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly |
420 | 425 | 430 | |||||||||||||
Glu | val | ile | Lys | Lys | Asn | Met | Ala | Asp | Phe | Thr | Gly | Glu | Ala | Pro | Gin |
435 | 440 | 445 | |||||||||||||
Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser | Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly |
450 | 455 | 460 | |||||||||||||
Thr | Val | Glu | Asn | Gin | Pro | Thr | Glu | Asn | Lys | Pro | Ala | Asp | ser | Leu | Pro |
465 | 470 | 475 | 480 | ||||||||||||
Glu | Ala | Pro | Asn | Glu | Lys | Pro | val | Lys | Pro | Glu | Asn | Ser | Thr | Asp | Asn |
485 | 490 | 495 | |||||||||||||
Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn | val | Gly | Ser | Asp | Pro | Met | Leu | Asp |
500 | 505 | 510 | |||||||||||||
Pro | Ala | Leu | Glu | Glu | Ala | Pro | Al a | Val | Asp | Pro | val | Gin | Glu | Lys | Leu |
515 | 520 | 525 | |||||||||||||
Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly | Leu | Gly | Leu | Asp | Ser | val | ile | Phe |
530 | 535 | 540 | |||||||||||||
Asn | Met | Asp | Gly | Thr | ile | Glu | Leu | Arg | Leu | Pro | Ser | Gly | Glu | Val | Ile |
545 | 550 | 555 | 560 | ||||||||||||
Lys | Lys | Asn | Leu | Ser | Asp | Phe | Ile | Ala | Xaa | Xaa | Asp | Ile | Asp | Ser | Leu |
565 | 570 | 575 | |||||||||||||
Leu | Lys | Gin | Leu | Tyr | Lys | Leu | pro | Leu | Ser | Gin | Arg | His | Val | Glu | ser |
580 | 585 | 590 | |||||||||||||
Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | ile | Thr | Ser | Arg | Thr | Ala | Arg |
595 | 600 | 605 | |||||||||||||
Gly | Val | Ala | Val | Pro | Hi S | Gly | Asn | His | Tyr | His | Phe | Ile | Pro | Tyr | Glu |
610 | 615 | 620 | |||||||||||||
Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala | Arg | Ile | ile | Pro | Leu | Arg |
625 | 630 | 635 | 640 | ||||||||||||
Tyr | Arg | Ser | Asn | His | Trp | Val | pro | Asp | Ser | Arg | Pro | Glu | Gl u | Pro | ser |
645 | 650 | 655 | |||||||||||||
Pro | Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser | Pro | Gin | Pro | Ala | Pro | Asn |
660 | 665 | 670 | |||||||||||||
Pro | Gin | pro | Ala | Pro | Ser | Asn | pro | Ile | Asp | Glu | Lys | Leu | val | Lys | Glu |
675 | 680 | 685 | |||||||||||||
Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val | Phe | Glu | Glu | Asn | Gly | val |
690 | 695 | 700 | |||||||||||||
Ser | Arg | Tyr | Ile | Pro | Al a | Lys | Asn | Leu | Ser | Ala | Glu | Thr | Ala | Ala | Gly |
705 | 710 | - | 715 | 720 | |||||||||||
Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser | Leu | Ser | Hi s | Lys | Leu | Gly |
725 | 730 | 735 | |||||||||||||
Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser | Asp | Arg | Glu | Phe | Tyr | Asn | Lys |
740 | 745 | 750 | |||||||||||||
Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin | Asp | Leu | Leu | Asp | Asn | Lys |
755 | 760 | 765 | |||||||||||||
Gly | Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp | Asn | Leu | Leu | Glu | Arg | Leu |
770 | 775 | 780 | |||||||||||||
Lys | ASp | val | Ser | Ser | Asp | Lys | val | Lys | Leu | val | Asp | Asp | Ile | Leu | Ala |
785 | 790 | 795 | 800 | ||||||||||||
Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu | Gly | Lys | Pro | Asn | Ala |
805 | 810 | 815 | |||||||||||||
Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | val | Ala | Lys | Leu | Ala | Gly |
820 | 825 | 830 | |||||||||||||
Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe | Asp | Pro | Arg | ASp | Ile | Thr |
835 | 840 | 845 | |||||||||||||
Ser | Asp | Glu | Gly | Asp | Ala | Tyr | val | Thr | Pro | His | Met | Thr | HÍS | Ser | His |
850 | 855 | 860 | |||||||||||||
Trp | Ile | Lys | Lys | Asp | ser | Leu | Ser | Glu | Ala | Glu | Arg | Ala | Ala | Ala | Gin |
865 | 870 | 875 | 880 | ||||||||||||
Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | Pro | Ser | Thr | ASp | His | Gin |
885 | 890 | 895 | |||||||||||||
Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu | Ala | Ile | Tyr | Asn | Arg |
900 | 905 | 910 | |||||||||||||
Val | Lys | Al a | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg | Met | Pro | Tyr | Asn | Leu |
915 | 920 | 925 | |||||||||||||
Gin | Tyr | Thr | Val | Glu | val | Lys | Asn | Gly | Ser | Leu | Ile | Ile | Pro | His | Tyr |
930 | 935 | 940 | |||||||||||||
Asp | His | Tyr | Hi s | Asn | ile | Lys | Phe | Glu | Trp | Phe | Asp | Glu | Gly | Leu | Tyr |
945 | 950 | 955 | 960 | ||||||||||||
Glu | Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp | Leu | Leu | Ala | Thr | val | Lys |
965 | 970 | 975 | |||||||||||||
Tyr | Tyr | val | Glu | His | Pro | Asn | Glu | Arg | Pro | His | Ser | Asp | Asn | Gly | Phe |
980 | 985 | 990 | |||||||||||||
Gly | Asn | Ala | Ser | Asp | His | Val | |||||||||
995 |
<210> 378 <211> 1378 <212> PRT <213> Unknown <220>
<223> NEW 26 <221> VARIANT <222> (1)...(1) <223> Xaa = Methionine or nothing <221> VARIANT <222> (570)...(570) <223> Xaa = Glycine or nothing <221> VARIANT <222> (571)...(571) <223> Xaa = Proline or nothing <400> 378
Xaa Glu Asn Ile Ser Ser Leu Leu Arg Glu Leu Tyr Ala Lys Pro Leu 15 10 15
Ser Glu Arg His Val Glu Ser Asp Gly Leu Ile Phe Asp Pro Ala Gin • · · · · ΧΙΑ
25 30
Ile Thr | Ser 35 | Arg Thr Ala Arg Gly 40 | val | Ala | val | Pro | His 45 | Gly | Asn | His | |||||
Tyr | Hi S | Phe | Ile | Pro | Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | ile |
50 | 55 | 60 | |||||||||||||
Ala | Arg | Ile | Ile | Pro | Leu | Arg | Tyr | Arg | ser | Asn | His | Trp | val | Pro | Asp |
65 | 70 | 75 | 80 | ||||||||||||
Ser | Arg | Pro | Glu | Gin | Pro | Ser | Pro | Gin | ser | Thr | Pro | Glu | Pro | Ser | Pro |
85 | 90 | 95 | |||||||||||||
Ser | Leu | Gin | Pro | Ala | Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile |
100 | 105 | 110 | |||||||||||||
Asp | Glu | Lys | Leu | Val | Lys | Glu | Ala | val | Arg | Lys | val | Gly | Asp | Gly | Tyr |
115 | 120 | 125 | |||||||||||||
val | phe | Glu | Glu | Asn | Gly | val | Ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asp | Leu |
130 | 135 | 140 | |||||||||||||
Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu |
145 | 150 | 155 | 160 | ||||||||||||
Ser | Leu | Ser | Hi s | Lys | Leu | Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser |
165 | 170 | 175 | |||||||||||||
Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His |
180 | 185 | 190 | |||||||||||||
Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Val | Leu |
195 | 200 | 205 | |||||||||||||
Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp | val | Ser | Ser | ASp | Lys | val | Lys |
210 | 215 | 220 | |||||||||||||
Leu | Val | Asp | Asp | Ile | Leu | Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu |
225 | 230 | 235 | 240 | ||||||||||||
Arg | Leu | Gly | Lys | Pro | Asn | Ala | Gin | ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile |
245 | 250 | 255 | |||||||||||||
Gin | val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile |
260 | 265 | 270 | |||||||||||||
Phe | Asp | Pro | Arg | Asp | Ile | Thr | ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr |
275 | 280 | 285 | |||||||||||||
Pro | His | Met | Thr | His | Ser | His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu |
290 | 295 | 300 | |||||||||||||
Al a | Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr |
305 | 310 | 315 | 320 | ||||||||||||
Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly |
325 | 330 | 335 | |||||||||||||
Al a | Glu | Ala | ile | Tyr | Asn | Arg | val | Lys | Ala | Ala | Lys | Lys | val | Pro | Leu |
340 | 345 | 350 | |||||||||||||
Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | val | Glu | Val | Lys | Asn | Gly |
355 | 360 | 365 | |||||||||||||
Ser | Leu | Ile | ile | Pro | His | Tyr | ASp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu |
370 | 375 | 380 | |||||||||||||
Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu |
385 | 390 | 395 | 400 | ||||||||||||
ASp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr | val | Glu | Hi s | Pro | Asn | Glu | Arg |
405 | 410 | 415 | |||||||||||||
Pro | His | Ser | Asp | Asn | Gly | Phe | Gly | Asn | Al a | Ser | Asp | Hi s | val | Arg | Lys |
420 | 425 | 430 | |||||||||||||
Asn | Lys | Ala | Asp | Gl n | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp |
435 | 440 | 445 | |||||||||||||
Glu | val | Ser | Glu | Pro | Thr | Hi s | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | HÍS |
450 | 455 | 460 | |||||||||||||
Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | ASp |
465 | 470 | 475 | 480 | ||||||||||||
Thr | Gl u | Glu | Thr | Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu |
485 | 490 | 495 | |||||||||||||
Ile | Pro | Gin | val | Glu | Asn | Ser | val | Ile | Asn | Ala | Lys | Ile | Ala | Asp | Ala |
500 | 505 | 510 | |||||||||||||
Glu | Ala | Leu | Leu | Glu | Lys | Val | Thr | Asp | Pro | Ser | ile | Arq | Gin | Asn | Ala |
515 | 520 | 525 | |||||||||||||
Met | Gl u | Thr | Leu | Thr | Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr | Lys |
530 | 535 | 540 | |||||||||||||
Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | val | Asp | Ser | Leu | Leu | Ala | Leu | Leu |
545 | 550 | 555 | 560 | ||||||||||||
Lys | Glu | Ser | Gin | Pro | Al a | pro | ile | Gin | xaa | Xaa | Asn | Met | Gin | Pro | ser |
• · · · • · · · tlí
565 | 570 | 575 | ||||||||||||
Gin | Leu | Ser | Tyr | Ser | Ser | Thr | Ala | Ser | Asp Asn | Asn | Thr | Gin | Ser | val |
580 | 585 | 590 | ||||||||||||
Ala | Lys | Gly | Ser | Thr | ser | Lys | Pro | Al a | Asn Lys | Ser | Glu | Asn | Leu | Gin |
595 | 600 | - | 605 | |||||||||||
Ser | Leu | Leu | Lys | Glu | Leu | Tyr | Asp | Ser | Pro Ser | Ala | Gin | Arg | Tyr | Ser |
610 | 615 | 620 | ||||||||||||
Glu | Ser | Asp | Gly | Leu | val | Phe | Asp | Pro | Ala Lys | ile | Ile | Ser | Arg | Thr |
625 | 630 | 635 | 640 | |||||||||||
Pro | Asn | Gly | Val | Ala | ile | Pro | Hi S | Gly | Asp His | Tyr | His | Phe | ile | Pro |
645 | 650 | 655 | ||||||||||||
Tyr | Ser | Lys | Leu | ser | Ala | Leu | Glu | Glu | Lys ile | Ala | Arg | Met | Val | Pro |
660 | 665 | 670 | ||||||||||||
ile | Ser | Gly | Thr | Gly | Ser | Thr | val | Ser | Thr Asn | Ala | Lys | Pro | Asn | Glu |
675 | 680 | 685 | ||||||||||||
val | Val | Ser | Ser | Leu | Gly | Ser | Leu | Ser | Ser Asn | Pro | Ser | Ser | Leu | Thr |
690 | 695 | 700 | ||||||||||||
Thr | Ser | Lys | Glu | Leu | Ser | Ser | Ala | Ser | Asp Gly | Tyr | ile | Phe | Asn | Pro |
705 | 710 | 715 | 720 | |||||||||||
Lys | Asp | Ile | val | Glu | Glu | Thr | Ala | Thr | Ala Tyr | Ile | val | Arg | His | Gly |
725 | 730 | 735 | ||||||||||||
Asp | His | Phe | His | Tyr | Ile | Pro | Lys | Ser | Asn Gin | ile | Gly | Gin | Pro | Thr |
740 | 745 | 750 | ||||||||||||
Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr | Pro | Ser Pro | Ser | Leu | Pro | ile | Asn |
755 | 760 | 765 | ||||||||||||
Pro | Gly | Thr | Ser | His | Glu | Lys | His | Glu | Glu Asp | Gly | Tyr | Gly | Phe | Asp |
770 | 775 | 780 | ||||||||||||
Ala | Asn | Arg | Ile | ile | Ala | Glu | Asp | Glu | Ser Gly | Phe | val | Met | Ser | His |
785 | 790 | 795 | 800 | |||||||||||
Gly | Asp | His | Asn | His | Tyr | Phe | Phe | Lys | Lys Asp | Leu | Thr | Glu | Glu | Gin |
805 | 810 | 815 | ||||||||||||
Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu | Glu Val | Lys | Thr | Ser | His | Asn |
820 | 825 | 830 | ||||||||||||
Gly | Leu | Asp | Ser | Leu | Ser | Ser | Hi s | Glu | Gin Asp | Tyr | Pro | Gly | Asn | Ala |
835 | 840 | 845 | ||||||||||||
Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | ile Glu | Glu | Lys | ile | Ala | Gly |
850 | 855 | 860 | ||||||||||||
ile | Met | Lys | Gl n | Tyr | Gly | Val | Lys | Arg | Glu Ser | Ile | val | Val | Asn | Lys |
865 | 870 | 875 | 880 | |||||||||||
Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | His | Gly Asp | His | His | His | Ala | Asp |
885 | 890 | 895 | ||||||||||||
Pro | Ile | Asp | Glu | His | Lys | Pro | val | Gly | ile Gly | His | Ser | His | Ser | Asn |
900 | 905 | 910 | ||||||||||||
Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly | Val Ala | Lys | Lys | Glu | Gly | Asn |
915 | 920 | 925 | ||||||||||||
Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn Val | Val | Asn | Leu | Leu | Lys |
930 | 935 | 940 | ||||||||||||
Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr Leu | Ala | Asn | Gly | Gin | Lys |
945 | 950 | 955 | 960 | |||||||||||
Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu | Leu Glu | Lys | Lys | Leu | Gly | ile |
965 | 970 | 975 | ||||||||||||
Asn | Met | Leu | val | Lys | Leu | Ile | Thr | Pro | Asp Gly | Lys | val | Leu | Glu | Lys |
980 | 985 | 990 | ||||||||||||
Val | Ser | Gly | Lys | val | Phe | Gly | Glu | Gly | Val Gly | Asn | ile | Ala | Asn | Phe |
995 | 1000 | 1005 | ||||||||||||
Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly | Gin Thr | Phe | Lys | Tyr | Thr | ile |
1010 | 1015 | 1020 | ||||||||||||
Al a | Ser | Lys | Asp | Tyr | Pro | Glu | val | Ser | Tyr Asp | Gly | Thr | Phe | Thr | val |
1025 | 1030 | 1035 | 1040 | |||||||||||
Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala | Ser Gin | Thr | ile | Phe | Tyr | Pro |
1045 | 1050 | 1055 | ||||||||||||
Phe | His | Ala | Gly | ASp | Thr | Tyr | Leu | Arg | Val Asn | Pro | Gl n | Phe | Ala | val |
1060 | 1065 | 1070 | ||||||||||||
Pro | Lys | Gly Thr | ASp | Ala | Leu | Val | Arg | val Phe | Asp | Glu | Phe | His | Gly | |
1075 | 1080 | 1085 | ||||||||||||
Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | val Gly | Glu | Ile | Lys | Leu | pro |
1090 | 1095 | 1100 |
Ile Pro | Lys | Leu | Asn | Gin Gly Thr Thr | Arg Thr | Ala Gly Asn | Lys | ile |
1105 | 1110 | 1115 | 1120 | |||||
Pro val | Thr | Phe | Met | Ala Asn Ala Tyr | Leu Asp | Asn Gin ser | Thr | Tyr |
1125 | 1130 | 1135 | ||||||
ile val | Glu | val | Pro | ile Leu Glu Lys | Glu Asn | Gin Thr Asp | Lys | Pro |
1140 | 1145 | 1150 | ||||||
Ser ile | Leu | Pro | Gin | Phe Lys Arg Asn | Lys Ala | Gin Glu Asn | Ser | Lys |
1155 | 1160 | 1165 | ||||||
Leu Asp | Glu | Lys | val | Glu Glu Pro Lys | Thr Ser | Glu Lys val | Glu | Lys |
1170 | 1175 | 1180 | ||||||
Glu Lys | Leu | Ser | Glu | Thr Gly Asn Ser | Thr Ser | Asn ser Thr | Leu | Glu |
1185 | 1190 | 1195 | 1200 | |||||
Glu val | Pro | Thr | Val | Asp Pro val Gin | Glu Lys | val Ala Lys | Phe | Ala |
1205 | 1210 | 1215 | ||||||
Glu Ser | Tyr | Gly | Met | Lys Leu Glu Asn | Val Leu | Phe Asn Met | Asp | Gly |
1220 | 1225 | 1230 | ||||||
Thr ile | Glu | Leu | Tyr | Leu Pro Ser Gly | Glu val | ile Lys Lys | Asn | Met |
1235 | 1240 | 1245 | ||||||
Ala Asp | Phe | Thr | Gly | Glu Ala Pro Gin | Gly Asn | Gly Glu Asn | Lys | Pro |
1250 | 1255 | 1260 | ||||||
Ser Glu | Asn | Gly | Lys | val Ser Thr Gly | Thr Val | Glu Asn Gin | Pro | Thr |
1265 | 1270 | 1275 | 1280 | |||||
Glu Asn | Lys | Pro | Ala | Asp Ser Leu Pro | Glu Ala | Pro Asn Glu | Lys | Pro |
1285 | 1290 | 1295 | ||||||
Val Lys | Pro | Glu | Asn | Ser Thr Asp Asn | Gly Met | Leu Asn pro | Glu | Gly |
1300 | 1305 | 1310 | ||||||
Asn val | Gly | Ser | Asp | Pro Met Leu Asp | Pro Ala | Leu Glu Glu | Ala | Pro |
1315 | 1320 | 1325 | ||||||
Ala Val | ASp | Pro | val | Gin Glu Lys Leu | Glu Lys | Phe Thr Ala | Ser | Tyr |
1330 | 1335 | 1340 | ||||||
Gly Leu Gly | Leu | Asp | Ser val Ile Phe | Asn Met | Asp Gly Thr | ile | Glu | |
1345 | 1350 | 1355 | 1360 | |||||
Leu Arg | Leu | Pro | Ser | Gly Glu val ile | Lys Lys | Asn Leu Ser | Asp | Phe |
1365 1370 1375
Ile Ala <210> 379 <211> 1152 <212> PRT <213> Unknown <220>
<223> NEW 27 <221> VARIANT <222> (1)...(1) <223> Xaa = Methionine or nothing <221> VARIANT <222> (344)...(344) <223> Xaa = Glycine or nothing <221> VARIANT <222> (345)...(345) <223> xaa = Proline or nothing <400> 379
Xaa | Asp | Ile | Leu | Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg | Leu |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Pro | Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin | val |
20 | 25 | 30 | |||||||||||||
Ala | Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | ile | Phe | Asp |
35 | 40 | 45 | |||||||||||||
Pro | Arg | ASp | Ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His |
50 | 55 | 60 |
»* <··« ·· *99 ·
11¾
Met | Thr | His | Ser | His | Trp | ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Arg | Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro | pro |
85 | 90 | 95 | |||||||||||||
Ser | Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu |
100 | 105 | 110 | |||||||||||||
Ala | ile | Tyr | Asn | Arg | val | Lys | Ala | Ala | Lys | Lys | val | Pro | Leu | Asp | Arg |
115 | 120 | 125 | |||||||||||||
Met | Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | Val | Glu | val | Lys | Asn | Gly | Ser | Leu |
130 | 135 | 140 | |||||||||||||
ile | Ile | Pro | Hi s | Tyr | Asp | His | Tyr | Hi s | Asn | ile | Lys | Phe | Glu | Trp | Phe |
145 | 150 | 155 | 160 | ||||||||||||
Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu |
165 | 170 | 175 | |||||||||||||
Leu | Ala | Thr | Val | Lys | Tyr | Tyr | val | Glu | His | Pro | Asn | Glu | Arg | Pro | His |
180 | 185 | 190 | |||||||||||||
ser | Asp | Asn | Gly | Phe | Gly | Asn | Ala | ser | Asp | His | Val | Arg | Lys | Asn | Lys |
195 | 200 | 205 | |||||||||||||
Ala | Asp | Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | HÍS | Asp | Glu | val |
210 | 215 | 220 | |||||||||||||
Ser | Glu | Pro | Thr | His | Pro | Glu | ser | Asp | Glu | Lys | Glu | Asn | HÍS | Ala | Gly |
225 | 230 | 235 | 240 | ||||||||||||
Leu | Asn | Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu |
245 | 250 | 255 | |||||||||||||
Glu | Thr | Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro |
260 | 265 | 270 | |||||||||||||
Gin | val | Glu | Asn | Ser | val | ile | Asn | Ala | Lys | Ile | Ala | Asp | Ala | Glu | Ala |
275 | 280 | 285 | |||||||||||||
Leu | Leu | Glu | Lys | Val | Thr | Asp | Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu |
290 | 295 | 300 | |||||||||||||
Thr | Leu | Thr | Gly | Leu | Lys | Ser | ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn |
305 | 310 | 315 | 320 | ||||||||||||
Asn | Thr | Ile | Ser | Al a | Glu | val | Asp | Ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu |
325 | 330 | 335 | |||||||||||||
Ser | Gin | Pro | Ala | Pro | Ile | Gin | xaa | Xaa | Asn | Met | Gin | Pro | Ser | Gl n | Leu |
340 | 345 | 350 | |||||||||||||
Ser | Tyr | Ser | ser | Thr | Ala | Ser | Asp | Asn | Asn | Thr | Gin | Ser | val | Ala | Lys |
355 | 360 | 365 | |||||||||||||
Gly | Ser | Thr | Ser | Lys | Pro | Ala | Asn | Lys | Ser | Glu | Asn | Leu | Gin | Ser | Leu |
370 | 375 | 380 | |||||||||||||
Leu | Lys | Glu | Leu | Tyr | Asp | ser | Pro | Ser | Ala | Gin | Arg | Tyr | ser | Glu | Ser |
385 | 390 | 395 | 400 | ||||||||||||
ASp | Gly | Leu | val | Phe | Asp | Pro | Ala | Lys | Ile | Ile | Ser | Arg | Thr | Pro | Asn |
405 | 410 | 415 | |||||||||||||
Gly | Val | Ala | Ile | Pro | His | Gly | Asp | His | Tyr | His | Phe | ile | Pro | Tyr | Ser |
420 | 425 | 430 | |||||||||||||
Lys | Leu | Ser | Ala | Leu | Glu | Gl u | Lys | ile | Ala | Arg | Met | val | Pro | Ile | Ser |
435 | 440 | 445 | |||||||||||||
Gly | Thr | Gly | Ser | Thr | Val | Ser | Thr | Asn | Ala | Lys | Pro | Asn | Glu | val | val |
450 | 455 | 460 | |||||||||||||
Ser | Ser | Leu | Gly | ser | Leu | Ser | Ser | Asn | Pro | Ser | Ser | Leu | Thr | Thr | Ser |
465 | 470 | 475 | 480 | ||||||||||||
Lys | Glu | Leu | Ser | ser | Ala | Ser | Asp | Gly | Tyr | Ile | Phe | Asn | Pro | Lys | ASp |
485 | 490 | 495 | |||||||||||||
Ile | Val | Glu | Glu | Thr | Ala | Thr | Ala | Tyr | Ile | val | Arg | His | Gly | ASp | Hi S |
500 | 505 | 510 | |||||||||||||
Phe | His | Tyr | Ile | Pro | Lys | Ser | Asn | Gin | Ile | Gly | Gin | Pro | Thr | Leu | Pro |
515 | 520 | 525 | |||||||||||||
Asn | Asn | Ser | Leu | Ala | Thr | Pro | Ser | Pro | Ser | Leu | Pro | Ile | Asn | Pro | Gly |
530 | 535 | 540 | |||||||||||||
Thr | Ser | Hi s | Glu | Lys | His | Glu | Glu | Asp | Gly | Tyr | Gly | Phe | Asp | Ala | Asn |
545 | 550 | 555 | 560 | ||||||||||||
Arg | Ile | Ile | Ala | Glu | ASp | Glu | Ser | Gly | Phe | Val | Met | Ser | His | Gly | Asp |
His | 565 | 570 | 575 | ||||||||||||
Asn | His | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr | Glu | Glu | Gin | Ile | Lys | |
580 | 585 | 590 | |||||||||||||
Ala | Al a | Gin | Lys | His | Leu | Glu | Glu | val | Lys | Thr | Ser | His | Asn | Gly | Leu |
595 | 600 | 605 |
• · · · · · • · · • ·
• · · · · lil | • · | • · | • · | • · | |
Asp Ser Leu | Ser Ser His Glu Gin Asp tyr Pro | Gly Asn | Ala | Lys Glu | |
610 | 615 | 620 | |||
Met Lys Asp | Leu Asp Lys Lys ile Glu Glu Lys | Ile | Ala | Gly | Ile Met |
625 | 630 635 | 640 | |||
Lys Gin Tyr | Gly val Lys Arg Glu Ser ile Val | val | Asn | Lys | Glu Lys |
645 650 | 655 | ||||
Asn Ala Ile | Ile Tyr Pro His Gly Asp His His | His | Ala | ASp | Pro Ile |
660 665 | 670 | ||||
Asp Glu His | Lys Pro val Gly Ile Gly His Ser | His | Ser | Asn | Tyr Glu |
675 | 680 | 685 | |||
Leu Phe Lys | Pro Glu Glu Gly Val Ala Lys Lys | Glu | Gly | Asn | Lys val |
690 | 695 | 700 | |||
Tyr Thr Gly | Glu Glu Leu Thr Asn val val Asn | Leu | Leu | Lys | Asn Ser |
705 | 710 715 | 720 | |||
Thr Phe Asn | Asn Gin Asn Phe Thr Leu Ala Asn | Gly | Gin | Lys | Arg Val |
725 730 | 735 | ||||
Ser Phe Ser | Phe Pro pro Glu Leu Glu Lys Lys | Leu | Gly | ile | Asn Met |
740 745 | 750 | ||||
Leu val Lys | Leu ile Thr Pro Asp Gly Lys val | Leu | Glu | Lys | val Ser |
755 | 760 | 765 | |||
Gly Lys val | Phe Gly Glu Gly Val Gly Asn Ile | Ala | Asn | Phe | Glu Leu |
770 | 775 | 780 | |||
Asp Gin Pro | Tyr Leu Pro Gly Gin Thr Phe Lys | Tyr | Thr | Ile | Ala Ser |
785 | 790 795 | 800 | |||
Lys Asp Tyr | Pro Glu Val Ser Tyr Asp Gly Thr | Phe | Thr | val | Pro Thr |
805 810 | 815 | ||||
Ser Leu Ala | Tyr Lys Met Ala Ser Gin Thr Ile | Phe | Tyr | pro | Phe His |
820 825 | 830 | ||||
Ala Gly Asp | Thr Tyr Leu Arg Val Asn Pro Gin | Phe | Ala | val | Pro Lys |
835 | 840 | 845 | |||
Gly Thr Asp | Ala Leu val Arg Val Phe Asp Glu | Phe | His | Gly | Asn Ala |
850 | 855 | 860 | |||
Tyr Leu Glu | Asn Asn Tyr Lys Val Gly Glu Ile | Lys | Leu | Pro | Ile Pro |
865 | 870 875 | 880 | |||
Lys Leu Asn | Gin Gly Thr Thr Arg Thr Ala Gly | Asn | Lys | ile | Pro Val |
885 890 | 895 | ||||
Thr Phe Met | Ala Asn Ala Tyr Leu Asp Asn Gin | Ser | Thr | Tyr | Ile Val |
900 905 | 910 | ||||
Glu val Pro | ile Leu Glu Lys Glu Asn Gin Thr | Asp | Lys | Pro | Ser Ile |
915 | 920 | 925 | |||
Leu Pro Gin | Phe Lys Arg Asn Lys Ala Gin Glu | Asn | Ser | Lys | Leu Asp |
930 | 935 | 940 | |||
Glu Lys Val | Glu Glu Pro Lys Thr Ser Glu Lys | Val | Glu | Lys | Glu Lys |
945 | 950 955 | 960 | |||
Leu Ser Glu | Thr Gly Asn Ser Thr Ser Asn ser | Thr | Leu | Glu | Glu Val |
965 970 | 975 | ||||
Pro Thr val | Asp Pro val Gin Glu Lys val Ala | Lys | Phe | Ala | Glu Ser |
980 985 | 990 | ||||
Tyr Gly Met | Lys Leu Glu Asn Val Leu Phe Asn | Met | Asp | Gly | Thr Ile |
995 | 1000 | 1005 | |||
Glu Leu Tyr | Leu Pro Ser Gly Glu Val Ile Lys | Lys | Asn | Met | Ala Asp |
1010 | 1015 | 1020 | |||
Phe Thr Gly | Glu Ala Pro Gin Gly Asn Gly Glu | Asn | Lys | Pro | Ser Glu |
1025 | 1030 1035 | 1040 | |||
Asn Gly Lys | val ser Thr Gly Thr Val Glu Asn | Gin | Pro | Thr | Glu Asn |
1045 1050 | 1055 | ||||
Lys Pro Ala | Asp Ser Leu Pro Glu Ala Pro Asn | Glu | Lys | Pro | Val Lys |
1060 1065 | 1070 | ||||
Pro Glu Asn | Ser Thr Asp Asn Gly Met Leu Asn | Pro | Glu | Gly | Asn Val |
1075 1080 1085
Gly Ser Asp Pro Met Leu Asp Pro Ala Leu Glu Glu Ala Pro Ala val 1090 1095 1100
Asp Pro Val Gin Glu Lys Leu Glu Lys Phe Thr Ala Ser Tyr Gly Leu
1105 1110 1115 1120
Gly Leu Asp ser val Ile Phe Asn Met Asp Gly Thr Ile Glu Leu Arg
1125 1130 1135
Leu Pro ser Gly Glu Val Ile Lys Lys Asn Leu Ser Asp Phe Ile Ala 1140 1145 1150 • · · · <210> 380 <211> 1139 <212> PRT <213> Unknown <220>
<223> NEW 28 <221> VARIANT <222> (1)...(1) <223> xaa = Methionine or nothing <221> VARIANT <222> (570)...(570) <223> Xaa = Glycine or nothing <221> VARIANT <222> (571)...(571) <223> Xaa = Proline or nothing <400> 380
Xaa 1 | Glu | Asn | Ile | Ser 5 | ser Leu Leu Arg Glu Leu Tyr Ala Lys 10 | Pro 15 | Leu | ||||||||
Ser | Glu | Arg | His | val | Glu | Ser | Asp | Gly | Leu | ile | Phe | Asp | Pro | Ala | Gin |
20 | 25 | 30 | |||||||||||||
Ile | Thr | Ser | Arg | Thr | Ala | Arg | Gly | val | Ala | val | Pro | His | Gly | Asn | His |
35 | 40 | 45 | |||||||||||||
Tyr | His | Phe | Ile | Pro | Tyr | Glu | Gin | Met | ser | Glu | Leu | Glu | Lys | Arg | Ile |
50 | 55 | 60 | |||||||||||||
Ala | Arg | ile | Ile | Pro | Leu | Arg | Tyr | Arg | ser | Asn | His | Trp | Val | Pro | Asp |
65 | 70 | 75 | 80 | ||||||||||||
Ser | Arg | pro | Glu | Gin | Pro | Ser | pro | Gin | ser | Thr | Pro | Glu | Pro | ser | Pro |
85 | 90 | 95 | |||||||||||||
Ser | Leu | Gin | Pro | Ala | Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile |
100 | 105 | 110 | |||||||||||||
Asp | Glu | Lys | Leu | val | Lys | Glu | Ala | Val | Arg | Lys | val | Gly | Asp | Gly | Tyr |
115 | 120 | 125 | |||||||||||||
val | Phe | Glu | Glu | Asn | Gly | val | Ser | Arg | Tyr | Ile | pro | Ala | Lys | Asp | Leu |
130 | 135 | 140 | |||||||||||||
Ser | Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu |
145 | 150 | 155 | 160 | ||||||||||||
Ser | Leu | Ser | His | Lys | Leu | Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | Ser |
165 | 170 | 175 | |||||||||||||
Asp | Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His |
180 | 185 | 190 | |||||||||||||
Gin | Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Val | Leu |
195 | 200 | 205 | |||||||||||||
Asp | Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp | val | Ser | Ser | Asp | Lys | Val | Lys |
210 | 215 | 220 | |||||||||||||
Leu | val | Asp | Asp | ile | Leu | Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu |
225 | 230 | 235 | 240 | ||||||||||||
Arg | Leu | Gly | Lys | Pro | Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile |
245 | 250 | 255 | |||||||||||||
Gl n | val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | ile |
260 | 265 | 270 | |||||||||||||
Phe | Asp | Pro | Arg | Asp | Ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | val | Thr |
275 | 280 | 285 | |||||||||||||
pro | His | Met | Thr | His | Ser | His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu |
290 | 295 | 300 | |||||||||||||
Ala | Glu | Arg | Ala | Al a Al a | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | |
305 | 310 | 315 | 320 | ||||||||||||
Pro | Pro | Ser | Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr | Gl u | Ala | Lys | Gly |
325 | 330 | 335 | |||||||||||||
Ala | Glu | Ala | Ile | Tyr | Asn | Arg | val | Lys | Ala | Ala | Lys | Lys | val | Pro | Leu |
·»·· ·· ····
• • • · · 110 | • · · • • · | • * • «. · | » • · • · | » · · » · | • • 4 1 * · | • • > | |||||||||
340 | 345 | 350 | |||||||||||||
Asp | Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | val | Glu | val | Lys | Asn | Gly |
355 | 360 | 365 | |||||||||||||
ser | Leu | Ile | Ile | Pro | His | Tyr | ASp | Hi s | Tyr | His | Asn | Ile | Lys | Phe | Glu |
370 | 375 | 380 | |||||||||||||
Trp | Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu |
385 | 390 | 395 | 400 | ||||||||||||
Asp | Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr | Val | Glu | His | pro | Asn | Glu | Arg |
405 | 410 | 415 | |||||||||||||
Pro | Hi s | Ser | Asp | Asn | Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | Val | Arg | Lys |
420 | 425 | 430 | |||||||||||||
Asn | Lys | Ala | Asp | Gin | Asp | Ser | Lys | Pro | Asp | Glu | Asp | Lys | Glu | His | Asp |
435 | 440 | 445 | |||||||||||||
Glu | val | Ser | Glu | Pro | Thr | His | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | HÍS |
450 | 455 | 460 | |||||||||||||
Ala | Gly | Leu | Asn | Pro | Ser | Ala | Asp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp |
465 | 470 | 475 | 480 | ||||||||||||
Thr | Glu | Glu | Thr | Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu |
485 | 490 | 495 | |||||||||||||
ile | Pro | Gin | Val | Glu | Asn | ser | val | Ile | Asn | Ala | Lys | Ile | Ala | Asp | Ala |
500 | 505 | 510 | |||||||||||||
Glu | Ala | Leu | Leu | Glu | Lys | Val | Thr | Asp | Pro | Ser | ile | Arg | Gin | Asn | Ala |
515 | 520 | 525 | |||||||||||||
Met | Glu | Thr | Leu | Thr | Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr | Lys |
530 | 535 | 540 | |||||||||||||
Asp | Asn | Asn | Thr | Ile | Ser | Ala | Glu | Val | ASp | Ser | Leu | Leu | Ala | Leu | Leu |
545 | 550 | 555 | 560 | ||||||||||||
Lys | Glu | ser | Gin | Pro | Ala | Pro | ile | Gin | xaa | Xaa | Asp | Leu | Thr | Glu | Glu |
565 | 570 | 575 | |||||||||||||
Gin | Ile | Lys | Ala | Ala | Gin | Lys | His | Leu | Glu | Glu | val | Lys | Thr | Ser | His |
580 | 585 | 590 | |||||||||||||
Asn | Gly | Leu | ASp | Ser | Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn |
595 | 600 | 605 | |||||||||||||
Al a | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala |
610 | 615 | 620 | |||||||||||||
Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg | Glu | Ser | Ile | val | Val | Asn |
625 | 630 | 635 | 640 | ||||||||||||
Lys | Glu | Lys | Asn | Al a | Ile | Ile | Tyr | Pro | His | Gly | Asp | His | His | His | Ala |
645 | 650 | 655 | |||||||||||||
Asp | Pro | Ile | Asp | Glu | His | Lys | Pro | val | Gly | Ile | Gly | His | ser | His | Ser |
660 | 665 | 670 | |||||||||||||
Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly | Val | Ala | Lys | Lys | Glu | Gly |
675 | 680 | 685 | |||||||||||||
Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn | val | val | Asn | Leu | Leu |
690 | 695 | 700 | |||||||||||||
Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin |
705 | 710 | 715 | 720 | ||||||||||||
Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly |
Ile | 725 | 730 | 735 | ||||||||||||
Asn | Met | Leu | Val | Lys | Leu | ile | Thr | Pro | Asp | Gly | Lys | Val | Leu | Glu | |
740 | 745 | 750 | |||||||||||||
Lys | val | Ser | Gly | Lys | val | Phe | Gly | Glu | Gly | val | Gly | Asn | Ile | Ala | Asn |
755 | 760 | 765 | |||||||||||||
Phe | Glu | Leu | Asp | Gin | pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr |
770 | 775 | 780 | |||||||||||||
Ile | Ala | ser | Lys | Asp | Tyr | Pro | Glu | val | Ser | Tyr | ASp | Gly | Thr | Phe | Thr |
785 | 790 | 795 | 800 | ||||||||||||
val | Pro | Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala | Ser | Gin | Thr | ile | Phe | Tyr |
805 | 810 | 815 | |||||||||||||
Pro | Phe | His | Ala | Gly | ASp | Thr | Tyr | Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala |
820 | 825 | 830 | |||||||||||||
Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | val | Arg | val | Phe | Asp | Glu | Phe | His |
835 | 840 | 845 | |||||||||||||
Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | Val | Gly | Gl u | Ile | Lys | Leu |
850 | 855 | 860 | |||||||||||||
Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg | Thr | Al a | Gly | Asn | Lys |
865 | 870 | 875 | 880 | ||||||||||||
Ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr |
• · · ·
885 | 890 | 895 |
Tyr Ile Val Glu val Pro Ile Leu Glu 900 905 | Lys | Glu Asn Gin Thr Asp Lys 910 |
Pro Ser Ile Leu Pro Gin Phe Lys Arg 915 920 - | Asn | Lys Ala Gin Glu Asn Ser 925 |
Lys Leu Asp Glu Lys val Glu Glu Pro 930 935 | Lys | Thr ser Glu Lys Val Glu 940 |
Lys Glu Lys Leu Ser Glu Thr Gly Asn 945 950 | Ser | Thr Ser Asn Ser Thr Leu 955 960 |
Glu Glu Val Pro Thr Val Asp Pro val 965 | Gin 970 | Glu Lys val Ala Lys Phe 975 |
Ala Glu Ser Tyr Gly Met Lys Leu Glu 980 985 | Asn | val Leu Phe Asn Met Asp 990 |
Gly Thr Ile Glu Leu Tyr Leu Pro Ser 995 1000 | Gly | Glu Val Ile Lys Lys Asn 1005 |
Met Ala Asp Phe Thr Gly Glu Ala Pro 1010 1015 | Gin | Gly Asn Gly Glu Asn Lys 1020 |
Pro Ser Glu Asn Gly Lys Val Ser Thr 1025 1030 | Gly | Thr Val Glu Asn Gin Pro 1035 1040 |
Thr Glu Asn Lys Pro Ala Asp Ser Leu 1045 | Pro Glu Ala Pro Asn Glu Lys 1050 1055 | |
Pro val Lys Pro Glu Asn Ser Thr Asp Asn 1060 1065 | Gly Met Leu Asn Pro Glu 1070 | |
Gly Asn Val Gly Ser Asp Pro Met Leu 1075 1080 | Asp | Pro Ala Leu Glu Glu Ala 1085 |
Pro Ala Val Asp pro val Gin Glu Lys 1090 1095 | Leu | Glu Lys Phe Thr Ala Ser 1100 |
Tyr Gly Leu Gly Leu Asp Ser val Ile 1105 1110 | phe | Asn Met Asp Gly Thr Ile 1115 1120 |
Glu Leu Arg Leu Pro Ser Gly Glu val 1125 | Ile 113C | Lys Lys Asn Leu Ser Asp i 1135 |
Phe ile Ala <210> 381 <211> 1238 <212> PRT <213> unknown <220>
<223> NEW 29 <221> VARIANT <222> (1)...(1) <223> xaa = Methionine or nothing <221> VARIANT <222> (430)...(430) <223> Xaa = Glycine or nothing <221> VARIANT <222> (431)...(431) <223> Xaa = Proline or nothing <400> 381
Xaa | Asp | ile | Asp | Ser | Leu | Leu | Lys | Gin | Leu | Tyr | Lys | Leu | Pro | Leu | Ser |
1 | 5 | 10 | 15 | ||||||||||||
Gin | Arg | Hi s | Val | Glu | Ser | Asp | Gly | Leu | ile | Phe | ASp | Pro | Al a | Gin | Ile |
20 | 25 | 30 | |||||||||||||
Thr | Ser | Arg | Thr | Ala | Arg | Gly | val | Ala | val | Pro | His | Gly | Asn | His | Tyr |
35 | 40 | 45 | |||||||||||||
His | Phe | Ile | Pro | Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala |
50 | 55 | 60 | |||||||||||||
Arg | Ile | Ile | Pro | Leu | Arg | Tyr | Arg | Ser | Asn | Hi s | Trp | Val | Pro | Asp | Ser |
65 | 70 | 75 | 80 | ||||||||||||
Arg | Pro | Glu | Glu | Pro | Ser | Pro | Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser |
85 | 90 | 95 |
Pro | Gin Pro Ala Pro 100 | Asn Pro | Gin Pro Ala 105 | Pro Ser Asn | Pro 110 | ile | Asp | ||||||||
Glu | Lys | Leu | val | Lys | Glu | Ala | Val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val |
115 | 120 | 125 | |||||||||||||
Phe | Glu | Glu | Asn | Gly | val | ser | Arg | Tyr | ile | Pro | Ala | Lys | Asn | Leu | Ser |
130 | 135 | 140 | |||||||||||||
Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser |
145 | 150 | 155 | 160 | ||||||||||||
Leu | Ser | His | Lys | Leu | Gly | Ala | Lys | Lys | Thr | ASp | Leu | Pro | Ser | Ser | Asp |
165 | 170 | 175 | |||||||||||||
Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | His | Gin |
180 | 185 | 190 | |||||||||||||
Asp | Leu | Leu | ASp | Asn | Lys | Gly | Arg | Gin | Val | Asp | Phe | Glu | Ala | Leu | Asp |
195 | 200 | 205 | |||||||||||||
Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp | Val | Ser | Ser | Asp | Lys | val | Lys | Leu |
210 | 215 | 220 | |||||||||||||
val | ASp | Asp | Ile | Leu | Ala | Phe | Leu | Ala | Pro | Ile | Arg | His | Pro | Glu | Arg |
225 | 230 | 235 | 240 | ||||||||||||
Leu | Gly | Lys | Pro | Asn | Ala | Gin | ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin |
245 | 250 | 255 | |||||||||||||
val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe |
260 | 265 | 270 | |||||||||||||
Asp | Pro | Arg | Asp | Ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro |
275 | 280 | 285 | |||||||||||||
Hi s | Met | Thr | His | Ser | His | Trp | Ile | Lys | Lys | Asp | ser | Leu | Ser | Glu | Ala |
290 | 295 | 300 | |||||||||||||
Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro |
305 | 310 | 315 | 320 | ||||||||||||
Pro | Ser | Thr | Asp | Hi s | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Al a |
325 | 330 | 335 | |||||||||||||
Glu | Ala | ile | Tyr | Asn | Arg | val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp |
340 | 345 | 350 | |||||||||||||
Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | Val | Glu | val | Lys | Asn | Gly | Ser |
355 | 360 | 365 | |||||||||||||
Leu | Ile | Ile | Pro | His | Tyr | Asp | His | Tyr | Hi s | Asn | ile | Lys | Phe | Glu | Trp |
370 | 375 | 380 | |||||||||||||
Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp |
385 | 390 | 395 | 400 | ||||||||||||
Leu | Leu | Ala | Thr | val | Lys | Tyr | Tyr | val | Glu | His | Pro | Asn | Glu | Arg | Pro |
405 | 410 | 415 | |||||||||||||
His | Ser | Asp | Asn | Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | val | Xaa | Xaa | Asn |
420 | 425 | 430 | |||||||||||||
Met | Gin | Pro | Ser | Gin | Leu | ser | Tyr | Ser | Ser | Thr | Ala | Ser | Asp | Asn | Asn |
435 | 440 | 445 | |||||||||||||
Thr | Gin | ser | Val | Ala | Lys | Gly | Ser | Thr | Ser | Lys | Pro | Ala | Asn | Lys | Ser |
450 | 455 | 460 | |||||||||||||
Glu | Asn | Leu | Gin | Ser | Leu | Leu | Lys | Glu | Leu | Tyr | Asp | Ser | Pro | Ser | Ala |
465 | 470 | 475 | 480 | ||||||||||||
Gin | Arg | Tyr | Ser | Glu | Ser | Asp | Gly | Leu | Val | Phe | Asp | Pro | Ala | Lys | Ile |
485 | 490 | 495 | |||||||||||||
ile | Ser | Arg | Thr | Pro | Asn | Gly | val | Ala | Ile | Pro | HIS | Gly | Asp | His | Tyr |
500 | 505 | 510 | |||||||||||||
Hi s | Phe | Ile | Pro | Tyr | Ser | Lys | Leu | ser | Al a | Leu | GlU | Glu | Lys | ile | Ala |
515 | 520 | 525 | |||||||||||||
Arg | Met | val | Pro | Ile | Ser | Gly | Thr | Gly | Ser | Thr | Val | Ser | Thr | Asn | Ala |
530 | 535 | 540 | |||||||||||||
Lys | Pro | Asn | Glu | Val | Val | Ser | Ser | Leu | Gly | Ser | Leu | Ser | Ser | Asn | Pro |
545 | 550 | 555 | 560 | ||||||||||||
Ser | ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | ser | Al a | Ser | Asp | Gly | Tyr |
565 | 570 | 575 | |||||||||||||
Ile | Phe | Asn | Pro | Lys | Asp | ile | val | Glu | Glu | Thr | Ala | Thr | Ala | Tyr | Ile |
580 | 585 | 590 | |||||||||||||
Val | Arg | His | Gly | Asp | Hi s | Phe | His | Tyr | ile | Pro | Lys | Ser | Asn | Gin | Ile |
595 | 600 | 605 | |||||||||||||
Gly | Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr | Pro | Ser | Pro | Ser |
610 | 615 | 620 | |||||||||||||
Leu | Pro | ile | Asn | Pro | Gly | Thr | ser | His | Glu | Lys | His | Glu | Glu | Asp | Gly |
625 | 630 | 635 | 640 |
• · · ·
Tyr Gly Phe Asp Ala | Asn Arg | Ile Ile Ala Glu Asp 650 | Glu | Ser | Gly 655 | Phe | |
645 | |||||||
val Met Ser His | Gly | Asp Hi s | Asn His Tyr Phe Phe | Lys | Lys | Asp | Leu |
660 | 665 | 670 | |||||
Thr Glu Glu Gin | Ile | Lys Ala | Ala Gin Lys His Leu | Glu | Glu | val | Lys |
675 | 680 | 685 | |||||
Thr Ser His Asn | Gly | Leu Asp | Ser Leu Ser ser His | Glu | Gin | Asp | Tyr |
690 | 695 | 700 | |||||
Pro Gly Asn Ala | Lys | Glu Met | Lys Asp Leu Asp Lys | Lys | Ile | Glu | Glu |
705 | 710 | 715 | 720 | ||||
Lys ile Ala Gly | Ile | Met Lys | Gin Tyr Gly Val Lys | Arg | Glu | Ser | Ile |
725 | 730 | 735 | |||||
Val Val Asn Lys | Glu | Lys Asn | Ala Ile Ile Tyr Pro | His | Gly | Asp | His |
740 | 745 | 750 | |||||
His His Ala Asp | Pro | Ile Asp | Glu His Lys Pro val | Gly | Ile | Gly | His |
755 | 760 | 765 | |||||
Ser His Ser Asn | Tyr | Glu Leu | Phe Lys Pro Glu Glu | Gly | val | Ala | Lys |
770 | 775 | 780 | |||||
Lys Glu Gly Asn | Lys | Val Tyr | Thr Gly Glu Glu Leu | Thr | Asn | val | Val |
785 | 790 | 795 | 800 | ||||
Asn Leu Leu Lys | Asn | ser Thr | Phe Asn Asn Gin Asn | Phe | Thr | Leu | Ala |
805 | 810 | 815 | |||||
Asn Gly Gin Lys | Arg | Val Ser | Phe Ser Phe Pro Pro | Glu | Leu | Glu | Lys |
820 | 825 | 830 | |||||
Lys Leu Gly Ile sm | Asn | Met Leu | val Lys Leu Ile Thr | Pro | ASp | Gly | Lys |
0 J Z) val Leu Glu Lys | val | Ser Gly | Lys Val Phe Gly Glu | ÍW j Gly | Val | Gly | Asn |
850 | 855 | 860 | |||||
ile Ala Asn Phe | Glu | Leu Asp | Gin Pro Tyr Leu Pro | Gly | Gin | Thr | Phe |
865 | 870 | 875 | 880 | ||||
Lys Tyr Thr Ile | Ala | Ser Lys | Asp Tyr Pro Glu val | Ser | Tyr | Asp | Gly |
885 | 890 | 895 | |||||
Thr Phe Thr Val | Pro | Thr Ser | Leu Ala Tyr Lys Met | Ala | ser | Gin | Thr |
900 | 905 | 910 | |||||
Ile Phe Tyr Pro | Phe | His Ala | Gly Asp Thr Tyr Leu | Arg | Val | Asn | Pro |
915 | 920 | 925 | |||||
Gin Phe Ala Val | Pro | Lys Gly | Thr Asp Ala Leu Val | Arg | val | Phe | Asp |
930 | 935 | 940 | |||||
Glu Phe His Gly | Asn | Ala Tyr | Leu Glu Asn Asn Tyr | Lys | val | Gly | Glu |
945 | 950 | 955 | 960 | ||||
Ile Lys Leu Pro | ile | Pro Lys | Leu Asn Gin Gly Thr | Thr | Arg | Thr | Ala |
965 | 970 | 975 | |||||
Gly Asn Lys ile | Pro | val Thr | Phe Met Ala Asn Ala | Tyr | Leu | ASp | Asn |
980 | 985 | 990 | |||||
Gin Ser Thr Tyr | Ile | val Glu | Val Pro ile Leu Glu | Lys | Glu | Asn | Gin |
995 | 1000 | 1005 | |||||
Thr Asp Lys Pro | Ser | Ile Leu | Pro Gin Phe Lys Arg | Asn | Lys | Ala | Gin |
1010 | 1015 | í 1020 | |||||
Glu Asn Ser Lys | Leu | Asp Glu | Lys val Glu Glu Pro | Lys | Thr | Ser | Glu |
1025 | 1030 | 1035 | 1040 | ||||
Lys val Glu Lys | Glu | Lys Leu | Ser Glu Thr Gly Asn | Ser | Thr | Ser | Asn |
1045 | 1050 | 1055 | |||||
Ser Thr Leu Glu | Glu | Val Pro | Thr Val Asp Pro val | Gin | Glu | Lys | val |
1060 | 1065 | 1070 | |||||
Ala Lys Phe Ala | Glu | Ser Tyr | Gly Met Lys Leu Glu | Asn | Val | Leu | Phe |
1075 | 1080 | 1085 | |||||
Asn Met Asp Gly | Thr | Ile Glu | Leu Tyr Leu Pro Ser | Gly | Glu | val | ile |
1090 | 1095 | 1100 | |||||
Lys Lys Asn Met | Ala | Asp Phe | Thr Gly Glu Ala Pro | Gin | Gly | Asn | Gly |
1105 | 1110 | 1115 | 1120 | ||||
Glu Asn Lys Pro | Ser | Glu Asn | Gly Lys val ser Thr | Gly | Thr | val | Glu |
1125 | 1130 | 1135 | |||||
Asn Gin Pro Thr | Glu | Asn Lys | Pro Ala Asp Ser Leu | Pro | Glu | Ala | Pro |
1140 | 1145 | 1150 | |||||
Asn Glu Lys Pro | val | Lys Pro | Glu Asn Ser Thr Asp | Asn | Gly Met | Leu | |
1155 | 1160 | 1165 | |||||
Asn Pro Glu Gly Asn | Val Gly | Ser Asp Pro Met Leu | Asp | Pro Ala | Leu | ||
1170 | 1175 | 1180 |
Glu | Glu | Ala | Pro | Ala val Asp | Pro | val | Gin Glu | Lys | Leu | Glu | Lys Phe |
1185 | 1190 | 1195 | 1200 | ||||||||
Thr | Ala | Ser | Tyr | Gly Leu Gly | Leu | Asp | Ser Val | ile | Phe | Asn | Met Asp |
1205 | 1210 | 1215 | |||||||||
Gly | Thr | ile | Glu | Leu Arg Leu | Pro | ser | Gly Glu | val | ile | Lys | Lys Asn |
1220 | 1225 | 1230 |
Leu Ser Asp Phe Ile Ala 1235 <210> 382 <211> 1365 <212> PRT <213> Unknown <22O>
<223> NEW 30 <221> VARIANT <222> (1)...(1) <223> Xaa = Methionine or nothing <221> VARIANT <222> (557)...(557) <223> Xaa = Glycine or nothing <221> VARIANT <222> (558)...(558) <223> Xaa = Proline or nothing <400> 382
Xaa Asp ile Asp Ser Leu Leu Lys Gin Leu Tyr Lys Leu Pro Leu Ser | |||||||||||||||
1 | 5 | 10 | 15 | ||||||||||||
Gin | Arg | Hi s | Val | Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile |
20 | 25 | 30 | |||||||||||||
Thr | Ser | Arg | Thr | Ala | Arg | Gly | val | Ala | Val | Pro | His | Gly | Asn | His | Tyr |
35 | 40 | 45 | |||||||||||||
His | Phe | ile | Pro | Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala |
50 | 55 | 60 | |||||||||||||
Arg | Ile | ile | Pro | Leu | Arg | Tyr | Arg | Ser | Asn | His | Trp | val | Pro | Asp | Ser |
65 | 70 | 75 | 80 | ||||||||||||
Arg | Pro | Glu | Glu | Pro | Ser | Pro | Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser |
85 | 90 | 95 | |||||||||||||
Pro | Gin | Pro | Ala | Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp |
100 | 105 | 110 | |||||||||||||
Glu | Lys | Leu | val | Lys | Glu | Ala | val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | val |
115 | 120 | 125 | |||||||||||||
Phe | Glu | Glu | Asn | Gly | val | Ser | Arg | Tyr | ile | Pro | Ala | Lys | Asn | Leu | Ser |
130 | 135 | 140 | |||||||||||||
Ala | Glu | Thr | Ala | Al a | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser |
145 | 150 | 155 | 160 | ||||||||||||
Leu | Ser | His | Lys | Leu | Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | ser | Ser | Asp |
165 | 170 | 175 | |||||||||||||
Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | ile | His | Gin |
180 | 185 | 190 | |||||||||||||
Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg | Gin | val | Asp | Phe | Glu | Ala | Leu | Asp |
195 | 200 | 205 | |||||||||||||
Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp | val | ser | Ser | Asp | Lys | val | Lys | Leu |
210 | 215 | 220 | |||||||||||||
Val | Asp | Asp | ile | Leu | Ala | Phe | Leu | Ala | Pro | Ile | Arg | Hi S | Pro | Glu | Arg |
225 | 230 | 235 | 240 | ||||||||||||
Leu | Gly | Lys | Pro | Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin |
245 | 250 | 255 | |||||||||||||
val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe |
260 | 265 | 270 | |||||||||||||
Asp | Pro | Arg | Asp | Ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro |
275 | 280 | 285 |
• · • · · · • · · · * « • · « • · · • * · • · · · • · · · ί,ϊί
His | Met 290 | Thr | His | Ser His | Trp Ile Lys Lys Asp 295 | Ser 300 | Leu | Ser | Glu | Ala | |||||
Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro |
305 | 310 | 315 | 320 | ||||||||||||
Pro | Ser | Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala |
325 | 330 | 335 | |||||||||||||
Glu | Ala | Ile | Tyr | Asn | Arg | val | Lys | Ala | Ala | Lys | Lys | val | Pro | Leu | Asp |
340 | 345 | 350 | |||||||||||||
Arg | Met | Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | val | Glu | val | Lys | Asn | Gly | Ser |
355 | 360 | 365 | |||||||||||||
Leu | ile | Ile | Pro | His | Tyr | Asp | His | Tyr | His | Asn | ile | Lys | Phe | Glu | Trp |
370 | 375 | 380 | |||||||||||||
Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp |
385 | 390 | 395 | 400 | ||||||||||||
Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro |
405 | 410 | 415 | |||||||||||||
His | ser | Asp | Asn | Gly | Phe | Gly | Asn | Ala | Ser | Asp | Hi s | Val | Gin | Arg | Asn |
420 | 425 | 430 | |||||||||||||
Lys | Asn | Gly | Gin | Ala | Asp | Thr | Asn | Gin | Thr | Glu | Lys | Pro | Ser | Glu | Glu |
435 | 440 | 445 | |||||||||||||
Lys | Pro | Gin | Thr | Glu | Lys | Pro | Glu | Glu | Glu | Thr | Pro | Arg | Glu | Glu | Lys |
450 | 455 | 460 | |||||||||||||
Pro | Gin | Ser | Glu | Lys | Pro | Glu | Ser | Pro | Lys | Pro | Thr | Glu | Glu | Pro | Glu |
465 | 470 | 475 | 480 | ||||||||||||
Glu | Glu | Ser | Pro | Glu | Glu | Ser | Glu | Glu | Pro | Gin | val | Glu | Thr | Glu | Lys |
485 | 490 | 495 | |||||||||||||
val | Glu | Glu | Lys | Leu | Arg | Glu | Ala | Glu | Asp | Leu | Leu | Gly | Lys | Ile | Gin |
500 | 505 | 510 | |||||||||||||
Asp | Pro | Ile | ile | Lys | Ser | Asn | Ala | Lys | Glu | Thr | Leu | Thr | Gly | Leu | Lys |
515 | 520 | 525 | |||||||||||||
Asn | Asn | Leu | Leu | Phe | Gly | Thr | Gin | Asp | Asn | Asn | Thr | Ile | Met | Ala | Glu |
530 | 535 | 540 | |||||||||||||
Al a | Glu | Lys | Leu | Leu | Ala | Leu | Leu | Lys | Glu | Ser | Lys | Xaa | Xaa | Asn | Met |
545 | 550 | 555 | 560 | ||||||||||||
Gin | Pro | ser | Gin | Leu | Ser | Tyr | Ser | Ser | Thr | Ala | Ser | Asp | Asn | Asn | Thr |
565 | 570 | 575 | |||||||||||||
Gin | Ser | val | Ala | Lys | Gly | Ser | Thr | Ser | Lys | Pro | Ala | Asn | Lys | Ser | Glu |
580 | 585 | 590 | |||||||||||||
Asn | Leu | Gin | Ser | Leu | Leu | Lys | Glu | Leu | Tyr | Asp | Ser | pro | Ser | Ala | Gin |
595 | 600 | 605 | |||||||||||||
Arg | Tyr | Ser | Glu | Ser | Asp | Gly | Leu | Val | Phe | Asp | Pro | Ala | Lys | Ile | Ile |
610 | 615 | 620 | |||||||||||||
ser | Arg | Thr | Pro | Asn | Gly | Val | Ala | Ile | Pro | His | Gly | Asp | His | Tyr | His |
625 | 630 | 635 | 640 | ||||||||||||
Phe | Ile | Pro | Tyr | Ser | Lys | Leu | Ser | Ala | Leu | Glu | Glu | Lys | ile | Ala | Arg |
645 | 650 | 655 | |||||||||||||
Met | Val | Pro | Ile | Ser | Gly | Thr | Gly | Ser | Thr | val | Ser | Thr | Asn | Ala | Lys |
660 | 665 | 670 | |||||||||||||
Pro | Asn | Glu | Val | Val | Ser | Ser | Leu | Gly | Ser | Leu | ser | ser | Asn | Pro | Ser |
675 | 680 | 685 | |||||||||||||
Ser | Leu | Thr | Thr | Ser | Lys | Glu | Leu | Ser | Ser | Ala | Ser | Asp | Gly | Tyr | Ile |
690 | 695 | 700 | |||||||||||||
Phe | Asn | Pro | Lys | Asp | ile | Val | Glu | Glu | Thr | Al a | Thr | Ala | Tyr | ile | val |
705 | 710 | 715 | 720 | ||||||||||||
Arg | His | Gly | Asp | Hi s | Phe | His | Tyr | Ile | Pro | Lys | Ser | Asn | Gin | Ile | Gly |
725 | 730 | 735 | |||||||||||||
Gin | Pro | Thr | Leu | Pro | Asn | Asn | Ser | Leu | Ala | Thr | Pro | Ser | Pro | Ser | Leu |
740 | 745 | 750 | |||||||||||||
Pro | ile | Asn | Pro | Gly | Thr | Ser | Hi s | Glu | Lys | His | Glu | Glu | Asp | Gly | Tyr |
755 | 760 | 765 | |||||||||||||
Gly | Phe | Asp | Ala | Asn | Arg | Ile | ile | Ala | Glu | Asp | Glu | Ser | Gly | Phe | val |
770 | 775 | 780 | |||||||||||||
Met | Ser | HÍS | Gly | Asp | His | Asn | Hi s | Tyr | Phe | Phe | Lys | Lys | Asp | Leu | Thr |
785 | 790 | 795 | 800 | ||||||||||||
Glu | Glu | Gin | ile | Lys | Ala | Ala | Gin | Lys | Hi s | Leu | Glu | Glu | Val | Lys | Thr |
805 | 810 | 815 | |||||||||||||
Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr | Pro |
820 | 825 | 830 |
•:· 2jťC | • · • · | » · • · | • • * | • · * • « | |
Gly Asn Ala 835 | Lys Glu Met Lys Asp Leu Asp Lys 840 | Lys | Ile 845 | Glu | Glu Lys |
Ile Ala Gly 850 | ile Met Lys Gin Tyr Gly val Lys 855 | Arg 860 | Glu | Ser | Ile val |
val Asn Lys 865 | Glu Lys Asn Ala Ile ile Tyr Pro 870 875 | His | Gly | Asp | His His 880 |
His Ala Asp | Pro ile Asp Glu His Lys Pro val 885 890 | Gly | Ile | Gly | His ser 895 |
His Ser Asn | Tyr Glu Leu Phe Lys Pro Glu Glu 900 905 | Gly | val | Ala 910 | Lys Lys |
Glu Gly Asn 915 | Lys Val Tyr Thr Gly Glu Glu Leu 920 | Thr | Asn 925 | val | val Asn |
Leu Leu Lys 930 | Asn Ser Thr Phe Asn Asn Gin Asn 935 | Phe 940 | Thr | Leu | Ala Asn |
Gly Gin Lys 945 | Arg Val Ser Phe Ser Phe Pro Pro 950 955 | Glu | Leu | Glu | Lys Lys 960 |
Leu Gly ile | Asn Met Leu val Lys Leu Ile Thr 965 970 | Pro | Asp | Gly | Lys Val 975 |
Leu Glu Lys | Val Ser Gly Lys val Phe Gly Glu 980 985 | Gly | val | Gly 990 | Asn ile |
Ala Asn Phe 995 | Glu Leu Asp Gin Pro Tyr Leu Pro 1000 | Gly | Gin Thr 1005 | Phe Lys | |
Tyr Thr ile 1010 | Ala Ser Lys Asp Tyr Pro Glu Val 1015 | ser Tyr 1020 | Asp | Gly Thr | |
Phe Thr val 1025 | Pro Thr Ser Leu Ala Tyr Lys Met Ala 1030 1035 | Ser | Gin | Thr ile 1040 | |
Phe Tyr Pro | Phe His Ala Gly Asp Thr Tyr Leu 1045 1050 | Arg | Val | Asn | Pro Gin 1055 |
Phe Ala Val | Pro Lys Gly Thr Asp Ala Leu Val 1060 1065 | Arg | Val | Phe Asp Glu 1070 | |
Phe His Gly Asn Ala Tyr Leu Glu Asn Asn Tyr 1075 1080 | Lys | val Gly 1085 | Glu Ile | ||
Lys Leu Pro 1090 | Ile Pro Lys Leu Asn Gin Gly Thr 1095 | Thr Arg 1100 | Thr | Ala Gly | |
Asn Lys Ile 1105 | Pro Val Thr Phe Met Ala Asn Ala Tyr 1110 1115 | Leu | Asp | Asn Gin 1120 | |
Ser Thr Tyr | ile val Glu Val Pro ile Leu Glu 1125 1130 | Lys | Glu | Asn | Gin Thr 1135 |
Asp Lys Pro | Ser Ile Leu Pro Gin Phe Lys Arg 1140 1145 | Asn | Lys | Ala Gin Glu 1150 | |
Asn Ser Lys Leu Asp Glu Lys Val Glu Glu Pro 1155 1160 | Lys | Thr 1165 | Ser | Glu Lys | |
val Glu Lys 1170 | Glu Lys Leu Ser Glu Thr Gly Asn 1175 | Ser Thr 1180 | Ser | Asn Ser | |
Thr Leu Glu 1185 | Glu Val Pro Thr val Asp Pro val 1190 1195 | Gin | Glu | Lys | val Ala 1200 |
Lys Phe Ala | Glu Ser Tyr Gly Met Lys Leu Glu 1205 1210 | Asn | val | Leu | phe Asn 1215 |
Met Asp Gly | Thr Ile Glu Leu Tyr Leu Pro Ser 1220 1225 | Gly | Glu | val ile Lys 1230 | |
Lys Asn Met 1235 | Ala Asp Phe Thr Gly Glu Ala Pro 1240 | Gin | Gly 1245 | Asn | Gly Glu |
Asn Lys Pro 1250 | Ser Glu Asn Gly Lys Val Ser Thr 1255 | Gly 126C | Thr | val | Glu Asn |
Gin Pro Thr 1265 | Glu Asn Lys Pro Ala Asp Ser Leu 1270 1275 | Pro | Glu | Ala | Pro Asn 1280 |
Glu Lys Pro | val Lys Pro Glu Asn ser Thr Asp 1285 1290 | Asn | Gly | Met | Leu Asn 1295 |
Pro Glu Gly | Asn val Gly Ser Asp Pro Met Leu 1300 1305 | Asp | Pro | Ala 1310 | Leu Glu |
Glu Ala Pro 1315 | Ala val Asp Pro val Gin Glu Lys 1320 | Leu | Glu 1325 | Lys | Phe Thr |
Ala Ser Tyr 1330 | Gly Leu Gly Leu Asp Ser Val ile 1335 | Phe 1340 | Asn | Met | Asp Gly |
Thr ile Glu 1345 Ser Asp Phe | Leu Arg Leu Pro Ser Gly Glu val 1350 1355 Ile Ala 1365 | Ile | Lys | Lys | Asn Leu 1360 |
<210> 383 <211> 1126 <212> PRT <213> Unknown <220>
<223> NEW 31 <221> VARIANT <222> (1)...(1) <223> xaa = Methionine or nothing <221> VARIANT <222> (557)...(557) <223> Xaa = Glycine or nothing <221> VARIANT <222> (558)...(558) <223> Xaa = Proline or nothing <400> 383
xaa Asp Ile Asp ser Leu Leu Lys Gin Leu Tyr Lys Leu Pro Leu Ser | |||||||||||||||
1 | 5 | 10 | 15 | ||||||||||||
Gin | Arg | His | val | Glu | Ser | Asp | Gly | Leu | Ile | Phe | Asp | Pro | Ala | Gin | Ile |
20 | 25 | 30 | |||||||||||||
Thr | Ser | Arg | Thr | Ala | Arg | Gly | Val | Ala | Val | Pro | HÍS | Gly | Asn | His | Tyr |
35 | 40 | 45 | |||||||||||||
His | Phe | Ile | Pro | Tyr | Glu | Gin | Met | Ser | Glu | Leu | Glu | Lys | Arg | Ile | Ala |
50 | 55 | 60 | |||||||||||||
Arg | ile | Ile | Pro | Leu | Arg | Tyr | Arg | Ser | Asn | Hi s | Trp | Val | Pro | ASp | Ser |
65 | 70 | 75 | 80 | ||||||||||||
Arg | Pro | Glu | Glu | Pro | Ser | Pro | Gin | Pro | Thr | Pro | Glu | Pro | Ser | Pro | Ser |
85 | 90 | 95 | |||||||||||||
Pro | Gin | Pro | Ala | Pro | Asn | Pro | Gin | Pro | Ala | Pro | Ser | Asn | Pro | Ile | Asp |
100 | 105 | 110 | |||||||||||||
Glu | Lys | Leu | Val | Lys | Glu | Ala | val | Arg | Lys | Val | Gly | Asp | Gly | Tyr | Val |
115 | 120 | 125 | |||||||||||||
Phe | Glu | Glu | Asn | Gly | Val | Ser | Arg | Tyr | Ile | Pro | Ala | Lys | Asn | Leu | Ser |
130 | 135 | 140 | |||||||||||||
Ala | Glu | Thr | Ala | Ala | Gly | Ile | Asp | Ser | Lys | Leu | Ala | Lys | Gin | Glu | Ser |
145 | 150 | 155 | 160 | ||||||||||||
Leu | Ser | His | Lys | Leu | Gly | Ala | Lys | Lys | Thr | Asp | Leu | Pro | Ser | ser | Asp |
165 | 170 | 175 | |||||||||||||
Arg | Glu | Phe | Tyr | Asn | Lys | Ala | Tyr | Asp | Leu | Leu | Ala | Arg | Ile | Hi S | Gin |
180 | 185 | 190 | |||||||||||||
Asp | Leu | Leu | Asp | Asn | Lys | Gly | Arg | Gin | Val | A5P | Phe | Glu | Ala | Leu | Asp |
195 | 200 | 205 | |||||||||||||
Asn | Leu | Leu | Glu | Arg | Leu | Lys | Asp | val | Ser | Ser | Asp | Lys | val | Lys | Leu |
210 | 215 | 220 | |||||||||||||
val | Asp | Asp | Ile | Leu | Ala | Phe | Leu | Ala | Pro | ile | Arg | His | Pro | Glu | Arg |
225 | 230 | 235 | 240 | ||||||||||||
Leu | Gly | Lys | Pro | Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | Ile | Gin |
245 | 250 | 255 | |||||||||||||
val | Ala | Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | Ile | Phe |
260 | 265 | 270 | |||||||||||||
Asp | Pro | Arg | Asp | ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro |
275 | 280 | 285 | |||||||||||||
His | Met | Thr | HiS | Ser | His | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala |
290 | 295 | 300 | |||||||||||||
Glu | Arg | Ala | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Glu | Lys | Gly | Leu | Thr | Pro |
305 | 310 | 315 | 320 | ||||||||||||
Pro | Ser | Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala |
325 | 330 | 335 | |||||||||||||
Glu | Ala | Ile | Tyr | Asn | Arg | val | Lys | Ala | Ala | Lys | Lys | val | Pro | Leu | Asp |
340 | 345 | 350 |
• · · ·
Arg | Met Pro 355 | Tyr Asn | Leu Gin Tyr 360 | Thr | val | Glu val | Lys 365 | Asn | Gly | Ser | |||||
Leu | Ile | Ile | Pro | His | Tyr | Asp | His | Tyr | His | Asn | Ile | Lys | Phe | Glu | Trp |
370 | 375 | 380 | |||||||||||||
Phe | Asp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Thr | Leu | Glu | Asp |
385 | 390 | 395 | 400 | ||||||||||||
Leu | Leu | Ala | Thr | Val | Lys | Tyr | Tyr | val | Glu | His | Pro | Asn | Glu | Arg | Pro |
405 | 410 | 415 | |||||||||||||
His | Ser | Asp | Asn | Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | val | Gin | Arg | Asn |
420 | 425 | 430 | |||||||||||||
Lys | Asn | Gly | Gin | Ala | Asp | Thr | Asn | Gin | Thr | Glu | Lys | Pro | Ser | Glu | Glu |
435 | 440 | 445 | |||||||||||||
Lys | Pro | Gin | Thr | Glu | Lys | Pro | Glu | Glu | Glu | Thr | Pro | Arg | Glu | Glu | Lys |
450 | 455 | 460 | |||||||||||||
Pro | Gin | Ser | Glu | Lys | Pro | Glu | Ser | Pro | Lys | Pro | Thr | Glu | Glu | Pro | Glu |
465 | 470 | 475 | 480 | ||||||||||||
Glu | Glu | Ser | Pro | Glu | Glu | Ser | Glu | Glu | Pro | Gin | val | Glu | Thr | Glu | Lys |
485 | 490 | 495 | |||||||||||||
Val | Glu | Glu | Lys | Leu | Arg | Glu | Ala | Glu | Asp | Leu | Leu | Gly | Lys | Ile | Gin |
500 | 505 | 510 | |||||||||||||
Asp | Pro | ile | Ile | Lys | Ser | Asn | Ala | Lys | Glu | Thr | Leu | Thr | Gly | Leu | Lys |
515 | 520 | 525 | |||||||||||||
Asn | Asn | Leu | Leu | Phe | Gly | Thr | Gin | Asp | Asn | Asn | Thr | Ile | Met | Ala | Glu |
530 | 535 | 540 | |||||||||||||
Ala | Glu | Lys | Leu | Leu | Al a | Leu | Leu | Lys | Glu | Ser | Lys | xaa | Xaa | Asp | Leu |
545 | 550 | 555 | 560 | ||||||||||||
Thr | Glu | Glu | Gin | Ile | Lys | Ala | Ala | Gin | Lys | Hi S | Leu | Glu | Glu | Val | Lys |
565 | 570 | 575 | |||||||||||||
Thr | Ser | His | Asn | Gly | Leu | Asp | Ser | Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr |
580 | 585 | 590 | |||||||||||||
Pro | Gly | Asn | Ala | Lys | Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu |
595 | 600 | 605 | |||||||||||||
Lys | ile | Ala | Gly | Ile | Met | Lys | Gin | Tyr | Gly | val | Lys | Arg | Glu | Ser | ile |
610 | 615 | 620 | |||||||||||||
val | Val | Asn | Lys | Glu | Lys | Asn | Ala | Ile | Ile | Tyr | Pro | His | Gly | Asp | His |
625 | 630 | 635 | 640 | ||||||||||||
Hi s | His | Ala | Asp | Pro | ile | Asp | Glu | His | Lys | Pro | Val | Gly | Ile | Gly | His |
645 | 650 | 655 | |||||||||||||
Ser | His | Ser | Asn | Tyr | Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly | Val | Ala | Lys |
660 | 665 | 670 | |||||||||||||
Lys | Glu | Gly | Asn | Lys | val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn | val | val |
675 | 680 | 685 | |||||||||||||
Asn | Leu | Leu | Lys | Asn | Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala |
690 | 695 | 700 | |||||||||||||
Asn | Gly | Gin | Lys | Arg | val | Ser | Phe | Ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys |
705 | 710 | 715 | 720 | ||||||||||||
Lys | Leu | Gly | Ile | Asn | Met | Leu | val | Lys | Leu | Ile | Thr | Pro | Asp | Gly | Lys |
725 | 730 | 735 | |||||||||||||
Val | Leu | Glu | Lys | Val | Ser | Gly | Lys | Val | Phe | Gly | Glu | Gly | val | Gly | Asn |
740 | 745 | 750 | |||||||||||||
ile | Ala | Asn | Phe | Glu | Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe |
755 | 760 | 765 | |||||||||||||
Lys | Tyr | Thr | ile | Ala | ser | Lys | Asp | Tyr | Pro | Glu | Val | Ser | Tyr | Asp | Gly |
770 | 775 | 780 | |||||||||||||
Thr | Phe | Thr | val | Pro | Thr | Ser | Leu | Al a | Tyr | Lys | Met | Ala | Ser | Gin | Thr |
785 | 790 | 795 | 800 | ||||||||||||
Ile | Phe | Tyr | Pro | Phe | His | Ala | Gly | Asp | Thr | Tyr | Leu | Arg | val | Asn | Pro |
805 | 810 | 815 | |||||||||||||
Gin | Phe | Ala | Val | Pro | Lys | Gly | Thr | Asp | Ala | Leu | Val | Arg | Val | Phe | Asp |
820 | 825 | 830 | |||||||||||||
Glu | Phe | His | Gly | Asn | Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | val | Gly | Glu |
835 | 840 | 845 | |||||||||||||
Ile | Lys | Leu | Pro | Ile | Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala |
850 | 855 | 860 | |||||||||||||
Gly | Asn | Lys | ile | Pro | val | Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn |
865 | 870 | 875 | 880 | ||||||||||||
Gin | Ser | Thr | Tyr | ile | val | Glu | Val | Pro | Ile | Leu | Glu | Lys | Glu | Asn | Gin |
885 | 890 | 895 |
• · · ·
Thr | Asp | Lys Pro Ser 900 | Ile Leu Pro Gin 905 | Phe Lys Arg Asn | Lys 910 | Ala | Gin |
Glu | Asn | Ser Lys Leu | Asp Glu Lys Val | Glu Glu Pro Lys | Thr | Ser | Glu |
915 | 920 | 925 | |||||
Lys | val | Glu Lys Glu | Lys Leu Ser Glu | Thr Gly Asn Ser | Thr | ser | Asn |
930 | 935 | 940 | |||||
Ser | Thr | Leu Glu Glu | val Pro Thr Val | Asp Pro val Gin | Glu | Lys | val |
945 | 950 | 955 | 960 | ||||
Ala | Lys | Phe Ala Glu | Ser Tyr Gly Met | Lys Leu Glu Asn | Val | Leu | Phe |
965 | 970 | 975 | |||||
Asn | Met | Asp Gly Thr | Ile Glu Leu Tyr | Leu Pro ser Gly | Glu | Val | Ile |
980 | 985 | 990 | |||||
Lys | Lys | Asn Met Ala | Asp Phe Thr Gly | Glu Ala Pro Gin | Gly | Asn | Gly |
995 | 1000 | 1005 | |||||
Glu | Asn | Lys Pro ser | Glu Asn Gly Lys | Val ser Thr Gly | Thr | val | Glu |
1010 | 1015 | 1020 | |||||
Asn | Gin | Pro Thr Glu | Asn Lys Pro Ala | Asp Ser Leu Pro | Glu | Ala | Pro |
1025 | 1030 | 1035 | 1040 | ||||
Asn | Glu | Lys Pro val | Lys Pro Glu Asn | Ser Thr Asp Asn | Gly | Met | Leu |
1045 | 1050 | 1055 | |||||
Asn | Pro | Glu Gly Asn | val Gly Ser Asp | Pro Met Leu Asp | Pro | Ala | Leu |
1060 | 1065 | 1070 | |||||
Glu | Glu | Ala Pro Ala | val Asp Pro val | Gin Glu Lys Leu | Glu | Lys | Phe |
1075 | 1080 | 1085 | |||||
Thr | Ala | Ser Tyr Gly | Leu Gly Leu Asp | Ser val ile Phe | Asn | Met | Asp |
1090 | 1095 | 1100 | |||||
Gly | Thr | ile Glu Leu | Arg Leu Pro Ser | Gly Glu val Ile | Lys | Lys | Asn |
1105 | 1110 | 1115 | 1120 | ||||
Leu | Ser Asp Phe Ile | Ala | |||||
1125 |
<210> 384 <211> 913 <212> PRT <213> unknown <220>
<223> NEW 32 <221> VARIANT <222> (1)...(1) <223> Xaa = Methionine or nothing <221> VARIANT <222> (344)...(344) <223> Xaa = Glycine or nothing <221> VARIANT <222> (345)...(345) <223> Xaa = Proline or nothing <400> 384
Xaa | Asp | ile | Leu | Ala | Phe | Leu | Ala | Pro | Ile | Arg | HÍS | Pro | Glu | Arg | Leu |
1 | 5 | 10 | 15 | ||||||||||||
Gly | Lys | Pro | Asn | Ala | Gin | Ile | Thr | Tyr | Thr | Asp | Asp | Glu | ile | Gin | Val |
20 | 25 | 30 | |||||||||||||
Ala | Lys | Leu | Ala | Gly | Lys | Tyr | Thr | Thr | Glu | Asp | Gly | Tyr | ile | phe | Asp |
35 | 40 | 45 | |||||||||||||
Pro | Arg | Asp | Ile | Thr | Ser | Asp | Glu | Gly | Asp | Ala | Tyr | Val | Thr | Pro | His |
50 | 55 | 60 | |||||||||||||
Met | Thr | Hi s | Ser | Hi s | Trp | Ile | Lys | Lys | Asp | Ser | Leu | Ser | Glu | Ala | Glu |
65 | 70 | 75 | 80 | ||||||||||||
Arg | Al a | Ala | Ala | Gin | Ala | Tyr | Ala | Lys | Gl u | Lys | Gly | Leu | Thr | Pro | Pro |
85 | 90 | 95 | |||||||||||||
Ser | Thr | Asp | His | Gin | Asp | Ser | Gly | Asn | Thr | Glu | Ala | Lys | Gly | Ala | Glu |
100 | 105 | 110 | |||||||||||||
Ala | Ile | Tyr | Asn | Arg | Val | Lys | Ala | Ala | Lys | Lys | Val | Pro | Leu | Asp | Arg |
• · · · · · • · • · · ·
σ | • · | • · | « | • · | • | ||||||||||
115 | 120 | 125 | |||||||||||||
Met | Pro | Tyr | Asn | Leu | Gin | Tyr | Thr | val | Glu | val | Lys | Asn | Gly | ser | Leu |
130 | His | 135 | 140 | ||||||||||||
Ile | Ile | Pro | Tyr | Asp | His | Tyr | Hi s | Asn | ile | Lys | Phe | Glu | Trp | Phe | |
145 | 150 | - | 155 | 160 | |||||||||||
ASp | Glu | Gly | Leu | Tyr | Glu | Ala | Pro | Lys | Gly | Tyr | Ser | Leu | Glu | Asp | Leu |
165 | 170 | 175 | |||||||||||||
Leu | Ala | Thr | val | Lys | Tyr | Tyr | Val | Glu | His | Pro | Asn | Glu | Arg | Pro | His |
180 | 185 | 190 | |||||||||||||
Ser | Asp | Asn | Gly | Phe | Gly | Asn | Ala | Ser | Asp | His | val | Arg | Lys | Asn | Lys |
195 | 200 | 205 | |||||||||||||
Ala | Asp | Gin | Asp | ser | Lys | Pro | Asp | Glu | ASp | Lys | Glu | His | Asp | Glu | val |
210 | 215 | 220 | |||||||||||||
Ser | Glu | Pro | Thr | Hi s | Pro | Glu | Ser | Asp | Glu | Lys | Glu | Asn | HiS | Ala | Gly |
225 | 230 | 235 | 240 | ||||||||||||
Leu | Asn | Pro | Ser | Ala | ASp | Asn | Leu | Tyr | Lys | Pro | Ser | Thr | Asp | Thr | Glu |
245 | 250 | 255 | |||||||||||||
Glu | Thr | Glu | Glu | Glu | Ala | Glu | Asp | Thr | Thr | Asp | Glu | Ala | Glu | Ile | Pro |
260 | 265 | 270 | |||||||||||||
Gin | Val | Glu | Asn | Ser | val | Ile | Asn | Ala | Lys | ile | Ala | Asp | Ala | Glu | Ala |
275 | 280 | 285 | |||||||||||||
Leu | Leu | Glu | Lys | val | Thr | Asp | Pro | Ser | Ile | Arg | Gin | Asn | Ala | Met | Glu |
290 | 295 | 300 | |||||||||||||
Thr | Leu | Thr | Gly | Leu | Lys | Ser | Ser | Leu | Leu | Leu | Gly | Thr | Lys | Asp | Asn |
305 | 310 | 315 | 320 | ||||||||||||
Asn | Thr | Ile | Ser | Ala | Glu | Val | Asp | ser | Leu | Leu | Ala | Leu | Leu | Lys | Glu |
325 | 330 | 335 | |||||||||||||
Ser | Gin | Pro | Ala | Pro | Ile | Gin | xaa | xaa | Asp | Leu | Thr | Glu | Glu | Gin | Ile |
340 | 345 | 350 | |||||||||||||
Lys | Ala | Ala | Gin | Lys | His | Leu | Glu | Glu | val | Lys | Thr | Ser | His | Asn | Gly |
355 | 360 | 365 | |||||||||||||
Leu | Asp | Ser | Leu | Ser | Ser | His | Glu | Gin | Asp | Tyr | Pro | Gly | Asn | Ala | Lys |
370 | 375 | 380 | |||||||||||||
Glu | Met | Lys | Asp | Leu | Asp | Lys | Lys | Ile | Glu | Glu | Lys | Ile | Ala | Gly | Ile |
385 | 390 | 395 | 400 | ||||||||||||
Met | Lys | Gin | Tyr | Gly | val | Lys | Arg | Glu | ser | Ile | val | Val | Asn | Lys | Glu |
405 | 410 | 415 | |||||||||||||
Lys | Asn | Ala | Ile | Ile | Tyr | Pro | His | Gly | Asp | Hi s | His | His | Ala | Asp | Pro |
420 | 425 | 430 | |||||||||||||
ile | Asp | Glu | Hi s | Lys | Pro | Val | Gly | Ile | Gly | His | ser | His | Ser | Asn | Tyr |
435 | 440 | 445 | |||||||||||||
Glu | Leu | Phe | Lys | Pro | Glu | Glu | Gly | val | Ala | Lys | Lys | Glu | Gly | Asn | Lys |
450 | 455 | 460 | |||||||||||||
val | Tyr | Thr | Gly | Glu | Glu | Leu | Thr | Asn | Val | val | Asn | Leu | Leu | Lys | Asn |
465 | 470 | 475 | 480 | ||||||||||||
Ser | Thr | Phe | Asn | Asn | Gin | Asn | Phe | Thr | Leu | Ala | Asn | Gly | Gin | Lys | Arg |
485 | 490 | 495 | |||||||||||||
val | Ser | Phe | Ser | Phe | Pro | Pro | Glu | Leu | Glu | Lys | Lys | Leu | Gly | Ile | Asn |
500 | 505 | 510 | |||||||||||||
Met | Leu | val | Lys | Leu | Ile | Thr | Pro | Asp | Gly | Lys | val | Leu | Glu | Lys | val |
515 | 520 | 525 | |||||||||||||
Ser | Gly | Lys | val | Phe | Gly | Glu | Gly | val | Gly | Asn | Ile | Ala | Asn | Phe | Glu |
530 | 535 | 540 | |||||||||||||
Leu | Asp | Gin | Pro | Tyr | Leu | Pro | Gly | Gin | Thr | Phe | Lys | Tyr | Thr | Ile | Ala |
545 | 550 | 555 | 560 | ||||||||||||
Ser | Lys | Asp | Tyr | Pro | Glu | val | Ser | Tyr | Asp | Gly | Thr | Phe | Thr | val | Pro |
565 | 570 | 575 | |||||||||||||
Thr | Ser | Leu | Ala | Tyr | Lys | Met | Ala | Ser | Gin | Thr | ile | Phe | Tyr | Pro | Phe |
580 | 585 | 590 | |||||||||||||
His | Al a | Gly | Asp | Thr | Tyr | Leu | Arg | Val | Asn | Pro | Gin | Phe | Ala | Val | Pro |
595 | 600 | 605 | |||||||||||||
Lys | Gly | Thr | Asp | Ala | Leu | val | Arg | val | Phe | Asp | Glu | Phe | His | Gly | Asn |
610 | 615 | 620 | |||||||||||||
Ala | Tyr | Leu | Glu | Asn | Asn | Tyr | Lys | val | Gly | Glu | Ile | Lys | Leu | Pro | ile |
625 | 630 | 635 | 640 | ||||||||||||
Pro | Lys | Leu | Asn | Gin | Gly | Thr | Thr | Arg | Thr | Ala | Gly | Asn | Lys | Ile | Pro |
645 | 650 | 655 | |||||||||||||
Val | Thr | Phe | Met | Ala | Asn | Ala | Tyr | Leu | Asp | Asn | Gin | Ser | Thr | Tyr | Ile |
Μ ·· · · • · • · • · • · · · • · « • · · · « • ·· ·· ··
660 665 670
val | Glu Val 675 | Pro Ile Leu Glu Lys Glu Asn Gin Thr Asp Lys Pro | ser | ||||||||||||
680 | 685 | ||||||||||||||
Ile | Leu | Pro | Gin | Phe | Lys | Arg | Asn | Lys | Ala | Gin | Glu | Asn | ser | Lys | Leu |
690 | 695 | 700 | |||||||||||||
Asp | Glu | Lys | Val | Glu | Glu | Pro | Lys | Thr | Ser | Glu | Lys | Val | Glu | Lys | Glu |
705 | 710 | 715 | 720 | ||||||||||||
Lys | Leu | Ser | Glu | Thr | Gly | Asn | Ser | Thr | Ser | Asn | Ser | Thr | Leu | Glu | Glu |
725 | 730 | 735 | |||||||||||||
val | Pro | Thr | val | ASp | Pro | val | Gin | Glu | Lys | Val | Ala | Lys | Phe | Ala | Glu |
740 | 745 | 750 | |||||||||||||
Ser | Tyr | Gly | Met | Lys | Leu | Glu | Asn | Val | Leu | Phe | Asn | Met | Asp | Gly | Thr |
755 | 760 | 765 | |||||||||||||
Ile | Glu | Leu | Tyr | Leu | Pro | Ser | Gly | Glu | val | ile | Lys | Lys | Asn | Met | Ala |
770 | 775 | 780 | |||||||||||||
ASp | Phe | Thr | Gly | Glu | Ala | Pro | Gin | Gly | Asn | Gly | Glu | Asn | Lys | Pro | Ser |
785 | 790 | 795 | 800 | ||||||||||||
Glu | Asn | Gly | Lys | Val | Ser | Thr | Gly | Thr | val | Glu | Asn | Gin | Pro | Thr | Glu |
805 | 810 | 815 | |||||||||||||
Asn | Lys | Pro | Ala | ASp | Ser | Leu | Pro | Glu | Ala | Pro | Asn | Glu | Lys | Pro | Val |
820 | 825 | 830 | |||||||||||||
Lys | pro | Glu | Asn | Ser | Thr | Asp | Asn | Gly | Met | Leu | Asn | Pro | Glu | Gly | Asn |
835 | 840 | 845 | |||||||||||||
val | Gly | Ser | Asp | Pro | Met | Leu | Asp | Pro | Ala | Leu | Glu | Glu | Ala | Pro | Ala |
850 | 855 | 860 | |||||||||||||
val | Asp | Pro | val | Gin | Glu | Lys | Leu | Glu | Lys | Phe | Thr | Ala | Ser | Tyr | Gly |
865 | 870 | 875 | 880 | ||||||||||||
Leu | Gly | Leu | Asp | Ser | Val | ile | Phe | Asn | Met | ASp | Gly | Thr | ile | Glu | Leu |
885 | 890 | 895 | |||||||||||||
Arg | Leu | Pro | ser | Gly | Glu | val | Ile | Lys | Lys | Asn | Leu | Ser | Asp | Phe | ile |
900 | 905 | 910 | |||||||||||||
Al a |
• · · ·
Claims (32)
1. Izolovaný polynukleotid obsahující polynukleotid vybraný z;
(a) polynukleotidu kódujícího polypeptid, který je alespoň ze 70 % identický s druhým polypeptidem vybraným z: tabulky B, E nebo H;
(b) polynukleotidu kódujícího polypeptid, který je alespoň z 95 % identický s druhým polypeptidem vybraným z: tabulky B, E nebo H;
(c) polynukleotidu kódujícího polypeptid, který má aminokyselinovou sekvenci vybranou z tabulky B, E nebo H nebo jejich fragmentů, analogů nebo derivátů;
(d) polynukleotidu kódujícího polypeptid vybraný z: tabulky B, E nebo H;
(e) polynukleotidu kódujícího polypeptid schopný tvorby protilátek majících vazebnou specifitu k polypeptidů, který má sekvenci vybranou z: tabulky B, E nebo H, (f) polynukleotidu kódujícího epitop nesoucí část polypeptidů vybraného z tabulky B, E nebo H; a (g) polynukleotidu komplementárního k polynukleotidu z (a) , (b) , (c) , (d) , (e) nebo (f) .
2. Izolovaný polynukleotid podle nároku 1, ve kterém tento polynukleotid je (a).
3. Izolovaný polynukleotid podle nároku 1, ve kterém tento polynukleotid je (b).
4. Izolovaný polynukleotid podle nároku 1, ve kterém tento polynukleotid je (c).
5. Izolovaný polynukleotid podle nároku 1, ve kterém tento polynukleotid je (d).
243
6. Izolovaný polynukleotid podle nároku 1, ve kterém tento polynukleotid je (e).
7. Izolovaný polynukleotid podle nároku 1, ve kterém tento polynukleotid je (f).
8. Izolovaný polynukleotid podle nároku 1, ve kterém tento polynukleotid je (g).
9. Izolovaný polynukleotid podle nároku 7, ve kterém tento polynukleotid je vybrán z tabulky B.
10. Izolovaný polynukleotid podle nároku 9, ve kterém epitop nesoucí část je vybrána z tabulky C.
11. Izolovaný polynukleotid podle nároku 7, ve kterém tento polynukleotid je vybrán z tabulky E.
12. Izolovaný polynukleotid podle nároku 11, ve kterém epitop nesoucí část je vybrána z tabulky F.
13. Polynukleotid podle kteréhokoliv z nároků 1 až 12, ve kterém tento polynukleotid je DNA.
14. Polynukleotid podle kteréhokoliv z nároků 1 až 12, ve kterém tento polynukleotid je RNA.
15. Vektor obsahující polynukleotid podle nároku 13, ve kterém je tato DNA funkčně spojena s kontrolní oblastí exprese.
16. Hostitelská buňka transfekovaná vektorem podle nároku 15.
* « · · • · · · •244
17. Způsob produkce polypeptidu, vyznačuj ící se tím, že zahrnuje kultivaci hostitelské buňky podle nároku 16 za podmínek vhodných pro expresi tohoto polypeptidu.
18. Izolovaný polypeptid obsahující člen vybraný z:
(a) polypeptidu který je alespoň ze 70 % identický s druhým polypeptidem, který má aminokyselinovou sekvenci vybranou z: tabulky Β, E nebo H;
(b) polypeptidu který je alespoň z 95 % identický s druhým
nebo derivátů;
aminokyselinovou sekvenci vybranou z tabulky Β, E nebo H;
(g) polypeptidu podle (a) , (b) , (c) , (d) , (e) nebo (f) ,ve kterém N-koncový Met zbytek chybí; nebo (h) polypeptidu podle (a) , (b) , (c) , (d) , (e) nebo (f) ,ve kterém sekreční aminokyselinová sekvence chybí.
19. Polypeptid podle nároku 18, kde tento polypeptid je (f) .
20. Polypeptid podle nároku 19, který je vybrán z tabulky B.
21. Polypeptid podle nároku 20, kde epitop nesoucí část je vybrána z tabulky C.
« φ φ ·
..245*..*
22. Polypeptid podle nároku 19, který je vybrán z tabulky E.
23. Polypeptid podle nároku 22, kde epitop nesoucí část je vybrána z tabulky F.
24. Chimerní polypeptid obsahující dva nebo více polypeptidů vybraných z tabulky B, E nebo H, za předpokladu, že polypeptidy jsou spojeny tak, že tvoří chimerní polypeptid.
25. Očkovací prostředek, vyznačující se tím, že obsahuje polypeptid podle kteréhokoliv z nároků 18 až 24 a farmaceuticky přijatelný nosič, ředidlo nebo adjuvans.
26. Způsob terapeutického nebo profylaktického léčení meningitidy, zánětu středního ucha, bakteremie nebo pneumonie u jedince náchylného k meningitidě, zánětu středního ucha, bakteremii nebo pneumonii, vyznačující se tím, že zahrnuje podávání terapeutického nebo profylaktického množství prostředku podle nároku 25 tomuto jedinci.
27. Způsob terapeutického nebo profylaktického léčení streptokokové bakteriální infekce u jedince náchylného k streptokokové infekci, vyznačující se tím, že zahrnuje podávání terapeutického nebo profylaktického množství prostředku podle nároku 25 tomuto jedinci.
Φ· ·· «··· · * · · * · • · · · t » · · ···«· · · · ··« · · · ··· · * • ···· · · · · --- · · « « • ·<246 *· ·*
30. Způsob podle nároku 26, vyznačující se tím, že jedinec je člověk.
31. Způsob podle nároku 27, vyznačující se tím, že jedinec je člověk.
32. Způsob podle nároku 27, vyznačující se tím, že bakteriální infekce je S. pneumoniae, skupina A streptococcus - pyogenes, skupina B streptococcus - GBS nebo agalactiae, dysgalactiae, uberis, nocardia nebo Staphylococcus aureus.
33. Způsob podle nároku 27, vyznačující se tím, že bakteriální infekce je S. pneumoniae.
34. Použití očkovacího prostředku podle nároku 25 pro profylaktické nebo terapeutické léčení streptokokové infekce u zvířat náchylných k nebo infikovaných streptokokovou infekcí zahrnující podávání profylaktického nebo terapeutického množství prostředku tomuto zvířeti.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21268300P | 2000-06-20 | 2000-06-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
CZ2003154A3 true CZ2003154A3 (cs) | 2003-06-18 |
Family
ID=22792041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CZ2003154A CZ2003154A3 (cs) | 2000-06-20 | 2001-06-19 | Antigeny streptokoka |
Country Status (18)
Country | Link |
---|---|
EP (2) | EP1303612A2 (cs) |
JP (2) | JP5051959B2 (cs) |
KR (1) | KR100927767B1 (cs) |
CN (2) | CN1449446A (cs) |
AR (1) | AR033980A1 (cs) |
AU (2) | AU2001270381B2 (cs) |
CA (1) | CA2413450C (cs) |
CZ (1) | CZ2003154A3 (cs) |
EA (1) | EA006232B1 (cs) |
HU (1) | HU228706B1 (cs) |
IL (2) | IL153558A0 (cs) |
MX (1) | MXPA03000103A (cs) |
NO (1) | NO331103B1 (cs) |
NZ (1) | NZ553554A (cs) |
PL (1) | PL214229B1 (cs) |
TR (1) | TR200704553T2 (cs) |
UY (1) | UY26783A1 (cs) |
WO (1) | WO2001098334A2 (cs) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7128918B1 (en) | 1998-12-23 | 2006-10-31 | Id Biomedical Corporation | Streptococcus antigens |
US7074415B2 (en) | 2000-06-20 | 2006-07-11 | Id Biomedical Corporation | Streptococcus antigens |
US7262024B2 (en) | 2001-12-20 | 2007-08-28 | Id Biomedical Corporation | Streptococcus antigens |
TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
EP3470080A1 (en) | 2005-12-22 | 2019-04-17 | GlaxoSmithKline Biologicals S.A. | Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
NZ575272A (en) | 2006-09-07 | 2012-02-24 | Glaxosmithkline Biolog Sa | Inactivated poliovirus type 1, diptheria toxoid, tetanus toxoid and killed whole-cell Bordetella pertussis vaccine |
US20100074918A1 (en) | 2007-05-02 | 2010-03-25 | Jan Poolman | Vaccine |
KR20100045445A (ko) | 2007-06-26 | 2010-05-03 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 스트렙토코쿠스 뉴모니애 캡슐 다당류 컨쥬게이트를 포함하는 백신 |
BRPI0814127A2 (pt) * | 2007-07-23 | 2015-02-03 | Sanofi Pasteur Ltd | Polipeptídeos imunegênicos e anticorpos monoclonais |
SI2271360T1 (sl) | 2008-04-16 | 2015-12-31 | Glaxosmithkline Biologicals S.A. | Cepivo |
CA2738245A1 (en) | 2008-09-26 | 2010-04-01 | Nanobio Corporation | Nanoemulsion therapeutic compositions and methods of using the same |
WO2010125480A1 (en) | 2009-04-30 | 2010-11-04 | Coley Pharmaceutical Group, Inc. | Pneumococcal vaccine and uses thereof |
WO2010132833A1 (en) | 2009-05-14 | 2010-11-18 | The Regents Of The University Of Michigan | Streptococcus vaccine compositions and methods of using the same |
WO2010141312A2 (en) | 2009-06-01 | 2010-12-09 | Wake Forest University Health Sciences | Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same |
MX2012002639A (es) | 2009-09-03 | 2012-03-14 | Pfizer Vaccines Llc | Vacuna de pcsk9. |
GB201003920D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Method of treatment |
GB201003924D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Immunogenic composition |
KR101272351B1 (ko) * | 2010-04-23 | 2013-06-07 | 이화여자대학교 산학협력단 | 새로운 카나마이신 화합물, 카나마이신 생산 스트렙토마이세스 속 미생물 및 카나마이신의 생산 방법 |
EP2680883B1 (en) | 2011-03-02 | 2018-09-05 | Pfizer Inc | Pcsk9 vaccine |
MX339058B (es) | 2011-05-17 | 2016-05-09 | Glaxosmithkline Biolog Sa | Vacuna contra streptococcus pneumoniae. |
WO2015095868A1 (en) | 2013-12-20 | 2015-06-25 | Wake Forest University Health Sciences | Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines |
EP3096783B1 (en) | 2014-01-21 | 2021-07-07 | Pfizer Inc. | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof |
US11160855B2 (en) | 2014-01-21 | 2021-11-02 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
EP3096786B1 (en) | 2014-01-21 | 2021-07-07 | Pfizer Inc. | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof |
PE20161095A1 (es) | 2014-01-21 | 2016-10-26 | Pfizer | Composiciones inmunogenicas que comprenden antigenos de sacaridos capsulares conjugados y uso de los mismos |
CA2939416A1 (en) | 2014-02-14 | 2015-08-20 | Pfizer Inc. | Immunogenic glycoprotein conjugates |
MX2017009308A (es) | 2015-01-15 | 2017-11-08 | Pfizer | Composiciones inmunogenicas para usar en vacunas neumococicas. |
KR20230058726A (ko) | 2015-07-21 | 2023-05-03 | 화이자 인코포레이티드 | 접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도 |
GB201518684D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
JP6884145B2 (ja) | 2015-11-20 | 2021-06-09 | ファイザー・インク | 肺炎連鎖球菌ワクチンにおいて用いるための免疫原性組成物 |
PL3570879T3 (pl) | 2017-01-20 | 2022-06-20 | Pfizer Inc. | Kompozycje immunogenne do zastosowania w szczepionkach przeciw pneumokokom |
KR102650073B1 (ko) | 2017-01-31 | 2024-03-20 | 머크 샤프 앤드 돔 엘엘씨 | 스트렙토코커스 뉴모니아 혈청형 19f 유래의 협막 다당류 단백질 접합체의 제조 방법 |
CN111093650B (zh) | 2017-09-07 | 2024-03-01 | 默沙东有限责任公司 | 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途 |
TWI725359B (zh) | 2017-12-06 | 2021-04-21 | 美商默沙東藥廠 | 包含肺炎鏈球菌多醣-蛋白結合物之組合物及其使用方法 |
US11260119B2 (en) | 2018-08-24 | 2022-03-01 | Pfizer Inc. | Escherichia coli compositions and methods thereof |
US20220016229A1 (en) | 2018-12-12 | 2022-01-20 | Pfizer Inc. | Immunogenic Multiple Hetero-Antigen Polysaccharide-Protein Conjugates and uses thereof |
BR112021011961A8 (pt) | 2018-12-19 | 2023-02-07 | Merck Sharp & Dohme | Composições compreendendo conjugados de polissacarídeo-proteína de streptococcus pneumoniae e métodos de uso dos mesmos |
JP7239509B6 (ja) | 2019-02-22 | 2023-03-28 | ファイザー・インク | 細菌多糖類を精製するための方法 |
EP3952906A1 (en) | 2019-04-10 | 2022-02-16 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof |
CN114728050A (zh) | 2019-07-31 | 2022-07-08 | 圣诺菲·帕斯图尔公司 | 多价肺炎球菌多糖-蛋白质缀合物组合物及其使用方法 |
MX2022005252A (es) | 2019-11-01 | 2022-06-08 | Pfizer | Composiciones de escherichia coli y metodos de las mismas. |
EP4107192A1 (en) | 2020-02-21 | 2022-12-28 | Pfizer Inc. | Purification of saccharides |
KR20220143910A (ko) | 2020-02-23 | 2022-10-25 | 화이자 인코포레이티드 | 에스케리키아 콜라이 조성물 및 그의 방법 |
CA3199094A1 (en) | 2020-10-22 | 2022-04-28 | Pfizer Inc. | Methods for purifying bacterial polysaccharides |
MX2023004912A (es) | 2020-10-27 | 2023-05-16 | Pfizer | Composiciones de escherichia coli y metodos de las mismas. |
CN116744965A (zh) | 2020-11-04 | 2023-09-12 | 辉瑞大药厂 | 用于肺炎球菌疫苗的免疫原性组合物 |
US20220202923A1 (en) | 2020-12-23 | 2022-06-30 | Pfizer Inc. | E. coli fimh mutants and uses thereof |
TW202245835A (zh) | 2021-02-04 | 2022-12-01 | 美商默沙東有限責任公司 | 用於肺炎球菌結合物疫苗之奈米乳化液佐劑組合物 |
JP2024517780A (ja) | 2021-05-03 | 2024-04-23 | ファイザー・インク | 細菌およびベータコロナウイルス感染症に対するワクチン接種 |
WO2022234416A1 (en) | 2021-05-03 | 2022-11-10 | Pfizer Inc. | Vaccination against pneumoccocal and covid-19 infections |
KR20230175284A (ko) | 2021-05-28 | 2023-12-29 | 화이자 인코포레이티드 | 접합된 피막 사카라이드 항원을 포함하는 면역원성 조성물 및 그의 용도 |
EP4346893A2 (en) | 2021-05-28 | 2024-04-10 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
KR20240128715A (ko) | 2022-01-13 | 2024-08-26 | 화이자 인코포레이티드 | 접합된 피막 사카라이드 항원을 포함하는 면역원성 조성물 및 그의 용도 |
WO2023161817A1 (en) | 2022-02-25 | 2023-08-31 | Pfizer Inc. | Methods for incorporating azido groups in bacterial capsular polysaccharides |
WO2023218322A1 (en) | 2022-05-11 | 2023-11-16 | Pfizer Inc. | Process for producing of vaccine formulations with preservatives |
WO2024084397A1 (en) | 2022-10-19 | 2024-04-25 | Pfizer Inc. | Vaccination against pneumoccocal and covid-19 infections |
WO2024110827A1 (en) | 2022-11-21 | 2024-05-30 | Pfizer Inc. | Methods for preparing conjugated capsular saccharide antigens and uses thereof |
US20240181028A1 (en) | 2022-11-22 | 2024-06-06 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
WO2024116096A1 (en) | 2022-12-01 | 2024-06-06 | Pfizer Inc. | Pneumococcal conjugate vaccine formulations |
WO2024166008A1 (en) | 2023-02-10 | 2024-08-15 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
WO2024201324A2 (en) | 2023-03-30 | 2024-10-03 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
WO2024214016A1 (en) | 2023-04-14 | 2024-10-17 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
WO2024224266A1 (en) | 2023-04-24 | 2024-10-31 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4431739A (en) | 1979-11-05 | 1984-02-14 | Genentech, Inc. | Transformant bacterial culture capable of expressing heterologous protein |
US4425437A (en) | 1979-11-05 | 1984-01-10 | Genentech, Inc. | Microbial polypeptide expression vehicle |
US4338397A (en) | 1980-04-11 | 1982-07-06 | President And Fellows Of Harvard College | Mature protein synthesis |
US5866135A (en) * | 1994-04-21 | 1999-02-02 | North American Vaccine, Inc. | Group A streptococcal polysaccharide immunogenic compositions and methods |
NZ309713A (en) * | 1995-06-07 | 1999-11-29 | Alberta Res Council | Oligosaccharides of S pneumoniae serotype 8 and their use in a vaccine |
AU6909098A (en) | 1996-10-31 | 1998-05-22 | Human Genome Sciences, Inc. | Streptococcus pneumoniae polynucleotides and sequences |
CA2305016A1 (en) * | 1997-09-24 | 1999-04-01 | Regents Of The University Of Minnesota | Human complement c3-degrading proteinase from streptococcus pneumoniae |
EP1100921B1 (en) * | 1998-07-27 | 2007-05-02 | Sanofi Pasteur Limited | Streptococcus pneumoniae proteins and nucleic acid molecules |
ATE446107T1 (de) * | 1998-08-19 | 2009-11-15 | Baxter Healthcare Sa | Immunogenes beta-propionamido-gebundenes polysaccharid-protein konjugat geeignet als impfstoff und hergestellt bei verwendung von n- acryloyliertem polysaccharid |
BR9914066A (pt) * | 1998-09-24 | 2002-04-23 | Univ Minnesota | Polipeptìdio degradador de c3 de complemento humano de streptococcus pneumoniae |
AU776828B2 (en) * | 1998-12-21 | 2004-09-23 | Medimmune, Llc | Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
EP1141306B1 (en) | 1998-12-23 | 2008-05-07 | ID Biomedical Corporation | Streptococcus antigens |
-
2001
- 2001-06-19 AU AU2001270381A patent/AU2001270381B2/en not_active Ceased
- 2001-06-19 PL PL360413A patent/PL214229B1/pl unknown
- 2001-06-19 IL IL15355801A patent/IL153558A0/xx unknown
- 2001-06-19 KR KR1020027017453A patent/KR100927767B1/ko not_active IP Right Cessation
- 2001-06-19 JP JP2002504289A patent/JP5051959B2/ja not_active Expired - Fee Related
- 2001-06-19 AU AU7038101A patent/AU7038101A/xx not_active Withdrawn
- 2001-06-19 CN CN01814388A patent/CN1449446A/zh active Pending
- 2001-06-19 CA CA2413450A patent/CA2413450C/en not_active Expired - Fee Related
- 2001-06-19 CZ CZ2003154A patent/CZ2003154A3/cs unknown
- 2001-06-19 TR TR2007/04553T patent/TR200704553T2/xx unknown
- 2001-06-19 WO PCT/CA2001/000908 patent/WO2001098334A2/en active IP Right Grant
- 2001-06-19 EP EP01949136A patent/EP1303612A2/en not_active Withdrawn
- 2001-06-19 EP EP10179497A patent/EP2281891A3/en not_active Withdrawn
- 2001-06-19 HU HU0301656A patent/HU228706B1/hu not_active IP Right Cessation
- 2001-06-19 EA EA200201280A patent/EA006232B1/ru not_active IP Right Cessation
- 2001-06-19 NZ NZ553554A patent/NZ553554A/en not_active IP Right Cessation
- 2001-06-19 MX MXPA03000103A patent/MXPA03000103A/es active IP Right Grant
- 2001-06-19 CN CN200710181645.XA patent/CN101260149B/zh not_active Expired - Fee Related
- 2001-06-20 AR ARP010102945A patent/AR033980A1/es not_active Application Discontinuation
- 2001-06-20 UY UY26783A patent/UY26783A1/es not_active Application Discontinuation
-
2002
- 2002-12-19 NO NO20026121A patent/NO331103B1/no not_active IP Right Cessation
- 2002-12-19 IL IL153558A patent/IL153558A/en not_active IP Right Cessation
-
2012
- 2012-05-23 JP JP2012117846A patent/JP5889103B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CZ2003154A3 (cs) | Antigeny streptokoka | |
US7262024B2 (en) | Streptococcus antigens | |
KR100891398B1 (ko) | 신규한 스트렙토코커스 항원 | |
KR100771148B1 (ko) | 그룹 b 스트렙토코커스 항원 | |
AU2001270381A1 (en) | Streptococcus antigens | |
US20120308596A1 (en) | Novel streptococcus antigens | |
US20060177465A1 (en) | Streptococcus antigens | |
JP4718099B2 (ja) | ストレプトコッカス・パイオジェンス抗原 | |
EP1950302B1 (en) | Streptococcus antigens | |
AU2008229967B2 (en) | Novel streptococcus antigens | |
AU2007207883A1 (en) | Streptococcus antigens |